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ABSTRACT
This book outlines important suggestions by international experts to improve the health of those in prison and to reduce 
both the health risks and risks to society of imprisonment. In particular, it aims to facilitate better prison health practices 
in the fields of: (i) human rights and medical ethics, (ii) communicable diseases, (iii) noncommunicable diseases, (iv) oral 
health, (v) risk factors, (vi) vulnerable groups and (vii) prison health management. It is aimed at professional staff at all 
levels of responsibility for the health and well-being of detainees and at people with political responsibility. The term 
“prison” covers all institutions where a state holds people deprived of their liberty. 
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Foreword
Some six million men and women are imprisoned in the 
WHO European Region every year. Most of these prisoners 
are from poor and vulnerable communities.
Prisons are not healthy places. Communicable diseases 
are frequently transmitted among prisoners, and the 
rates of HIV, hepatitis and tuberculosis are much higher 
among them than in the general population. There is also 
a high prevalence of mental health problems, including 
substance abuse disorders, and a higher prevalence of 
noncommunicable diseases. Unhealthy conditions such 
as overcrowding and poor hygiene are common in many 
prisons.
Prison health is part of public health and prisons are part 
of our society. One third of prisoners leave prison every 
year and the interaction between prisons and society is 
huge. We have to ensure that prisons are not becoming 
breeding places for communicable and noncommunicable 
diseases, and we must also seek to use the experience 
of imprisonment for the benefit of prisoners and society.
The WHO European health policy framework, Health 
2020, aims at improving public health and reducing health 
inequalities. It considers that social values such as human 
rights and equity are the key to good governance for 
health.
This also applies to prison health, with no compromise. 
When a state deprives people of their liberty, it must 
guarantee their right to health and provide them with the 
best possible care.
A great number of efforts are being made to improve the 
health of prisoners in our Region. However, many Member 
States still do not fully meet their responsibility to protect 
the health of their prisoners.
An expert group advising the Regional Office on the 
organization of prison health concluded that:
•	 the	 management	 and	 coordination	 of	 all	 relevant	
agencies and resources contributing to the health 
and well-being of prisoners is a whole-of-government 
responsibility;
•	 health	ministries	 should	provide	and	be	accountable	
for health care services in prisons and advocate 
healthy prison conditions.
I commend this book  as a major step towards promoting 
the health and well-being of prisoners in our Region, and 
as an important contribution to better public health and to 
fewer health inequalities. It is aimed at professional staff 
at all levels of responsibility for the health and well-being 
of prisoners and at people with political responsibility in 
this field.
Zsuzsanna Jakab
WHO Regional Director for Europe
Foreword
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11. The essentials about prisons and health
Alex Gatherer, Stefan Enggist, Lars Møller
Key points 
•	 The	state	has	a	special	duty	of	care	for	those	in	places	
of detention which should cover safety, basic needs 
and recognition of human rights, including the right to 
health.
•	 A	 primary	 health	 care	 service	 in	 prisons	 must	 be	
provided with staff, resources and facilities of at least 
the same standard as those available in the community. 
This principle of equivalence is an important measure 
of the adequacy of health care provision in places of 
detention.
•	 All	 health	 staff	 should	 have	 complete	 professional	
independence and should preferably be employed by a 
health authority. Their right to practise their profession 
within their professional codes of conduct and ethical 
rules should be clearly understood and accepted.
•	 It	is	important	that	all	staff	working	in	prisons	accept	
that to the health team, prisoners are patients and 
must be treated as such. The duty of care placed on 
professional staff is the same whether the patient is 
at liberty or in prison.
•	 The	prisoner	as	patient	has	the	right	to	confidentiality	
and to treatment and care that is subject to informed 
consent.
•	 The	 importance	 of	 initial	 health	 screening	 and	
evaluation must be recognized and the best possible 
service should be provided. All staff involved should be 
aware of the benefits of diversion to other institutions 
for those prisoners who need to be in special facilities.
•	 Continuity	of	care	is	a	crucial	element	of	a	sustainable	
prison health service. Prison health staff should 
make arrangements for continuous access to care on 
transfer or on release, which should be facilitated by 
prison management.
•	 Prison	 services	 have	 a	 responsibility	 to	 ensure	 that	
prisoners are not exposed to hazards likely to injure 
their health.
•	 Health	in	prisons	is	too	important	to	be	left	solely	to	
the health team. All staff working in prisons should 
have further training in health issues so that they 
have a better understanding of what the health team 
is doing and can support those efforts through their 
duties concerning the prison environment and regimes.
•	 Health	resilience	is	an	important	aim	of	prison	health	
care and an important contribution towards successful 
resettlement after discharge and to the reduction of 
health inequalities.
•	 A	 prison	 health	 service	 should	 be	 seen	 as	 helping	
to build a healthier society. An element of this is to 
support, where possible, the work of the prison staff 
in encouraging changes in attitude and behaviour with 
the objective of a crime-free society.
•	 Prison	 health	 services	 should	 not	 be	 isolated	 but	
should be integrated into regional and national health 
systems.
Background
In 1994, when it was first suggested to the WHO Regional 
Office for Europe that special attention should be given to 
the health of those in prisons and other places of detention, 
the Regional Director was Dr Jo E. Asvall, whose special 
enthusiasm was for health for all. Research at that time 
was drawing attention to tuberculosis (TB) and HIV/AIDS 
in prisons. It was clear that prisoners were a vulnerable 
group drawn from those parts of society which were hard 
to reach as regards health. The Region was leading the 
world in the settings approach to promoting health, and 
there was a strong case being made that prisons were 
a suitable setting, different from health-promoting cities 
and schools but open to the same holistic approaches that 
were so successful in daily living settings. Furthermore, in 
most countries, prison health was the responsibility of the 
ministry of justice or the ministry of the interior and was 
thus excluded from any influence from WHO working with 
the ministry of health.
In 1995, WHO and the United Kingdom organized a pilot 
meeting of some eight countries and various experts 
to discuss the proposal to establish a network for the 
exchange of experience in tackling health problems in 
prisons. The network, known as the WHO Health in Prisons 
Programme (HIPP), which developed from that pilot now 
includes most of the Member States in the Region. The 
purpose of the network is to exchange experience in 
tackling the health issues facing prisoners and prisons 
and to produce consensual statements of advice. The 
absence of a single publication drawing together advice 
from experts and members of HIPP led, in 2007, to the 
publication of the first edition of this guide.
The duty of care
There are several unique factors pertaining to people 
remanded in custody by a judicial authority or deprived 
of their liberty following conviction. The first is that 
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the detaining authority has to assume a duty of care 
for them, that is, a comprehensive obligation to meet 
at least their basic needs. The second is that prisoners 
are entirely dependent on the staff of prisons and 
detention centres for all aspects of their daily lives, 
as well as for protection and safety. This dependence 
must be understood by the staff since they share the 
duty of care with their employing authority, which should 
influence their attitude and approach. The third factor is 
that detainees retain all human rights other than their 
freedom. Their right to health is in no way diminished by 
their detention.
Why prison health is important
There are two other compelling reasons for providing 
health care in prisons. First is the importance of prison 
health to public health in general. Prison populations 
contain a high prevalence of people with serious and often 
life-threatening conditions. Sooner or later most prisoners 
will return to the community, carrying back with them new 
diseases and untreated conditions that may pose a threat 
to community health and add to the burden of disease in 
the community. Thus there is a compelling interest on the 
part of society that this vulnerable group receive health 
protection and treatment for any ill health.
The second reason is society’s commitment to social 
justice. Healthy societies have a strong sense of fair 
play: those involved in the provision of health care are 
committed to reducing health inequalities as a significant 
contribution to health for all. It is a fact that the majority 
of prisoners come from the poorest parts of society, with 
deficiencies in education and employment experience. 
Their admission to prison can be the first time they have 
had a settled life with adequate nutrition and a chance to 
reduce their vulnerability to ill health and social failure. 
Prison health care can play an important role in reducing 
health inequalities.
All this underlines the need for governments to give a 
degree of priority to health in prisons. First, they should 
meet their duty of care for those deprived of their liberty. 
Second, they should respect prisoners’ human rights, aid 
the protection of their health and contribute to public 
health as a whole, thus making a major contribution 
towards reducing health inequalities in a vulnerable part 
of the population while society awaits the effects of 
action on the broader social determinants of health.
It is not, however, easy to provide health care in prisons 
which by their nature are designed for safe custody and 
provided with regimes that have necessarily developed 
around questions of security.
Difficulties with isolation of services
One of the early and important lessons learned by 
the network is that prison health services cannot be 
adequately provided in isolation from other health 
and social services. In 2003, the network agreed, and 
WHO published, the Moscow Declaration, which called 
attention to the need for prison health services to be 
integrated or work closely with public health services 
(1). Since then, the need to avoid professional isolation 
has been further developed as part of WHO’s work with 
health systems. It is now realized that prison health has 
important implications for health governance as a whole. 
A modern prison health service takes as its working 
method the “health in all policies” approach, in which 
effective and systematic action for the improvement of 
health genuinely uses all available measures in all policy 
fields. In 2013, WHO and the United Nations Office on 
Drugs and Crime (UNODC) published a policy brief on the 
organization of prison health, Good governance for prison 
health in the 21st century (2), with the following main 
findings: 
•	 prisoners	 share	 the	 same	 right	 to	 health	 and	 well-
being as other people;
•	 prisoners	generally	come	from	socially	disadvantaged	
segments of the community and carry a higher burden 
of communicable and noncommunicable diseases 
compared with the general population;
•	 prisons	 are	 settings	 with	 high	 risks	 of	 disease;	
because their inhabitants continuously exchange 
with outside communities, they present a complex 
and difficult challenge for public health, especially 
where communicable diseases such as HIV or TB are 
concerned;
•	 states	 have	 a	 special,	 sovereign	 duty	 of	 care	 for	
prisoners: they are accountable for all avoidable health 
impairments to prisoners caused by inadequate health 
care measures or inadequate prison conditions with 
regard to hygiene, catering, space, heating, lighting, 
ventilation, physical activity and social contacts;
•	 prison	 health	 services	 should	 work	 to	 at	 least	
the equivalent professional, ethical and technical 
standards to those applying to public health services 
in the community;
•	 prison	health	services	should	be	provided	exclusively	
to care for prisoners and must never be involved in the 
punishment of prisoners;
•	 prison	 health	 services	 should	 be	 fully	 independent	
of prison administrations and liaise effectively with 
them;
•	 prison	 health	 services	 should	 be	 integrated	 into	
national health policies and systems, including the 
training and professional development of health care 
staff.
3The essentials about prisons and health
Essential components of a prison health 
service
Each of these aspects features strongly throughout this 
guide, as they underpin the objectives of a prison health 
service and support the motivation of the staff. This 
overview aims to give a brief outline of prison health 
services and their main features.
The prison service is the least known and understood of 
all the public services despite its importance for society. 
Where health is concerned, a lack of prison health care 
can threaten public health and add to the health burden 
on communities. By helping to build healthy communities, 
a prison health service can help to avoid an increase in the 
general burden of disease. Good prison health care will 
also contribute to a reduction in reoffending after release.
The essential points can be summarized under four 
headings:
•	 medical	care
•	 health	protection
•	 health	promotion
•	 health	resilience.
Medical care
The first essential is the provision of medical care for 
prisoners in need of it, which requires access to fully 
trained doctors and nurses with a supply of modern 
medicines and appropriate facilities, such as consultation 
rooms, treatment rooms and short-stay beds with some 
nursing supervision. The recruitment, retention and 
continuing professional training of health care staff should 
be arranged so as to create a dedicated and specialized 
health service for people in detention. It is important to 
maintain the professional interest of health staff, which is 
more easily done when the prison service is not isolated 
from the community health services and has good links to 
specialist health services.
Health care should include the continuance of any 
treatment started before admission, so the second 
essential is a full assessment of a prisoner’s health and 
related needs as soon as possible after admission. This 
is important to ensure that the prisoner does not have a 
medical condition that could affect the health of others, 
such as TB, and that he/she is not a danger or threat 
to him/herself or others. The initial health screening is 
recognized as an extremely important phase in prison 
health. It ensures that a good assessment of the health 
status of the prisoner and other needs are noted so that 
a personalized treatment and care programme can be 
established with the health team and others. Importantly, 
it draws attention to prisoners whose health needs are 
too complex to be managed in that prison, so that steps 
can be taken to move the prisoner to a more appropriate 
institution. This is of great value to those with serious 
mental illness and/or substance abuse problems, who 
need to be transferred to a facility with specialized 
expertise. Furthermore, as it offers the possibility to 
establish evidence of ill-treatment, the initial health 
screening constitutes a basic safeguard against torture 
and any other kind of ill-treatment.
The core of prison health is a primary care service, along 
the lines of primary care in the community. It is not easy 
to provide such a service within prisons, as easy access 
to health clinics is usually not possible. What is possible 
is for a service to be designed, with the agreement of 
the staff and the prisoners kept fully informed, to provide 
prompt access to an appropriate level of care. This 
includes training and retraining for prison staff in first aid 
and the management of acute mental illness, and training 
for non-health staff on how to access acute care when the 
health care staff are not on site.
The prison health services must also have good access 
to specialist and diagnostic health services, including 
hospitals, since prison hospitals are often unable to meet 
the standards of hospitals serving the population outside. 
Access has to be carefully planned with prison staff. Plans 
to meet this need must be made in advance and made 
known to all staff. These will vary with national policies 
and local circumstances. The arrangements should be 
known to the prisoners.
Finally, for health care provision in prison to be 
sustainable, prison health services should do their best 
to make arrangements for continuity of care on the 
transfer or release of prisoners. This requires continuing 
communication between the health team and the 
management of prisoners so that all steps can be planned 
in time and all necessary information can be transferred 
with the prisoner.
Health protection
Governments have a responsibility to ensure health 
protection, meaning that prisoners in their care are 
not exposed to serious threats to their health. Many 
prisons are old and often overcrowded, so this is quite a 
challenge. Health training for all staff (as recommended 
in Chapter 22) should include the social determinants of 
health, the causes of disease and the determinants and 
mechanisms of ill health. This should greatly increase their 
understanding of what should be done for the maintenance 
and protection of good health. The aim is for all prison staff 
to work with the health care team so that prisoners are 
discharged with better health and health resilience than 
they had on admission to prison. A clear understanding of 
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the expected roles of the health team and those of other 
prison staff is important for good collaboration.
The key steps in protecting health include: a reduction 
of hazards in the environment, a good health screening 
service, attention to immediate health needs, proper 
nutrition, exercise in the fresh air if possible, and two 
important additions to the prison service: where possible, 
a method of using peer groups in what some prisons have 
developed as a listening service for drawing attention to 
prisoners in need, and a good complaints service.
Health promotion
Health promotion is now regarded as an essential part of 
primary health care. The provision of health information 
in a manner that prisoners can understand remains an 
important part of promoting health. But this is not enough 
not on its own. Prisoners’ attitudes to health should be 
assessed and encouraged, and help given to change 
unhealthy behaviour such as tobacco use, substance 
abuse and alcohol abuse.
Prison authorities should ensure that health promotion 
services are available and that deficiencies, such as any 
necessary immunizations, can be rectified in prison.
It is well recognized that admission to prison can create 
considerable pain and distress. Nearly all prisoners are 
challenged by their loss of freedom. Prison regimes leave 
scant room for self-determination. This is one of the 
greatest challenges in prisons, and one which should be 
the subject of regular staff development and continuing 
training. It is assumed that all prisoners with serious 
mental illness are diverted to specialist care, but there 
may be periods when such prisoners have to remain in 
their prison. Staff need to be trained in the management 
of these patients.
Prison authorities should be aware of the pressure on 
staff from prisoners with special needs. Support for staff 
and opportunities to discuss particular issues should be 
part of the service provided. It is critically important to 
maintain confidentiality in all prison health work; this 
poses a particular challenge to prison staff, who often 
feel they have a right to know.
All prisoners need assistance to cope with and 
control the effects of imprisonment. They also need 
better preparation for life after discharge. This latter 
challenge involves the whole prison programme, so that 
educational deficiencies are at least partially met, work 
experience has been made available and social skills 
have been greatly enhanced.
Health resilience
Health resilience can be an important part of the 
rehabilitation and resettlement process. Only in this way, 
with health teams working collaboratively with other staff 
in the prison, can prison health care play a part in reducing 
inequalities, reducing recidivism and helping to produce a 
better and healthier community.
Good governance for prison health
The management of prisons and places of detention has 
become a difficult and challenging task. This is often 
not recognized in government and society. The complex 
and widely ranging needs of prisoners, combined with 
their increasing awareness of their rights and greater 
expectations as well as (in some countries) access to a 
good complaints system and to legal assistance, play a 
considerable part in how best to provide prison health 
services.
The expert group advising the Regional Office on 
the policy brief on the organization of prison health 
concluded that:
•	 the	 management	 and	 coordination	 of	 all	 relevant	
agencies and resources contributing to the health 
and well-being of prisoners is a whole-of-government 
responsibility;
•	 health	ministries	 should	provide	and	be	accountable	
for health care services in prisons and advocate 
healthy prison conditions.
A whole-of-government approach to prison health in the 
longer term will have beneficial effects such as:
•	 lower	health	 risks	and	 improved	health	protection	 in	
prisons;
•	 better	health	for	prisoners;
•	 improved	performance	of	national	health	systems;
•	 better	health	in	deprived	communities;
•	 better	public	health	in	the	whole	community;
•	 better	integration	of	prisoners	into	society	on	release;
•	 lower	rates	of	 reoffending	and	reincarceration	and	a	
reduction in the size of the prison population; and
•	 increased	 governmental	 credibility	 based	 on	 greater	
efforts to protect human rights and reduce health 
inequalities.
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62. Standards in prison health: the prisoner as a patient
Andrew Coyle
Key points 
•	 People	who	are	in	prison	have	the	same	right	to	health	
care as everyone else.
•	 Prison	administrations	have	a	responsibility	to	ensure	
that prisoners receive proper health care and that 
prison conditions promote the well-being of both 
prisoners and prison staff.
•	 Health	care	staff	must	deal	with	prisoners	primarily	as	
patients and not prisoners.
•	 Health	 care	 staff	 must	 have	 the	 same	 professional	
independence as their professional colleagues 
working in the community.
•	 Health	 policy	 in	 prisons	 should	 be	 integrated	 into	
national health policy, and the administration of public 
health should be closely linked to the health services 
administered in prisons.
•	 This	 applies	 to	 all	 health	matters	 but	 is	 particularly	
important for communicable diseases.
•	 The	 European	 Prison	 Rules	 of	 the	 Council	 of	 Europe	
provide important standards for prison health care.
Basic principles
Several international standards define the quality of 
health care that should be provided to prisoners. A 
provision in Article 12 of the International Covenant on 
Economic, Social and Cultural Rights establishes “the right 
of everyone to the enjoyment of the highest attainable 
standard of physical and mental health” (1). This applies 
to prisoners just as it does to every other human being. 
Those who are imprisoned retain their fundamental right 
to enjoy good health, both physical and mental, and 
retain their entitlement to a standard of health care that 
is at least the equivalent of that provided in the wider 
community.
The United Nations Basic Principles for the Treatment of 
Prisoners (2) indicate how the entitlement of prisoners 
to the highest attainable standard of health care should 
be delivered: “Prisoners shall have access to the health 
services available in the country without discrimination 
on the grounds of their legal situation” (Principle 9). In 
other words, the fact that people are in prison does not 
mean that they have any reduced right to appropriate 
health care. Rather, the opposite is the case. When a state 
deprives people of their liberty, it takes on a responsibility 
to look after their health in terms both of the conditions 
under which it detains them and of the individual 
treatment that may be necessary. Prison administrations 
have a responsibility not simply to provide health care 
but also to establish conditions that promote the well-
being of both prisoners and prison staff. Prisoners should 
not leave prison in a worse condition than when they 
entered. This principle is reinforced by Recommendation 
No. R (98) 7 of the Committee of Ministers of the Council 
of Europe (3) concerning the ethical and organizational 
aspects of health care in prison and by the European 
Committee for the Prevention of Torture and Inhuman or 
Degrading Treatment or Punishment (CPT), particularly in 
its 3rd general report (4). The European Court of Human 
Rights is also producing an increasing body of case law 
confirming the obligation of states to safeguard the health 
of prisoners in their care.1 
The argument is sometimes advanced that states cannot 
provide adequate health care for prisoners because of 
shortage of resources. In the 11th general report on 
its activities, the CPT underlined the obligations state 
governments have to prisoners even in times of economic 
difficulty (8):
The CPT is aware that in periods of economic difficulty 
sacrifices have to be made, including in penitentiary 
establishments. However, regardless of the difficulties 
faced at any given time, the act of depriving a person of 
his liberty always entails a duty of care which calls for 
effective methods of prevention, screening, and treatment. 
Compliance with this duty by public authorities is all the 
more important when it is a question of care required to 
treat life-threatening diseases. In respect of the obligation 
to provide adequate health care to prisoners, there are two 
fundamental considerations. One concerns the relationship 
between the prisoner and the health care staff and the other 
concerns how prison health care is organized. 
Relationship between the prisoner and 
health care staff
All health care staff working in prisons must always 
remember that their first duty to any prisoner who is their 
patient is clinical. This is underlined in the first of the 
United Nations Principles of Medical Ethics relevant to 
the Role of Health Personnel, particularly Physicians, in 
the Protection of Prisoners and Detainees against Torture 
1  See, for example, the cases of Mouisel v. France [2002] (5), Henaf v. France [2003] (6) and McGlinchey and others v. The United Kingdom [2003] (7).
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and Other Cruel, Inhuman or Degrading Treatment or 
Punishment (9), which states the following:
Health personnel, particularly physicians, charged with 
the medical care of prisoners and detainees have a duty to 
provide them with protection of their physical and mental 
health and treatment of disease of the same quality and 
standard as is afforded to those who are not imprisoned or 
detained.
The International Council of Prison Medical Services 
confirmed this principle when it agreed on the Oath of 
Athens (10):
We, the health professionals who are working in prison 
settings, meeting in Athens on September 10, 1979, hereby 
pledge, in keeping with the spirit of the Oath of Hippocrates, 
that we shall endeavour to provide the best possible health 
care for those who are incarcerated in prisons for whatever 
reasons, without prejudice and within our respective 
professional ethics.
This principle is particularly important for physicians. In 
some countries, full-time physicians can spend their whole 
careers working in the prison environment. It is virtually 
inevitable in such situations that these physicians will 
form a close relationship with the prison management 
and indeed may be members of the senior management 
team of the prison. One consequence of this may be 
that the director of the prison will occasionally expect 
the physician to assist in managing prisoners who are 
causing difficulty. For example, the security staff may 
ask the physician to sedate prisoners who are violent 
to themselves, to other prisoners or to staff. In some 
jurisdictions, prison administrations may demand that 
physicians provide them with confidential information 
about a person’s HIV status. Physicians should never lose 
sight of the fact that their relationship with every prisoner 
should be first and foremost that between physician and 
patient. A physician should never do anything to patients 
or cause anything to be done to them that is not in their 
best clinical interests. Similarly, as with all other patients, 
physicians should always seek consent from the patient 
before taking any clinical action, unless the patient is not 
competent on clinical grounds to give this consent. An 
internet diploma course entitled Doctors working in prison: 
human rights and ethical dilemmas, provided free on the 
internet by the Norwegian Medical Association (11) on 
behalf of the World Medical Association, focuses on many 
of these issues. See also the World Medical Association 
Declaration on Hunger Strikers adopted by the 43rd World 
Medical Assembly, Malta, November 1991 and revised 
by the World Medical Association General Assembly in 
Pilanesberg, South Africa, in October 2006 (12).
This primary duty to deal with prisoners as patients 
applies equally to other health care staff. In many 
countries nurses carry out a variety of basic health care 
functions. These may include carrying out preliminary 
health assessments of newly admitted prisoners, issuing 
medicines or applying treatments prescribed by a physician 
or being the first point of contact for prisoners concerned 
about their health. The nurses who carry out these duties 
should be properly qualified for what they do and should 
treat people primarily as patients rather than as prisoners 
when carrying out their duties. The International Council 
of Nurses published a statement saying, among other 
things, that national nursing associations should provide 
access to confidential advice, counselling and support for 
prison nurses (13).
Organization of prison health care
One method of ensuring that prisoners have access to an 
appropriate quality of health care is by providing close 
links between prison-administered health services and 
public health. In recent years, some countries have begun 
to create and strengthen such relationships. Many prison 
and public health reformers argue, however, that a close 
relationship is not enough and that prison health should 
be part of the general health services of the country rather 
than a specialist service under the government ministry 
responsible for the prisons. There are strong arguments 
for moving in this direction in terms of improving the 
quality of health care provided to prisoners. In Norway, 
for example, the process of giving local health authorities 
responsibility for providing health care services in prison 
was completed in the 1980s. In France, legislation was 
introduced in 1994 placing prison health under the General 
Health Directorate for Public Health Issues in the Ministry 
of Health. In the United Kingdom (England and Wales), 
responsibility and the budget for prison health care were 
transferred to the National Health Service in 2002.
The Committee of Ministers of the Council of Europe has 
urged that “health policy in custody should be integrated 
into, and compatible with, national health policy” (3). The 
Committee points out that, as well as being in the interest 
of prisoners, this integration is in the interest of the 
health of the population at large, especially as concerns 
policies relating to infectious diseases that can spread 
from prisons to the wider community. The vast majority 
of prisoners will return to civil society one day, often to 
the communities from which they came. Some are in 
prison for very short periods. When they are released, it is 
important for the good of society that they return in good 
health rather than needing more support from the public 
health services or bringing infectious diseases with them. 
Continuity of care between prisons and communities is a 
public health imperative. Many other people go into and 
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come out of prison on a daily basis: staff, lawyers, officials 
and other visitors. This means that there is significant 
potential for transmitting serious disease or infection. For 
these reasons, prisons cannot be seen as separate health 
sites from other institutions in society.
WHO strongly recommends that prison and public health 
care be closely linked. The Moscow Declaration on Prison 
Health as a Part of Public Health (14) elaborated on some 
of the reasons why close working relationships with 
public health authorities are so important, as under:
•	 Penitentiary	 populations	 contain	 an	 overrepresentation	
of members of the most marginalized groups in society, 
people with poor health and chronic untreated conditions, 
drug users, vulnerable people and those who engage in 
risky activities such as injecting drugs and commercial 
sex work.
•	 The	movement	of	people	already	infected	with	or	at	high	
risk of disease to penitentiary institutions and back into 
civil society without effective treatment and follow-up 
gives rise to the risk of the spread of communicable 
diseases both within and beyond the penitentiary 
system. Prevention and treatment responses must 
be based on scientific evidence and on sound public 
health principles, with the involvement of the private 
sector, nongovernmental organizations and the affected 
population.
•	 The	 living	 conditions	 in	 most	 prisons	 of	 the	 world	 are	
unhealthy. Overcrowding, violence, lack of light, fresh 
air and clean water, poor food and infection-spreading 
activities such as tattooing are common. Rates of 
infection with TB, HIV and hepatitis are much higher than 
in the general population.
The Declaration makes a series of recommendations that 
would form the basis for improving the health care of all 
detained people, protecting the health of prison personnel 
and contributing to the public health goals of every 
Member State in the Region:
•	 Member	 governments	 are	 recommended	 to	 develop	
close working links between the Ministry of Health and 
the ministry responsible for the penitentiary system so 
as to ensure high standards of treatment for detainees, 
protection for personnel, joint training of professionals 
in modern standards of disease control, high levels of 
professionalism amongst penitentiary medical personnel, 
continuity of treatment between the penitentiary and 
outside society, and unification of statistics.
•	 Member	governments	are	 recommended	 to	ensure	 that	
all necessary health care for those deprived of their 
liberty is provided to everyone free of charge.
•	 Public	and	penitentiary	health	systems	are	recommended	
to work together to ensure that harm reduction becomes 
the guiding principle of policy on the prevention of HIV/
AIDS and hepatitis transmission in penitentiary systems.
•	 Public	and	penitentiary	health	systems	are	recommended	
to work together to ensure the early detection of 
tuberculosis, its prompt and adequate treatment, and the 
prevention of transmission in penitentiary systems.
•	 State	authorities,	civil	and	penitentiary	medical	services,	
international organizations and the mass media are 
recommended to consolidate their efforts to develop 
and implement a complex approach to tackle the dual 
infection of tuberculosis and HIV.
•	 Governmental	 organizations,	 civil	 and	 penitentiary	
medical services and international organizations are 
recommended to promote their activities and consolidate 
their efforts in order to achieve quality improvements in 
the provision of psychological and psychiatric treatments 
to people who are imprisoned.
•	 Member	 governments	 are	 recommended	 to	 work	 to	
improve prison conditions so that the minimum health 
requirements for light, air, space, water and nutrition are 
met.
•	 The	WHO	 Regional	 Office	 for	 Europe	 is	 recommended	
to ensure that all its specialist departments and country 
officers take account in their work of the health care 
needs and problems of penitentiary systems and develop 
and coordinate activities to improve the health of 
detainees.
European Prison Rules
All the countries that are members of the WHO Health in 
Prisons Project are also members of the Council of Europe. 
In 1973, the Committee of Ministers of the Council of 
Europe adopted the European Standard Minimum Rules 
for the Treatment of Prisoners (15), which were closely 
modelled on the United Nations Standard Minimum Rules 
for the Treatment of Prisoners (16). In that year, the Council 
of Europe had 15 members. At the beginning of 1987, 
when it had expanded to 21 members, the Committee of 
Ministers of the Council of Europe adopted a new set of 
European Prison Rules (17). At the time, the Committee of 
Ministers noted “that significant social trends and changes 
in regard to prison treatment and management have made 
it desirable to reformulate the Standard Minimum Rules 
for the Treatment of Prisoners, drawn up by the Council of 
Europe (Resolution (73) 5) so as to support and encourage 
the best of these developments and offer scope for future 
progress”. By 2005, the membership of the Council of 
Europe expanded further to 46 states. For that reason, the 
Council of Europe decided to revise the 1987 European 
Prison Rules.
The revised European Prison Rules, adopted on 11 January 
2006 by the Committee of Ministers of the Council of 
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Europe (18), contain a significantly expanded section on 
health care in the prison setting. For the first time, the 
European Prison Rules specifically refer to the obligation 
of prison authorities to safeguard the health of all 
prisoners (§39) and the need for prison medical services to 
be organized in close relationship with the general public 
health administration (§40).
Every prison is recommended to have the services of at 
least one qualified general medical practitioner and to 
have other personnel suitably trained in health care (§41). 
Arrangements to safeguard health care begin at the point 
of first admission, when prisoners are entitled to have 
a medical examination (§42), and continue throughout 
the course of detention (§43). The commentary to the 
European Prison Rules refers to some recent developments 
in imprisonment with implications for health care. One 
is the increasing tendency for courts to impose very 
long sentences, which increases the possibility that old 
prisoners may die in prison. Related to this is the need 
to give proper and humane treatment to any prisoner 
who is terminally ill. The Committee of Ministers of the 
Council of Europe has also made a recommendation on 
the treatment of prisoners on hunger strike (3). In addition 
to dealing with the health needs of individual prisoners, 
those responsible for prison health are also recommended 
to inspect the general conditions of detention, including 
food, water, hygiene, sanitation, heating, lighting and 
ventilation, as well as the suitability and cleanliness of 
the prisoners’ clothing and bedding (§44). The European 
Prison Rules also recommend that provision is made for 
prisoners who require specialist treatment (§46) and 
those who have mental health needs (§47).
One important change should be noted. The 1987 European 
Prison Rules provided that prison authorities could only 
impose “punishment by disciplinary confinement and any 
other punishment which might have an adverse effect 
on the physical or mental health of the prisoner” if the 
medical officer certified in writing that the prisoner was 
fit to undergo such punishment. This led to concerns that, 
by providing this certification, the physician was in effect 
authorizing the imposition of punishment, in contradiction 
to the Hippocratic Oath. The revised European Prison 
Rules remove this requirement.
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3. Prison-specific ethical and clinical problems 
Jean-Pierre Restellini, Romeo Restellini
Key points 
•	 Regardless	of	the	circumstances,	the	ultimate	goal	of	
health care staff in prisons must remain the welfare 
and dignity of the patients.
•	 The	 results	 of	 medical	 examinations	 and	 tests	
undertaken in prison with the patient’s consent as part 
of clinical care must be treated with the same respect 
for confidentiality as is normal according to medical 
ethics in general medical practice.
•	 Prison	 physicians	 should	 avoid	 dual	 roles	 with	 the	
same patient. To avoid as far as possible any confusion 
about the role of the doctor in medical examinations 
and treatment in the caregiving role and in other 
functions (such as providing medical expertise for, for 
example, forensic reports), the doctor should make it 
clear to the patient at the outset of the consultation 
that medical confidentiality will not apply to the results 
of any medical examinations and tests undertaken for 
forensic purposes.
•	 Regardless	of	security	issues,	health	care	staff	should	
have unrestricted access at any time and any place to 
all prisoners, including those undergoing disciplinary 
sanctions.
•	 Health	 care	 staff	 should	 under	 no	 circumstances	
participate in enforcing any sanctions against 
prisoners or in the underlying decision-making process, 
as this will jeopardize any subsequent doctor–patient 
relationship. This includes any medical examination to 
determine if a prisoner is fit to undergo punishment.
•	 Medical	 staff	 should	 not	 carry	 out	 any	medical	 acts	
on prisoners who are restrained (including with 
handcuffs). An exception may be considered when the 
person concerned suffers from an acute mental illness 
which may create an immediate serious risk for him/
herself or others.
•	 Prison	doctors	should	not	carry	out	any	body	searches	
or examinations requested by an authority, except in 
an emergency when no other doctor can be called in 
or in cases where there is a lack of other qualified 
health staff. In such cases doctors must explain to 
the prisoner, before proceeding with the body search, 
that they are intervening purely as experts, and that 
their act does not have any diagnostic or therapeutic 
purpose. Any such body search must have the informed 
consent of the prisoner.
•	 During	 a	 hunger	 strike,	 doctors	 must	 avoid	 the	 risk	
that prisoners, the prison or the judiciary authorities 
manipulate medical decisions.
•	 Doctors	have	a	duty	to	document	physical	signs	and/
or mental symptoms compatible with a prisoner 
having been subjected to torture or cruel, inhuman 
and degrading treatment, and to report through the 
appropriate channels any sign or indication that 
prisoners may have been treated violently.
•	 The	health	service	in	a	prison	can	potentially	play	an	
important role in the prevention of ill-treatment within 
the establishment and elsewhere. The physical and 
psychological examinations carried out on admission 
are particularly important in this respect.
•	 All	 health	 care	 staff	 working	 with	 prisoners	 on	 an	
ongoing basis should have access to a specific training 
programme. Training should address the specificities 
and inner workings of different types of prison, the 
handling of potentially dangerous or violent situations, 
and the risks of ethical breaches specific to their 
activities as health care providers in prisons.
Introduction
Other chapters of this guide raise important issues relating 
to equivalence of care, confidentiality and informed 
consent of the patient detainee. This chapter will address 
other highly specific and sensitive health problems faced 
by health care staff (as well as the prison administration) 
in the practice of prison medicine.
Health care staff in prisons
General role of the medical doctor
The role of a prison doctor is not limited to the provision of 
care. As already noted, prison doctors should take part in 
the general management of a prison establishment (such 
as in control of food and hygiene). As far as possible, 
a prison doctor should also have a say in the design of 
various detention regimes as well as participating in the 
promotion of alternatives to detention, while keeping in 
mind that the role of the doctor is to promote prisoners’ 
health and social rehabilitation.
In practical terms, the doctor should submit a report to 
the prison director whenever he/she considers that the 
physical or mental health of a prisoner or the prison 
population is at serious risk as a result of prolonged 
imprisonment or of the conditions of detention, including 
isolation. Further, the doctor should adopt a proactive 
approach when the prisoner’s state of health is seriously 
affected and release on medical grounds is required. If 
the prison management does not accept the doctor’s 
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recommendations, the doctor should ensure that his/her 
report is submitted to a higher authority (1).
The possible subordination of prison health care to the 
ministry of health does not exempt doctors working 
in prison from any functions specific to the practice of 
medicine in a prison setting.
Multiple loyalties
Doctors working in prisons are frequently torn between 
various loyalties. Their primary duty is to protect and 
promote the health of prisoners and to ensure that they 
receive the best care possible. This duty may, however, 
conflict with other priorities, notably those of the 
prison management. In practice, the health care team 
is frequently obliged, despite its reticence, to take into 
account issues of order and security. Conversely, security 
staff may find it difficult to accept attitudes, beliefs and 
behaviour on the part of the health care staff that they 
perceive to conflict with prison rules and regulations (2,3).
Although it is not recommended, the prison doctor 
sometimes also acts as a treating doctor for security 
staff (and occasionally even for their families). In such 
a context, the position of prison doctors is extremely 
complex since their duty is to take care of people who are 
in opposition to each other, if not in conflict, at the same 
time. The two types of doctor’s activity should preferably 
be clearly distinguished physically. It should be stipulated 
beforehand, for example, what percentage of the doctor’s 
time is to be devoted to staff care and that two stocks of 
medication (for prisoners and staff) will be kept separately. 
Two separate consultation rooms would be best.
This permanent state of tension can only be dealt with 
through regular meetings between the prison director and 
the medical director to make any necessary adjustments. 
The exchanges during such meetings are even more 
essential as, in a large proportion of establishments, 
the acute lack of health care staff can force the prison 
management to delegate certain tasks related to health 
care to the security staff.
Regardless of the circumstances, the ultimate goal of 
health care staff must remain the welfare and dignity 
of the patients. It should be made clear to the patients, 
prison staff and the prison director that the primary task of 
the prison health care staff is the health care of prisoners, 
and that all work is based on the strict medical and ethical 
principles of health care professionalism: independence, 
equivalence and confidentiality of care.
Parallel and conflicting activities
A doctor working in a prison may be called upon to play 
two somewhat opposing roles: that of a care provider 
to the prisoner as a patient, and that of an independent 
medical expert providing medical evidence concerning a 
patient to a court or other official body. While the care-
provider is concerned with the well-being of the individual 
patient, the doctor acting as a medical expert is asked 
to reveal medical information that would otherwise be 
confidential, in the interests of justice and in the service 
of the community. The latter role may not be in the doctor’s 
patient’s interest. According to common ethical rules, a 
doctor should be one or the other. Only in an emergency 
is it tolerated for a doctor to combine these two functions 
without the formal consent of the patient.
In practice, however, the reality of prison life frequently 
obliges doctors to go beyond their role as care providers. 
For instance, the judiciary or prison authorities may ask 
doctors to establish a person’s fitness to be detained or 
to prepare forensic reports in cases of allegations of ill-
treatment. Ideally, such tasks should be performed by an 
independent doctor from outside the prison system. If, 
however, a prison doctor has to perform such a task, the 
doctor charged with examining a prisoner as a medical 
expert should clearly inform the patient at the outset of 
the consultation that medical secrecy will not apply to the 
results of the medical examination and tests, to avoid a 
confusion of the two roles.
A prison doctor may be asked to evaluate the threat 
to society posed by a prisoner in connection with, for 
example, a request for parole or leave of absence. In 
such situations, the doctor must respond with extreme 
caution and clearly establish that his/her opinion can only 
be based on a current assessment of physical and mental 
function and must not predict future criminal conduct. 
Doctors are neither trained nor qualified to predict 
criminal behaviour. In such cases, since the prisoner may 
see the prison doctor as effectively playing a role in his/
her release or continued detention, this has the potential 
to affect the doctor–patient relationship. Thus again, 
it is best for an independent opinion to be given by a 
professional qualified to make judgments on criminality.
Issues of conscience and serious ethical conflict
The multiple parameters affecting the work of prison 
doctors may run contrary to their personal convictions. It is, 
therefore, highly preferable to employ prison health care 
staff who choose to work in prisons and to provide them 
with focused training. In countries where prison health 
care services have been integrated with the community 
health services, patients inside the prison are considered 
as simply another group within the wider community and 
the health staff are expected to deliver services at the 
same level as in the wider community.
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In attempting to carry out their duties according to the 
usual professional and ethical standards, doctors may 
face conflicts not only with the decisions of the prison 
administration but also with local regulations and even 
national laws. In such cases, doctors should ask their 
national professional organization (national medical 
association) for advice and, if needed, ask the opinion 
of colleagues working in other countries in the same 
field, including seeking the support of the World Medical 
Association. Another possibility is to contact the national 
prevention organization, if one exists in the country.
Disciplinary measures
In any prison, access to health care facilities may be 
difficult because of security practices. This is particularly 
the case in disciplinary and maximum security units. The 
prison authorities often want to limit contact with certain 
prisoners to a strict minimum.
Regardless of the security issues, health care staff should 
have unrestricted access at any time and any place to 
all prisoners, including those subject to disciplinary 
measures. The doctor in charge is responsible for ensuring 
that each prisoner can, in practice, exert his/her right of 
access to health care at any time.
When the prison authorities decide to punish a prisoner 
for breach of regulations, sanctions may take different 
forms. Health care staff should never participate in the 
initiation or enforcement of any sanctions, as this is not 
a medical act and thus to participate will jeopardize any 
subsequent doctor–patient relationship with this prisoner 
and with all prisoners.
Doctors may frequently be approached when the sanction 
considered is solitary confinement. Solitary confinement 
has clearly been shown to be detrimental to health (4). In 
cases where it is enforced, its use should be limited to the 
shortest time possible. Thus, doctors should not collude in 
moves to segregate or restrict the movement of prisoners 
except on purely medical grounds, and they should not 
certify a prisoner as being fit for solitary confinement or 
any other form of punishment. Prisoners who are placed 
in isolation should be evaluated initially and periodically 
for acute mental illness, drug or alcohol withdrawal and 
injuries. If these are identified, prisoners should have 
access to prompt and effective treatment. Doctors should 
not certify fitness for isolation.
Once a sanction is enforced, however, doctors must follow 
the prisoner being punished with extreme vigilance. It is 
well-established that solitary confinement constitutes an 
important stressor and risk, notably of suicide. Doctors 
must pay particular attention to such prisoners and 
visit them regularly on their own initiative, as soon as 
possible after an isolation order has taken effect and 
daily thereafter, to assess their physical and mental 
state and determine any deterioration in their well-being. 
Furthermore, doctors must immediately inform the prison 
management if a prisoner presents a health problem.
Physical restraint
In prison, situations of extreme tension can occur. In such 
cases, the prison authorities can decide to use physical 
restraints on one or more prisoners for the purpose of 
preventing self-harm or harm to other prisoners and staff. 
Restraints must only be applied for the shortest time 
possible to achieve these purposes and should never be 
used as a form of punishment. Since the decision to use 
restraints in situations of violence is not a medical act, the 
doctor must have no role in the process.
There may, however, be instances where some form of 
restraint must be applied for medical reasons, such as 
acute mental disturbance in which the patient is at high 
risk of injuring him/herself or others. The decision to use 
restraints or to move a prisoner to a cell for such purposes 
must be confirmed in each case by health care staff, based 
purely upon clinical criteria.
Medical personnel should never carry out medical acts on 
prisoners who are under restraint (including handcuffed), 
except for patients suffering from an acute mental illness 
or delirium with potential for immediate serious risk for 
themselves or others. Moreover, doctors should never 
agree to examine a blindfolded prisoner.
Intimate body searches
For security reasons, it may be necessary to search a 
prisoner to ensure that he/she is not hiding anything in a 
natural body cavity. In many cases it may suffice to keep 
the prisoner under close surveillance and wait for the illicit 
object to be naturally expelled. Prison doctors and nurses 
should not carry out body searches, blood or urine tests 
for drug metabolites or any other examinations except 
on medical grounds and with the consent of the patient. 
Vaginal, anal and other intrusive bodily inspections are 
primarily a security rather than a medical procedure, and 
thus should not form part of the duties of prison health care 
staff. On the rare occasions when intimate body searches 
are deemed necessary, they should be performed by doctors 
who are, as far as possible, external to the prison.
Prisoners who stop eating or go on hunger 
strikes
Differential diagnosis
It is vital to understand why a prisoner stops eating since 
the medical care will differ completely depending on the 
reason for refusing food. Prisoners may stop eating:
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•	 for	 religious	 reasons,	 as	 a	 part	 of	 specific	 religious	
festivals or if food is served that is not prepared 
in accordance with religious precepts; the prison 
administration should deal with such issues and 
ensure that religious considerations are taken into 
account in the preparation of food for prisoners;
•	 because	of	somatic	problems	such	as	dental	problems,	
ulcers, obstructions of the digestive tract, very poor 
general health and fever; the appropriate treatment 
should be provided;
•	 because	 of	 mental	 disorders	 such	 as	 psychosis,	
poisoning, delusion, major depressive disorders and 
anorexia nervosa; such prisoners should benefit from 
health care support of the kind they would receive in 
open society;
•	 with	 the	 intention	 of	 protesting	 to	 achieve	 some	
change in their regime or to obtain perceived or actual 
rights.
In the last case, two sets of values clash:
•	 the	duty	of	the	state	to	preserve	the	physical	integrity	
and life of those directly under its charge, notably 
people it has deprived of liberty; and
•	 the	right	of	every	individual	to	dispose	freely	of	his/her	
own body.
Ethical aspect
Such situations are challenging for prison health care 
staff. Pressure is often brought to bear on the doctor, who 
should avoid the risk that the prisoner, prison or judiciary 
authorities manipulate medical decisions.
The most important guidance for prison doctors regarding 
hunger strikes is the World Medical Association’s 
Declaration of Malta (5). This Declaration is summarized 
below and some important issues are discussed.
•	 Physicians	 have	 the	 duty	 to	 act	 ethically.	Whatever	
their role, they must try to prevent coercion or 
maltreatment.
•	 The	 autonomy	 of	 the	 patient	 must	 be	 respected.	
In order to do so, the physician must assess an 
individual’s mental capacity. Getting a second opinion 
from an independent psychiatrist as to soundness of 
mind is always wise in every case of food refusal.
•	 A	thorough	examination	of	the	patient	should	be	made	
and the physician should make sure that the patient 
fully understands the consequences of his/her hunger 
strike. It is important to recognize that the refusal of 
certain treatments must not prejudice any other aspect 
of medical care, such as treatment of infection or pain.
•	 The	wish	 to	continue	 the	strike	must	be	ascertained	
on a daily basis, and the physician should talk to the 
prisoner concerned in private.
 The physician must visit patients regularly and, if they 
agree, conduct regular follow-up examinations. These 
consultations should be held in a positive, personalized 
climate, and the physician should inform the patient of 
the progressive decline in his/her health. In this way, 
hunger strikers can freely change their mind at any time 
and abandon the strike, having been duly informed of 
the worsening nature of the risks to which they are 
exposing themselves. The doctor must evaluate each 
prisoner individually and should be particularly careful 
in case of a collective hunger strike, as prisoners are 
often subjected to external pressure.
 Physicians should offer detainees the possibility to 
access a special diet whenever this is possible. It is 
widely accepted that liquids, vitamins, sugar and trace 
nutrients protect the striker’s health from irreversible 
damage (6). By lengthening the time of the fast, it can 
allow both the prisoner and the authorities to propose 
a mutually acceptable solution in order to avoid lethal 
deadlock.
•	 Confidentiality	 must	 be	 respected,	 unless	 it	 is	
necessary to share information in order to prevent a 
serious threat to the patient or to others.
•	 The	doctor	must	keep	the	prison	and	judicial	authorities	
informed of the evolution of the health condition of the 
patient through regular and successive health reports. 
These carefully established and strictly objective 
health reports are part of the medical care for a person 
in danger and allow the authorities to take more 
adequate decisions.
•	 If	no	discussion	is	possible	with	the	patient	(for	example	
because he/she has already lost mental capacity), the 
physician must respect the patient’s wish, but has to 
consider very carefully the instructions given by the 
patient as the situation might have changed or the 
instructions may have been written under pressure. In 
case of doubt, the physician must act in the patient’s 
best interest.
•	 In	a	case	of	conflict	between	loyalty	to	the	authorities	
and to the patient, the physician’s primary obligation 
is to the patient.
•	 Forcible	 feeding	 of	 prisoners	 is	 never	 ethically	
acceptable.
 Such a procedure can only be justified if a serious 
mental disorder affects the decision-making capacity 
of the patient (see Differential diagnosis above). In 
such a case, this constitutes artificial nutrition and not 
force-feeding, and must be carried out in a hospital 
setting.
 If there is no obvious alteration in the prisoner’s 
decision-making capacity, the doctor must carefully 
consider a course of action, keeping in mind that, in 
the vast majority of cases, the prisoners do not want 
to die. On the contrary, they want to enjoy better 
conditions. Patients frequently expect that the doctor, 
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who will invariably be called in if a hunger strike is 
kept up, will act as an intermediary and may act to 
protect them in this struggle.
 In these situations, the medical approach should 
sometimes be frankly paternalistic. It should entail 
a discussion with the patients on hunger strike to 
try and persuade them to accept at least a minimal 
calorie intake. Faced with a firm medical attitude, the 
prisoner may recover some hope and accept a normal 
healthy diet later. Some patients do not consider 
dying as part of their struggle and may even accept 
artificial feeding, but will not indicate this explicitly. 
The evaluation of the real volition of the detainee in 
these situations is very difficult.
 Patients may ask for hospitalization to give their 
case more weight. In this situation, hospitalization 
unwarranted by clinical status should not appear as an 
indirect support to achieve their aims. Nevertheless, 
early hospitalization may allow better follow-up of 
biological parameters. Further, a radical change of 
atmosphere could lead to a situation in which the 
prisoner may choose to interrupt the hunger strike 
without losing face in front of his/her comrades.
•	 If	 the	 patient’s	 position	 remains	 firm,	 based	 on	 his/
her free will to exert pressure through his/her body to 
modify his/her prison situation or to conduct a political 
struggle, doctors should limit interventions to warning 
of the dangers to which strikers expose themselves by 
refusing to eat.
Clinical aspects
The capacity of the human body to survive starvation or 
water deprivation is not yet fully understood. Obviously, 
data in this area tend to be anecdotal rather than 
interventional studies.
In dry fasting, the person refuses all solid or fluid intake. 
Death occurs in 4 to 10 days, depending on factors such as 
ambient temperature and humidity and the striker’s level 
of stress and physical activity.
Severe electrolytic imbalance can rapidly cause death 
due to cardiac arrhythmia or damage to the central 
nervous system. A hypovolemic state causes multiorgan 
dysfunction and acute renal insufficiency, worsening an 
electrolytic imbalance (7,8).
In total fasting, the individual only consumes clear water, 
with no other intake of nutrients.
Clinical evolution of a hunger strike
The usual clinical evolution of a hunger strike in a healthy, 
young patient who continues to drink water is as follows:
•	 first	week:	sensation	of	hunger	and	fatigue;	possible	
occasional abdominal cramping;
•	 second	 and	 third	 weeks:	 increasing	 weakness	
accompanied by dizziness, making the upright position 
difficult to maintain; progressive disappearance of the 
feelings of hunger and thirst; permanent sensation of 
chilliness;
•	 third	 and	 fourth	 weeks:	 progressive	 worsening	 of	
the symptoms mentioned above; slowing down of 
intellectual faculties;
•	 fifth	 week:	 alteration	 of	 consciousness	 from	 mild	
confusion to stupor and sleepiness, apathy and 
anosognosia, followed by anomalies of ocular 
movements (initially uncontrollable movements 
followed by paralysis); generalized lack of motor 
coordination with notable difficulty in swallowing; 
diminished vision and hearing, leading to loss of vision 
and hearing; sometimes diffuse haemorrhaging.
Death can occur abruptly either due to cardiac rhythm 
alterations, sepsis or several hours after the induction of 
a comatose state due to hypoglycaemia (11).
In theory, the reserves of the human body should allow 
a person to survive for 75–80 days without absorbing a 
single calorie.
In practice, it is usually accepted that there is little risk of 
dying within the first six weeks of a fast for a previously 
well-nourished and healthy person (9). Nevertheless, 
serious, sometimes deadly, clinical disorders may appear 
after a few weeks of complete fasting, mainly because 
of susceptibility to infection due to decreased immunity 
and impaired wound healing. As with dry fasting, renal 
insufficiency also often causes complications (10).
It should be noted that death is not usually due to tissue 
loss per se but to organ failure or infection. The limit of a 
body mass index compatible with life itself is thus not the 
only parameter that should be taken into account.
It is vital to recognize that certain medical factors can 
predispose to the rapidly fatal evolution of a fast. The 
major factors include heart disease, renal insufficiency and 
diabetes, especially if the patient is insulin-dependent. 
Gastric or duodenal ulcers can manifest as problems as 
early as one week after the start of the fast.
Today most hunger-strikers follow dietary fasts with the 
absorption of certain vitamins, trace minerals and some 
food (sweet drinks, candy or small amounts of various 
foods). This type of hunger strike allows them to hold on 
for several months. Prisoners going on a fast should have 
access to this diet because the risk of permanent damage 
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to the nervous system is significantly reduced. However, 
a prolonged hunger strike poses a substantial risk of 
permanent damage to the nervous system (12) (such as 
Wernicke syndrome), and it should be emphasized that 
glucose intake without vitamin B1 accelerates the process 
of neurological damage.
In practice, because many different factors affect a fast, such 
as the type of fast, conditions of detention (temperature, 
humidity) and mental stressors, it is virtually impossible to 
determine medically the risk and timing of death.
Re-feeding
The major electrolytes and vitamin depletion in people 
suffering from malnutrition cause serious threats when 
it comes to re-feeding. Indeed, glycaemia triggers 
insulin secretion, which in turns starts the movement of 
electrolytes and fluids across cellular membranes (mainly 
of phosphates and potassium). These very rapid changes 
can lead to lethal consequences, such as cardiac arrest. 
As mentioned above, glucose intake in a case of vitamin 
depletion can also precipitate Wernicke syndrome. In 
consequence, re-feeding should be considered very 
carefully in people at risk, that is, those who have had no 
food intake for more than 10 days (5 days if the body mass 
index is under 18.5 kg/m2) or with laboratory low levels of 
phosphate and potassium (13).
Torture and inhumane or degrading  
treatment
Medical personnel seriously violate the rules of medical 
ethics if they:
•	 in	 any	way	 assist	 in	 (even	 by	merely	 being	 present)	
sessions of torture or inhumane and degrading 
treatment or advise the torturers or those inflicting 
such treatment;
•	 provide	 facilities,	 instruments	 or	 substances	 to	 that	
effect;
•	 certify	that	a	prisoner	is	able	to	withstand	a	torture	or	
inhumane treatment session; or
•	 weaken	 the	 resistance	 of	 the	 victim	 to	 torture	 or	
inhumane treatment.
The health service in a prison can, however, potentially 
play a very important role in the fight against ill-treatment 
within prisons and elsewhere, specifically police stations. 
In the context of medical consultations, people sometimes 
show physical signs or mental symptoms compatible with 
having been subjected to torture or other forms of cruel, 
inhumane or degrading treatment.
In view of this, the physical and mental examinations 
carried out on admission of a prisoner are particularly 
important.
During a physical examination (most specifically, the one 
carried out on arrival), any trace of violence compatible 
with torture or inhumane treatment must be duly noted 
and registered (photos are desirable) both in the prisoner’s 
personal file and in any general register of traumatic 
injuries. Likewise, any psychological or psychiatric 
disturbances that may indicate that a person has been 
subjected to ill-treatment must be recorded. Such 
information must be automatically transmitted without 
delay to the supervising authorities. Prisoners should be 
entitled to obtain a copy of the medical report concerning 
them at any time.
However, the simple fact of being identified by the health 
care services as bearing traces of traumatic lesions or 
mental symptoms compatible with torture or inhumane 
treatment can trigger reprisal measures against the 
victim. To protect patients from this risk of retaliation, 
doctors must formally inform them that they are going to 
report to the competent authority the evidence they have 
gathered during the consultation. If the patients fear that 
they will be subjected to reprisal, they may decide not to 
divulge how the lesions were inflicted and even lie about 
them.
In their reports, doctors must clearly distinguish between 
the patient’s allegations (circumstances of the physical or 
mental trauma as described by the patient) and complaints 
(subjective sensations experienced by the patient), and 
the clinical and para-clinical objective findings (such 
as mental state; size, location, aspect of the lesions; 
X-rays and laboratory results). If the doctors’ training 
and/or experience allow, they must indicate whether 
the patients’ allegations are compatible with their own 
clinical findings.
Capital punishment and executed prisoners as 
sources of organs
Health professionals should never be complicit in any 
way (even by their presence) with capital punishment, 
and should not be involved in examining the detainee 
immediately before the execution nor in confirming death 
or issuing the death certificate. The donation of organs 
after an execution associates the medical profession with 
the execution and should, therefore, be prohibited (14).
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4. Violence, sexual abuse and torture in prisons 
Jens Modvig
Key points 
•	 Violence	in	prisons	is	often	clandestine	because	of	the	
fear of reprisal when it is reported.
•	 Because	 violence	 is	 not	 brought	 into	 the	 open,	 it	 is	
easily overlooked or underestimated.
•	 Authorities	 are	 obliged	 to	 protect	 prisoners	 against	
violence, which must not constitute an additional 
punishment on top of deprivation of liberty.
•	 Violence	begets	 violence,	 so	 prison	 violence	 inhibits	
rehabilitation for normal life.
•	 Violence	occurs	mostly	 in	high-security	 facilities	and	
prisons with coercive practices, even though the 
security measures have been established to minimize 
the violence.
•	 A	 key	 performance	 indicator	 for	 the	 prevention	 of	
violence is that prisoners feel safe and secure.
•	 About	 25%	 of	 prisoners	 are	 victimized	 by	 violence	
each year while 4–5% experience sexual violence and 
1–2% are raped.
•	 Prevention	may	focus	on	the	prisoners	by	 identifying	
groups with special needs who are at risk of being 
victimized.
•	 Prevention	 may	 focus	 on	 creating	 a	 positive	 prison	
climate to encourage respect, humanity and fairness.
Introduction
Prisons are violent places compared to the community. 
United States government statistics demonstrate that 
rates of physical assault for male inmates are more than 
18 times higher than the equivalent rates for males in 
the general population. For female inmates, the rates are 
more than 27 times higher (1).
Violence in prisons is and should be a prison management 
and prison health service priority issue for several reasons. 
First, violence begets violence, that is, exposure to violence 
during adolescence increases the risk of later violent and 
non-violent crime, drug use and intimate violence against 
or from a partner (2). Thus, the rehabilitation or corrective 
dimension of imprisonment is undermined if prisoners are 
placed in an environment that makes them more violent 
and more criminal than before.
Second, in international law, prisoners are entitled to 
protection against violence such as assault, rape and 
torture. According to principle 5 of the United Nations 
Basic Principles for the Treatment of Prisoners: “Except 
for those limitations that are demonstrably necessitated 
by the fact of incarceration, all prisoners shall retain the 
human rights and fundamental freedoms set out in the 
Universal Declaration of Human Rights …” (3).
Thus, state authorities have an obligation to ensure 
that prisoners enjoy protection against all human rights 
violations.
Third, a violent institution is more difficult and expensive to 
manage than a secure and safe institution with a positive 
climate, including a positive working environment.
Violence is difficult to address and assess precisely 
because it is surrounded by silence and, therefore, 
often underreported. Violence is – except for a justified 
proportionate use of force by staff – illegal and punishable. 
For this reason, reporting of violence committed by 
prisoners or by staff may lead to reprisals and retaliation 
(“snitches get stitches”). While this may also be the 
case in the world outside the prison, the deprivation 
of liberty means that a victim who reports the violence 
has no possibility of escape from the retaliation by the 
perpetrator. A study found that 25% of respondents who 
had not reported their most recent experiences of assault 
said that they did not believe that reporting victimization 
would make a difference. An additional 20% did not 
report an assault because they feared retaliation (4). 
Comparisons of official violence and disorder statistics 
with unofficial statistics indeed reveal that the official 
statistics underestimate the problems (5).
Definitions of violence in prison
WHO has defined violence as “The intentional use of physical 
force or power, threatened or actual, against oneself, 
another person, or against a group or community, that either 
results in or has a high likelihood of resulting in injury, death, 
psychological harm, maldevelopment or deprivation” (6).
It is noteworthy that the definition includes threats such as 
the potential use of force, and that the defining outcome 
is not only injury or death but also psychological harm, 
maldevelopment and deprivation.
Violence may further be categorized as self-directed, 
interpersonal or collective when directed towards: 
(i) oneself; (ii) one’s family, intimate partner or unrelated 
person; and (iii) specifically defined groups for reasons of 
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a social, political or economic agenda. Organized groups 
or states may perpetrate collective violence. The nature 
of the violence may be physical, psychological, sexual or 
deprivation/neglect (7).
In a prison context, the prison authorities have a general 
obligation to protect inmates against any type of violence, 
including excessive use of force. This chapter will address 
how prison authorities, including prison health services, 
may address the issue of violence.
Except for a proportionate use of force required for 
security procedures (which is outside the scope of this 
chapter), the many types of violence that may occur in 
prisons include:
•	 suicides,	suicide	attempts	and	self-harm;
•	 physical	violence	(beatings,	fights)	among	prisoners;
•	 psychological	 violence	 such	 as	 threats,	 bullying	 or	
humiliation;
•	 sexual	assaults	of	prisoners	by	other	prisoners	or	by	
prison staff;
•	 excessive	violence	committed	by	prison	staff	towards	
prisoners amounting to torture or ill-treatment;
•	 violence	by	prisoners	against	prison	staff,	from	single	
events to prison riots.
Suicide attempts and self-harm are outside the scope 
of this chapter. The following discussion will deal with 
violence more generally between prisoners, between 
prisoners and staff, sexual violence, torture and ill-
treatment. The occurrence of the violence and underlying 
risk factors will be addressed and the final section will 
discuss the prevention of prison violence, both among 
inmates and perpetrated by prison staff.
On a technical note, the measures of violence used in the 
studies reviewed include the proportion of all prisoners 
exposed to violence, whether victimized once or several 
times (sometimes called the prevalence rate). This 
measure reflects the proportion of all prisoners surveyed 
as to their exposure to violence in the period of interest. 
This might be their lifetime prevalence or those who were 
exposed during a current or recent period of incarceration, 
for example, in the previous 6 or 12 months.
The studies of violence in prisons do not have uniform 
measures of frequency, although United States studies 
tend to focus on the most recent six months. In some 
studies, the reference period is not explicit. The 
differences between the estimates may be rather small, 
especially if the average period in prison was between 6 
and 12 months, exposed prisoners were typically exposed 
more than once, and the prisoner had been in prison only 
once or twice before.
Violence in prisons
Prisoner-on-prisoner 
A recent study found a six-month male prevalence rate 
of 205 per 1000 for prisoner-on-prisoner physical violence 
and 246 per 1000 for staff-on-inmate physical violence (1). 
In other words, 20% of the prisoners had been subjected 
to physical violence by other prisoners and 25% to 
violence by prison staff during the preceding six months. 
For females, the prisoner-on-prisoner rate was the same 
whereas the staff-on-prisoner rate was 8%, that is, male 
prisoners experience more staff-on-inmate violence than 
female prisoners do.
Small to medium-sized facilities had higher prevalence 
rates of inmate-on-inmate physical violence, whereas 
medium-sized and large facilities had higher staff-on-
inmate rates of physical violence. For comparison, the six-
month sexual violence victimization rates for both sexes 
were 42 per 1000 for any sexual victimization and 15 for 
non-consensual sexual acts (8).
Fairly consistent with the American study, a recent 
Australian study reported that 34% of the male inmates and 
24% of the female inmates reported having been physically 
assaulted at any time during their imprisonment, and 7% of 
both genders had been threatened with sexual assault (9).
Juveniles seem to be involved in prison misconduct and 
violence more frequently than slightly older prisoners and 
even more than adults (10).
Prisoner-on-staff
Obviously, violence in prisons makes prisons a violent 
workplace for the staff. A study of direct, injury-producing 
violence using workers’ compensation claims in a random 
sample of 807 correctional officers in an urban prison 
revealed that 25.9% reported one episode and 20.3% 
reported two or more violent episodes during an average 
length of employment of approximately 10 years (11). 
Thus, at least half of the prison staff suffered injury due 
to violence during a 10-year employment period. The 
main risk factors for male employees being exposed to 
workplace violence were long-term substance-abuse, 
whereas female employees seem to have a violence-
reducing effect on the inmate population.
Kratcoski (12) found that more than 70% of the violence 
against staff occurred in the detention/high security 
areas, during the day shift, predominantly directed 
towards trainees with little experience and committed by 
young inmates aged 25 years or less.
Sexual violence in prisons
Sexual violence is particularly difficult to study and assess 
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because of the stigma associated with being raped or 
abused and also because of the risk of reprisals from the 
perpetrator. Sexual violence may be defined as behaviour 
that leads a person to feel that he/she is the target of 
aggressive intentions (13). This may also include sexual 
pressure. In a recent study, sexual victimization was 
viewed more narrowly as non-consensual sexual acts with 
oral, vaginal or anal penetration as well as abusive sexual 
contacts (touching or grabbing in a sexually threatening 
manner or touching genitals) (14).
Estimates of sexual assault victimization have varied 
between 1% and 41%, depending on what was included. 
The annual rate in United States prisons seems to converge 
at about 5% or less (14). A thorough review and meta-
analysis of studies of prison rape proper concluded that 
1.9% of inmates have experienced a completed episode 
of sexual victimization during their entire period(s) of 
incarceration (15). 
Recently, Wolff & Shi (14) found that 4% of male inmates 
and 22% of female inmates reported that they had been 
subject to prisoner-on-prisoner sexual victimization 
(most often abusive sexual contact such as inappropriate 
touching) during the previous six months. At least one type 
of staff-on-prisoner sexual victimization was reported by 
7% of male inmates and 8% of female inmates. Non-
consensual prisoner-on-prisoner sexual acts amounted 
to less than 2% over six months, while staff-on-prisoner 
non-consensual sexual acts were less than 1.1%.
In 2007, the United States Department of Justice 
conducted a national inmate survey of 60 500 prisoners 
using an audio computer-assisted self-interview. The 
survey showed that 2.1% of the prisoners reported 
inmate-on-inmate victimization and 2.9% reported staff-
on-inmate victimization. Of the latter, about half was 
reported as unwilling activity (16).
A study in a juvenile correctional centre in South Africa, 
comprising interviews with 439 offenders, revealed that 
29% said that they had been assaulted, attacked or 
physically hurt while in the facility. Of these, 68% had 
been beaten, pushed, stamped on or the like, 21% had 
been stabbed and 7% had been assaulted sexually (4).
Of a random sample of current prisoners in California, 
4% had experienced sexual violence (rape, other sexual 
assault) and 59% of transgender prisoners reported that 
they had been the victim of such experiences (17,18). A 
British study found, by interviewing ex-prisoners, that 1% 
of prisoners had been sexually coerced involving sexual 
intimacy and 4% had been subjected to forced drug 
searches.
Sexual coercion in United States female facilities 
showed rates almost as high as male rates: up to 27% 
of female prisoners had experienced sexual coercion at 
some point in any prison in the state. Of these, about 
25% (7/27) resulted in rape (19), that is, a prison-life rate 
of 7–8%.
Sexual victimization during imprisonment is experienced 
by between 1% and 40% of the inmates, while physical 
victimization is experienced by between 10% and 25% 
of the inmates (20). However, the resulting estimates 
obviously depend on the investigation methodology, 
including the sample and the phrasing of the question 
posed to the interviewees. Wolff and colleagues found 
that when they used the same questions, 0.2% of women 
in a community sample reported being raped (attempted 
or completed) during a 12-month period compared to 4.6% 
of women during a 6-month period in prison. The rates 
of physical assault on men were 0.9% in a community 
sample over a 12-month period and 32.9% in prison during 
a 6-month period (19).
Wolff & Shi (14) included in their survey questions about 
the emotional consequences of their worst incidents of 
sexual victimization. The majority of the targets reported at 
least one consequence – most frequently feeling distrust, 
nervousness, social apprehension, and worry about 
recurrence and depression. Also, sexual victimization 
within the previous six months was associated with 
feeling unsafe. Lockwood (13) reports that a victim of a 
prison sexual assault finds it difficult to reintegrate into 
society and tends to become more violent. Many prisoners 
worry about their sexual identity.
Torture and ill-treatment
Torture is a subgroup of collective violence, defined 
specifically by the severity of the pain, the intentionality, 
the purpose and the perpetrator. In the United Nations 
Convention Against Torture and other Cruel, Inhuman 
or Degrading Treatment (21), torture is defined as: 
(i) severe pain or suffering, physical or mental; (ii) inflicted 
intentionally; (iii) with a specific purpose such as to obtain 
a confession or to punish; and (iv) by a person acting in a 
public capacity. In contrast, cruel, inhuman or degrading 
treatment (also called ill-treatment) may involve less but 
still substantial pain or suffering and not necessarily be 
committed for a specific purpose.
Torture is prohibited according to international law, and 
there are no circumstances that justify an exception to 
this prohibition. Nevertheless, according to human rights 
reports, torture is practised in about 130 countries and is 
widespread and systematically used in 80–100 countries 
(22). 
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Hostilities facilitate torture, for example, between the 
warring parties in an armed conflict or between religious, 
sexual or political majorities and minorities. Such 
hostility may develop into de-individualization and de-
humanization. Torture may be interpreted as socialized 
obedience in an environment where the perpetrators see 
themselves as performing a great service by punishing a 
group that they perceive deserves ill-treatment (23). For 
this reason, minorities (of a sexual, political or religious 
nature) are at increased risk of being victims of torture 
and may be in need of stronger protection measures.
Pre-trial detainees are at special risk of torture because 
their investigation is ongoing. Obtaining a coerced 
confession may be viewed as attractive by law enforcement 
authorities. In addition to coercing a confession by use of 
torture or other types of excessive use of force, isolation 
is particularly sensitive for pre-trial detainees. The mental 
health impact of isolation is well documented (24); the use 
of solitary confinement on an accused pre-trial detainee 
may cause suffering and pressure to force confession to 
a crime that the detainee might not have committed or 
admitted.
In some torture settings, the signs of torture may serve a 
political purpose as a show-case, to scare the opposition 
or dissidents from being politically active. Here, methods 
leaving physical marks (unsystematic and systematic 
beatings, electrical torture, cuts and amputations) indeed 
serve their purpose. In other settings, the regime pretends 
to comply with human rights and applies torture methods 
which leave no marks so that international missions do 
not detect them. Torture that leaves no visible marks 
can include psychological torture, such as deprivation, 
induced desperation, threats, sexual humiliation or 
desecration (25). Humiliation through strip-searching is a 
routine practice  in many countries (26).
Documentation of torture, both the torture methods 
used and the medical documentation of the health 
consequences of torture, is best made according to 
an internationally recognized standard procedure: the 
Istanbul Protocol (27). Documentation of torture in places 
of detention often takes place in connection with national 
or international external monitoring mechanisms.
Torture leaves severe marks on the body and mind. A 
recent review of 181 studies demonstrates that post-
traumatic stress disorder and depression are frequent 
consequences of torture and related trauma (28).
The main approach to the prevention of torture is 
the independent monitoring of prisons. Monitoring 
mechanisms, which represent the outside world looking 
at what goes on behind bars, can contribute to prevention 
through making recommendations to the authorities and/
or by making the findings known to the public.
National monitoring mechanisms include:
•	 prison	inspectorate/police	inspectorate;
•	 parliamentary	committees;
•	 lay	monitoring	committees;
•	 national	 preventive	 mechanisms	 established	 or	
appointed according to the Optional Protocol to the 
United Nations Convention against Torture – often an 
ombudsman or national human rights institutes;
•	 national	nongovernmental	organizations.
International mechanisms include:
•	 the	United	Nations	Sub-Committee	for	the	Prevention	
of Torture;
•	 the	United	Nations	Special	Rapporteur	for	Torture;
•	 the	International	Committee	for	the	Red	Cross;
•	 the	 Council	 of	 Europe	 Committee	 for	 the	 Prevention	
of Torture and Inhuman or Degrading Treatment or 
Punishment;
•	 international	nongovernmental	human	rights	organiza-
tions.
Many intergovernmental monitoring bodies operate with a 
mandate based on confidentiality, and publication of their 
findings may only take place if the host state party agrees. 
Thus documentation of the occurrence of torture rarely 
originates publicly from these bodies, but rather from 
national and international nongovernmental organizations 
(such as Amnesty International and Human Rights Watch) 
in their country or annual reports.
Prevention of violence in prisons
To address the prevention of violence, the starting point 
is in the explanation of models of violence. To understand 
prison violence, there are two main schools of thought (29). 
The importation model emphasizes that prisoners bring 
their violence-prone behaviour to the institutions through 
their histories, personal attributes and links to criminal 
groups, for example. This model would direct prevention 
efforts toward addressing the individual prisoners’ 
proneness to violence through initiatives such as anger 
management programmes.
The deprivation model holds that the prison environment 
and loss of freedom cause psychological trauma so that, 
for self-preservation, prisoners create an oppositional 
prison subculture promoting violence. This model would 
direct prevention efforts towards the environmental 
factors and general prison climate, which need to be 
addressed by prison management.
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Recent literature has predominantly focused on the details 
of prison organization, interactions between people and 
situational factors of considerable significance for prison 
violence.
Risk factors associated with prisoners
Individual risk factors for committing violence range from 
potential violence to assaults with serious injuries. Youth 
and short sentences are associated with higher levels of 
violent misconduct, while older age, drug convictions and 
a higher educational attainment indicate reduced violent 
misconduct (30). Using injury registries (violence- and 
accident-related), Sung (31) found that a history of violent 
offences, violent victimization and psychiatric treatment 
were associated with increased risk of injuries. Work 
assignments reduced violence-related risks but increased 
the possibility of accident-related risks.
Wolff, Blitz & Shi (32) studied sexual victimization in 
prison for inmates with and without mental disorders, and 
found that the rates were approximately 2.5 times higher 
for inmates with a mental disorder and three times higher 
among female inmates compared to males.
Other special needs groups are likely to be at risk of 
victimization, such as inmates suffering from chronic 
diseases, minorities (ethnic, sexual, religious) and inmates 
with substance abuse. Also the rising population of older 
prisoners is victimized to a large degree (33). Considering 
the health problems and functional deficits prevailing 
among older prisoners, it is likely that such victimization 
has a considerable impact on their quality of life and 
feelings of safety and security.
Situational risk factors
Studies have found a greater risk of violent incidents in 
higher-security facilities (34). This might be expected 
because high-security facilities host more violence-
prone prisoners. However, it might also be expected that 
security measures serve to manage the risk of violence 
and thereby prevent it. An explanation put forward by 
Gadon and colleagues is that increased surveillance 
creates greater levels of violence through a self-fulfilling 
prophecy.
There is also evidence that mixing the ages of prisoners 
may be associated with lower levels of violence than 
those found among groups of younger prisoners.
A study including 371 American prisons revealed that 
poor prison management is associated with assaults on 
both prisoners and staff (35). The management variables 
included the guard–inmate ratio, guard turnover rate, 
ratio of white–black correctional staff, involvement in 
educational, vocational or industrial programmes and size 
of institution. Violence between inmates and violence 
against staff are correlated because staff are often injured 
during attempts to break up fights between inmates (12).
Most violent episodes occur at the weekends, which could 
be a consequence of the lack of vocational and educational 
activities during the weekends (34). Crowding is assumed 
to be a risk factor for violence, but the evidence for this is 
not convincing (34). 
In conclusion, risk factors for violence in prison settings 
involve factors related to the level of security, mix 
of prisoners, staff experience, days of the week and 
management approaches and relationships between 
different staff groups (34).
It is also a plausible assumption that fights among 
inmates are often triggered by disagreements about 
underground economy issues such as money, drugs, 
weapons and mobile phones. Copes et al (36) studied the 
phenomenon in survey data from 208 recently released 
inmates in a midwestern state (United States) and 
concluded that participation in the prison economy (being 
in debt, borrowing money and having too little money to 
buy goods) is predictive of victimization through violence:
Although the picture is complex, and some inconsistent 
findings have emerged, generally the literature supports the 
notion that the more coercive the prison environment the 
greater potential for violence. This is especially so where 
prison management and treatment of prisoners are perceived 
by prisoners as unfair or illegitimate, as this strengthens 
prisoner solidarity in opposition to the authorities (29).
The joint efforts of ombudsmen, prison inspectorates 
and independent monitoring bodies have not managed 
to change the culture of casual cruelty in prisons (37). 
Inspection standards developed in a monitoring context 
may, however, serve as standards for further quality 
assurance. One example is the healthy prison concept 
developed by Her Majesty’s Prison Inspectorate in the 
United Kingdom (37), testing whether prisoners are:
•	 held	in	safety
•	 treated	with	respect	for	their	human	rights
•	 offered	purposeful	activity	
•	 prepared	for	re-settlement	into	the	community.
Recently, performance indicators have emerged as a 
way of measuring institutional development. In terms of 
violence prevention, an example of a key performance 
indicator may be the proportion (say, 90%) of prisoners who 
felt safe the first night in prison and generally thereafter. 
Measuring the status of this indicator empirically (through 
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surveys) and comparing actual performance to the target 
performance will provide an indication of the need for 
further measures.
On a more holistic note, the concept of the moral 
performance of prisons has been developed by Liebling 
(38) to identify the important qualities of a prison from the 
point of view of inmates. This is a conceptual framework 
that is related to the overall social climate and respect 
for prisoners in general, and to the occurrence of violence 
and abuses specifically. The overall values included in this 
concept are: 
•	 respect
•	 humanity
•	 staff–prisoner	relationships
•	 trust
•	 support
•	 power/authority
•	 social	relations
•	 fairness
•	 order
•	 safety
•	 well-being
•	 personal	development
•	 family	contact
•	 decency
•	 meaning
•	 quality	of	life.
A tool has been developed (Measuring Quality of Prison 
Life) to measure the compliance of prisons with this 
conceptual framework. This tool has been included in 
the routine assessments made by Her Majesty’s Prison 
Inspectorate in the United Kingdom.
The role of the prison health services
While the prison management, including security 
measures and prison climate, has been identified above as 
the key factor in preventing violence, the health services 
have the potential to make an important contribution 
to the prevention of violence. Access to health care is 
associated with the prison climate: a positive prison 
climate facilitates interactions between correctional and 
health care staff and prisoners, while in negative climates 
correctional staff act as a filter or barrier between inmates 
and the health services (39).
Registration and documentation of violence
When violence leads to injuries or to psychological 
consequences, the prison health service is frequently 
involved in attending to the victims. In delicate cases (cases 
of sexual violence, torture, or staff-on-prisoner violence), 
the health services may be involved under a false pretext, 
such as accidents, fights between prisoners or “falls”. They 
may even be pressured to make a false report on the causes 
of the injury. However, it is important to develop a precise 
health information registry of the causes and circumstances 
of the injury, that is, violence between prisoners or between 
staff and prisoner. With an injury registry in place, the 
injury data can provide indispensable information on how 
to prevent violence through the examination of such factors 
as the place, time and day, circumstances, persons involved 
and the nature of the violence.
Of particular importance for the prevention of violence is 
the initial medical examination carried out on arrival in the 
institution (40). This examination should focus on, inter 
alia, identification of indications (report, signs, symptoms) 
of violence or even torture experienced prior to arrival at 
the institution. A careful record should be made of such 
signs and symptoms and made available to the prisoner 
for potential subsequent complaint or legal remedy.
In addition to the health information registry of episodes of 
violence for internal consumption and quality development, 
the health services need to have a reporting mechanism 
to independent authorities, such as the ministry of health 
or an independent human rights body, to ensure that the 
delicate and punishable cases of violence, torture or 
sexual abuse may be evaluated neutrally, according to 
international standards such as the Istanbul Protocol.
The integrity of the health services, that is, the ability 
to operate professionally independent of the prison 
management, is at stake here, as is the technical capacity 
to document sensitive cases of violence, torture and 
sexual abuse for future documentation and legal remedy.
Protecting special needs groups
As mentioned above, many special needs groups (ethnic, 
sexual and religious minorities, minors) are at increased 
risk of being victimized by violence, sexual abuse and 
even torture. This also applies to prisoners with mental 
health disorders.
The initial medical examination may serve to identify 
prisoners with such special needs at an early stage. This 
allows the prison health service – with the consent of 
the prisoners – to put forward recommendations for their 
protection, often through meeting the special needs that 
apply to each group.
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5. Solitary confinement as a prison health issue
Sharon Shalev
Key points 
•	 Solitary	confinement	is	used	in	prison	systems	across	
the world.
•	 Research	demonstrates	that	solitary	confinement	has	
a negative impact on the health and well-being of 
those subjected to it, especially for a prolonged time.
•	 Those	with	pre-existing	mental	illness	are	particularly	
vulnerable to the effects of solitary confinement.
•	 Solitary	 confinement	 can	 affect	 rehabilitation	 efforts	 
and former prisoners’ chances of successful reintegra-
tion into society following their release.
•	 International	human	rights	 law	requires	 that	 the	use	
of solitary confinement must be kept to a minimum 
and reserved for the few cases where it is absolutely 
necessary, and that it should be used for as short a 
time as possible.
Introduction
WHO defines health as a “state of complete physical, 
mental and social wellbeing, not merely the absence 
of disease or infirmity”, affirming that health, as 
defined, is a fundamental human right (1). Solitary 
confinement negatively affects all these aspects of 
health. It is an extreme form of confinement whose 
deleterious physical, mental and social health 
effects have long been observed and documented 
by practitioners and researchers alike. Yet solitary 
confinement is a common and universal feature of 
prison systems worldwide, used throughout the 
various stages of the criminal justice process and for a 
variety of reasons including punishment, containment 
and protection. This chapter offers a brief overview 
of the practice, with a particular focus on key issues 
relevant to prison health care staff.
What is solitary confinement?
The term “solitary confinement” refers to the physical 
and social isolation of an individual in a single cell 
for 22.5 to 24 hours a day, with the remaining time 
typically spent exercising in a barren yard or cage (2–4).2 
Different jurisdictions may use other terms to describe 
what is essentially a regime of solitary confinement as 
defined above, including segregation, isolation, closed 
confinement, 23/7 regime, cellular confinement and 
super-maximum security (supermax).3 
The deprivation of human contact inherent in solitary 
confinement is usually accompanied by additional 
restrictions and controls applied to the prisoner. The exact 
nature of these will of course vary from one jurisdiction 
to another. But in most, isolated prisoners will have very 
limited, if any, access to educational, vocational and 
recreational activities, all conducted in isolation from 
others. The number and type of personal belongings 
allowed in prisoners’ small, sometimes windowless cells 
are highly restricted and closely regulated. Their cells 
and few belongings are closely monitored and regularly 
searched. Inside their cells, prisoners are monitored 
either by closed circuit television or directly by guards. 
Family visits, where allowed at all, may be held through 
a glass barrier, preventing any physical contact between 
the prisoner and others. On the few occasions prisoners 
leave their cells, they are typically escorted by a minimum 
of two guards and restrained with handcuffs and in some 
cases placed in additional body restraints, such as leg-
irons and body-belts. Prior to being returned to their cells, 
they will be body-searched and, in some jurisdictions, 
subject to a full body-cavity search.
In short, isolated prisoners would typically spend a 
minimum of 22.5 hours a day locked up alone in a small 
cell with few personal belongings and little to do. 
They are routinely subjected to body searches and the 
application of physical restraints, as well as limits on their 
communication with the outside world. This regime can 
last for months or years, and can be of an indeterminate 
duration.
How does solitary confinement affect 
health and well-being?4
The physical conditions in solitary cells range from 
reasonably sized cells with windows and natural light, 
self-contained with a toilet and a shower screened-off 
from the rest of the cell to protect the prisoner’s privacy, 
to small, windowless, filthy cells where prisoners have 
to use a bucket to relieve themselves. Similarly, in some 
2  The requirement to provide prisoners with a minimum of one hour of fresh air and exercise daily is enshrined in international law as well as in national laws in 
many jurisdictions. 
3  This should be distinguished from isolation (or seclusion) for medical purposes, which is not discussed here.
4  This section is adapted from Chapter 2 of the Sourcebook on solitary confinement (3).
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prisons, isolated prisoners may have access to books, 
television and a radio inside their cells, whereas in others 
prisoners may only be allowed a copy of a religious text, if 
any books at all. Finally, the degree and quality of human 
contact prisoners enjoy varies greatly, from no human 
contact other than with silent prison staff who deliver 
food and medication to the prisoner inside his cell, to 
regular contact with family, lawyers, religious personnel 
and so on.
Three main factors are inherent in all solitary confinement 
regimes: social isolation, reduced activity and 
environmental input, and loss of autonomy and control 
over almost all aspects of daily life. Each of these factors 
is potentially distressing. Together they create a potent 
and toxic mix, the effects of which were well summarized 
as early as 1861 by the Chief Medical Officer at the 
Fremantle Convict Establishment in Western Australia: 
In a medical point of view I think there can be no question 
but that separate or solitary confinement acts injuriously, 
from first to last, on the health and constitution of anybody 
subjected to it ... the symptoms of its pernicious constitutional 
influence being consecutively pallor, depression, debility, 
infirmity of intellect, and bodily decay (5).
The rich body of literature that has accumulated since 
that time on the effects on health of solitary confinement 
largely echoes these observations and includes anxiety, 
depression, anger, cognitive disturbances, perceptual 
distortions, paranoia and psychosis among other 
symptoms resulting from solitary confinement. Levels of 
self-harm and suicide, which are already much higher 
among prisoners than in the general population (6), rise 
even further in segregation units (3,7).
The effects on health of solitary confinement include 
physiological signs and symptoms, such as:
Psychological symptoms occur in the following areas and 
range from acute to chronic: 
•	 anxiety,	ranging	from	feelings	of	tension	to	full-blown	
panic attacks:
 − persistent low level of stress;
 − irritability or anxiety;
 − fear of impending death;
 − panic attacks;
•	 depression,	varying	from	low	mood	to	clinical	depression:
 − emotional flatness/blunting;
 − emotional liability (mood swings);
 − hopelessness; 
 − social withdrawal, loss of initiation of activity or 
   ideas, apathy, lethargy;
 − major depression;
•	 anger,	ranging	from	irritability	to	rage:
 − irritability and hostility;
 − poor impulse control;
 − outbursts of physical and verbal violence against 
   others, self and objects;
 − unprovoked anger, sometimes manifesting as rage;
•	 cognitive	 disturbances,	 ranging	 from	 lack	 of	
concentration to confused states: 
 − short attention span;
 − poor concentration;
 − poor memory;
 − confused thought processes, disorientation;
•	 perceptual	 distortions,	 ranging	 from	 hypersensitivity	
to hallucinations:
 − hypersensitivity to noises and smells;
 − distortions in time and space;
 − depersonalization, detachment from reality;
 − hallucinations affecting all five senses (for example, 
   hallucinations of objects or people appearing in the 
   cell, or hearing voices);
•	 paranoia	 and	 psychosis,	 ranging	 from	 obsessional	
thoughts to full-blown psychosis: 
 − recurrent and persistent thoughts (ruminations) 
  often of a violent and vengeful character (for 
     example, directed against prison staff);
 − paranoid ideas, often persecutory;
 − psychotic episodes or states: psychotic depression, 
   schizophrenia;
•	 self-harm	and	suicide.
How individuals will react to the experience of being 
isolated from the company of others depends on personal, 
environmental and institutional factors, including their 
individual histories, the conditions in which they are held, 
the regime provisions which they can access, the degree 
and form of human contact they can enjoy and the context 
of their confinement. Research has also shown that both 
the duration of solitary confinement and uncertainty as to 
the length of time the individual can expect to spend in 
solitary confinement promote a sense of helplessness and 
increase hostility and aggression (3). These are important 
determinants of the extent of adverse health effects 
experienced.
•	 gastro-intestinal	and 
 genito-urinary problems
•	 diaphoresis
•	 insomnia
•	 deterioration	of 
 eyesight
•	 lethargy,	weakness,	 
 profound fatigue
•	 feeling	cold
•	 heart	palpitations
•	 migraine	headaches
•	 back	and	other	joint 
 pains
•	 poor	appetite,	weight 
 loss, diarrhoea
•	 tremulousness
•	 aggravation	of 
 pre-existing medical 
 problems.
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The adverse effects of solitary confinement will thus vary, 
depending on the pre-morbid adjustment of the individual 
and the context, length and conditions of confinement. 
The experience of previous trauma will render the person 
more vulnerable, as will the involuntary nature of his/her 
solitary confinement and confinement that persists over 
a sustained period of time. Initial acute reactions may be 
followed by chronic symptoms if the regime of solitary 
confinement persists.
There is, however, and regardless of these variables and 
with a few notable exceptions,5 a general consensus 
among health practitioners and researchers that solitary 
confinement adversely affects health and well-being 
and prisoners’ chances of successful reintegration into 
society.6 Indeed, observations on the effects of solitary 
confinement are so consistent that Harvard psychiatrist 
Stuart Grassian, a long-time researcher of and 
commentator on solitary confinement, contends that the 
constellation of these effects forms a unique syndrome, 
which he terms the “isolation syndrome”:
… while this syndrome is strikingly atypical for the 
functional psychiatric illnesses, it is quite characteristic of 
an acute organic brain syndrome: delirium, characterized 
by a decreased level of alertness, EEG abnormalities 
... perceptual and cognitive disturbances, fearfulness, 
paranoia, and agitation; and random, impulsive and self-
destructive behaviour … (13).
Particularly vulnerable groups
While the effects of solitary confinement vary from one 
individual to another and depend on the factors listed 
above, some individuals are particularly vulnerable to 
the negative effects of isolation, including those with 
pre-existing mental and learning disabilities, children 
and young people and detainees held on remand. These 
categories are briefly examined below.
Prisoners with mental problems
People who suffer mental problems are grossly 
overrepresented in prisons in general, and in 
segregation units in particular (7,14). Such individuals 
may be segregated for their own protection because 
they are victimized by other prisoners, or they may end 
up in isolation because they misunderstand the rules 
and regulations that govern prison life. They may also 
behave in ways that, in the context of high-security 
confinement, are interpreted as violations of rules rather 
than a manifestation of their mental problems. Where 
prisoners’ progression through the system depends on 
their behaviour and perceived adherence to prison rules, 
this can “turn a minor incident into a serious situation” 
(15) and lead to a vicious cycle which results in a 
prolonged stay in isolation, where these very conditions 
make them worse and less able to abide by the rules 
and regulations. Furthermore, placement in isolation, as 
noted earlier, also limits prisoners’ access to privileges, 
programmes and work release assignments and affects 
their chance of early parole (15).
Experts largely agree that individuals with pre-existing mental 
illness are at a particularly high risk of worsening psychiatric 
problems as a result of their isolation (for example, Grassian 
(13); Haney (16); Kupers (17); Reid (18)). This is increasingly 
being recognized by the courts on both sides of the Atlantic. 
In a case involving the placement of a prisoner with known 
mental health problems in punitive isolation for 45 days and 
his subsequent suicide, for example, the European Court on 
Human Rights reiterated that:
… the vulnerability of mentally ill persons calls for special 
protection. This applies all the more where a prisoner 
suffering from severe disturbance is placed, as in [this] case, 
in solitary confinement or a punishment cell for a prolonged 
period, which will inevitably have an impact on his mental 
state, and where he has actually attempted to commit 
suicide shortly beforehand (19).
In a class action lawsuit involving the Security Housing 
Unit at Pelican Bay, California, federal judge Thelton 
Henderson observed that conditions there may well “hover 
on the edge of what is humanly tolerable for those with 
normal resilience, particularly when endured for extended 
periods of time” (20). But for some, the conditions of 
prolonged isolation at the Unit were not tolerable. These 
prisoners included, according to the court:
The already mentally ill, as well as persons with borderline 
personality disorders, brain damage or mental retardation, 
impulse-ridden personalities, or a history of prior psychiatric 
problems or chronic depression. For these inmates, placing 
them in the SHU is the mental equivalent of putting an 
asthmatic in a place with little air to breathe (18).
The particularly devastating effects that solitary 
confinement has on the mentally ill were more recently 
also recognized by the American Psychiatric Association, 
5   Most recently, these include O’Keefe et al. (8), who found that: “segregated offenders were elevated on multiple psychological and cognitive measures when 
compared to normative adult samples. However, elevations were present among the comparison groups too, suggesting that high degrees of psychological 
disturbances are not unique to the [administrative segregation] environment”. The study also found that mentally ill prisoners were more aggravated by their 
experiences of isolation than prisoners who were not (diagnosed as) mentally ill, but this was true whether they were in segregation or the general population. The 
study and its methodology were the subject of much criticism, including by Cassela (9) and Grassian (10), among others (11).
6   For full referencing and review of the literature, see Shalev (3) and Scharff Smith (12).
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which stated that: “Prolonged segregation of adult inmates 
with serious mental illness, with rare exceptions, should be 
avoided due to the potential for harm to such inmates” (21).
Children and young adults 
Children and young adults are still developing physically, 
mentally and socially. This makes them particularly 
vulnerable to the negative effects of solitary confinement 
which, as psychologist Craig Haney put it, is the 
equivalent of placing them in a deep-freeze. Furthermore, 
the prevalence of mental illness among young people in 
prison is even higher than among adult prisoners, with as 
many as 95% having at least one mental health problem 
and 80% having more than one (6). In this context, it is 
important to note that young people in prisons are 18 
times more likely to commit suicide than their counterparts 
in the community (6). In 2012, a task force appointed by 
the United States Attorney General to report on children 
exposed to violence noted the following:
Nowhere is the damaging impact of incarceration on 
vulnerable children more obvious than when it involves 
solitary confinement .... Juveniles experience symptoms 
of paranoia, anxiety, and depression even after very short 
periods of isolation. Confined youth who spend extended 
periods isolated are among the most likely to attempt or 
actually commit suicide. One national study found that among 
the suicides in juvenile facilities, half of the victims were in 
isolation at the time they took their own lives, and 62 percent 
of victims had a history of solitary confinement (22).
The practice of isolating young people, both in juvenile 
facilities and in adult prisons, either for their own 
protection or as punishment is nonetheless common. In 
Texas, for example, a 2012 survey found that “the majority 
of jails held juveniles in solitary confinement for  6 months 
to more than a year” (22).7 An inquiry into the use of 
physical restraint and solitary confinement of children in 
England and Wales found that solitary confinement was 
widely used in institutions for young offenders: during an 
18-month period, for example, 519 children were placed in 
solitary confinement in 6 such institutions (23).
Such practices and the particular vulnerability of 
young people have led international bodies as well as 
professional associations to call for a prohibition on the 
use of solitary confinement for juveniles. Rule 67 of the 
United Nations Rules for the Protection of Juveniles 
Deprived of their Liberty (24) specifically lists solitary 
confinement among a list of prohibited treatments:
All disciplinary measures constituting cruel, inhuman or 
degrading treatment shall be strictly prohibited, including 
corporal punishment, placement in a dark cell, closed or solitary 
confinement or any other punishment that may compromise 
the physical or mental health of the juvenile concerned. The 
reduction of diet and the restriction or denial of contact with 
family members should be prohibited for any purpose. 
The Istanbul Statement (2), the United Nations Special 
Rapporteur on Torture (4) and the Essex Expert Group (25), 
among others, all call for a complete ban on the use of 
solitary confinement with juveniles and young people. The 
American Academy of Child and Adolescent Psychiatry 
has stated that where solitary confinement is used, the 
young person should be evaluated by a mental health 
professional within 24 hours (26).
Pre-trial detainees
Detainees held on remand are another particularly 
vulnerable group, and research shows that their 
vulnerability is made worse in solitary confinement. In 
England and Wales, one study found that 54% of prison 
suicides took place among detainees held on remand, 
and that around half of these occurred within one month 
of being taken into custody (27). Another study, of 
detainees held on remand in Denmark, found that where 
detainees were isolated for four weeks, “the probability 
of being admitted to hospital for a psychiatric reason 
was about 20 times as high as for a person remanded 
in non-solitary confinement for the same period of time” 
(28,29). A more recent longitudinal study commissioned 
by the Swedish Prisons and Probation Service to 
examine the health effects of restricted detention among 
those held on remand (including solitary confinement) 
found that such detention poses a “significant risk of 
mental illness” (30) even when other factors (previous 
psychiatric contact, substance abuse, gender, parenting) 
are controlled for. One in four of those detained with 
restrictions suffered mental illness, compared to one 
in five of those held without restrictions. A qualitative 
study carried out in parallel to the main study found that 
three factors are particularly harmful to mental well-
being and behaviour in prison: passivity, uncertainty and 
feelings of impotence. These factors, which are present 
to some degree in any form of confinement, are of course 
magnified in isolation.
In sum, the literature shows that solitary confinement is 
damaging across the board, with young people, detainees 
held on remand and people with learning difficulties and 
mental illness being particularly vulnerable to the damaging 
7   In the United States, a jail is a city or county prison.
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effects of solitary confinement. The key negative health 
effects of solitary confinement are listed above.
Long-term effects
While some of the adverse health effects of solitary 
confinement will subside on its termination, others 
may persist. The lasting effects of solitary confinement 
are perhaps most evident in social settings and with 
interpersonal relationships:  
Although many of the acute symptoms suffered by 
inmates are likely to subside upon termination of solitary 
confinement, many – including some who did not become 
overtly psychiatrically ill during their confinement in solitary 
– will likely suffer permanent harm as a result of such 
confinement. This harm is most commonly manifested by a 
continued intolerance of social interaction, a handicap which 
often prevents the inmate from successfully readjusting 
to the broader social environment of general population in 
prison and … often severely impairs the inmate’s capacity 
to reintegrate into the broader society upon release from 
imprisonment (13).
The transition from life in solitary confinement to co-
existence with others, whether in general prisons or in 
free society, can be sharp and unsettling. Some of the very 
survival skills adopted in reaction to the pains of isolation, 
such as withdrawal and going mute, render the individual 
dysfunctional upon release. Some become so dependent 
on the structure and routines of the prison for controlling 
their behaviour that they find it difficult to function 
without them. This problem of becoming institutionalized 
is experienced by many prisoners on their release, but it 
takes on a much more acute form when the transition is 
from years of social isolation (31). Unable to regain the 
necessary social skills to lead a functioning social life, 
some of those held in solitary confinement in prison may 
continue to live in relative social isolation after their 
release. In this sense, solitary confinement operates 
against one of the main purposes of the prison, which is 
to rehabilitate offenders and facilitate their reintegration 
into society.
When and why is solitary confinement 
used in contemporary penal systems?
Each state has its own peculiarities but in most, solitary 
confinement is used throughout the different stages of 
the criminal process: pre-charge, pre-trial and following 
conviction. The principle of isolation is common to all these 
uses, but each entails slightly different arrangements and 
has a different rationale and different official goals.
Solitary confinement can be used:
•	 when	 a	 suspect	 is	 being	 questioned	 before being 
charged, to prevent collusion between suspects; it 
is also an  interrogation technique, particularly for 
people suspected of committing acts against state 
security;
•	 when	 a	 suspect	 has been charged and is awaiting 
trial; the purpose of isolating detainees held on 
remand is to prevent collusion and to prevent them 
from intimidating potential witnesses;
•	 during the trial and immediately after it in a penal 
institution while the newly arrived prisoner is being 
risk assessed.
Solitary confinement also has several roles or purposes 
during imprisonment. It can be used:
•	 as	a	 short	 term-punishment	 for	prisoners	who	break	
prison rules;
•	 to	prevent	escape;
•	 for	the	prisoners’	own	protection	to	prevent	them	from	
harming themselves or being harmed by others;
•	 as	a	prison	management	tool	for	the	safe	management	
of difficult and challenging prisoners, and for the 
management of prisoners belonging to certain groups 
(such as prison gang members);
•	 where	capital	punishment	is	still	practised;	death	row	
prisoners are typically held in solitary confinement, 
and where the death penalty has been abolished it is 
often substituted with a sentence of life in conditions 
of solitary confinement, on the basis that prisoners 
sentenced to death have nothing to lose and may 
therefore commit serious crimes inside prison or 
indeed attempt to escape;
•	 increasingly,	with	immigration	detainees	(32,33);
•	 while	 awaiting	 transfer	 to	 another	 prison	 or	 to	 a	
hospital, disciplinary or classification hearing, or a 
bed; these are temporary measures, but in some cases 
the prisoner may be isolated for many weeks and 
sometimes months;
•	 de facto; staff shortages, convenience or as group 
punishment can mean that prisoners are confined to 
their cells for an entire day or for several days at a 
time in what is commonly known as lockdown.
As Hayes (14) notes, all these protocols could be 
considered hidden forms of isolation.
Whatever the reason for placing a detainee or prisoner 
in solitary confinement, its use in any one case must be 
proportionate and reasonable and the decision taken by 
the competent lawful authority. The prisoner must be 
informed, in writing, of the reasons for his/her placement 
in solitary confinement, its expected duration and the 
appeal process. A record of the decision must be kept 
on file, and it must be substantively reviewed at regular 
intervals by a body different to that which took the initial 
decision (3,25,34).
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How do international law and human rights 
bodies view solitary confinement?
The severity of solitary confinement and its potentially 
devastating effects on the health and well-being of those 
subjected to it are recognized under international law, 
where the practice occupies a special place. The United 
Nations has gone as far as calling for its abolition as 
punishment (35). Rule 60.5 of the European Prison Rules 
states: “Solitary confinement shall be imposed as a 
punishment only in exceptional cases and for a specified 
period of time, which shall be as short as possible” (36).
The courts and international monitoring bodies also pay 
particular attention to the practice and, in the light of its 
severity, have asserted that it is a practice which in some 
circumstances constitutes a form of torture, inhuman 
or degrading treatment (see, for example, the United 
Nations Special Rapporteur on Torture (4,37); the CPT 
(34); and European Court of Human Rights cases including 
Ramirez Sanchez v. France [2006] (38) and Razvyazkin v. 
Russia [2012] (39)).
As far back as 1978, the former European Commission of 
Human Rights stated the following: 
Complete sensory isolation coupled with complete social 
isolation can no doubt ultimately destroy the personality; 
thus it constitutes a form of inhuman treatment which 
cannot be justified by the requirements of security, the 
prohibition on torture and inhuman treatment contained in 
Article 3 being absolute in character (40).
This position has since been affirmed and reaffirmed by 
the European Court in numerous cases: see, for example, 
Ramirez Sanchez, v. France [2006] (38), Öcalan v. Turkey 
[2005] (41) and Babar Ahmad and Others v. the United 
Kingdom (42). More recently, in a case involving the 
isolation for more than three years of a prisoner labelled 
as a persistent rule-breaker, the court reiterated that: 
“... solitary confinement without appropriate mental and 
physical stimulation is likely, in the long term, to have 
damaging effects, resulting in deterioration of mental 
faculties and social abilities” (39).
To fall under the scope of Article 3, the prisoner’s treatment 
must cause suffering which exceeds the unavoidable 
level inherent in detention (Onoufriou v. Cyprus [2010] 
(43)), depending on the court’s assessment of all the 
circumstances of the case, such as the duration of the 
treatment, its physical and mental effects and, in some 
cases, the state of health of the victim (Kudła v. Poland 
[2000] (44); Peers v. Greece [2001] (45)). The purpose of 
such treatment will be taken into account, in particular 
the question of whether it was intended to humiliate or 
debase the victim, but the absence of any such purpose 
does not necessarily mean that Article 3 has not been 
violated (45).
While solitary confinement has always been viewed 
by international human rights law and bodies as an 
undesirable, if legitimate, prison practice, it is only in 
the last few years that a more concentrated and targeted 
campaign against its use  especially for prolonged 
periods, has begun. In 2007, a group of international 
experts adopted the Istanbul Statement on the Use and 
Effects of Solitary Confinement, calling on states to 
limit the use of solitary confinement to very exceptional 
cases, for as short a time as possible, and only as a 
last resort (2). In 2008, the then United Nations Special 
Rapporteur on Torture, Manfred Nowak, endorsed these 
recommendations and added that: “Regardless of the 
specific circumstances of its use, effort is required to raise 
the level of social contacts for prisoners: prisoner-prison 
staff contact, allowing access to social activities with 
other prisoners, allowing more visits and providing access 
to mental health services” (35).
In August 2011, the then new United Nations Special 
Rapporteur on Torture, Juan Mendez, focused his periodic 
report to the United Nations General Assembly on the 
practice of solitary confinement, stating that it is a “harsh 
measure which may cause serious psychological and 
physiological adverse effects on individuals” and which 
can violate the international prohibition against torture 
and cruel, inhuman or degrading treatment (4). Importantly, 
the Special Rapporteur called for the absolute prohibition 
of prolonged solitary confinement, which he defined as a 
period in excess of 15 days. Soon thereafter, in November 
2011, the CPT also focused its annual report on solitary 
confinement, stating that it is a practice which “can have 
an extremely damaging effect on the mental, somatic and 
social health of those concerned. This damaging effect 
can be immediate and increases the longer the measure 
lasts and the more indeterminate it is” (34). The CPT called 
on states to reduce the use of solitary confinement to an 
absolute minimum and ensure that its use in any given 
case meets what the CPT has termed the PLANN test: it 
must be proportionate, lawful, accountable, necessary 
and non-discriminatory (34).
Conclusion
Solitary confinement is a prison practice whose harmful 
effects on health and well-being are well documented. The 
extent of psychological damage varies and will depend on 
individual factors (such as personal background and pre-
existing health problems), environmental factors (physical 
conditions and provisions), regime (time out of cell, degree 
of human contact), context of the isolation (punishment, 
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own protection, voluntary/non-voluntary, political/
criminal) and its duration. Notwithstanding variations in 
individual tolerance and environmental and contextual 
factors, there is remarkable consistency in research 
findings on the health effects of solitary confinement 
dating back to the 19th century. These have demonstrated 
negative health effects, in particular psychological but 
also physiological.
The best way to avoid such damage to health and well-
being is not to isolate prisoners. Where this is absolutely 
necessary, it should only be done as a last resort and for as 
short a time as possible. The decision to place a prisoner in 
solitary confinement must always be made by a competent 
body, transparently and in accordance with due process 
requirements, and be subject to regular, independent and 
substantive review. The prisoner must be kept in decent 
physical conditions and have regular access to fresh air 
and exercise. Educational, recreational and vocational 
programmes must be provided to prisoners, ideally in 
association with others, and prisoners should be allowed 
to keep books, magazines, hobbies and craft materials 
in their cells. They must be afforded regular, meaningful 
human contact, ideally also with people from outside 
the prison, but prison staff should also be encouraged to 
communicate informally with prisoners who are held in 
solitary confinement. Finally, isolated prisoners should be 
allowed, and encouraged, to maintain contact with their 
friends and family, through open (contact) visits, letters 
and telephone communications. Crucially, prisoners must 
always be treated with respect for their inherent dignity 
as human beings.
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Key points 
Pre-trial detainees are a particularly vulnerable group 
when it comes to health conditions and the provision of 
health services.
•	 Many	 more	 people	 move	 in	 and	 out	 of	 pre-trial	
detention than will spend time in prison after 
conviction.
•	 People	 in	pre-trial	detention	have	been	arrested	and	
accused of a crime but not been found guilty of the 
crime(s) charged.
•	 Places	of	pre-trial	detention	are	often	ill-equipped	to	
provide health services.
•	 People	 in	 pre-trial	 detention	 often	 spend	 time	 in	
worse conditions than people who have already been 
convicted.
•	 According	 to	 international	 legal	 standards,	 health	
interventions should be available at the earliest 
possible stage in the criminal justice system.
•	 Particular	 attention	 should	 be	 devoted	 to	 ensuring	
continuity of treatment at all stages of the criminal 
justice process.
•	 Under	international	legal	standards,	pre-trial	detention	
is to be used as an exceptional cautionary measure and 
wide use is to be made of alternatives to detention.
•	 Pre-trial	 release	 (release	 pending	 completion	 of	 the	
criminal justice process) can be an effective health 
intervention by allowing people to be supervised in 
the community where health services are more readily 
available. It is also an effective way to reduce prison 
overcrowding.
Introduction
It is estimated that about one third of the global prison 
population is detained prior to the completion of a 
criminal justice process. In a single year, more than 
10 million people globally will spend some time in this 
type of detention. That is, they have been arrested 
for an alleged offence and are held but have not been 
found guilty of that crime. In many countries, pre-trial 
detainees account for the majority of people incarcerated 
by the criminal justice system, thereby contributing to 
overcrowding issues (where such exist).
In some instances, pre-trial detainees are held in special 
pre-trial detention centres but in others, they are held 
in police cells or in prisons along with the convicted 
population. Where pre-trial detainees are held in special 
pre-trial detention centres, these centres may not provide 
the same health services as the prisons because they are 
considered short-term detention facilities. Police cells are 
often ill-equipped to house detainees longer-term, and 
often lack even basic necessities such as toilets or beds. 
On the other hand, where pre-trial detainees are held in 
prisons with convicted prisoners, they may not be provided 
with access to the existing facilities owing to their non-
convicted status. For example, they may be denied 
treatment that requires a long-term commitment (such 
as treatment for TB) because they are deemed temporary 
detainees, or they may not have access to prison services 
simply because they are not under the legal jurisdiction of 
the prison while they are awaiting trial. In addition, people 
frequently experience interruption of critically important 
medications, such as medication to treat HIV, TB or drug 
dependence, upon arrest, when they are detained in 
police cells, transferred to pre-trial detention facilities or 
appearing in court.
Defining pre-trial detention
Most criminal justice systems formally differentiate 
between sentenced and unsentenced prisoners, that is, 
people who have been charged and convicted of a crime 
and people who have been arrested on suspicion of a crime 
but have yet to be tried and convicted. It is helpful to note 
that the terms unsentenced prisoner, pre-trial detainee, 
remand prisoner, remandee, awaiting trial detainee and 
untried prisoner are used interchangeably in the literature. 
According to Penal Reform International, “remand 
prisoners are detained during criminal investigations and 
pending trial. Pre-trial detention is not a sanction, but a 
measure to safeguard a criminal procedure” (1). Most 
countries will also afford individuals who are accused 
but not convicted a different legal status, in keeping with 
international standards and norms.
Guidelines
International human rights norms emphasize the important 
distinction between people who have been found guilty 
(convicted by a court of law and sentenced to prison) and 
those who have not. Prisoners awaiting their trial, or the 
outcome of their trial, are regarded differently because 
the law sees them as innocent until found guilty (2–5).
The use of pre-trial detention is restricted by several 
international human rights treaties. The International 
Covenant on Civil and Political Rights states the following 
in the relevant part (2):
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Anyone arrested or detained on a criminal charge shall be 
brought promptly before a judge or other officer authorized 
by law to exercise judicial power and shall be entitled to trial 
within a reasonable time or to release. It shall not be the general 
rule that persons awaiting trial shall be detained in custody, but 
release may be subject to guarantees to appear for trial.
International standards permit detention before trial only 
under certain, limited circumstances. In 1990, the Eighth 
United Nations Congress on the Prevention of Crime and 
Treatment of Offenders (6) established the following 
principle:
Pre-trial detention may be ordered only if there are reasonable 
grounds to believe that the persons concerned have been 
involved in the commission of the alleged offences and 
there is a danger of their absconding or committing further 
serious offences, or a danger that the course of justice will 
be seriously interfered with if they are let free.
One of the major achievements of the Eighth United 
Nations Congress was the adoption, by consensus, of the 
United Nations Standard Minimum Rules for Non-custodial 
Measures (the Tokyo Rules) (7). These rules provide that 
pre-trial detention shall be used as a means of last resort 
in criminal proceedings, and that alternatives to pre-trial 
detention shall be employed at as early a stage as possible.
The tenor of international norms and standards in relation 
to pre-trial detention is clear: restricting a defendant’s 
freedom should be used sparingly and under prescribed 
circumstances only. It follows that detention of an 
accused should occur under circumstances that preserve 
the presumption of innocence and will not entail a 
punishment without a trial.
Challenges of pre-trial detention
Pre-trial detainees can be a particularly vulnerable 
group. The hours following an arrest can be confusing: 
there may be a delay in communicating with the outside 
world; torture to obtain confessions, when it happens, 
typically occurs before trial; and temporary places of 
detention (such as police cells) are often dirty, poorly lit 
and ventilated, overcrowded and lacking basic equipment 
such as beds and toilets.
Various factors exacerbate poor health conditions in 
pre-trial detention. Firstly, pre-trial detention is seen as 
a temporary circumstance with the ultimate goal being 
dismissal of charges, acquittal or conviction after trial. 
This creates three subsets of problems:
•	 in	many	countries	pre-trial	detention	occurs	in	facilities	
that are ill-equipped to deliver health services or to 
house long-term residents, such as police stations;
•	 in	 other	 countries,	 pre-trial	 detainees	 fall	 under	 the	
jurisdiction (care) of an institution other than the 
agency that oversees convicted prisoners, leading to 
accountability and oversight problems;
•	 in	many	countries,	pre-trial	detainees	are	not	entitled	
to participate in programmes that facilitate recovery 
and re-entry into the community because these are 
characterized as rehabilitation programmes and 
a person who has not been convicted cannot by 
definition be rehabilitated.
Unfortunately for pre-trial detainees, the short-term nature 
of their status is often part of an illusory legal construct. 
In 2003, the average length of pre-trial detention in 19 of 
the then 25 member states of the European Union (EU) 
was five and a half months, according to a European 
Commission investigation (8). But in some EU countries 
(such as France), pre-trial detention can be allowed for 
years and there are reports of people spending as many 
as six years without conviction (9, p.25). In Ireland, 
individuals can spend 12 months without even a review 
of the grounds for detention, let alone a trial (9, p.26). 
In many developing countries, the situation is worse. In 
2005, the average length of pre-trial detention in Nigeria 
was 3.7 years (10). In 2010, half of Nigeria’s pre-trial 
detainees had been detained for between 5 and 17 years, 
according to the country’s National Prison Service (11), 
with cases reported of detainees awaiting trial for up 
to 20 years (12). In Pakistan, many defendants “spend 
more time behind bars awaiting trial than the maximum 
sentence they would receive if eventually convicted” 
(13), notwithstanding the fact that the law stipulates that 
detainees must be brought to trial within 30 days of their 
arrest.
In many countries the majority of people in prison are pre-
trial detainees. Likewise, in many countries, prisons are 
overcrowded by housing many more inmates than they 
were designed to hold. Where these two factors conflate, 
the health problems associated with prison overcrowding 
arise from a failure to provide provisional release – in 
violation of international norms – to people who have not 
been convicted and are qualified to await their trial in the 
community.
Interruption of treatment is one of the most complex 
issues facing pre-trial detention centres and detainees. 
For people who have been receiving treatment for a 
medical condition in the community, arrest and detention 
represent a potentially deadly interruption of treatment. 
Treatment may be discontinued for short or long periods of 
time following arrest and detention in police cells, when 
detainees are transferred to other facilities or have to 
appear in court, and upon release. Of particular concern 
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is the interruption of treatments (such as for HIV) that 
can lead to negative health outcomes for the individual 
patient and also, through development of drug-resistant 
strains of HIV, to negative public health consequences.
Even where pre-trial detainees have access to the same 
services as convicted prisoners, prison health care is 
often limited in some ways. Prisons may not have the 
necessary specialized equipment, they may carry some 
types of medication but not others, the medical team in 
the prison may not be experienced in a particular illness, 
and/or prison regulations may prevent family members 
from providing medical assistance, such as doctors or 
medication, even when it is not available in the institution 
and they have the resources to provide it.8 
Improving health conditions at the pre-trial 
stage
Health delivery in prisons should meet the minimum standards 
set out in international laws, rules and conventions. Most of 
the problems described here would be greatly diminished by 
a reduction in pre-trial detention and the use of less restrictive 
alternatives, such as provisional release paired with a referral 
to community health care. Without reduced use of pre-trial 
detention and the attendant problems of overcrowding, 
it is difficult to imagine how these problems will be 
addressed. As stated in the 2013 policy brief HIV prevention, 
treatment and care in prisons and other closed settings: a 
comprehensive package of interventions, “reducing the 
excessive use of pre-trial detention and greatly increasing 
the use of non-custodial alternatives to imprisonment 
are essential components of any response to HIV and 
other health issues in prisons and other closed settings” 
(14, p.1). In addition to this solution, however, there are ways 
in which health services could be improved and the possibility 
enhanced for observing the health rights of persons in 
detention. Some of these measures might also generate 
information that would be helpful in advocating the reduced 
use of pre-trial detention. Some avenues toward improved 
practices and enhanced information are described below.
Investing in improved pre-trial detention health 
services as a state obligation and an opportunity for 
early detection, care and linkage to continued care
Pre-trial health services and staffing are often inadequate 
compared to those in prisons and do not fulfil the state’s 
obligation for early detection of health problems and 
initiation of care. The non-involvement of ministries of 
health in remand health services undermines links to 
community-based care and may compromise the quality 
of health services in remand facilities and the right to 
equivalence of services for detainees. Pre-trial detention 
is often a missed opportunity to avert illness and even 
death, especially in cases of HIV, hepatitis, TB and some 
mental disorders that require extended treatment and for 
which early detection and treatment are crucial to good 
outcomes. As mentioned above, it is extremely important 
to ensure the continuation of therapy begun before a 
person’s entry into detention. Each of the situations in 
which treatment may be interrupted should be addressed 
and mechanisms established to ensure this does not 
happen. Policies and guidelines should be developed 
specifying that people living with HIV (and other conditions 
necessitating uninterrupted treatment) are allowed to 
keep their medication with them, or are to be provided 
with their medication upon arrest and detention and at 
any time they are transferred within the system or to court 
hearings. Police and staff working in detention settings 
need to be educated about the importance of continuity 
of treatment. Particular attention should be devoted to 
discharge planning and links to community aftercare.
Because the organization of pre-trial detention may be 
chaotic, with a rapid turnover of detainees, there is a 
tendency not to initiate services that could be sustained 
even in such an environment. Again, links between 
community-based and prison-based care are crucial. 
It should be possible to include pre-trial detention in a 
continuum of care with regard to methadone therapy, 
for example, as well as directly observed treatment, 
short-course for TB and antiretroviral treatment for HIV. 
Health promotion and information involving peers should 
be possible, even with a high turnover, if staff develop 
rapid orientation and training to build capacity for peer 
leadership and engagement.
Finally, the provision of adequate basic services, including 
health care, water, sanitation, food and protection from 
the cold and/or heat, would have important benefits 
beyond the obvious public health outcomes. To the degree 
that detainees, including children and women, have to 
trade sex for access to food, blankets and water, adequate 
provision of these basic services will be a disincentive to 
coercive sex. Violence linked to competition for access to 
basic amenities would also be reduced.
Transparency, complaint mechanisms, access to 
counsel
Much of what is known about the unhealthy and 
inhumane conditions faced by pre-trial detainees is 
8 It is commonplace in the United States, for example, to refuse to provide any medication to inmates that was not purchased through the prison system, to avoid 
issues of provenance and legality of substances. This means that if, for instance, a schizophrenic person is arrested and is carrying medication on his/her person, 
the authorities will confiscate that medication, assuming that it is contraband, and substitute the closest equivalent found in the prison dispensary.
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found in reports of occasional visits by regional and 
international human rights monitors. There is an urgent 
need to open pre-trial detention conditions to wider 
scrutiny, and to establish regular monitoring and public 
reporting mechanisms. In many countries, access to legal 
counsel and to the courts by pre-trial detainees would 
be one avenue for addressing abusive and negligent 
health practices. There should also be functioning and 
sustained mechanisms for detainees to report abuses 
and seek redress without endangering themselves. Such 
mechanisms should involve competent and independent 
health professionals.
Mechanisms for prison staff to be independent and 
to speak out against abuse
Health professionals working in detention settings 
need to be able to make independent, evidence-based 
decisions to ensure that health needs and rights are met. 
Their role as advocates for the health of detainees should 
be safeguarded. They should also be protected from 
being complicit in any practice that may constitute cruel, 
inhuman or degrading treatment or torture, but must be 
held accountable if they cross that line.
Involvement of ministries of health 
Achieving equivalence of care in prisons and remand 
facilities to that of care in the community argues for 
greater involvement of ministries of health. At a minimum, 
they should be responsible for monitoring the quality 
of care for detainees. The complete isolation of prison 
and remand health services from the principal health 
authorities of the state is a recipe for trouble.
Awareness-raising among key stakeholders
In addition to the need for more information and research, 
there is an urgent need for what is already known 
about health in pre-trial detention to be more widely 
disseminated, especially to those whose actions might 
affect change. Ministries of health may be shielded 
from day-to-day knowledge of conditions and services 
if they are not involved in remand facilities, but their 
involvement and awareness of conditions are important 
for positive change to happen. Beyond the health sector, 
judges, prosecutors, police, juvenile justice officials 
and other people involved in law enforcement must be 
made aware of the health consequences of heavy use 
of pre-trial detention. Human rights commissions and 
nongovernmental organizations not already involved with 
prison health should be engaged.
Research and access to research results
Access to detention settings for researchers may be 
restricted in many countries. The fact that health services 
may be managed in remand facilities by ministries other 
than the ministry of health may be a barrier to researchers 
accustomed to interacting with health sector officials. In 
particular, there are research needs in the following areas:
•	 better	 data	 on	 the	 extent	 of	 pre-trial	 detention,	
particularly among women, children, people living 
with drug dependency, people with mental illness and 
others vulnerable to abuse and health problems;
•	 the	 relationship	 between	 the	 extent	 and	duration	 of	
pre-trial detention and a variety of health outcomes;
•	 the	physical	and	mental	health	impact	of	overcrowding	
in pre-trial detention, including whether it is possible 
to determine critical levels of crowding that trigger 
accelerated transmission of infectious diseases;
•	 the	 physical	 and	 mental	 health	 impact	 of	 extended	
pre-trial detention on men, women and children;
•	 the	 difficulties	 faced	 by	 health	 professionals	 in	
situations of pre-trial detention where services are 
inadequate and abuse is prevalent;
•	 best	 practices	 for	 ensuring	 continuity	 of	 care	 for	 a	
wide range of physical and mental health conditions 
between the community and pre-trial detention, and 
pre-trial detention and prison or the community;
•	 the	 feasibility	of	and	best	practices	 in	TB	detection,	
treatment and support in pre-trial detention and 
beyond.
Where there are efforts to reform pre-trial justice and 
reduce the use of pre-trial detention, health officials 
and practitioners should be involved in the planning and 
implementation of reforms, and the health impact of 
reforms should be documented.
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7. HIV and other bloodborne viruses in prisons 
Fabienne Hariga
Key points 
•	 The	prevalence	of	HIV,	hepatitis	B	and	hepatitis	C	 is	
particularly high in pre-trial detention centres and in 
prisons.
•	 All	modes	of	transmission	of	these	diseases	occurring	
in the community also occur in prisons: through blood, 
sexual activity and vertical transmission to a child.
•	 Measures	 to	 address	 HIV	 and	 hepatitis	 in	 prisons	
should be comprehensive.
•	 Guidelines	 and	 standard	 operating	 orders	 should	 be	
developed, in line with national guidelines and based 
on international guidelines, to address bloodborne 
viral diseases in prisons.
•	 All	 preventive,	 curative	 and	 supportive	 interventions	
for HIV, hepatitis C and B that are available in the 
community are effective, feasible and needed in 
prisons.
•	 Continuity	of	treatment	is	key	in	the	response	to	HIV,	
including for people going into, transferring between 
or released from prisons.
•	 Measures	 to	 address	 HIV	 and	 AIDS	 in	 prisons	 also	
address HIV and AIDS for staff working in prisons, for 
people visiting prisons and for the entire community.
•	 HIV	 testing	 cannot	 be	 mandatory	 and	 all	 health	
interventions need to have the informed consent of 
the people concerned.
•	 People	living	with	HIV	should	not	be	segregated.
 
Introduction
People in prisons and other closed settings, including 
people working in prisons, are particularly at risk 
for hepatitis B, hepatitis C and HIV, due to their own 
vulnerability compounded by the characteristics of the 
environment. The prevalence of individuals who use 
drugs, including injecting drugs, is particularly high 
in prisons in Europe, a region with an HIV epidemic 
concentrated among the most vulnerable populations, 
especially people who inject drugs. Such people are also 
particularly affected by viral hepatitis, especially hepatitis 
C. Each of these diseases is preventable and each has 
a treatment. The overuse of imprisonment and pre-
trial detention for drug users is responsible for the high 
prevalence of HIV and hepatitis among prisoners. In the 
absence of preventive measures, transmission can also 
occur in prisons. The lack of access to preventive, curative 
and palliative care in prisons, poor prison conditions and 
poor prison management all contribute to increasing the 
risk of transmission of bloodborne diseases.
Bloodborne viruses
HIV and AIDS
HIV is a virus that infects cells of the human immune system 
and progressively impairs their function. Infection with HIV 
leads to immune deficiency, making people vulnerable to 
a wide range of diseases. About one year after an initial 
infection, symptoms will develop. AIDS describes the 
collection of symptoms and infections associated with the 
deficiency of the immune system caused by HIV infection. 
The level of CD4 cells (cells from the immune system) and 
the appearance of certain infections or cancers are used 
as indicators that HIV infection has progressed to AIDS. 
Diseases associated with severe immunodeficiency are 
known as opportunistic diseases. In the prison context, 
the most significant of these is TB, which can spread very 
quickly in overcrowded conditions.
HIV is transmitted when infected blood, semen, vaginal 
fluids or breast-milk enter another person’s body. This 
occurs during unprotected sex, when sharing needles 
during injection drug use or tattooing and piercing, through 
blood transfusion, through unsafe medical care (such as 
the use of improperly sterilized syringes and other medical 
equipment in health-care settings) or through accidental 
puncture with contaminated medical wastes. Women 
living with HIV who become pregnant can transmit HIV 
to their babies during pregnancy or delivery as well as 
through breastfeeding. All these modes of transmission 
can occur in prisons if appropriate measures are not taken.
HIV is not transmitted through casual contact. HIV infection 
is asymptomatic for a long period during which the virus 
can be transmitted to another person. The only way to 
determine whether HIV is present in a person’s body is by 
taking a test for it. There is no vaccine to prevent HIV, and 
there is a treatment but no cure. Antiretroviral therapy 
(ART) slows down the progression of the disease by 
decreasing the amount of virus (viral load) in an infected 
body. The decrease in viral load, for example when people 
are on antiretroviral treatment, also reduces the risk of 
transmission to another person.
Hepatitis B
Hepatitis B is a viral infection of the liver that can cause 
both acute and chronic disease. About 10% of infected 
adults will develop chronic liver disease, with a high risk 
of death from cirrhosis of the liver and/or liver cancer. 
The virus is transmitted through contact with the blood 
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or other bodily fluids (semen and vaginal fluid) of an 
infected person or from an infected mother to her child 
at birth. Hepatitis B is not spread through food or water 
or by casual contact, such as hugging, kissing and sharing 
food or drinks with an infected person. The transmission 
of hepatitis B is thus similar to HIV but the virus is 50 
to 100 times more infectious than HIV. Hepatitis B virus 
(HBV) can survive outside the body for at least seven days. 
It is an occupational hazard for health workers, but it is 
preventable with a vaccine and is curable. More and more 
countries vaccinate infants against hepatitis B during 
national immunization.
Hepatitis C
Hepatitis C is also a liver disease, caused by the 
hepatitis C virus (HCV). It can also be acute or chronic, 
but most of the time the acute phase is unnoticed. 
About 70% of infected persons develop chronic liver 
disease. In the absence of treatment, after 20 years 
of evolution, 5–20% will develop cirrhosis and 1–5% 
will die from cirrhosis or liver cancer. HCV is most 
commonly transmitted through contact with the blood 
of an infected person, such as through receipt of 
contaminated blood transfusions, blood products and 
organ transplants; injections given with contaminated 
syringes, needle-stick injuries; injection drug use; and 
vertical transmission from an HCV-infected mother. It is 
less commonly transmitted through sex with an infected 
person and sharing of personal items contaminated with 
infectious blood. Hepatitis C is also very infectious. It 
is not spread through breast-milk, food or water or by 
casual contact such as hugging, kissing and sharing food 
or drinks with an infected person. Currently, there is no 
vaccine to prevent hepatitis C but it is curable.
The issues or challenges within the prison 
environment
HIV prevalence is generally higher in prisons and pre-
trial detention centres than in the community. People in 
prisons typically come from socially and educationally 
disadvantaged groups with poor access to health care and 
prevention in the community. The populations at highest 
risk for HIV, hepatitis B and C infections in the community, 
such as people who inject drugs and sex workers, are 
over-represented in prison populations. In the absence 
of preventive measures, transmission occurs in prisons. 
Risky behaviour such as sexual intercourse (consensual 
or forced) without protection, sharing injection equipment 
and tattooing and piercing equipment, sharing razors or 
scissors or sharing blood through brotherhood rituals 
occur in prisons in all countries in the world. Epidemics 
have been described in several countries such as 
Estonia (2002), where 300 people were infected in less 
than 6 months. Factors related specifically to the prison 
system and environment that contribute indirectly to HIV 
vulnerability are: overcrowding, poor prison conditions, 
violence, sexual abuse, gang activities, poor classification, 
lack of protection for vulnerable prisoners, stigma and 
discrimination, corruption and poor medical services.
Medical services that are separate from national public 
health programmes, especially from HIV programmes, 
often do not access or use the resources available 
in the community such as medication and guidelines 
for prevention, diagnosis, follow-up or treatment. 
Underfunded and underskilled medical services and 
programmes may be responsible for transmission through 
the use of contaminated medical or dental equipment, 
inadequate sterilization procedures and absence of or 
inadequate universal precautions. In the absence of 
programmes for comprehensive prevention of mother-
to-child transmission, pregnant and nursing mothers can 
transmit hepatitis B or HIV to their children.
A comprehensive approach 
As mentioned above, there are many factors and co-factors 
contributing to the prevalence of bloodborne diseases 
in prisons. Health authorities alone cannot address 
prevention, early identification and treatment. Attention 
from other actors, such as in the environmental, criminal 
justice and prison management areas, is often required. 
The health sector does, however, have a crucial role to 
play in the implementation of health-specific measures 
and in raising the awareness of prison managers about 
other essential interventions.
A comprehensive approach needs to be taken, including 
protecting staff, since transmission can occur in prisons, 
people entering prison can already be infected with HIV 
and some can be severely ill (Fig. 1). In 2013, UNODC in 
collaboration with the International Labour Organization, 
the United Nations Development Programme, WHO and the 
Joint United National Programme on HIV/AIDS (UNAIDS) 
published a policy brief on a comprehensive response to 
HIV in prisons (1). This included a comprehensive package 
of interventions, mainly in connection with the health 
sector, as under: 
•	 information,	education	and	communication;	
•	 condom	programmes;
•	 prevention	of	sexual	violence;
•	 drug	 dependence	 treatment	 including	 opioid	
substitution therapy;
•	 needle	and	syringe	programmes;
•	 prevention	of	transmission	through	medical	or	dental	
services;
•	 prevention	of	transmission	through	tattooing,	piercing	
and other forms of skin penetration; 
•	 post-exposure	prophylaxis;
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•	 HIV	testing	and	counselling;
•	 HIV	treatment,	care	and	support;
•	 prevention,	diagnosis	and	treatment	of	TB;	
•	 prevention	of	mother-to-child	transmission	of	HIV;
•	 prevention	 and	 treatment	 of	 sexually	 transmitted	
infections;
•	 vaccination,	diagnosis	and	treatment	of	viral	hepatitis;
•	 protection	of	staff	from	occupational	hazards.
The evidence
By definition, an intervention that is effective in the 
community to prevent or to treat a disease should be 
effective in prisons. However, the prison system, and 
sometimes each prison in the system, needs to develop 
or adapt new implementation modalities to ensure 
effective access to and impact from the intervention. 
There is a need to be creative and to discuss the objective 
of the interventions with all stakeholders to ensure 
they understand and to identify the best modalities for 
implementation and evaluation. Prison-specific evidence 
has been collected on the prevention of sexually-
transmitted infections (STIs) and programmes for condoms, 
treatment for HIV, needle and syringe programmes and 
treatment for drug dependence in prisons.
Interventions
Prevention
The similarities in modes of transmission of bloodborne 
diseases means that measures for their prevention are 
almost all valid for all three diseases.
Information, education and communication for 
prisoners and prison staff
Information is not enough to prevent the transmission 
of HIV or hepatitis but it is an essential precondition 
to the implementation of HIV prevention measures in 
prisons. The main principle is that all information on 
bloodborne diseases that is available to the community 
should be tailored to the needs, cultural and educational 
backgrounds and languages of the prison population, both 
staff and prisoners. All types of support, including hard 
copy, videos, radio programmes and electronic support can 
be used, and staff or prisoners should actively participate 
in developing them. Education programmes in prisons 
Fig. 1. HIV management in prison settings men who have sex with men
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are more likely to be effective if they are developed 
and delivered by peers, although nongovernmental 
organizations can play a leading role in developing, 
implementing and monitoring them. These programmes 
should cover all the aspects of the diseases – prevention 
of transmission, testing and treatment – and they should 
address stigma and discrimination.
Prevention of sexual transmission and provision of 
condoms and lubricants
In prisons, consensual sex occurs between men, between 
women and between men and women. However, sex in 
prison is a major taboo, which makes access to condoms 
a particular challenge. There is evidence that when 
programmes are well-prepared and well-implemented 
they are effective and are not the source of problems.
Condoms and lubricant should be easily, discreetly and 
freely accessible. Staff in each prison should identify the 
best locations for making them accessible, taking into 
account the layout of the building, leadership and the 
movement of prisoners within the premises. In addition, 
it is essential to make condoms available in the intimate 
visit rooms.
Measures to prevent sexual violence, such as proper 
classification, protection of the most vulnerable, rooms 
for conjugal visits and reporting systems must also be put 
in place by prison management.
Prevention of transmission through needles shared 
by injecting drug users
Different modalities have been adopted in several 
countries to make safe injection equipment available in 
prisons through health staff, by peers or through dispensing 
machines. There is evidence that these programmes are 
effective and not the source of security problems. They 
have also been shown to facilitate contacts with health 
staff and enrolment in a drug dependence treatment 
programme. Not only do they prevent transmission 
between injecting drug users but they also protect staff 
by reducing the risk of accidental puncture during cell 
searches. To prevent hepatitis C, the injection kits should 
contain (in addition to the syringes) filters, water and 
cups. Bleach, especially in the prison context, is barely 
or not effective for disinfecting injection equipment 
and preventing the transmission of HIV and hepatitis. 
Whichever system is chosen to provide needles and 
syringes or kits, the method should include a component 
for the safe disposal of used needles and syringes.
Safe tattooing and piercing equipment
Tattooing or piercing is highly prevalent in prisons and 
closely linked to the prison sub-culture. Research has 
demonstrated that injecting drug users tend to get 
tattooed in prison more frequently than other prisoners.
Tattooing workshops, with professionals well-trained to 
give information and show how to operate safely, can be 
held. Alternatively, professional tattooists could be invited 
to offer their services. Information, needles and bleach 
can be distributed to the prisoners. Nongovernmental 
organizations can also play an important role in the 
implementation of such programmes.
Prevention of transmission of hepatitis through 
shavers, scissors, etc.
It is important to ensure that information on the risks 
of transmission, especially of hepatitis, from sharing 
toothbrushes, shavers or scissors is communicated to all 
prisoners. In some countries, all prisoners entering prison 
are given kits with items for personal hygiene to prevent 
the sharing of equipment.
Prevention of mother-to-child transmission
Prevention of the transmission of virus to children begins 
with access to reproductive health and contraception. As 
with pregnant women outside prison, pregnant women in 
prisons need access to the full range of interventions for 
the prevention of mother-to-child transmission, including 
family planning and ART prophylaxis for pregnant and 
breastfeeding mothers. Children born to women living with 
HIV should be followed up according to national guidelines.
To prevent transmission of hepatitis B from mother to child, 
newborns should be vaccinated at birth. The schedule for 
hepatitis B immunization of children recommended by WHO 
consists of a dose within 12–24 hours of birth, followed by 
a second and third dose of vaccines containing hepatitis B 
at intervals of at least 4 weeks. If, as recommended, the 
mother gives birth at the hospital, it must be ensured that 
the vaccination is given to the child as soon as possible 
after birth if the mother has HBV infection, and before they 
leave the hospital in other cases.
To prevent transmission of HIV, all pregnant women who 
are not in need of ART for their own health (CD4 >350 and 
no symptoms of AIDS) require an effective antiretroviral 
prophylaxis strategy to prevent HIV transmission to the 
infant. This prophylaxis should start at the 14th week of 
pregnancy, or as soon as possible when women present 
late in pregnancy, in labour or at delivery (2). Infants born 
to HIV-infected women receiving ART for their own health 
should receive ART for six weeks.
To prevent transmission of HCV, caesarean sections are 
not recommended for HCV-infected pregnant women. 
Mothers with chronic hepatitis C can breastfeed their 
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babies unless they are co-infected with HIV. Children 
of HCV-infected mothers should be tested for HCV-
ribonucleic acid (RNA) one month after birth.
Universal precautions and safe health services (3)
Universal precautions are essential to ensure a safe 
workplace for staff and to prevent accidental or iatrogenic 
transmission of HIV and hepatitis in prisons. In addition 
to the transmission through blood transfusion of infected 
blood or through transplantations, HIV and hepatitis 
can be transmitted through used needles or dental and 
gynaecological equipment or any medical equipment that 
can be in contact with blood. Up-to-date sterilization 
measures, the safe collection and disposal of sharps and 
disposal of medical waste, based on guidelines for health 
(and dental) settings in the community, apply in prisons. 
All cuts and abrasions should be covered. Prison staff 
can be provided with gloves and eye protection to avoid 
accidental exposure to contaminated blood. Training of 
staff is essential for the understanding and application of 
these measures. Posters could be placed in different parts 
of the prisons as reminders of these essential measures.
Hepatitis B vaccination
All staff working in prisons and prisoners should be 
vaccinated against hepatitis B. All prisoners entering 
prisons who have not been vaccinated should be offered 
the hepatitis B vaccination. There is no need to check the 
serological status for hepatitis B before vaccination if 
there is no suspicion of hepatitis B infection. Three doses 
are needed and different schedules are possible. A classic 
schedule requires a minimum of two months. In view of 
the high turnover in prisons and the need to get early 
protection, a rapid schedule might be the best choice, 
as national regulatory authorities allow. But this type of 
schedule requires a booster after one year. A combined 
hepatitis A and B vaccine is particularly indicated for 
people affected by hepatitis C (Table 1).
Post-exposure prophylaxis
Both prisoners and staff can be accidentally exposed to 
body fluids potentially infected by HIV. Post-exposure 
prophylaxis is short-term (one month) ART to reduce 
the likelihood of HIV infection after potential exposure, 
either through sexual activity or blood. Post-exposure 
prophylaxis should only be offered for exposure that has 
the potential for HIV transmission and must be initiated 
within 72 hours after exposure. It is, therefore, essential 
that clear guidelines and standard procedures to follow 
in case of suspected accidental exposure are produced 
and disseminated (4). These guidelines, based on national 
guidelines for post-exposure prophylaxis, should include 
first aid measures, reporting mechanisms, persons to 
contact, support and counselling measures. Most countries 
have a reference centre for post-exposure prophylaxis, 
with people trained to prescribe the treatment.
Drug dependence treatment
Drug dependence treatment, including opioid substitution 
therapy for maintenance, is an essential component of the 
prevention of transmission through injection equipment 
(see Chapter 14).
Testing and counselling
Testing for HIV or hepatitis is both an information 
(prevention) measure and a diagnostic measure. Thus 
whatever the context in which a test is conducted, it 
should be accompanied by pre- and post-counselling for 
both positive and negative test results. Testing for HIV and 
hepatitis, as with any other medical intervention, cannot 
be mandatory. In view of the window period during which 
the test is negative even if a person is infected, and of the 
risk of a person acquiring HIV while in pre-trial detention 
or prison, mandatory testing is not effective. Health 
services in prisons can use rapid tests with laboratory 
confirmation, according to national regulations.
All tests need to ensure the informed consent of the person 
and confidentiality. Every effort must be made to return 
the final results confidentially and within a reasonable 
time (about one week), accompanied by counselling. All 
persons with a positive test for HIV or hepatitis should 
be referred to a service that provides follow-up and 
treatment, including ART and other treatments as needed. 
There is no need for anyone, except the patient and the 
medical doctor, to be informed about the result of a test.
Table 1. Hepatitis B simmunization schedules for adults
Dose Hepatitis B Hepatitis A-B Hepatitis A-B
  (very rapid schedule) (rapid schedule)
First dose day 0 day 0 day 0
Second dose month 1 day 7 1 month later
Third dose 1–12 months later day 21 2 months later
Booster – after 1 year after 1 year
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Testing and counselling for HIV
Health care providers should offer confidential HIV 
testing and counselling to all detainees during medical 
examinations, especially when prisoners ask for it and 
if the previous test was more than 12 months earlier. 
The test should be recommended to all prisoners with 
symptom markers of HIV infection, those with TB, and 
female prisoners who are pregnant.
All detainees should have unhindered access to voluntary 
counselling and HIV testing programmes at any time during 
their detention. Nongovernmental organizations can most 
effectively organize and provide voluntary counselling and 
testing in prisons. Often prisoners will prefer to be tested 
by an external organization.
Testing for hepatitis B 
The viral incubation period for hepatitis B is 90 days on 
average, but can vary from about 30 to 180 days. HBV 
may be detected 30 to 60 days after infection and persist 
for widely variable periods of time. Hepatitis B surface 
antigen (HBsAg) testing is the primary tool for screening 
and diagnosis. A second test a few weeks later is needed 
to confirm a first positive test (5) (Table 2).
Testing for hepatitis C 
The diagnosis of HCV infection is based on detection of 
anti-HCV antibodies by enzyme immunoassay. A positive 
test must be confirmed with an HCV RNA qualitative assay 
or, ideally, with a real-time polymerase chain reaction 
assay.
Hepatitis B test Result Interpretation
HBsAg Negative Susceptible (no recent or old infection)
anti-HBca Negative 
anti-HBsb Negative 
  
HBsAg Negative Immune due to natural infection
anti-HBc Positive 
anti-HBs Positive 
  
HBsAg Negative Immune due to hepatitis B vaccination
anti-HBc Negative 
anti-HBs Positive 
  
HBsAg Positive Acutely infected (less than 6 months)
anti-HBc Positive 
IgMc anti-HBc Positive 
anti-HBs Negative 
  
HBsAg Positive Chronically infected
anti-HBc Positive 
IgM anti-HBc Negative 
anti-HBs Negative 
HBsAg Negative Interpretation unclear; four possibilities:
anti-HBc	 Positive	 •	 resolved	infection	(most	common)
anti-HBs	 Negative	 •	 false-positive	anti-HBc,	thus	susceptible
	 	 •	 low-level	chronic	infection
	 	 •	 resolving	acute	infection
  
a anti-HBc – hepatitis B core antibody
b anti-HBs – hepatitis B surface antibody
c IgM – immunoglobulin
Source: US Centers for Disease Control (6).
Table 2. How to interpret a hepatitis B serological test 
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The diagnosis of chronic hepatitis C is based on the 
detection of HCV infection, confirmed by HCV RNA assay 
(positive anti-HCV antibodies and HCV RNA) in a patient 
with signs of chronic hepatitis.
Collaborative HIV/TB programme
The risk of developing TB is about 12–20 times greater 
among people living with HIV than among those who 
do not have HIV infection. These risks are especially 
serious in prisons, with their high HIV prevalence, high 
TB prevalence rates and environmental conditions 
that include overcrowding, poor ventilation and poor 
light.
Collaborative HIV/TB programmes aim to reduce TB-
related mortality and morbidity among people living with 
HIV and to reduce HIV-related morbidity and mortality (see 
Chapter 8).
Assessment, treatment and follow-up 
HIV
Sustainable HIV treatment programmes in prisons are 
either integrated into or linked to countries’ general HIV 
treatment programmes.
The strategies for treating people living with HIV are:
•	 provision	of	ART	to	reduce	the	progression,	mortality	
and transmission of the disease; 
•	 prevention,	diagnosis	and	 treatment	of	opportunistic	
diseases.
Assessment
The first step for a person diagnosed with HIV is to 
determine the stage of the disease and when to start 
ART. It is, therefore, most important to check any person 
diagnosed with HIV infection every six months. Both 
clinical and immunological criteria are used. Where 
clinical and immunological classifications are both 
available, immune status (reflected by CD4) is usually 
more informative. If there is no access in the country to 
CD4 count, clinical criteria can be used alone.
CD4 cells count is the standard way to assess the 
severity of HIV-related immunodeficiency. HIV infection 
is responsible for a decrease in the number of a specific 
type of lymphocyte, the T cells that bear the CD4 receptor. 
The progressive depletion of CD4 is associated with an 
increased likelihood of opportunistic infections, wasting 
and death. The immune status of a person living with HIV/
AIDS can be assessed by measuring the absolute number 
(per mm3) or percentage of CD4+ cells. It is recommended 
that all patients, irrespective of the clinical stage, have 
access to CD4 counts (7).
Viral load testing is not needed routinely and is only 
recommended to confirm suspected failure of treatment.
The assessment should include testing for hepatitis B and 
C and screening for TB.
Clinical assessment of HIV
Clinical assessment is used to guide decisions on when 
to start cotrimoxazole prophylaxis and when to start ART. 
Table 3 shows WHO’s recommendations for a staging 
system for HIV infection and disease in adults and 
adolescents (8).
ART
There is evidence that ART is feasible in prison settings 
(9). One of the problems of ART is resistance to some 
of the drugs that can be caused by the interruption of 
treatment. It is, therefore, most important to avoid any 
interruption of treatment when individuals are admitted 
to pre-trial detention centre or prison, when they are 
transferred from one prison or pre-trial detention centre 
to another, and when people under treatment are released 
into the community. In addition, specific attention should 
be paid to adherence to the treatment.
ART should be started:
•	 as	a	priority,	in	all	individuals	with	severe	or	advanced	
HIV clinical disease (WHO clinical stage 3 or 4) and 
individuals with CD4 count ≤350 cells/mm3 (strong 
recommendation, moderate-quality evidence);
•	 in	all	individuals	with	HIV	with	CD4	count	>350	cells/mm3 
and ≤500 cells/mm3 regardless of WHO clinical stage 
(strong recommendation, moderate-quality evidence);
•	 in	all	individuals	with	HIV	regardless	of	WHO	clinical	
stage or CD4 cell count in the following situations:
 – those with HIV and active TB disease (strong 
     recommendation, low-quality evidence);
 –    those co-infected with HIV and HBV with evidence of 
            severe chronic liver disease (strong recommendation, 
    low-quality evidence);
 – those with partners with HIV in serodiscordant 
    couples, to reduce HIV transmission to uninfected    
  partners (strong recommendation, high-quality 
    evidence);
 –  pregnant and breastfeeding women.
As the medical treatment is rapidly changing, please 
consult the WHO web site for the drug regimen (10).
Clinical and laboratory follow-up is needed to monitor the 
response to treatment. The minimum requirement is to 
monitor the level of CD4. All ART drugs have numerous 
adverse effects and the treatment requires monitoring for 
these effects.
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Prevention of opportunistic infections
Prevention of opportunistic infections is part of the 
treatment for HIV. In view of the higher risk in prison 
settings, this component is essential to prevent mortality 
linked to HIV. Please refer to the WHO web site for 
detailed information (10–12).
Adults and adolescents living with HIV and screened with 
a clinical algorithm for TB, and who report any one of the 
symptoms of current cough, fever, weight loss or night 
sweats may have active TB and should be evaluated for 
TB and other diseases.
HIV/hepatitis B co-infection
As mentioned above, ART should start in all individuals 
co-infected with HIV/HBV who require treatment for their 
HBV infection (chronic active hepatitis), irrespective of 
the CD4 cell count or the WHO clinical stage. The drug 
regimen should include two ARVs having both anti-HIV 
and anti-HBV activity.
HIV/TB co-infection
In cases with active TB co-infection, ART treatment 
should be initiated as soon as possible (within the first 
eight weeks) after starting TB treatment.
Co-infection with HCV is associated with a higher risk 
of death and of advanced liver disease. HIV infection 
accelerates the progression of and mortality from HCV-
related disease. The management of people co-infected 
by HIV and HCV is complicated owing to the increased 
toxicity and interactions between the ribavirin used for 
HCV treatment and several ARV used for the treatment 
of HIV.
Assessment and treatment of hepatitis B (13)
There is no specific treatment for acute hepatitis B. Care 
is aimed at maintaining comfort and adequate nutritional 
balance, including replacement of fluids that are lost from 
vomiting and diarrhoea.
Clinical stage Symptoms
   1. No symptoms No symptoms or only persistent generalized lymphadenopathy.
   
   2. Mild symptoms Moderate weight loss (5–10%).
 Recurrent upper respiratory tract infections (sinusitis, tonsillitis, otitis media, 
pharyngitis). Minor mucocutaneous manifestations (Herpes zoster, Angular cheilitis, 
recurrent oral ulcerations, Papular pruritic eruptions, Seborrhoeic dermatitis).
   
   3. Moderate symptoms Weight loss >10%.
 Unexplained chronic diarrhoea for longer than one month. Unexplained persistent 
fever (intermittent or constant for longer than one month). Persistent oral candidiasis. 
Oral hairy leukoplakia. Pulmonary TB. Severe bacterial infections (pneumonia, 
empyema, meningitis, pyomyositis, bone or joint infection, bacteraemia, severe 
pelvic inflammatory disease). Acute necrotizing ulcerative stomatitis, gingivitis or 
periodontitis. Unexplained anaemia (below 8 g/dl), neutropenia (below 0.5 x 109/litre) 
and/or chronic thrombocytopenia (below 50 x 109/litre).
   
   4. Severe symptoms (AIDS) HIV wasting syndrome.
 Pneumocystis jiroveci pneumonia. Recurrent severe bacterial pneumonia. Chronic 
herpes simplex infection (orolabial, genital or anorectal of more than one month’s 
duration or visceral at any site). Oesophageal candidiasis (or candidiasis of trachea, 
bronchi or lungs). Extrapulmonary TB. Kaposi sarcoma. Cytomegalovirus disease 
(retinitis or infection of other organs, excluding liver, spleen and lymph nodes). Central 
nervous system toxoplasmosis. HIV encephalopathy. Extrapulmonary cryptococcosis, 
including meningitis. Disseminated non-TB mycobacteria infection. Progressive 
multifocal leukoencephalopathy. Chronic cryptosporidiosis.
Table 3. WHO’s recommendations for a staging system for HIV infection and disease in adults and 
adolescents
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Assessment of and treatment for chronic hepatitis B is 
expensive and not available in all countries. The objectives 
of the assessment are to evaluate the severity of the liver 
disease and to decide when to start the treatment.
Assessment of the severity of the liver disease should 
include: 
•	 biochemical	 markers,	 including	 at	 least	 aspartate	
aminotransferase and alanine aminiransferase, and 
possibly gamma-glutamyl transpeptidase, alkaline 
phosphatase, prothrombin time and serum albumin;
•	 blood	counts;
•	 abdominal	ultrasounds;
•	 HBV	DNA	detection	and	measurement	of	the	HBV	DNA	
level as they are essential for the diagnosis, decision 
to treat and subsequent monitoring of patients;
•	 investigations	for	other	causes	of	liver	disease	and	co-
infection with hepatitis C or with HIV.
Liver biopsy is not always required (for example, when 
there are clinical symptoms of cirrhosis) but enables the 
determination of the degree of inflammation and fibrosis 
in patients with either increased alanine aminiransferase 
or HBV DNA levels >2000 IU/ml (or both). Recently, non-
invasive techniques (including serological techniques) 
have been developed to assess the level of fibrosis.
The goal of therapy for chronic hepatitis B is to prevent the 
progression of the disease to cirrhosis, decompensated 
cirrhosis, end-stage liver disease, hepatocellular 
carcinoma and death through suppression of HBV 
replication. HBV infection cannot, however, be completely 
eradicated.
Hepatitis C
As with hepatitis B, diagnosis and treatment for hepatitis 
C are expensive and not available in all countries.
Assessment for hepatitis C is very similar to assessment 
for hepatitis B (14). In addition to assessment of the 
severity of liver disease, it includes the determination 
of the genotype of the virus. Both components are 
critical to treatment decisions. It consists of the 
following steps:
•	 assess	 the	 severity	 of	 the	 liver	 disease	 (see	 
hepatitis B);
•	 investigate	 other	 causes	 of	 liver	 disease	 and	 co-
infection with hepatitis B or with HIV;
•	 determine	 HCV	 genotype	 (1	 to	 6)	 prior	 to	 antiviral	
treatment, as the genotype will determine the 
treatment;
•	 vaccinate	 for	 hepatitis	 A-B	 to	 prevent	 co-infection	
with these hepatitis viruses and protect the liver – the 
objective of the treatment is to cure the patient; the 
current standard therapy includes pegylated interferon 
in combination with ribavirin.
Nutrition support and diet
The energy needs of people living with HIV, and in 
particular people with AIDS, increase by about 10%. HIV 
infection affects the person’s appetite and ability to take 
in food and reduces the body’s ability to absorb ingested 
nutrients, while metabolic changes actually increase 
the person’s nutritional needs. Adherence to treatment 
is key to its success and to prevent interruption and 
possible development of resistance. Poor nutrition 
status and a low diet lead to difficulties in ingesting 
the medications and lower compliance with treatment. 
Malnutrition increases mortality among people living 
with HIV/AIDS who are on ARV treatment. People on 
ART are at an increased risk for metabolic diseases, 
such as dyslipidemia or diabetes.
People living with HIV require food supplements that 
complement their diet to enable them to meet their total 
micronutrient and macronutrient needs. In particular, 
fresh fruits and vegetables should complement the staple 
foods. A nutritionist should advise the prison authorities 
on the specific needs of patients without breaching 
confidentiality about the disease.
Continuity of treatment
For both HIV and hepatitis C, continuity of treatment is 
essential to ensure the best outcomes and prevent the 
development of resistance. Health programmes in prisons 
should, therefore, work in close collaboration with the HIV 
programme in the community to ensure that treatment is 
not interrupted when people enter and leave prison. It is 
also important to organize this continuity when prisoners 
are transferred from one prison to another within the 
police/justice system.
Before an individual is released from prison, links should 
be established with a service that will continue treatment. 
Sometimes it is difficult for ex-prisoners to go to these 
services. This situation should be identified in advance 
and remedies or support should be provided to ensure that 
contact will be established. The continuity of treatment is 
best when community services can provide support to a 
prisoner in prison and after release and accompany his/
her re-entry into the community. Before release, prisoners 
undergoing treatment should be provided with a stock of 
medications for one month and a complete copy of their 
medical files, including the results of all tests conducted 
during incarceration. When a prisoner is transferred 
between prisons, health professionals should ensure that 
the medical file follows the prisoner.
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Palliative care/compassionate release 
Terminally ill prisoners, if they have support from family 
or friends in the community, should be released on 
compassionate grounds so that they are able to die with 
dignity at home in the company of family or friends.
Quality assurance and monitoring of, and 
interventions for, HIV and hepatitis C and D
Different measures should be implemented to optimize 
the result of the HIV programme. The development of 
guidance notes and standard operating procedures, based 
on national guidelines, strengthens the adherence of 
prison staff, both security and health, to the policy and 
strategy. All staff should be trained in these guides and 
the rationale and importance of their role in the response 
explained.
Monitoring related to HIV should be aligned with and 
integrated into national HIV and other bloodborne 
diseases monitoring systems.
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Key points 
•	 TB	in	prisons	is	a	major	public	health	problem	in	many	
settings, particularly in countries with a high incidence 
of TB.
•	 The	TB	notification	rate	in	prisons	ranges	from	11	to	
81 times higher than in the general population. The 
situation is worsened by the emergence and spread 
of drug-resistant TB, particularly multidrug-resistant 
(MDR) and extensively drug-resistant (XDR) TB.
•	 Prompt	 detection	 of	 TB	 among	 prisoners	 should	 be	
ensured through a combination of screening methods 
(screening on entry, mass screening at regular 
intervals, passive screening, contact screening) 
based on clinical questionnaires, chest X-rays, smear 
microscopy and self-referrals.
•	 The	implementation	of	new,	rapid	diagnostic	methods	
such as Xpert MTB/RIF is an important breakthrough in 
the fight against TB and (X)MDR.
•	 Drug	susceptibility	testing	(DST)	should	be	performed	
on all patients with treatment adapted to the resistance 
pattern to help further amplification of resistance.
•	 Effectiveness	 is	 improved	 when	 treatment	 is	
administered under the direct observation of health 
care staff and in line with national TB programme 
(NTP) guidelines.
•	 Adequate	 procurement,	 supply	 and	 management	 of	
quality medication and effective administration should 
be in place. Airborne infection control, including 
protective measures for staff, should be ensured, and 
provider-initiated HIV counselling and testing to detect 
HIV and TB/HIV co-infected individuals should be 
promoted to provide the necessary support and care.
•	 Continuity	of	care	is	imperative	for	released	prisoners	
who are on treatment and for individuals who are on 
treatment before entering the prison services.
•	 TB	control	is	strengthened	in	prison-based	programmes	
by raising awareness of TB among prisoners and prison 
medical and non-medical staff through continuous 
educational activities.
•	 Operational	research	should	be	promoted	to	contribute	
to evidence-building for effectiveness.
Introduction
TB is a major global health and public health problem. 
There are clear challenges in two regions of the world: 
Africa (where there is also a high prevalence of HIV 
infection) and eastern Europe. In eastern Europe, the 
situation is serious due to MDR and XDR forms of TB 
and inadequate responses by health systems, leading 
to poor case management and the further emergence 
of drug-resistant cases. The situation in parts of Europe 
and central Asia has recently been aggravated by 
the increasing prevalence of HIV infection in certain 
populations, which considerably increases the risk of 
active TB in those infected with both TB and HIV (1).
The scourge of TB in prisons remains a persistent 
problem. The occurrence of active TB in prisons is 
generally reported to be much higher than the average 
levels reported for the corresponding general population. 
In the last survey of TB control in Europe, undertaken 
in 2006, it was estimated that European prisons notify 
TB at an average rate of 17 times more than in the 
population at large, ranging between 11 times more in 
western Europe to 81 times more in eastern Europe (2). 
TB in prisons is a major cause of death and constraint for 
TB control in the civilian system, especially in countries 
with a high incidence of TB.
High levels of TB in prison populations are likely to be 
attributable to the fact that a disproportionate number of 
prisoners are from population groups already at high risk 
of TB infection and TB disease, such as people who inject 
drugs, homeless people, mentally ill individuals, people 
returning to prison and undocumented immigrants from 
areas with a high incidence of TB.
Prison settings, where segregation criteria are based 
on crime characteristics rather than on public health 
concerns, may facilitate transmission. Overcrowding, 
late detection and treatment of infectious cases, 
frequent transfers between prisons and poor airborne 
infection control measures are all factors contributing to 
transmission of TB (3). Prisoners may be at higher risk of 
TB disease following a recent infection or reactivation 
of latent infection through co-immune-depressing 
pathologies, particularly HIV infection, intravenous 
drug use and poor nutritional status (4). Moreover, 
prisons represent a reservoir for transmission of the 
disease to the community at large through prison staff, 
visitors and close contacts of released prisoners with 
still active TB disease (5). The transmission dynamics 
between prisoners and the general population have 
been hypothesized as playing a key role in driving 
overall population-level incidence, prevalence and 
mortality rates of TB. Neglecting TB prevention 
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and control in prisons settings can, therefore, carry 
serious consequences for both prisoners and the 
general population, especially in countries with poorly 
performing NTPs and high incarceration rates.
On 13 October 2010, the Global Plan to Stop TB 2011–
2015 was launched by the Stop TB Partnership (a 
coalition of more than 1000 organizations worldwide), 
with the aim of halving TB mortality and prevalence 
rates by 2015 compared to the 1990 baseline (6). One of 
the main objectives in achieving this aim is to ensure the 
early diagnosis of all TB cases, including in vulnerable 
populations such as prisoners.
In 2013, the International Union against Tuberculosis and 
Lung Disease published an official statement urging health 
authorities, national and international technical agencies, 
civil society organizations and donor agencies to prioritize 
the prevention and control of TB in prison settings, with 
recommendations for 12 points for action (7).
Transmission
TB is an infectious disease caused by a bacillus named 
Mycobacterium tuberculosis. Transmission occurs by 
airborne droplets produced by coughing, sneezing or 
talking that are subsequently inhaled by contact people 
(8). The risk of inhalation increases when several 
coughing people are kept in a small, unventilated room. 
The risk of TB being transmitted in settings in which 
people are in close contact (as in prisons and hospitals) is 
particularly high. Thus, prisons provide ideal conditions 
for TB transmission.
In general, about 30% of contact people that inhale bacilli 
become infected. But in prisons with overcrowding, twice 
as many contacts or more could become infected (9). 
Smoking seems to aggravate the risk of becoming infected.
How are people exposed to TB? Exposure results from 
breathing the air containing the M. tuberculosis. Once 
an infectious TB patient breathes, sneezes or coughs, 
mycobacteria are spread in the air which can be inhaled 
by a healthy individual. Three factors play a role: the 
number of infectious patients, the duration of their 
infection and the intensity of the contact with them. 
Thus, by reducing the duration of infectiousness, or 
the contacts between infectious TB patients (such as 
prisoners), exposure can be reduced.
Despite being infected with M. tuberculosis, a person 
can stay healthy and never become sick. Most will 
remain at the stage of subclinical infection. That means 
they have been infected but are healthy. Only about 10% 
will progress to disease, of whom half will develop an 
infectious form of TB, while the other half will develop a 
non-infectious form.
However, when a person’s immune system is affected 
(through, for example, HIV infection, chemotherapy for 
cancer, old age, stress or imprisonment), the infected 
person will be more likely to develop TB disease. TB 
can affect any organ or part of the body, but especially 
the lungs. The pulmonary form of TB is that which is 
infectious through transmission of airborne droplets. 
Indoors, droplets produced by coughing or sneezing can 
remain airborne for extended periods of time, especially 
if the ventilation is poor.
When no treatment is available, at least half of those 
with TB disease die within two years. Some may heal 
spontaneously and others become chronic cases that 
continue to transmit the disease.
Five factors in the spread of TB in prisons are described 
in the Guidelines for control of tuberculosis in prisons 
(10), as follows.
Prisons receive TB. Prisoners mainly come from 
communities with high rates of TB, unhealthy lifestyles 
and addictions. As a result of ignorance or lack of means, 
they may enter prisons with untreated TB. Moreover, 
conditions for drug resistance are often created when 
prisoners arrive with partially treated TB or their 
treatment is interrupted upon arrival.
Prisons concentrate TB. Overcrowding, poor ventilation 
(lack of windows, or covering them to block cold air 
entering the cell) and prolonged incarceration inside 
prison cells are all factors conductive to the transmission 
of airborne infection. If a TB patient in the community 
can infect 15–20 people a year, a TB patient in prison 
could infect significantly more.
Prisons disseminate TB. In many countries, the lack 
of funding and management and the absence of 
laboratories and trained staff result in TB cases going 
undetected. Individuals with undetected TB can easily 
disseminate TB inside the prison system as they often 
move from one prison to another.
Prisons make TB worse. Several factors contribute 
to the worsening of TB disease in prison, including 
delayed diagnosis (caused by, for example, absence 
of entry screening, lack of trained staff and overload 
of medical personnel by overwhelming numbers of 
prisoners entering the system, weak infrastructure, bad 
organization of laboratory services and disruption of 
drug supply) and frequent interruptions to or incomplete 
58
Prisons and health
treatment (medical records do not always follow 
prisoners during regular prison transfers or on release). 
Many factors occurring in prison might worsen poor 
treatment outcome: malnutrition, drug addiction, mental 
stress, poorly treated co-morbid diseases (such as HIV, 
diabetes and hepatic insufficiency) and factors related to 
weak health services in the system.
Prisons export TB. Prisoners may export disease to the 
outside world through contact with prison staff and 
visitors, as well as when prisoners are released who 
have not finished their treatment. Prisons are reservoirs 
for the transmission of resistant forms, especially as 
release often takes place during the lengthy period of 
MDR-TB treatment (18–24 months).
What can be done to reduce the risk of transmission of 
TB? Interventions to interrupt the cycle of transmission 
can be directed at: (i) preventing transmission of TB 
from people with infectious TB to their contacts; and 
(ii) preventing the disease from developing once any 
contacts have become infected. To prevent transmission, 
early case detection, immediate and adequate treatment 
and infection control interventions are needed. To 
prevent infected contacts from developing active 
disease, preventive chemotherapy should be considered.
Case-finding
Case detection is one of the core elements of TB control. 
If conducted properly, systematically and effectively and 
followed by an adequate treatment regimen, it could 
lead to a reversal of the growing incidence of TB and to 
a reduction in TB mortality.
There are two strategies for case-finding: (i) through self-
referral and passive case-finding during incarceration; 
and (ii) through regular active case-finding during 
incarceration.
Passive case-finding
Passive case-finding examines TB suspects (individuals 
who have had a cough for three weeks or more) among 
people who spontaneously visit health centres seeking 
care for respiratory symptoms. It presumes that there 
is complete access to health services, without which 
there may be delays in case-finding. For case-finding to 
be effective, patients must be aware that the symptoms 
they experience may be symptoms of TB and that TB can 
be treated. They must be willing to seek diagnosis and 
treatment and must be able to access TB care. Educating 
everyone in prison about TB is, therefore, important.
Passive case-finding may, however, have limited success 
in prisons. Some inmates may be afraid to come forward, 
fearing the repercussions of a diagnosis of TB such as 
stigma, a delay in release or a transfer to another prison. 
TB disease may indeed be a reason to transfer a prisoner 
to a better setting, so there could be a secondary gain 
for some prisoners to try to be diagnosed with TB. 
Sometimes inmates may not be allowed to seek care 
because of their place in the internal prisoner hierarchy.
Active case-finding
Active case-finding involves the screening of prisoners 
at different points during their incarceration and the 
use of various methods, including questionnaires, chest 
radiography, tuberculin skin testing and immunoglobulin 
gamma interferon assay (IGRA), or a combination of 
these methods.
In prisons, passive and active case-finding should 
be carried out simultaneously and systematically. A 
combination of these two approaches will substantially 
increase case detection.
Some of the advantages and disadvantages of conducting 
passive and active case-finding are detailed in Table 4.
Screening strategies
How screening activities should be implemented 
depends on many factors, including the type of facility, 
the prevalence of TB infection and disease in the facility, 
the prevalence of TB in the inmates’ communities, the 
prevalence of other risk factors for TB (such as HIV) 
in the inmate population and the average length of 
stay of inmates in the facility. The type of screening 
recommended for a particular facility is determined by 
an assessment of the risk of TB transmission within that 
facility (11).
Screening for TB on entry
The revised European Prison Rules (12) state that 
prisoners are entitled to a medical examination at the 
point of first admission (§42) and that prison authorities 
have to safeguard the health of all prisoners (§39).
Screening on entry is aimed at detecting undiagnosed 
TB (among other things) and identifying patients who 
were receiving treatment before incarceration to ensure 
that they complete their treatment.
Medical screening on entry into the prison system is 
essential, as many prisoners come from communities 
with a high prevalence of TB. Prisoners should not enter 
the body of the prison population until it has been verified 
that they do not have infectious TB. When possible, 
newly arrived prisoners should not be housed with other 
inmates until they have been properly screened for TB. 
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This initial and temporary segregation is an opportune 
time to check for TB.
Entry screening should be documented on the screening 
register and must be followed up with standard 
procedures for diagnosis and treatment.
Contact investigation
In prisons, TB contacts are persons who share air for 
prolonged periods with an active TB case. These include 
the following: all prisoners who sleep in the same cell 
or housing unit as the TB patient, prisoners who spend 
time in closed or poorly ventilated work areas inside 
the prison, prisoners who interact with the TB patient 
during recreational activities, prison staff who come into 
contact with a TB case and visitors.
The Guidelines for control of tuberculosis in prison 
recommend (10) screening for TB among contacts of 
sputum-smear-positive cases, as these patients are 
infectious. Contacts should be identified through an 
interview with the patient regarding his social network 
and daily activities to help to identify groups of contacts 
who might be exposed. The next step will be contact 
investigation by sputum-smear microscopy or chest 
radiography.
Passive case-finding Active case-finding
Advantages
Table 4. Advantages and disadvantages of passive and active case-finding
•	 Identifies	cases	missed	through	other	case-finding	
measures (such as entry screening, contact 
investigation, mass screening or surveys).
•	 Identifies	cases	who	develop	TB	after	entry.
•	 Is	relatively	less	expensive	and	simpler	for	
programmes to implement.
Disadvantages
•	 Relies	on	patients’	readiness	to	attend	medical	
services for evaluation (self-referral).
•	 May	result	in	delayed	case-finding	and	initiation	of	
treatment, with prolonged chances of transmission 
to others.
•	 	May	result	in	advanced	disease	that	can	be	more	
difficult to treat.
•	 May	be	biased	by	internal	regulating	mechanisms	
among prisoners (for example, bullying or 
corruption) leading to a denial of access to the 
medical ward to certain subgroups by the “prisoner 
bosses”.
•	Increases	case	notification;	links	the	prison	health	
system to the NTP and feeds data into the system.
•	Reduces	delays	and	thus	transmission	through	
immediate removal of infectious cases by 
separating them from the general prison population 
and providing effective treatment.
•	If	done	early,	makes	it	easier	to	treat	patients	
detected in the early stages of TB.
•	Is	likely	to	find	prevalence	rates	much	higher	than	
the prevalence rates outside the prison, which can 
be a useful tool for advocacy.
•	Increases	duties	and	workload	of	the	health	staff	in	
prison, who are already limited in number and may 
not be sufficiently motivated.
•	Is	a	burden	on	the	penal	and	public	health	care	
system, which needs to support active case-finding 
activities; the high cost may render these activities 
unsustainable.
•	Overburdens	the	capacity	of	local	health	centres	
and hospital laboratories to respond to increases in 
smear and culture examinations.
•	Diverts	funds	from	other	directly	observed	
treatment, short course (DOTS) activities.
•	Leads	to	potential	over-diagnosis	of	TB,	if	diagnosis	
is only based on radiography.
Source: Dara M et al (10).
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Mass screening
Mass screening means to check the whole population 
of prisoners (or other segment of population) to identify 
suspected cases of TB and confirm diagnoses by sputum-
smear or other examinations. Two factors are obligatory 
with mass screening: it should cover the whole population 
group, and rounds must be regular. In the prison system, 
two massive screening rounds a year are ideal. This 
strategy is very useful to find previously undetected 
cases missed by passive case-finding. Mass screening 
is not, however, recommended as the sole method of 
case-finding in prisons. It is preferable to start with mass 
screening in the initial phases of project implementation 
and complement it with other screening strategies (on 
entry, passive) to ensure that prisoners with TB who enter 
prison or cases that occur between mass screening rounds 
are detected properly. Moreover, regular mass screening 
may not be sustainable in resource-limited settings due to 
cost and other logistical barriers. Thus, this intervention 
may be reserved to places where resources permit.
Screening methods
Symptom screening
Whenever possible, health care workers should conduct 
screening by special questionnaire (10). The questionnaire 
should be based on three crucial aspects: history of former 
TB disease (previous treatment, interrupted treatment), 
clinical symptoms and body/mass index. Prisoners who 
have a previous history of TB and/or clinical symptoms 
such as coughing for more than two weeks, sputum 
production, fever, night sweats, loss of weight and 
appetite, haemoptysis, chest pain and/or low body mass 
index may be considered as suspects for TB. All prisoners 
with signs or symptoms suggestive of TB should undergo 
a thorough medical evaluation, with confirmation of the 
diagnosis by smear investigation.
The questionnaire as a screening method can be used 
widely, as it is less expensive than radiography, is rapid, 
simple, does not require special equipment and is easy to 
implement. Its major disadvantage is that the predictive 
value of a positive test (the probability of smear-positive 
TB occurring among those identified as suspects) is likely 
to be low, resulting from a high false-positive rate for 
the questionnaire. Thus, it is very important that case-
finding staff should be trained in interview techniques 
and the correct completion of the questionnaire (10). A 
standardized approach should be emphasized and staff 
should avoid guiding a prisoner to one answer or another. 
Merely giving the questionnaires to the prisoners for self-
completion is unacceptable. Symptom screening alone is 
adequate and satisfactory in facilities with a minimal risk 
of TB (those with a small population or no cases in the 
previous year).
Screening through chest radiography
Many industrialized countries screen prisoners on entry 
by chest radiography. Studies show the utility of such 
screening in finding prisoners who would have been missed 
by symptom screening alone (13). Prisoners with abnormal 
chest radiography are then followed up with sputum 
examination. Most east European countries use mobile 
miniature radiography. Unfortunately, the overwhelming 
majority are old-fashioned machines, produced 30–40 
years ago, which causes significant logistical problems 
and errors in reading and interpretation. The use of mobile 
miniature radiography is not recommended unless it is 
digital, which provides a high-quality image.
Digital radiographs (miniature or full-size) provide 
enhanced imaging and improved storage and readability. A 
miniature radiograph can be performed in under a minute 
and exposes the patient to approximately one tenth of the 
radiation dose of a conventional radiograph. One cost–
effectiveness analysis of miniature chest radiography 
for TB screening on admission to jail indicated that 
more cases were detected with this method than either 
tuberculin skin test or symptom screening, and the cost 
of radiograph screening was less per case detected (14). 
The extent to which radiological screening is used in a 
given institution should be dictated by multiple factors, 
including: the local epidemiological characteristics of 
TB disease; inmates’ length of stay; the ability of the 
health-care professionals in the facility to conduct careful 
histories, tuberculin skin or QuantiFERON-TB Gold testing 
and cross-matches with state TB registries; and the right 
time for the radiographic study and its interpretation. 
Screening with chest radiographs might be appropriate in 
certain jails and detention facilities that house substantial 
numbers of inmates for short periods and serve populations 
at high risk of TB (such as those with a high prevalence of 
HIV infection or history of injection-drug use and foreign-
born persons from countries with a high prevalence of 
TB). In facilities where routine radiographic screening for 
all inmates is not carried out, a chest radiograph should 
be part of the initial screening of HIV-infected patients 
(often missed at a sputum-smear screening because of 
infiltrative TB infection in their lungs) and those who are 
at risk of HIV infection but whose status is unknown (11).
Other screening methods
The tuberculin skin test and IGRA are used for the detection 
of latent TB infection. Countries with a low incidence 
of TB sometimes use tuberculin skin test and IGRA in 
correctional institutions (11). Tuberculin skin test and 
IGRA can only indicate an infection but not active disease. 
The use of these tests is not, therefore, recommended in 
prisons in countries with a high incidence of TB, where 
most prisoners are already infected with TB and the 
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priority for TB control programmes is to detect and treat 
active TB cases.
Clinical features of TB
The disease starts in the lungs after inhalation and is 
most frequently manifested in the lungs as pulmonary 
TB. An immune system response causes the formation 
of abscesses in the lung’s parenchyma. As long as these 
abscesses are contained, there is little risk of transmission 
(closed TB), but if these abscesses break through into the 
airways, the infectious content will be coughed up (open 
TB). Abscesses contain billions of bacilli so that people 
with open TB are highly infectious. About 50–60% of 
people with TB eventually become infectious. In cases 
with weak immune defences that prevent the formation of 
an abscess (such as HIV infection), the lung’s parenchyma 
has a more diffusive inflammation which does not damage 
airways and bacilli do not break through. These cases are 
less infectious.
The bloodstream can carry bacilli to other parts of the 
body situation, which occurs in about 15–20% of people 
with TB. Almost all organs can be affected and sometimes 
serious illnesses, such as meningitis or septicaemia, may 
occur.
The most important symptoms of active TB are cough, 
haemoptysis, chest pain, breathlessness, fever, night 
sweats, fatigue and loss of appetite (8,9). Productive 
cough is the most common symptom of pulmonary TB. The 
presence of a cough is, however, non-specific: having the 
cough for three weeks or more is a criterion for defining 
the patient suspected of TB disease.
Diagnosis
Chest radiography
The introduction of radiography as a diagnostic and 
screening tool was an important landmark in the 
knowledge of the natural history and diagnosis of TB in 
humans. Practical experience and some studies have, 
however, proved that no radiographic picture is absolutely 
typical of TB (15). Many diseases of the lungs show a 
similar radiographic appearance and can easily imitate 
TB. Chest radiography can undoubtedly be very helpful in 
localizing abnormalities in the lung and indicative lesions 
of TB, but only bacteriology can provide the final proof of 
TB.
The efficacy of chest radiography is determined largely 
by the reader’s ability to detect abnormal opacities and 
interpret them correctly. This ability varies from one 
reader to another (inter-individual variation). It also 
happens that a reader may, on first examination of a film, 
see abnormalities that he/she does not see after a week 
or so when re-examining the same film. On the other 
hand, at the second reading, the reader may find new 
abnormalities on a film that were not seen at the previous 
examination (intra-individual variation).
The high number of false TB cases over-diagnosed by 
chest X-ray largely exceeds the number of those missed by 
smear microscopy. Moreover, X-ray and mobile miniature 
fluorography are expensive, require specially trained 
technicians and may face interruption in services in some 
settings due to breakdown of equipment, lack of spare 
parts and repair experts, scarcity of films and shortage of 
electricity.
The most important indication for chest radiography is 
when there are negative sputum smears by microscopy 
(two negative smears, or at least one culture negative, 
or both) but a clinical suspicion of TB. The diagnosis of 
bacteriologically negative TB is, therefore, presumptive 
and must be based on epidemiological and clinical 
information and failure to respond to a full course 
of broad-spectrum antibiotics to exclude other lung 
infections. A chest X-ray is also required if the patient has 
breathing difficulties, haemoptysis or suspected pleural or 
pericardial effusion, or may need specific treatment (such 
as pneumothorax). Radiography also plays an essential 
role in the diagnosis of TB in HIV-positive patients who 
may not have abnormalities in X-ray (12–14%). Digital 
radiography has the advantage of producing instant 
results which can be assessed remotely through an online 
transfer of the image.
Sputum-smear microscopy
Direct sputum-smear microscopy certainly has some 
technical shortcomings, but its operational advantage is 
obvious. That a diagnosis of TB (in persons producing large 
amounts of bacilli) may be established with certainty and 
chemotherapy started on the same day is without doubt 
the greatest advantage of smear microscopy. Direct smear 
microscopy is not, however, sensitive enough to detect TB 
bacilli in sputum when the number of bacilli is small. It 
requires a high volume of bacilli in the specimen (around 
10 000 per ml) to be read positive by an experienced 
laboratory technician. Direct smear microscopy is 
comparatively inexpensive and fast, does not require 
sophisticated equipment and can be carried out by trained 
technicians in primary care settings. Consequently, it is 
the method of choice for early identification of TB cases in 
low-resource settings.
Sensitivity for detection of TB bacilli in sputum 
increases substantially if the sputum is concentrated 
(decontaminated and centrifuged) and stained with 
fluorescent solutions (such as auramine O). Slides can 
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then be observed through a special microscope, such as 
a fluorescent or a light-emitting diode microscope. This 
technique requires lower magnification while examining 
the slides and reduces the time of observation. Thus, 
more slides can be read in less time. Prisoners suspected 
of having pulmonary TB should submit two samples to 
establish a diagnosis of TB. It is preferable to obtain early 
morning sputum as this is more likely to contain tubercle 
bacilli. The way sputum is produced is also very important. 
Sputum samples should be submitted following instructions 
from and under the supervision of a health care worker to 
ensure sampling with the right technique and from the right 
person. Samples should be collected in a well-ventilated 
area (better outdoors). In some prison settings, inmates 
may exchange their sputum samples or use other practices 
to get positive results from the sputum smear, so staff need 
to observe the production of the sample, using personal 
protective measures (filter face-piece 2 or N95 respirators) 
and/or other infection control measures.
Culture
Culturing a specimen means growing the bacilli on media, 
which are substances that contain nutrients, in the 
laboratory. Lowenstein Jensen is the most frequently used 
solid media. Not all TB patients have positive smears. If 
there are only a few bacilli in the sputum (around 10–20) 
the smear will appear negative but the culture will usually 
be positive. A positive culture is proof of TB. The isolation 
of TB bacilli in sputum (and other clinical specimens) 
through culture, with further biochemical or molecular 
tests for identification, constitutes a definitive diagnosis 
of TB. The sensitivity of the culture is substantially higher 
than that of smear microscopy; sputum-smear microscopy 
detects only up to 50% of culture-confirmed pulmonary 
TB cases. The technical superiority of culture over smear 
microscopy is largely due to quantitative factors. Usually 
only about 1–3% of the smear is examined by microscopy, 
whereas in the culture tube the whole yield of colonies 
may be seen practically at a glance. Although a large 
proportion of organisms are destroyed by decontamination 
procedures, the quantitative differences are still so large 
that the probability of finding bacilli by culture is many 
times greater than it is by direct smear microscopy. The 
importance of its use to confirm disease should, therefore, 
be emphasized, especially among HIV-infected individuals, 
who are frequently smear-negative.
Additionally, this method allows for identification of 
drug-susceptibility patterns, which is crucial for guiding 
therapeutic management. Culture and DST should, 
therefore, be considered for all TB patients who are 
suspected of being infected with multidrug-resistant 
strains. Culture is part of the routine work-up when 
evaluating TB suspects in industrialized countries.
However, important factors limit the widespread use 
of culture in developing countries. Traditional culture 
methods in solid media (Lowenstein-Jensen) require 
decontamination, homogenization and centrifugation 
of samples, which implies more equipment (such as a 
centrifuge and biosafety cabinets) and higher maintenance 
costs. Personnel require more training. These procedures 
produce more aerosols containing the TB bacilli, so the 
laboratory staff have to be adequately protected. The 
growth of TB bacilli in solid media can be observed within 
four to six weeks. More rapid culture results may be 
obtained through the use of automated or semiautomatic 
methods that make use of liquid media. These include 
the mycobacteria growth indicator tube (the BACTEC 
MGIT 960 system can detect results as early as one to 
two weeks) and molecular line probe assay, which can 
indicate the presence of M. tuberculosis within 12 hours.
Laboratories carrying out culture (especially rapid 
diagnostic methods) and DST need safety measures 
for staff. Such facilities are expensive to build and run, 
and maintenance and running costs may render them 
inaccessible to some TB programmes in prisons.
Alternatively, an adequate network of smear microscopy 
sites should be set up inside the prison system, so that 
peripheral prisons/colonies have easy and rapid access 
and the number of tests carried out is still sufficient 
to ensure adequate quality. The network in the prison 
system should be coordinated with the network of outside 
laboratories in the civilian sector and should be part of a 
laboratory quality assurance system.
Xpert MTB/RIF diagnostic molecular test
The development of the Xpert MTB/RIF assay for the 
GeneXpert platform was completed in 2009 and is 
considered an important breakthrough in the fight against 
TB. For the first time, a molecular test is simple and robust 
enough to be introduced outside conventional laboratory 
settings. Xpert MTB/RIF detects M. tuberculosis as well 
as rifampicin resistance-conferring mutations using 
three specific primers and five unique molecular probes 
to ensure a high degree of specificity. The assay provides 
results directly from sputum within 100 minutes, even in 
sputum-smear negative samples.
WHO strongly recommends that Xpert MTB/RIF should 
be used as the initial diagnostic test in individuals 
suspected of having MDR-TB or HIV-associated TB (16). 
The recommendations apply to the:
•	 use	of	Xpert	MTB/RIF	in	sputum	specimens	(including	
pellets from decontaminated specimens) (data on the 
utility of Xpert MTB/RIF in extrapulmonary specimens 
are still limited); 
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•	 use	 of	 one	 sputum	 specimen	 for	 diagnostic	 testing,	
acknowledging that multiple specimens increase the 
sensitivity of Xpert MTB/RIF but have major resource 
implications; 
•	 use	 in	 children,	 based	 on	 the	 generalization	 of	 data	
from adults and acknowledging the limitations of 
microbiological diagnosis of TB (including MDR-TB) in 
children. 
Access to conventional microscopy, culture and DST is 
still needed for monitoring therapy, for prevalence surveys 
and/or surveillance, and for recovering isolates for drug 
susceptibility testing other than rifampicin (including 
second-line anti-TB drugs).
WHO’s analyses of progress towards meeting the 
projected diagnostic targets in the Global Plan to Stop TB, 
2011–2015 (6) show that:
•	 for	MDR-TB:	 implementing	 Xpert	MTB/RIF	 to	meet	
diagnostic targets for MDR-TB will cost less than 
conventional culture and DST for diagnosis of MDR-
TB, both globally and in varied country settings, 
requiring less than 1% of current funding for TB 
control; 
•	 for	 HIV-associated	 TB:	 the	 cost	 of	 testing	 all	 HIV-
positive individuals suspected of having TB will 
be similar to the cost of conventional culture for 
diagnosis of TB, requiring 1–2% of current funding 
for TB control and amounting to <1% of current 
expenditure on HIV care in several countries with 
high burdens of TB-HIV; 
•	 testing	 all	 persons	 suspected	 of	 having	 TB	 will	 be	
strongly dependent on screening and diagnostic 
algorithms at the country level; in both low- and 
middle-income countries, pre-test screening strategies 
should be considered to optimize the efficiency and 
cost of Xpert MTB/RIF.
WHO recommends that the following groups of people 
should receive Xpert MTB/RIF tests as a primary 
diagnostic test:
•	 people	who	have	been	treated	with	anti-TB	drugs	and	in	
whom pulmonary TB has again been diagnosed, that is, 
all retreatment categories (failure, default, relapse); 
•	 people	suspected	of	having	pulmonary	TB	and	considered	
to be at risk of harbouring MDR-TB bacilli (risk groups as 
per national policies or as defined in WHO’s Guidelines 
for the programmatic management of drug-resistant 
tuberculosis, emergency update 2008 (17)); 
•	 all	people	living	with	HIV	who	have	signs	or	symptoms	
of TB, those seriously ill and suspected of having TB 
regardless of HIV status, and those with unknown HIV 
status presenting with strong clinical evidence of HIV 
infection in HIV-prevalent settings. 
Xpert MTB/RIF is suitable for use at district and sub-
district level and should not be restricted to the central/
reference laboratory level only.
It is considered essential that, in eastern European 
countries, Xpert MTB/RIF assay is placed in central 
prison hospitals or special TB colonies or facilities where 
prisoners receive TB treatment.
The introduction of Xpert MTB/RIF assay simplifies and 
changes the diagnostic algorithm. In eastern European 
prisons, where the X/MDR-TB level is significantly high, the 
following algorithm is proposed: all prisoners suspected 
of TB or X/MDR-TB should undergo smear investigation 
by microscopy. Regardless of the smear status, every case 
should receive the Xpert test (if resources are limited, 
priority should be given to the MDR high-risk group). 
Based on the results of the test, three groups should 
be defined: (i) no TB further clinical management; 
(ii) confirmed TB but no RIF resistance treat with first- 
line drugs; (iii) confirmed TB with RIF resistance treat 
with second-line drugs.
Although testing with Xpert MTB/RIF does not require 
additional laboratory equipment, the sophisticated nature 
of the device requires careful handling, that is, a stable 
and uninterrupted electrical supply to avoid interruption 
of the procedure and subsequent loss of results, security 
against theft, adequate storage space for the cartridges, 
dedicated staff to perform testing and biosafety 
procedures similar to microscopy.
Treatment
The aims of treatment for TB are to cure the patient and 
restore quality of life and productivity, to prevent death 
from active TB or its late effects, to prevent relapse of TB, 
to reduce transmission of TB to others and to prevent the 
development and transmission of drug resistance.
There are five anti-TB first line drugs: rifampicin (R), 
isoniazid (H), ethambutol (E), pyrazinamid (Z) and 
streptomycin (S). Rifampicin and isoniazid are the most 
powerful bactericidal medicines active against TB bacilli. 
In prison settings, a daily treatment is recommended and 
the whole process should be under the direct supervision 
of a health-care worker (16). WHO recommends the use 
of fixed-dose combination drugs as they are thought to 
improve adherence, errors in prescribing are avoided and 
the number of tablets to be ingested is reduced (18).
New patients (who have no history of previous TB 
treatment or who have received anti-TB drugs for less 
than one month) with pulmonary TB should receive 
a regimen including six months of rifampicin. In the 
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intensive phase the patient receives isoniazid, rifampicin, 
pyrazinamide and ethambutol daily for two months, and 
in the continuation phase isoniazid and rifampicin for four 
months (2HRZE/4HR).
Since in many settings, particularly prisons, the risk of 
drug-resistant TB may be high, it is highly recommended 
that the resistant pattern of the strains the patient 
is infected with is documented and the appropriate 
treatment administered accordingly.
The treatment for patients who have previously been 
treated is more complicated and depends mainly on 
facilities’ diagnostic capacity. The Consolidated Action 
Plan to Prevent and Combat Multidrug and Extensively 
Drug-Resistant Tuberculosis in the WHO European Region 
2011–2015 sets a target for all previously treated patients 
to have access to DST at the beginning of treatment by 
2015 (19). The purpose is to identify MDR-TB as early 
as possible so that the appropriate treatment can be 
given. Specimens for culture and DST should, therefore, 
be obtained from all previously treated TB patients at or 
before the start of treatment. It is highly recommended 
that people living with HIV and new TB cases in settings 
with higher than 10% of MDR-TB among new cases 
should be tested for drug susceptibility. If resources allow, 
DST should be performed for all patients. It should be 
performed for at least isoniazid and rifampicin.
The approach to the initiation of retreatment depends 
on the laboratory capacity of the country/institution, 
specifically when (or if) DST results are routinely available 
for the individual patient. Countries using rapid molecular-
based DST will have results for rifampicin/isoniazid 
available within one to two days; these results can be 
used in deciding which regimen to start for the individual 
patient.
The use of conventional DST methods yields results 
within weeks (for liquid media) or months (for solid 
media). Because of this delay, prison health facilities 
using conventional methods will need to start an empirical 
regimen while DST results are awaited and then modify 
the regimen based on the DST results. Alternatively, 
treatment might be started with the standard re-treatment 
regimen, which includes streptomycin and lasts for eight 
months (2HRZES/1HRZE/5HRE), and modified once the 
DST results are available.
Where DST is not yet routinely available for individual 
retreatment patients, an interim approach could be 
implemented while the country is strengthening its 
laboratory system. Under this exceptional circumstance, 
an NTP/health ministry may consider a short-term policy of 
directly starting patients from such a group on an empiric 
MDR-TB regimen without confirmation of isoniazid and 
rifampicin resistance. This is a temporary measure, while 
the country is building the laboratory capacity to perform 
routine DST for individual retreatment patients. Groups of 
patients whose likelihood of MDR is medium or low will 
receive the eight-month (full course) retreatment regimen 
with first-line drugs (2HRZES/1HRZE/5HRE).
It is obvious that implementation of Xpert in prison 
facilities will shorten the delay between date of diagnosis 
and initiation of treatment. In fact, a doctor can diagnose 
TB, determine whether the case is drug-resistant and 
initiate treatment, all in one day.
MDR-TB
The European Region has the highest rate of MDR-TB in 
the world, which illustrates the failure of health systems 
to treat the disease effectively. Additionally, the social 
determinants contributing to the emergence and spread 
of the disease still prevail in most settings. People 
living with HIV, migrants, prisoners and other vulnerable 
populations are at most risk. Despite the availability of 
new diagnostic techniques, only one third of estimated 
MDR-TB cases are diagnosed, and only two thirds of these 
are reported as receiving adequate treatment. Based on 
a decision of the sixtieth session of the WHO Regional 
Committee for Europe in 2010, the Consolidated Action 
Plan to Prevent and Combat Multidrug and Extensively 
Drug-Resistant Tuberculosis in the WHO European Region 
2011–2015 (19) has been developed to strengthen and 
scale up efforts to address the alarming problem of drug-
resistant TB in the Region. Another important document 
issued by WHO regarding MDR-TB is the 2011 update of 
Guidelines for the programmatic management of drug-
resistant tuberculosis (20).
An MDR-TB case is defined as a patient who is identified 
as infected with a strain that is resistant to at least 
isoniazid and rifampicin. XDR-TB is a case that is resistant 
to isoniazid, rifampicin, plus any fluoroquinolone, and at 
least one of three second-line injectables – amikacin, 
kanamycin or capreomycin.
From a microbiological perspective, resistance is caused 
by a genetic mutation that makes a drug ineffective 
against the mutant bacilli. Although its causes are 
microbial, MDR-TB essentially results from clinical and 
programmatic mistakes.
There are three main causes of drug resistance:
•	 mistakes caused by health care workers, inadequate 
regimens: inappropriate guidelines, non-compliance 
with guidelines, absent guidelines, poor training, no 
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monitoring of treatment, poorly organized or funded 
TB control programmes, poor adherence (or poor DOTs, 
unmotivated staff);
•	 inadequate supply or poor quality of medicine: 
unavailability of certain medicines (stock-outs or 
delivery disruptions), poor quality manufacturing, poor 
storage conditions, wrong dose or combination;
•	 inadequate medicine intake: poor adherence, lack of 
information, lack of money (no treatment available free of 
charge), lack of transport, adverse effects, social barriers, 
malabsorption, substance dependency, disorders.
The only way to confirm MDR-TB and XDR-TB is through 
DST of first- and second-line medicines, respectively. For 
the purposes of the recommendation, the expert group 
considered a rapid test as one providing a diagnosis of 
resistance to isoniazid and rifampicin or rifampicin alone 
within two days of specimen testing. Only molecular tests 
can detect resistance so fast, of which two technologies 
(line probe assay and Xpert MTB/RIF) are currently 
recommended for use by WHO (20). Conventional DST of 
cultured mycobacteria typically provides results within 
one to three months.
The best strategy for averting deaths and preventing 
acquired MDR-TB is to carry out DST in all patients before 
treatment, using a rapid test that detects resistance to 
isoniazid and rifampicin. The modelling work showed 
that rapid testing of both isoniazid and rifampicin at the 
time of diagnosis was the most cost-effective testing 
strategy for any patient group or setting, even at very low 
levels of resistance among TB patients. For previously 
untreated patients, DST at the start of treatment was a 
better strategy than waiting to test only those patients 
who remained sputum-smear-positive later in the course 
of their first-line treatment.
A short time to diagnosis may influence the composition of 
a patient’s initial treatment and increase the likelihood of 
starting appropriate treatment early. The likely benefits of 
rapid DST include increased cure rates, decreased mortality, 
reduced development of additional drug resistance, and a 
reduced likelihood of failure and relapse (20).
In designing a treatment regimen, the following groups of 
medicines might be used:
•	 first-line	anti-TB	drugs;
•	 second-line	 parenteral	 agent	 (injectable	 anti-TB	
drugs): kanamycin, amikacin, capreomycin;
•	 fluoroquinolones:	 levofloxacin,	 moxifloxacin,	
gatifloxacin, ofloxacin;
•	 oral	 bacteriostatic	 second-line	 anti-TB	 drugs:	
ethionamide, prothionamide, cycloserine, terizidone, 
p-aminosalicylic acid;
•	 group	 5	 drugs:	 clofazimine,	 linezolid,	 amoxicillin/
clavulanate, thioacetazone, clarithromycin, imipenem.
According to WHO’s latest recommendations (20) for the 
treatment of patients with MDR-TB:
•	 a	fluoroquinolone	should	be	used;
•	 a	 later-generation	 fluoroquinolone	 rather	 than	 an	
earlier-generation fluoroquinolone should be used;
•	 ethionamide	(or	prothionamide)	should	be	used;
•	 four	 second-line	 anti-TB	 drugs	 likely	 to	 be	 effective	
(including a parenteral agent), as well as pyrazinamide, 
should be included in the intensive phase;
•	 regimens	 should	 include	 at	 least	 pyrazinamide,	 a	
fluoroquinolone, a parenteral agent, ethionamide 
(or prothionamide), and either cycloserine or 
p-aminosalicylic acid if cycloserine cannot be used.
Compared to WHO’s previous recommendations, the last 
version emphasized the following principles of treatment:
•	 include	at	 least	 four	second-line	anti-TB	drugs	 likely	
to be effective as well as pyrazinamide during the 
intensive phase of treatment;
•	 if	 no	 evidence	 is	 found	 to	 support	 the	 use	 of	 more	
than four second-line anti-TB drugs in patients with 
extensive disease, it is permissible to increase the 
number of second-line drugs in a regimen if the 
effectiveness of some of the drugs is uncertain;
•	 ethambutol	may	be	used	but	is	not	included	among	the	
drugs making up the standard regimen;
•	 group	5	drugs	may	be	used	but	are	not	included	among	
the drugs making up the standard regimen.
The analysis (20) provided evidence of an association 
between the success of treatment and the total length 
of treatment and the length of the intensive phase. 
In the treatment of patients with MDR-TB (who had 
not previously received MDR-TB treatment), it is 
recommended that there should be an intensive phase of 
at least 8 months’ duration and total treatment duration of 
at least 20 months.
Three options or types of treatment scheme are 
recommended by WHO: 
(i) standardized treatment: all patients receive the same 
treatment regimen;
(ii) standardized treatment followed by individualized 
treatment: initially all patients receive the same 
regimen based on DST survey data for certain groups, 
and later the regimen is adjusted based on DST 
results; 
(iii) empirical treatment followed by individualized treat- 
ment: each regimen is individually designed on the 
basis of the patient’s history and then adjusted when 
DST results become available.
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These schemes use information obtained from DST 
results and drug-resistance surveillance within the local 
population. The latter can also be obtained from drug-
resistance surveys.
Despite good progress in several countries, the prison 
system is not fully included in the TB control network. There 
are still wide differences in policy and administration, 
including financial capacity, between ministries of health 
and prison health authorities in many countries, leading to 
unequal health care services.
The Consolidated Action Plan to Prevent and Combat 
Multidrug and Extensively Drug-Resistant Tuberculosis in 
the WHO European Region 2011–2015 has six strategic 
directions and seven areas of intervention (19). In view 
of the high prevalence of M/XDR-TB in prison settings, 
prison health systems should follow all the steps defined 
for the civilian sector, as only very close integration 
between civilian and prison health systems guarantees 
success countrywide. The Plan includes the following 
special action to be taken in prison settings:
7.2 Strengthen MDR-TB control in prisons
Activity 7.2.1 The Regional Office, using the successful model 
of its Health in Prison Project, will assist Member States in 
continuously improving TB control in penitentiary services.
Activity 7.2.2 Member States will ensure that early diagnosis 
and effective treatment of M/XDR-TB are available in all 
penitentiary services across the Region by the first quarter 
of 2013.
Activity 7.2.3 Member States will establish mechanisms for 
the continuum of care for released prisoners receiving TB 
treatment by the end of 2012.
TB/HIV co-infection
HIV is the strongest risk factor for developing TB disease 
in those with latent or new M. tuberculosis infection. The 
risk of developing TB is between 20 and 37 times greater in 
people living with HIV than among those who do not have 
HIV infection. TB is responsible for more than a quarter of 
deaths among people living with HIV. In response to the 
dual epidemics of HIV and TB, WHO has recommended 12 
collaborative TB/HIV activities as part of core HIV and TB 
prevention, care and treatment services (21).
Collaborative TB/HIV activities by NTPs and national HIV/
AIDS programmes should prioritize prisons, where the 
prevalence of both diseases is higher. The goal of these 
activities in prisons, as in any community, is to decrease 
the burden of TB and HIV. The specific objectives of the 
collaborative activities are threefold:
•	 to	 establish	 a	mechanism	 for	 collaboration	 between	
both programmes;
•	 to	decrease	the	burden	of	TB	in	people	living	with	HIV/
AIDS;
•	 to	decrease	the	burden	of	HIV	in	TB	patients.
There should be an adequate mechanism for collaboration 
between TB and HIV/AIDS programmes at the local level 
and district public health services, and both should include 
prisons in their workplans. All activities implemented 
in the community should also be made available for 
prisoners. Collaborative activities include surveillance of 
HIV among TB patients, joint planning and mobilization for 
TB/HIV and capacity-building for TB/HIV.
It is recommended that provider-initiated voluntary HIV 
testing and counselling of TB patients be implemented (22).
TB and HIV/AIDS programmes should coordinate TB/
HIV plans, and communicate and coordinate activities 
in prisons to prevent duplication of work. The roles and 
responsibilities of each programme and of the prison staff 
need to be clearly defined, understood and monitored.
Capacity-building for public health and prison personnel 
is crucial for delivering good quality and effective TB/
HIV interventions in prisons. The prison setting offers 
the advantage that the same health staff carry out all 
health-related activities and programmes; thus, a one-
stop approach can be implemented for TB/HIV activities. 
It is very important to involve different types of group, 
nongovernmental organization and religious community in 
educating and counselling suspected cases of TB.
Decreasing the burden of TB in people living with HIV is 
referred to as the three I’s: intensified TB case-finding, 
isoniazid preventive therapy (IPT) for HIV-infected people 
and infection control.
In prisons, all individuals living with HIV should be 
screened for TB either at the time of HIV diagnosis or 
before starting ART, when TB is most likely to be detected. 
In addition, intensified TB case-finding should be carried 
out regularly thereafter (for example, every six months), 
and can be done with the aid of a simple questionnaire, 
often the same form used during entry screening of 
prisoners (23). Intensified TB case-finding among HIV-
infected individuals prevents transmission and mortality, 
reduces the risk of nosocomial transmission and offers an 
opportunity for delivering IPT (24).
The latest WHO recommendations (24) regarding 
intensified TB case-finding and IPT issued in 2011 are the 
following.
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Adults and adolescents living with HIV should be screened 
for TB with a clinical algorithm. Those who do not report 
any one of the symptoms of current cough, fever, weight 
loss or night sweats are unlikely to have active TB and 
should be offered IPT.
Adults and adolescents living with HIV who have an 
unknown or positive tuberculin skin test status and are 
unlikely to have active TB should receive at least six 
months of IPT as part of a comprehensive package of HIV 
care. IPT should be given to such individuals irrespective 
of the degree of immunosuppression, and also to those on 
ART, those who have previously been treated for TB and 
pregnant women (WHO also advises 36 months duration 
taking into account the local epidemiology of TB and HIV 
in settings with a high prevalence of TB in people living 
with HIV).
Tuberculin skin test is not a requirement for initiating IPT 
in people living with HIV. People living with HIV who have 
a positive tuberculin skin test do, however, benefit more 
from IPT.
The provision of IPT to people living with HIV does not 
increase the risk of developing isoniazid-resistant TB. 
Concerns regarding the development of isoniazid resistance 
should not, therefore, be a barrier to providing IPT.
Decreasing the burden of HIV in TB patients includes 
the following activities: HIV counselling and testing 
of prisoners with TB, prevention of HIV transmission in 
prisons, co-trimoxazole preventive therapy and effective 
HIV treatment, care and support.
Prison health care workers should offer HIV counselling 
and voluntary testing to prisoners, especially TB patients, 
for several reasons: prisoners may want to know their HIV 
status; access to ART is increasingly available in many 
countries, including in prison populations; better diagnosis 
and management of other HIV-related illnesses can be 
achieved when the HIV status is known because some anti-
TB medicines are more suitable for HIV-positive individuals; 
a better selection of medicines is possible when the 
HIV status is clear; and prisoners can be given health 
education to reduce high-risk activities and avoid further 
HIV transmission. Counselling must be confidential and 
done before and after the HIV testing. WHO recommends 
provider-initiated HIV testing and counselling.
Preventing HIV transmission can contribute to the 
prevention of TB. The behaviour mainly responsible for HIV 
transmission in prisons is injecting drug use, unprotected 
sex between men, and piercing and tattooing with 
unhygienic tools. TB and HIV/AIDS programmes should 
collaborate to implement comprehensive HIV strategies 
that target sexual, parenteral and vertical transmission of 
HIV. Measures to reduce the sexual spread of HIV include 
promoting safer sexual behaviour and practices. The 
provision of condoms and the prevention of rape, sexual 
violence and coercion are recommended. Measures for 
decreasing parenteral HIV transmission include ensuring 
the use of sterilized injections and surgical equipment in 
prison clinics. WHO and UNODC recommend that harm 
reduction programmes, syringe and needle exchanges, 
substitution therapy and education for prisoners about HIV 
and drug-injecting should be introduced in settings with a 
high HIV prevalence among injection drug users (22).
Co-trimoxazole preventive therapy reduces mortality 
among smear-positive TB patients who are HIV-positive. It 
also reduces hospitalization and morbidity among persons 
living with HIV/AIDS. For TB patients, co-trimoxazole 
prophylaxis should be initiated irrespective of the CD4 
cell count.
Effective HIV treatment includes access to ART as part 
of comprehensive HIV/AIDS care. ART is recommended 
for all patients with HIV and drug-resistant TB requiring 
second-line anti-TB drugs, irrespective of CD4 cell count, 
as early as possible (ideally as early as two weeks, and 
no later than eight weeks) following initiation of anti-TB 
treatment (21).
The pooled individual patient data from longitudinal cohort 
studies showed a lower risk of death and a higher likelihood 
of cure and resolution of TB signs and symptoms in patients 
using ART compared with those not using ART (25). The 
strong recommendation for use of ART is based in part on 
indirect evidence from its use in any patient with active TB, 
which shows considerable beneficial effects and a very high 
mortality when ART is not employed, particularly in highly 
immune-compromised patients (CD4 cell count <50 cells/
mm3). In the absence of other data specific to patients with 
drug-resistant TB receiving second-line anti-TB medication, 
the decision on when to start ART should be no different 
from the approach to the HIV-positive drug-susceptible TB 
patient (25).
The successful implementation of this recommendation 
will depend on the availability of more providers trained 
specifically in the care of HIV, TB and drug-resistant TB 
and drug–drug interactions. A substantial increase in the 
availability of treatment and patients’ access to it will 
probably be needed together with additional support for 
ensuring adherence. The need for increased integration of 
HIV and TB care for effective patient management, prompt 
evaluation of adverse events and case-holding throughout 
treatment will require more resources.
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In 2011, WHO issued recommendations and a plan of 
action for improving TB/HIV collaborative mechanisms 
in the Region (20,26). All these recommendations apply 
to both civilian and prison populations, and include the 
following action: 
•	 the	 Regional	 Office	 will	 document	 best	 practices	
and experiences in effective integration and service 
delivery models for TB/HIV/drug dependence services;
•	 the	 Regional	 Office	 and	 other	 partners	 will	 support	
training and education for HIV and TB health care 
professionals on a regular basis;
•	 the	Regional	Office	and	other	partners	will	support	the	
revision of national TB/HIV policies;
•	 Member	 States	 will	 establish	 a	 functional	 TB/HIV	
coordinating mechanism to facilitate the delivery 
of integrated TB and HIV (and drug use/narcology) 
services within the same facilities, including in 
prisons;
•	 Member	 States	 will	 develop	 directives	 to	 deliver	
ART in TB dispensaries and TB treatment in AIDS 
dispensaries (or relevant/appropriate facilities), where 
these are lacking;
•	 all	 authorities	 under	 the	 ministries	 of	 health	 and	
justice in Member States will expand access to 
evidence-based harm reduction services, including TB 
and HIV prevention, diagnosis and treatment services 
for people living with or at risk of HIV, in particular 
people who use or inject drugs;
•	 Member	 States	 will	 scale	 up	 the	 provision	 of	 TB	
prophylactic treatment in all AIDS dispensaries as a 
core HIV care intervention in line with internationally 
recommended evidence-based policies;
•	 ministries	 of	 health	 will	 ensure	 the	 availability	 of	
isoniazid in AIDS dispensaries as part of HIV care 
intervention;
•	 national	TB	and	HIV	programmes	and	dispensaries	will	
actively engage with civil society partners to improve 
access to integrated TB/HIV and, where appropriate, 
harm reduction services for the most at-risk and 
vulnerable populations.
TB infection control 
TB infection control is a combination of measures aimed 
at minimizing the risk of TB transmission. The basis of 
such infection control is early and rapid identification of 
individuals with suspected and known TB and effective 
treatment of disease. TB infection control, as a component 
of WHO’s revised Stop TB Strategy (6), is intended to 
strengthen health systems.
Policy and service delivery areas related to TB infection 
control (27) may be studied at four levels:
•	 managerial	 (organizational)	 control	 measures,	
including the development of TB infection control 
policy, strategic planning, advocacy, human resource 
development, monitoring and evaluation, operational 
research;
•	 administrative	 control	 measures,	 including	 early	 TB	
case detection, TB screening, separation or isolation 
of patients, cough etiquette and hygiene;
•	 environmental	 control	 measures,	 including	 natural	
and mechanical ventilation, ultraviolet germicidal 
irradiation;
•	 personal	 protection	 control	 measures,	 including	
respirators and respiratory fit testing.
Several infection control measures could be conducted in 
prisons (10):
•	 preventing	 the	 spread	 of	 infection	 from	 community	
to prison by using intensified TB screening for new or 
transferred prisoners and preparing special quarantine 
blocks or cells (to be used for one or two weeks) for 
new or transferred prisoners;
•	 preventing	 the	 transmission	 of	 TB	 infection	 from	
one prisoner to other prisoners or to prison staff by: 
(i) conducting contact investigations for TB suspects 
and cases; (ii) improving infection control by carrying 
out organizational, administrative and environmental 
interventions in prisons; and (iii) using information, 
education and communication for prisoners;
•	 preventing	 the	 infection	 of	 family	members	 and	 the	
community by released prisoners or prison staff by 
examining prisoners before release and examining 
prison staff regularly;
•	 establishing	TB	infection	control	in	the	community	by	
instituting early TB case detection and using effective 
treatment.
Managerial activities in prisons
The full set of national managerial activities designed 
for the civilian sector should also apply to congregate 
settings. As a first step, policy-makers responsible for 
prison settings should be made part of the coordinating 
system for planning and implementing interventions to 
control TB infection. In particular, the medical service of 
the ministry of justice and correctional facilities should 
be fully engaged and encouraged to implement TB 
infection control. Overcrowding should be avoided in 
prisons because it can lead to non-infected individuals 
being exposed to TB. Prisons should be part of the 
country’s surveillance activities and should be included 
in assessment of facilities for TB infection control. Such 
assessment will be useful in determining the level of risk 
of the facility or building. Any advocacy and information, 
education and communication material should include 
a specific focus on prisons, as should monitoring and 
evaluation activities. There is a great need for more 
research on TB infection control in prisons.
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Facility-level managerial activities should also apply (with 
some adaptation) to prisons. Ideally, each prison should 
have a written TB infection control plan with a protocol 
for the prompt recognition, separation and provision of 
services for and investigation of TB, and referral of patients 
with suspected or confirmed TB disease. A designated 
infection control officer is responsible for overseeing 
the implementation of infection control measures and 
providing infection control training for health care and 
other staff members who may be exposed to TB infection.
Monitoring and evaluation provide the means to assess 
the quality, effectiveness, coverage and delivery of 
infection control interventions and to ensure that 
there is continuous improvement in the carrying out 
of programmes. Monitoring and evaluation should 
involve collaboration and sharing of indicators between 
programmes (for example, programmes related to TB, 
HIV, occupational health and infection control) and should 
include links between prison and civilian health services, 
particularly regarding the continuum of care and follow-up 
of released prisoners with TB.
Administrative measures
The implementation of administrative interventions 
in particular work practices has the highest possible 
impact on preventing TB transmission and is usually 
the least expensive measure and is, therefore, strongly 
advocated in most settings. To decrease TB transmission 
in prisons, cough etiquette and respiratory hygiene and 
early identification, followed by separation and proper 
treatment of infectious cases, should be implemented. 
In particular, all inmates in long-term stay facilities 
and inhabitants of other congregate settings should be 
screened for TB on entry. People suspected of having 
TB should be diagnosed as quickly as possible. Those 
patients should always be separated and, if possible, 
isolated in an adequately ventilated area until sputum-
smear conversion. In short-stay congregate settings, such 
as jails and shelters, a referral system for proper case 
management should be established.
In prisons with a high prevalence of HIV, patients living 
with HIV and other forms of immune suppression should 
be separated from those with suspected or confirmed 
infectious TB. All staff and persons residing in the setting 
should be given information and encouraged to undergo 
HIV testing and counselling. If diagnosed with HIV, they 
should be offered a package of prevention and care 
that includes regular screening for active TB. Additional 
measures for groups at high risk (such as injecting and 
other drug users) should be ensured. In prisons with 
patients having, or suspected of having, drug-resistant 
TB, such patients should be separated from other patients 
(including other TB patients) and referral for proper 
treatment established.
Environmental controls 
Buildings in congregate settings should comply with 
national norms and regulations for ventilation in public 
buildings and specific norms and regulations for prisons, 
where these exist. It is recommended that the air change 
rate should be no less than 6–12. Ideally, cells and wards 
in prison hospitals should have large windows which 
should be kept open often. When other environmental 
control measures are not in place, the emphasis should 
be on natural ventilation by maximizing the opening of 
windows.
Well-designed, well-maintained and correctly operated 
exhaust fans (mixed-mode ventilation) can help to obtain 
adequate ventilation when sufficient air change per hour 
cannot be achieved by natural ventilation alone.
In prisons in which there is a high risk of TB transmission 
and where adequate ventilation cannot be achieved (for 
example, because of design constraints or cold winters), 
another option is the use of an upper room or shielded 
ultraviolet germicidal irradiation device. If such a device 
is used, fixtures should be designed to prevent injury from 
improper use or tampering with the device.
Personal protective equipment in congregate 
settings
In addition to carrying out administrative and environmental 
controls, health-care workers may use respirators when 
caring for patients with infectious TB. Respirators (N95 or 
filter face-piece 2 equivalent or higher) provide reasonably 
good protection against TB by filtering out microscopic 
droplets and aerosols. The use of respirators provides 
protection for health-care workers in close contact with 
TB patients. This protection is particularly important when 
health staff are supervising a cough-inducing procedure 
(such as bronchoscopy) or sputum collection. Prisoners 
who are TB patients should use surgical masks when 
moving around inside the hospital.
Advocacy, communication and social  
mobilization
Advocacy, communication and social mobilization 
constitute the important component of the Stop TB 
Strategy. Although such initiatives are mainly aimed at 
the general population, their importance and applicability 
in prisons cannot be underestimated. At the institutional 
level, prison health authorities should address the 
following key strategies: improving TB case detection 
and compliance with treatment, combating stigma and 
discrimination, empowering people affected with TB and 
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mobilizing political commitment and resources to fight 
TB.
Usually, patients must present themselves to the prison 
health services when TB symptoms emerge (mainly in 
institutions where no active case-finding is in place) 
and adhere to treatment for at least six months. As 
this approach (passive case-finding) relies on prisoners’ 
awareness of TB symptoms, delays in diagnosis and the 
start of treatment are common in many settings. Studies 
document that in prisons where educational sessions 
are carried out (including talks, videos, flipcharts, other 
educational materials, contests, question-and-answer 
games), adherence to treatment improves and the cure 
rate rises. Good results have also been also achieved by 
involving peer educators (prisoners) (28).
Educational campaigns in prisons should be directed 
against stigmatization and discrimination, which are the 
greatest threats to TB programmes in both civilian and 
prison populations, and involve the prison administration 
as well as detainees.
In the fight against TB and HIV, it is highly recommended 
that the prisoners should be involved in the development 
and dissemination of educational programmes. Prisoners 
might be engaged as peer educators and treatment 
supporters and can play a crucial role in identifying TB 
suspects. During the educational campaigns everybody 
should be involved in designing and developing the 
activities: prison administration, health staff and prisoners. 
This kind of collaboration makes the information more 
sensitive and appropriate to the prison context, increases 
the sense of ownership among prisoners and contributes 
to the continuity of the programme.
A complementary political commitment lies at the 
core of efforts to establish and sustain effective TB 
control strategies in prisons. The common denominator 
of successful initiatives is the equal participation of 
decision-makers, administrators and those responsible for 
implementation in the public health and prison systems. 
Policies that support ongoing and sustainable programmes 
should be introduced, together with adequate resources to 
build the capacity to translate such policies into effective 
practice.
There must be political commitment at the various levels 
of the NTP and of the prison system. In the public health 
sector, the decentralization that has occurred in many 
resource-constrained countries has shifted the planning 
and resource allocation processes from the central level 
to provincial and district authorities, limiting in many 
instances the influence and involvement of the central 
level. Thus, strong advocacy and the continuous fostering 
of awareness are essential for TB services in prisons on 
the periphery, and decision-makers at these levels should 
become stakeholders in the programme to help ensure its 
continuity
In the Roadmap to prevent and combat drug-resistant 
tuberculosis (19), WHO addressed the challenges to the 
implementation of advocacy, communication and social 
mobilization activities in both the civilian and prison 
sectors and developed a package of recommendations, 
including the following:
•	 use	the	successful	model	of	the	HIPP	to	assist	NTPs	in	
improving TB activities in the prison system;
•	 facilitate	the	adaptation	and	development	of	advocacy,	
communication and social mobilization materials 
appropriate to the country (and prison setting);
•	 use	 all	 forms	 of	 the	media	 to	 inform,	 persuade	 and	
generate action among the whole population or 
targeted subpopulations (prisoners) about TB, and to 
generate awareness of the challenge of M/XDR-TB 
and thus the importance of prevention, increased and 
speedy detection and completion of treatment;
•	 train	 (prison)	 health	 care	 staff	 in	 patient-centred	
care and intrapersonal communication skills on a 
regular basis to enable them to develop appropriate 
consultation skills and supportive attitudes.
Continuum of care for released prisoners
Following release, prisoners face problems with housing, 
unemployment, registration of residence, social stigma, 
negligence and a cautious attitude by civil society. 
Since released prisoners often give priority to these 
competing issues over their health, they need to be 
followed by the local health centre, NTP or organization 
collaborating with the NTP. This follow-up often does 
not happen: in eastern European countries, reportedly 
around 60–70% of prisoners do not refer to TB facilities 
after release. To minimize the interruption of treatment in 
released prisoners, it is recommended that discharge or 
referral planning, post-release follow-up, notification of 
unplanned releases and monitoring of referrals should be 
implemented (10). 
Discharge or referral planning
Prison health staff, as case managers, should coordinate 
the follow-up of released prisoners with the civilian 
sector (district TB coordinators) regarding where prisoners 
live after release, any available social support and 
post-release assistance (with factors such as housing, 
employment, continuation of treatment and psychological 
support). An important factor is the education of family 
members about the importance of the prisoner adhering 
to treatment and the consequences of interruption. In this 
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regard, peer educators play a significant role in educating 
prisoners. While in treatment, prisoners with TB should 
supply the addresses and telephone numbers of relatives 
and family members and information about where they 
plan to live.
Post-release follow-up
The following activities can contribute to an easy 
transition. Prison health staff should complete a referral 
form (part of the NTP’s information system forms) for the 
prisoner to give to the local health centre staff where he/
she will continue treatment in the community. A copy 
should be kept in the prison and a second copy sent to the 
regional area or district NTP manager. The same procedure 
applies to prisoners who are transferred to another prison; 
wherever possible, the prisoner should be introduced 
(preferably face to face) to the TB programme manager or 
district TB programme supervisor who is responsible for 
treatment and care in the community (local health centre 
staff and district NTP). Post-release appointments should 
be made at the local TB facility, and the prisoner supplied 
on release with adequate TB drugs to last until the next 
medical appointment.
Depending on local resources and capacity, prison and 
NTP local staff can work with advocacy groups or private 
or government-funded programmes to facilitate a safe, 
supported transition for prisoners into the community. 
Substance use, mental health conditions and poverty 
affect health care. The greatest barriers to continuity of 
care for TB lie with adherence to medication, housing, 
social relationships and unemployment. Nongovernmental 
organizations and churches working in prisons can play 
crucial roles in helping to follow up prisoners undergoing 
TB treatment after their release from prison. It is essential 
to establish partnerships with them that include well-
defined tasks and responsibilities, and they should be 
sought out and included in planning and monitoring 
activities.
Notification of unplanned releases and unplanned 
transfers
Unplanned releases (amnesty, etc.) often create problems 
with the continuity of treatment. The prison administration 
should inform the health staff about all scheduled and 
unscheduled releases as soon as information becomes 
available. Prompt remedial steps need to be taken in 
collaboration with the local NTP supervisors to guarantee 
that the released TB patients visit the local health centre 
and continue therapy there. For this notification, prompt 
communication via telephone, text messages and other 
rapid methods are encouraged. The patient’s treatment 
card (or a copy of it) must be sent to the receiving health 
care facility that will follow up the patient.
A referral register is useful for monitoring and evaluating 
referral and should include feedback. Registers are kept in 
prisons or by district NTP supervisors or both. The important 
indicator in monitoring released prisoners is the number of 
released prisoners registered in civilian TB units.
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9. Infectious diseases in prison
Sven Todts
Key points 
•	 Infectious	diseases	are	an	important	problem	in	prisons,	
interacting dynamically with other problems of prisoners 
such as mental illness, addiction or homelessness.
•	 Contextual	factors	such	as	overcrowding,	limited	access	
to water or delays in diagnosis contribute to higher 
transmission rates.
•	 Every	 prison	 health	 care	 service	 should	 have	 a	
comprehensive vaccination programme for prisoners 
and prison staff.
Introduction
An effective infectious disease strategy is impossible 
without close collaboration between health care 
staff and custodial staff. As elsewhere in the world, 
prisoners in Europe have complex health needs, which 
result from an amalgam of mental and physical illness, 
unemployment, addiction and homelessness. Infectious 
diseases are an important constituent of this amalgam. 
The different elements do not exist as separate entities 
but interact dynamically, as shown in the case study of 
the dynamics between infections and mental illness 
described by Rutherford (1). People with mental illness 
are more likely to be infected with bloodborne viruses 
because of risky behaviour such as homelessness, 
rapidly changing moods and multiple partners. Brunette 
notes that the treatment for hepatitis with interferon 
can lead to depression and that people with mental 
illness may be less able to cope with side-effects such 
as fatigue (2).
Incoming prisoners are at higher risk of HIV, viral hepatitis, 
STIs, TB and methicillin-resistant Staphylococcus aureus 
(3). Contextual factors inside prisons contribute to a 
higher risk of transmission among prisoners. Among 
these factors are overcrowding, delays in diagnosis and 
treatment, limited access to water, soap or clean laundry 
and lack of availability of harm reduction measures such 
as condoms, clean tattooing equipment or syringes (4).
This chapter reviews the most important infectious 
diseases apart from HIV and TB, which are discussed in 
other chapters.
Influenza
Ever since Quinton described, for the first time, an 
outbreak of influenza in Wandsworth prison (United 
Kingdom) in 1890 (5), many more outbreaks have been 
documented. In fact, the 1918 outbreak in the prison of 
San Quentin (California, United States) seems to have 
been one of the primary foci of the 1918–1920 pandemic 
(6). Nevertheless, as Awofeso (6) states, outbreaks have 
become rather rare in recent times. Two major strategies 
to prevent an outbreak have been developed. The 
preferred strategy involves consideration of the whole 
prison population as a risk group and vaccination of as 
many prisoners as possible every year. The disadvantages 
of this strategy are that it is expensive (since outbreaks 
are rare) and that the distribution of vaccines can be 
complex. A recent evaluation in the United States 
showed that 20% of federal and state prisons and 33% 
of jails did not receive the necessary vaccines (7). The 
prison population should be vaccinated for seasonal 
influenza every year from October to December.
Another proposed strategy consists of quarantine, 
vaccination (if available) and short-term (prophylactic) 
treatment of cases and their close contacts (8). 
Mathematical modelling shows that this strategy might 
also work in a prison setting (6). If vaccination of the 
entire population is impossible, at least prisoners 
belonging to risk groups should be offered vaccination. 
Whichever model is chosen, it must be stressed that the 
model needs to take into account the equivalence of 
care issues (9).
In 2009, at a time when no vaccine was available, the 
H1N1 influenza epidemic also threatened the Belgian 
prison system. Preparations and procedures for dealing 
with it at national level included the following:
•	 organization	 of	 a	 direct	 link	 to	 the	 national	 crisis	
coordination centre (interior affairs);
•	 creation	of	a	crisis	coordination	centre	for	the	justice	
department and/or prison administration;
•	 appointment	of	a	responsible	person	for	all	information,	
announcements and publications;
•	 securing	of	funding	for	the	prevention	kits	(see	below:	
local level);
•	 setting	up	of	a	centralized	 registration	procedure	 for	
staff members and detainees who were ill:
 − staff returning after a bout of influenza to be 
          placed in sections with sick prisoners;
 − directives for separating prisoners who were not 
          yet ill, ill or had recovered in different sections;
 − centralized registration for the organization of help 
         for the hardest hit prisons;
74
Prisons and health
•	 issuing	 of	 directives	 for	 quarantine	 of	 diagnosed	
prisoners by the medical staff;
•	 issuing	of	guidelines	for	the	use	of	antiviral	medication	
and vaccines (when they became available);
•	 issuing	of	directives	to	limit	movement	inside	facilities	
and into or out of affected units.
Measures at local level consisted of cancelling common 
activities and issuing prevention kits for prisons (prisoners, 
staff and visitors) containing:
•	 non-alcoholic	hand	disinfection	dispensers;
•	 non-alcoholic	 disinfection	 gels	 in	 places	 with	 no	
access to running water;
•	 a	stock	of	disposable	mouth	masks;
•	 a	stock	of	disposable	gloves	and	paper	handkerchiefs;
•	 extra	dustbins	to	collect	all	the	disposable	material;
•	 posters	 and	 leaflets	with	 prevention	messages	 (also	
on the intranet);
•	 a	 stock	 of	 dry	 foods	 (in	 cases	 where	 kitchens	 or	
suppliers can no longer function).
Measles, mumps and rubella
Measles is a highly contagious viral disease spread by 
droplet infection through sneezing and coughing. Initial 
symptoms include high fever and a runny nose, followed 
by a rash descending from the head and neck. Serious 
complications can develop, specifically in malnourished 
patients or in patients with diminished immunity. Laurent 
et al (10) showed how the immune status of migrant 
populations in a Swiss prison was fairly low. Targeted 
vaccination programmes for migrant prisoners could 
reduce the risks of transmission. In fact, vaccination 
for measles (combined with mumps and rubella) should 
ideally be offered to all incoming prisoners without a 
reliable vaccine history.
Measles, mumps and rubella vaccination should also be 
offered to female prisoners of childbearing age without a 
reliable vaccine history, to protect them against rubella.
Some authors also suggest vaccination of prisoners 
against varicella zoster, the virus that causes chickenpox 
(4). There are combined measles, mumps, rubella and 
varicella zoster vaccines.
Viral hepatitis
Viral hepatitis is the leading cause of cirrhosis and liver 
cancer, which in turn ranks as the third cause of cancer death 
worldwide. Within the WHO European Region, approximately 
14 million people are chronically infected with HBV, and  
9 million people are chronically infected with HCV (11).
Across Europe, prisoner populations are 
disproportionately affected. The reasons are to be 
found in the lifestyles of many prisoners. Injecting drug 
use, tattooing and risky sexual behaviour all favour 
transmission of these bloodborne viruses. Another 
reason is the overrepresentation of migrants from 
endemic regions in European prisons.
With few exceptions, European countries now have 
universal vaccination for HBV in children. As a result, 
most new cases now occur among adults. Non-immune 
prisoners are at high risk of becoming infected and should 
be vaccinated. Different countries have allowed rapid or 
ultra-rapid vaccination schemes (for example, on days 0, 
7 and 21 with a booster after 1 year) for adult prisoners, 
thus avoiding the risk of incomplete vaccination when a 
regular scheme (0, 1 and 6 months) is used.
In the absence of a vaccine for hepatitis C, treatment 
is the only option. Ideally, all incoming prisoners should 
be screened for hepatitis C and, if found positive, liver 
damage and the need for treatment should be evaluated. 
Treatment is complex and expensive. Collaboration with 
haepatology departments is necessary. Most existing 
guidelines discourage the treatment of active drug 
users, but recently evidence has emerged that treatment 
of active users could help to contain the HCV epidemic:
A recent modelling study suggests that, based on realistic 
treatment capacity, treating 40 per 1000 IDUs annually 
could result in a 70% decrease in HCV prevalence over a 
10-year period. The underlying principle of this ‘treatment 
for prevention’ approach, also advocated by the HIV/AIDS 
research community, is that the overall viral load in the 
population can be reduced through effective treatment of 
those infected, thereby halting the cycle of transmission (11).
The transmission of hepatitis A happens through 
contaminated food or water or by faeco-oral 
contamination. Foodborne and waterborne outbreaks in 
prisons have been described. Patients are contagious 
from two to four weeks before the appearance of 
symptoms (pruritis, jaundice) until the disappearance of 
symptoms. Among other risk groups, food handlers, men 
who have sex with men, injecting drug users, people 
with mental deficiencies and patients with chronic liver 
disease should all be vaccinated. It is, therefore, sensible 
to vaccinate all non-immune incoming prisoners.
Tetanus
Tetanus is caused by Clostridium tetani, a bacterium that 
enters the body through soiled wounds. In the majority 
of cases, the entry place is a small wound. Puncture 
wounds, bite wounds, wounds that are soiled and wounds 
that are not treated within six hours carry a higher risk. 
Tetanus can also, although rarely, be transmitted through 
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injecting drug use (12,13). It causes focal or generalized 
muscular spasms. Even under the best of circumstances, 
the mortality from tetanus is 10–40%. Incoming 
prisoners should, therefore, be vaccinated unless they 
have proof of their immune status, notwithstanding 
that tetanus has become a rare disease in Europe. At 
the least, prisoners presenting themselves with wounds 
should be vaccinated immediately. A patient with a type 
of wound carrying a higher risk should also be treated 
with specific immunoglobulins.
Diphtheria
Diphtheria is caused by Corynebacterium diphtheriae, which 
is spread by sneezing or coughing by the diseased patient 
(droplet infection). The bacteria produce an exotoxin that is 
the cause of the symptoms: obstructive respiratory problems 
with the formation of false membranes in nose and throat. 
There can be systemic complications, such as heart failure 
or paralysis. Mortality is 5–10%. The level of immunization 
is below standard in many parts of the world. In 1993, a 
nationwide epidemic struck the Russian Federation, following 
the breakdown of vaccination programmes (14).
Treatment consists in immediate medical isolation and 
treatment (antitoxins and antibiotics) of the patient and 
close contacts. Antibiotic treatment renders the patient 
non-infectious within 24 hours.
Incoming prisoners should be vaccinated unless their 
immune status can be proven, using the combined 
diphtheria/tetanus vaccine for adults.
Sexually transmitted infections
As Tang (15) states: 
There is ample evidence worldwide that sexually transmitted 
infection and bloodborne viral infection are more highly 
prevalent in prison populations than in the outside community. 
STI diagnosis and treatment services in prisons are therefore 
an essential component of any STI control programme. 
Prisoners often belong to vulnerable groups in society, 
who have a higher risk of STI because of, for example, 
injecting drug use, engagement in commercial sex 
activities and unprotected intercourse. They also engage 
in high-risk sexual behaviour in prison, or can become 
the victim of sexual violence.
Apart from screening for HIV, HBV and HCV, voluntary 
screening for other STIs (chlamydia, gonorrhoea, syphilis) 
should be offered to all prisoners with risky behaviour.
With the advent of nucleic acid amplification tests for 
chlamydia and gonorrhoea, male patients show less 
resistance to testing. Nevertheless, prisoners may find 
donating a urine sample problematic for fear of drug 
testing. It is the responsibility of the prison health care 
team to build up the necessary trust and confidentiality.
Gonorrhoea is a bacterium that infects the urethra in 
men and the cervix, uterus and fallopian tubes in women. 
Although a silent (symptomless) infection is possible, 
many men will experience burning pain while urinating. 
The infection produces a white to green discharge. In 
women, symptoms are often less specific: burning 
sensations while urinating, blood loss and vaginal 
discharge. In both men and women, rectal infection can 
create painful defecation, rectal discharge, bleeding and 
anal itching.
Untreated, gonorrhoea can cause infertility through 
pelvic inflammatory disease in women and through 
epididymitis in men. Treatment consists of antibiotics. 
More and more strains of Neisseria gonorrhoea are 
resistant to ciproxine, penicillin or tetracyclines. 
Chlamydia trachomatis often presents without 
symptoms. In men, it can cause urethritis, epidydimitis 
and proctitis. In women it causes cervicitis (often 
with contact bleeding), which can develop into pelvic 
inflammatory disease. Diagnosis is preferably made 
by nucleic acid amplification tests (urine or urethral 
discharge in men, vaginal discharge or cervix in women, 
rectum if anal intercourse has taken place and pharynx 
in case of oral sex). 
Syphilis, caused by Treponema pallidum, evolves in 
several phases. The hallmark of primary syphilis is a 
painless wet ulcer (chancre) at the site of inoculation 
(genitals, anus and mouth), which disappears after three 
to six weeks. The secondary phase, which starts some 
weeks after the chancre, consists of body rashes, often 
on the palms of the hands and soles of the feet. It can 
last up to two years and be accompanied by subfebrility, 
fatigue, weight loss, patchy hair loss, swollen lymph 
nodes and muscle pains. In the third stage of late 
syphilis, serious and irreparable damage is done to the 
nervous system, the heart, the brain and other parts of 
the body.
As a primary screening test, treponema pallidum 
haemaglutination assay or enzyme immunoassay 
can be used. A fluorescent treponemal antibody test 
can then be used as confirmation. Venereal Disease 
Research Laboratory and rapid plasma reagin tests are 
used to monitor the response to antibiotic treatment. 
Interpretation of syphilis serology can be difficult and is 
best left to specialists. Syphilis is often found in people 
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with HIV/AIDS. A confirmed diagnosis of syphilis should, 
therefore, prompt HIV testing.
Notification and treatment of partners can be difficult in 
prison, either because of practical difficulties (if partners 
live in the community) or because of the taboo on sex 
among inmates. In the first case, collaboration with an 
outside agency can be a solution.
Ectoparasites
Ectoparasites such as scabies and lice are not uncommon 
in prisons.
Rash, pruritis and/or skin lesions are the hallmarks of 
scabies. In most instances, diagnosis is not too difficult. 
Indeed, it is often self-diagnosed. Efficient treatment 
is, however, only possible if there is close collaboration 
between medical and custodial staff. Efficient treatment 
requires the diagnosis and topical treatment of the 
index case and other cell-mates, together with access to 
showers and disinfection of bed linen, towels and clothes. 
Not infrequently, the handling of infected items in the 
prison laundry leads to new cases. This can be avoided by 
using protein-based laundry bags to collect the infected 
items: the bags can be put inside the washing machines 
without further handling of the infected clothes or linen.
Pediculosis capitis, or head lice, are caused by an insect 
parasite of human head hair. Apart from the hair, bed linen, 
clothes, combs and brushes can be infested. Treatment 
should, therefore, not only include topical treatment but 
also disinfection of the mentioned items. Prison barbers 
(often prisoners) should be educated on the cleaning and 
disinfection of their barbering equipment.
Vaccination, quarantine and personal 
hygiene
Table 5 gives a proposed vaccination scheme for certain 
infectious diseases.
In cases of highly contagious disease or a threatened 
epidemic, isolation for medical reasons (quarantine) can 
be warranted. In such cases, the following rules should 
apply.
Only a medical doctor can decide on the need for isolation. 
The beginning and end of quarantine measures are strictly 
medical decisions.
The duration of isolation should be limited to the strictly 
necessary minimum.
Medical and custodial staff will see to it that the rights 
of prisoners are guaranteed as far as possible (daily walk, 
legal assistance, contact with family).
The quarantined sections of the prison (a cell, a section or 
the entire prison) must be marked by biohazard signs (Fig. 2). 
Biohazard signs (such as posters and stickers) should 
always be available in the medical department. Other 
logograms at the entrance of the quarantined zones can 
show which protective measures (such as disposable 
mouth masks and gloves) are necessary to enter the zone.
Fig. 2. Biohazard sign
Disease Vaccination scheme
   Seasonal influenza All prisoners or risk groups (October–December)
   Tetanus/diphtheria All incoming prisoners without a reliable vaccination history
   Measles, mumps, rubella All incoming prisoners without a reliable vaccination history and women of childbearing 
age without a reliable vaccination history
   Hepatitis A All incoming non-immune prisoners
   Hepatitis B All incoming prisoners without a reliable vaccination history
   Pneumococcus Prisoners aged over 65 years and prisoners with HIV/AIDS
Table 5. Vaccination scheme for certain infectious diseases
Protective clothing and dustbins for used disposables 
should be made available at the entrances/exits of the 
quarantined zones.
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Finally, the following are the rules for personal hygiene.
1. All incoming prisoners should be educated about 
the importance of personal hygiene and should have 
regular access to decent toilets, toilet paper, sanitary 
napkins, clean water, soap and clean laundry. They 
should be aware of the importance of wound care and 
have access to wound care material if necessary.
2. Targeted efforts should be made to educate and assist 
prisoners who may have difficulties with personal 
hygiene, such as prisoners with an intellectual 
disability.
3. All incoming prisoners should be educated about the 
universal precautions against bloodborne viruses and 
have access to the means to protect themselves, such 
as sterile syringes, condoms, dental dams, personal 
towels and personal toothbrush or comb.
4. Prisoners and all staff must be able to recognize the 
biohazard sign (Fig. 2) and understand which measures 
need to be taken to protect themselves if necessary.
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10. Noncommunicable diseases and prisoners
Emma Plugge, Ruth Elwood Martin, Paul Hayton
Key points 
•	 The	global	burden	of	and	threat	from	noncommunicable	
diseases (NCDs) constitute a major public health 
challenge that undermines social and economic 
development throughout the world. Prisoners are at 
greater risk for such diseases.
•	 Most	 information	 on	 NCDs	 in	 prisoners	 comes	 from	
high-income countries despite the fact that globally, 
80% of these deaths from these diseases are in low- 
and middle-income countries.
•	 NCDs	comprise	mainly	cardiovascular	diseases	(48%),	
cancers (21%), chronic respiratory diseases (12%) and 
diabetes (3.5%). They share four key behavioural risk 
factors: tobacco use, unhealthy diet, physical inactivity 
and harmful use of alcohol. Prisoners are more likely to 
smoke and to drink harmful amounts of alcohol than the 
general population.
•	 Prisoners’	diets	are	often	unhealthy	with	either	under-	
or over-provision of calories and with excessive levels 
of sodium.
•	 The	 primary	 prevention	 and	 treatment	 of	 NCDs	 in	
prisons has largely been neglected.
Introduction
NCDs are increasingly recognized as a considerable global 
public health issue (1). Cardiovascular diseases, cancers, 
diabetes and chronic respiratory diseases are the four most 
common NCDs, causing an estimated 36 million deaths each 
year – 63% of all deaths globally (1). While these diseases 
affect people of all nationalities, ages and wealth, there 
are clear global inequalities in the burden of NCDs, with 
those in vulnerable situations particularly affected. There 
is a clear link between socioeconomic disadvantage and 
NCDs; given that most of the 10 million people imprisoned 
worldwide are from the poorest and most marginalized 
sections of society, they are likely be at greater risk for 
NCDs. The primary prevention and treatment of NCDs in 
prisons have, however, been largely neglected. In part 
this may be because of a lack of awareness of the global 
importance of NCDs, but there is also a perception that 
prisoners tend to be younger than the general population 
and thus NCDs are not likely to be an issue – despite the 
fact that 44% of all deaths in the general population are in 
people under the age of 70 years (2).
This chapter will highlight the importance of tackling 
NCDs in the prison population. It will focus on the burden 
of NCDs and risk factors in prisoners and examine the 
challenges in providing appropriate prevention and 
treatment in prisons.
Burden of disease and risk factors for 
NCDs in prisoners
Most of the information on the prevalence of 
cardiovascular diseases, cancers, diabetes and chronic 
respiratory diseases in prisons comes from high-income 
countries despite the fact that globally, 80% of deaths 
from these diseases are in low- and middle-income 
countries. Evidence from Australia, the United Kingdom 
and the United States shows that NCDs are an important 
public health problem in prisons. A study in the United 
States showed that prisoners had a higher prevalence of 
hypertension, diabetes, myocardial infarction, asthma and 
cancer (cervical) than non-imprisoned adults of similar 
ages and sex (3). Another United States study looking 
specifically at cancers found that the most common 
cancers in prisoners were lung carcinoma, non-Hodgkin 
lymphoma and carcinomas of the oral cavity and pharynx 
(4). Among women, cervical carcinoma was the most 
common. Lung carcinoma, non-Hodgkin lymphoma and 
hepatic carcinoma accounted for more cancer deaths 
among inmates than in a community comparison group, 
and the median survival time in prisoners was lower than 
in the comparison group: prisoners’ median survival time 
from diagnosis was 21 months compared to 54 months in 
the community cohort (4).
NCDs are an issue in other countries too. Women 
prisoners in Queensland, Australia, were three times 
more likely to suffer from asthma than women in the 
general population, with a prevalence of 36.3%. Diabetes 
was also more common in imprisoned women, found in 
6.2% of women prisoners compared to 0.3% of women 
aged 25–34 years in the general population (5). Important 
differences have been found within subgroups in the 
prison population, particularly ethnic/racial differences. 
Data from the United Kingdom and United States suggest 
that the prevalence of chronic conditions is greater in 
white populations compared to ethnic minorities. This 
is not, however, the pattern seen in Australian prisons 
where indigenous prisoners are more likely to suffer from 
NCDs.
It is important to note that NCDs are preventable. Up to 
80% of heart disease, stroke and type 2 diabetes and 
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over a third of cancers could be prevented by eliminating 
the common risk factors (6). The four key modifiable 
risk factors are smoking, the harmful use of alcohol, 
inadequate physical activity and unhealthy diet. The 
available evidence suggests that prisoners are likely to 
be at high risk of NCDs because of high risk behaviour. 
Smoking in prisons is a huge public health problem (see 
Chapter 16). Between 64% and 91.8% of prisoners smoke. 
In some countries, these rates were more than three times 
as high as in the general population (7). This may in part 
explain why lung cancer and cancers of the oral cavity 
and pharynx are higher in prisoners than in the general 
population.
The harmful use of alcohol is also an issue for many 
prisoners (Chapter 15). Estimates of the prevalence of 
alcohol abuse and dependence in male prisoners range 
from 18% to 30% and in female prisoners from 10% to 
24% (8). These figures may be an underestimate because 
of the strict inclusion criteria of the review but they point 
to a substantial health issue. In most prisons across the 
world, prisoners are allowed to smoke but the use of 
alcohol is prohibited. It is harder to smuggle alcohol in to 
prisons than illegal drugs; while prisoners may attempt 
to brew their own alcohol, it is rarely possible to do so 
in large quantities. As a result, alcohol is not widely 
consumed in prisons and prisoners may be protected from 
the immediate adverse effects, such as alcohol-related 
injury, although many prisoners remain at high risk of 
the longer-term consequences, such as hepatocellular 
carcinoma.
A recent review of 60 000 prisoners in Africa, Asia, 
Australia, Europe and North America indicates that 
unhealthy diets and a lack of physical activity are 
important health issues for prisoners (9). Diets for male 
prisoners in high-income countries provide an appropriate 
calorie intake but diets for women prisoners provided a 
substantial excess of total energy. This may be because 
women prisoners are detained in institutions designed by 
men for men with little concern for the needs of women, 
who form a minority of the global prison population; they 
are thus supplied with a diet appropriate for males. This 
is likely to contribute to obesity in the female prison 
population. Women prisoners are more likely to be 
overweight and obese than the age- and sex-adjusted 
population, with high prevalence rates estimates of 37% 
to 70%. Male prisoners, by contrast, were less likely to 
be overweight or obese than the general population; this 
held true in high-, middle- and low-income countries.
Other aspects of prisoners’ diets also put them at 
increased risk of NCDs. The review showed that dietary 
salt intake was over twice the recommended levels in 
diets for both males and females and that diets were 
high in carbohydrates, with an excess of percentage 
energy intake of fat. The problem may be compounded in 
high-income countries by the availability of extra snacks; 
prisoners are able to buy these to supplement their diet, 
but they tend to be energy-dense and salt-rich.
WHO recommends that all adults aged 18–64 years 
should undertake at least 150 minutes of moderate 
physical activity each week to benefit their health (10). 
Physical activity data on prisoners in Australia and the 
United Kingdom showed a contrasting picture, in which 
United Kingdom prisoners were less likely to achieve 
the recommended guidelines for physical activity in 
comparison both to Australian prisoners and to the 
general United Kingdom population. Australian prisoners 
were more likely than the sex-adjusted general population 
to do more than 150 minutes of moderate exercise per 
week. This is an important difference, which highlights 
the fact that it is possible to enable prisoners to take 
enough physical activity in the prison setting.
Challenges in providing appropriate  
prevention and care to prisoners
Primary prevention of NCDs
Smoking
Tackling smoking in prisons is a complex issue involving 
not simply health concerns but concerns about other 
important issues such as human rights. Smoking plays a 
complex role in prison life. Prisoners smoke for a variety 
of reasons, not just because they are addicted but also 
because of the perceived benefits in social situations, 
managing stress and alleviating boredom. Cigarettes may 
also be an important form of currency. Many prison staff 
smoke too, making the acceptability and implementation 
of smoking bans in the prison environment challenging. 
While total smoking bans in prisons may be seen as 
coercive and unrealistic as cigarettes would become, like 
drugs, an illicit substance to be smuggled and traded, 
partial smoking bans may be more effective. In the United 
Kingdom, smoking in public places in prisons is banned 
but prisoners are allowed to smoke in their own cells. The 
stated aim of the Prison Service in the United Kingdom 
(England and Wales) is for prisons to be smoke-free in 
the future. In the short term the partial ban has delivered 
health benefits, particularly where it is supported by 
appropriate interventions, such as counselling and 
nicotine replacement therapy, while enabling individual 
prisoners to retain the right to smoke. These issues are 
discussed further in Chapter 16.
Alcohol
In most prisons throughout the world, the consumption 
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of alcohol by prisoners is banned, which largely prevents 
excessive consumption in prisons. As already highlighted, 
however, a significant proportion of prisoners enter prison 
dependent on alcohol and needing appropriate care and 
treatment (11). This is discussed in detail in Chapter 15.
Diet
Prison administrations need to ensure that prisoners have 
access to a nutritionally adequate and balanced diet. The 
provision of healthy options does not, however, mean that 
prisoners will benefit from a good diet. As with tobacco, 
prisoners have a complex relationship with food and 
it is often used, for example, to relieve the boredom of 
imprisonment. There is also some evidence to support the 
high prevalence of eating disorders in women prisoners in 
high-income countries (12,13). Prisons need to ensure that 
all the options are healthy and should provide guidance to 
prisoners on the nutritional content of the food provided. 
Special diets must be provided for prisoners with specific 
cultural, religious or medical needs, and the different 
dietary needs of men and women should be catered for. In 
those countries where prisoners are able to supplement 
their diets with items they can purchase, there should 
be mechanisms in place to ensure that these snacks are 
healthy and not highly processed and calorie-dense. The 
prison environment can contribute to the development 
of healthy eating patterns in prisoners. A recent study in 
Spain demonstrated how the provision of a special diet 
to prisoners at high risk of cardiovascular disease led to 
positive changes in their weight, body mass index and 
blood pressure (14). In Japan, the metabolic profile of 
diabetic prisoners improved when in prison because of the 
high-fibre diet and increase in physical activity (15). Other 
prisons in Japan where prisoners are physically active at 
work for up to eight hours each day and have a calorie-
restricted diet have also demonstrated improvements in 
prisoners’ cardiovascular risk factor profiles following 
imprisonment (16).
In many prisons across the world, food is scarce and 
prisoners are not provided with sufficient calories or 
nutrients. Indeed, there have been documented outbreaks 
of nutritional deficiencies (17). Prisoners in such situations 
are at risk of health problems because of these deficiencies, 
and also because food becomes a commodity traded 
between prisoners and may be instrumental in bullying. 
Those denied food are at particular risk of developing 
health problems. It is important, therefore, that prison 
authorities provide not only an adequate diet but also 
ensure that the security and safety of prisoners include 
specific measures to reduce bullying.
Evidence is emerging to show that there are other good 
reasons why prison authorities should provide a nutritional 
diet. There is some suggestion that micronutrient 
deficiencies in young offenders play a role in poor 
behaviour while they are imprisoned and that correcting 
these deficiencies leads to a decrease in infractions of 
the rules (18). There is also increasing evidence to show 
that poor diet and poor mental health are related, and 
that dietary interventions may be of therapeutic value in 
conditions such as depression. Given the high prevalence 
of mental illness in prisons, this supports the need for 
efforts to prioritize the provision of a healthy diet for all 
prisoners.
Physical activity
Prison authorities have an important role in ensuring 
that there are appropriate opportunities for prisoners 
to undertake sufficient physical activity to benefit their 
health. In many countries this does not happen, and it is 
likely that the prison environment prevents individuals who 
want to exercise from doing so (19). There are a number 
of barriers to adequate physical activity in the prison 
setting, including security concerns, overcrowding and 
understaffing which make supervision of activities outside 
cells more difficult. As already outlined, however, there are 
health benefits for prisoners in the longer term, as well as 
immediate benefits (relief from boredom, an opportunity for 
positive social interaction, a feeling of wellbeing) (Box 1). 
The provision of adequate opportunities for physical 
activity is also likely to benefit the whole prison, including 
improved staff–prisoner relationships (20). 
In prisons worldwide, overcrowding is one of the greatest 
threats to prisoners’ ability to exercise. In some countries, 
prisoners have been so tightly packed in cells that they 
can barely move, let alone undertake the necessary 
moderate physical activity necessary to benefit their 
health. This is clearly not acceptable on health or human 
rights grounds and highlights the importance of decency 
within prisons. A “decent” prison regime will ensure that 
prisoners are able to meet WHO guidelines on physical 
activity, should they choose, and will provide them with 
appropriate health education materials to enable them to 
make an informed choice.
The care and treatment of prisoners with NCDs
The guiding principle for all prisoners with cardiovascular 
diseases, cancers, diabetes or chronic respiratory 
diseases must be that of equivalence of care, that is, they 
should receive the same standard of care and treatment 
for their disease in prison as they would if they were in the 
community. Care and treatment for these chronic diseases 
have some key elements that should also be provided in 
the prison setting. Some opportunities and challenges in 
making such provision are discussed below.
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Identification of NCDs – initial screening
When prisoners are first received in prison they should 
undergo health screening, including for detection of NCDs. 
Prisoners who are aware that they have an NCD must be 
given the opportunity to tell health care staff about their 
condition and medication. The initial screening also gives 
staff an opportunity to diagnose hitherto undetected 
diseases, such as diabetes by urinalysis or blood test 
and hypertension by blood pressure monitoring. This is 
particularly important for prisoners who, for a variety of 
reasons, are often not in contact with the appropriate 
health services in the community.
Encouragement of self-care
In the community, patients with long-term conditions are 
encouraged to care for themselves. The prison environment 
poses particular problems for self-care as security 
concerns preclude many prisoners from keeping their 
own medication and monitoring devices. The promotion 
of self-care runs contrary to the ethos of prison regimes, 
which are designed to disempower prisoners. There have, 
however, been some promising local initiatives in some 
countries. The model described in Box 2 may prove a cost-
effective way of ensuring adequate care.
Ensuring access to secondary care
While most prisoners with NCDs can be managed in 
primary care in prisons most of the time, many will 
need to visit hospitals for specialist care as outpatients. 
These visits can pose particular problems as appropriate 
transport must be arranged and escorts provided. 
Resource constraints often make this difficult for many 
prisons, but it is important to recognize and prioritize 
this particular health need. In some countries, innovative 
developments to circumvent these difficulties have 
encompassed the use of telemedicine or initiatives to 
bring specialists into prisons to visit patients. However, 
some aspects of the care of NCDs, such as the use of 
sophisticated scanning procedures, must necessarily be 
accessed in hospitals and prison regimes must adapt 
accordingly.
Throughcare
The majority of prisoners will be released into the 
community at some stage of their lives. Adequate 
planning to ensure appropriate throughcare is particularly 
important for those with NCDs. Prisoners should not be 
released without adequate medication and appropriate 
arrangements for follow-up in the community.
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11. Mental health in prison 
Graham Durcan, Jan Cees Zwemstra
Key points 
•	 Prisoners	 with	 mental	 health	 problems	 benefit	 from	
good basic prison care. The mental well-being of any 
prisoner can deteriorate if his or her needs are not 
met.
•	 Studies	have	consistently	shown	that	the	prevalence	
of poor mental health among prisoners is considerably 
higher than in the community. Prison mental health 
services should be based on the health needs of 
prisoners. This might require more intensive and 
integrated services than in the wider community.
•	 Prisoners	with	mental	health	problems	will	often	also	
have several other vulnerabilities, such as substance 
misuse problems, poor physical health, learning 
difficulties, poor life skills, histories of trauma, 
relationship difficulties, unstable housing and/or 
homelessness, poor education and limited experience 
of employment.
•	 Mental	health	treatment	and	care	need	to	address	all	
the prisoners’ needs, including their social needs, and 
be psychosocial in nature.
•	 The	 first	 step	 in	 understanding	 the	 mental	 health	
situation in a prison population is to ask prisoners 
their views on their needs and how these might be 
met.
•	 All	staff	working	in	prisons	should	have	an	appropriate	
level of mental health awareness training, which 
should cover the specific needs of those with 
personality disorders.
•	 Maintaining	 links	 between	 a	 prisoner	 and	 his/her	
family can be crucial for the mental well-being of the 
prisoner, for a successful return to society on release, 
as well as benefiting the family.
•	 All	prisoners	should	be	screened	on	entry	to	prison	for	
a range of mental health and related problems. There 
should also be other opportunities to identify needs.
•	 Some	 prisoners	 suffer	 from	 severe	 or	 acute	 mental	
health symptoms and may benefit from treatment in a 
psychiatric unit, either in the prison or in a hospital. 
•	 The	 mental	 health	 needs	 of	 different	 groups	 of	
prisoners such as women, older prisoners, children 
and young people, prisoners from minority ethnic or 
cultural groups and foreign prisoners, may need to be 
addressed differently. 
•	 Continuity	of	care	is	important	for	a	prisoner,	including	
the continuation of treatment that he/she was 
receiving prior to incarceration and the handing over 
of care to a community-based provider on release. 
•	 The	 notion	 of	 “mental	 health	 recovery”	 provides	
a useful approach for prison mental health care 
services. Mental health recovery is not the same as 
clinical recovery. It is much more about social recovery 
and support for sufferers in overcoming social deficits 
and thereby improving their quality of life.
•	 Fellow	 prisoners	 or	 ex-offenders	 can	 often	 help	 to	
support mental well-being through mentoring. 
•	 Where	 appropriate,	 preventing	 people	 with	 mental	
health problems from entering prison in the first 
place requires that mental health services liaise with 
police and courts and provide a diversion service. 
Comprehensive community care services should see 
those entering and leaving the criminal justice system 
as part of their business.
Introduction
This chapter focuses on the basic principles that can guide 
those with a responsibility for providing prison mental 
health care. How these principles are translated into 
practice will vary according to national legislation and 
the local prison system and culture. Prisoners often come 
from communities where there is significant deprivation 
or poverty. Houchin’s research in Scotland (1) found that 
in the most deprived communities one man in nine had 
been to prison at least once by the time they were 23 
years of age. These communities also have higher levels 
of ill health, greater psychiatric morbidity and many 
social issues. It is important to recognize these factors, 
as supporting prisoners in maintaining their well-being 
or treating those with poor mental health is not only a 
matter of providing the right medication and psychological 
treatment, but is also about helping them to address their 
physical health and social needs.
Human and prisoners’ rights and basic 
needs
Blaauw & van Marle (2) have pointed out the importance 
of ensuring that all those incarcerated have their most 
basic needs and human rights met, such as access to light, 
food and water and access to exercise and meaningful 
occupation.
The Standard Minimum Rules for the Treatment of 
Prisoners include the following (3).
•	 There	shall	be	no	discrimination	on	the	basis	of	race,	
colour, sex, language, religion, political or other 
opinion, sexual orientation, national or social origin, 
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property, birth or other status and, on the other hand, it 
is necessary to respect the religious beliefs and moral 
precepts of the group to which a prisoner belongs 
(Rule 6).
•	 Prisoners	shall	be	kept	 in	 rooms	that	are	sufficiently	
large and sufficiently lighted, heated and ventilated 
(Rule 10).
•	 Adequate	 bathing	 and	 shower	 installations	 shall	 be	
provided so that every prisoner may be enabled and 
required to have a bath or shower … at least once a 
week (Rule 13).
•	 Prisoners	 shall	 be	 provided	 with	 water	 and	 with	
such toilet articles as are necessary for health and 
cleanliness (Rule 15).
•	 In	order	that	prisoners	may	maintain	a	good	appearance	
compatible with their self-respect, facilities shall be 
provided for the proper care of the hair and beard, and 
men shall be enabled to shave regularly (Rule 16).
•	 Prisoners	shall	be	provided	with	a	separate	bed,	and	
with separate and sufficient bedding which shall be 
clean when issued, kept in good order and changed 
often enough to ensure its cleanliness (Rule 19).
•	 Every	 prisoner	who	 is	 not	 allowed	 to	wear	 his	 own	
clothing shall be provided with an outfit of clothing 
suitable for the climate and adequate to keep him 
in good health. Such clothing shall in no manner be 
degrading or humiliating (Rule 17).
•	 Every	 prisoner	 shall	 be	 provided	 at	 the	 usual	 hours	
with food of nutritional value adequate for health and 
strength, of wholesome quality and well prepared and 
served, and drinking-water shall be available to every 
prisoner whenever he or she needs it (Rule 20).
Additional factors essential to maintaining mental health 
are:
•	 reliable,	tangible	assistance	from	people,	settings	and	
services that facilitate self-advancement and self-
improvement;
•	 recognition	of	the	need	to	be	loved,	appreciated	and	
cared for, and of the desire for intimate relationships 
that provide emotional sustenance and empathy;
•	 activity	 and	 distraction	 to	maximize	 opportunities	 to	
be occupied and fill time;
•	 safety	and	environmental	stability	and	predictability;
•	 privacy	or	autonomy.
Prison systems that hold children and young people must 
take into consideration the United Nations Convention 
on the Rights of the Child (4), which underlines the 
importance of using custody as a last resort.
Equivalence
To meet the health needs of prisoners, prison health care 
services should aspire to equivalence of care between 
standards inside and outside prison. This can be defined 
in different ways. Lines (5) warns that caution needs to be 
used, since equivalence of health care can be defined as 
providing the same care as is provided outside the prison. 
Few systems achieve this, but Lines argues that this as a 
goal is not appropriate. Prison populations do not reflect the 
communities that surround them; instead prisons represent 
communities where the prevalence of all illnesses, 
including and especially mental illness, is much higher than 
in the community. This might require more intensive and 
integrated services than in the wider community. 
Prevalence of poor mental health
Most prevalence studies have been conducted in 
developed countries and show consistently that a very 
high proportion of prisoners suffer from poor mental 
health. For example, the most exhaustive study in the 
United Kingdom found that 90% of prisoners aged over 
16 years suffered from a mental illness, addiction or a 
personality disorder, and 70% of prisoners had two or 
more such problems (6). The prevalence of learning and 
communication difficulties and of addiction problems 
is also much higher than in the general population. In 
addition, prevalence studies in many countries show that 
10–15% of the prison population suffer from severe and 
enduring mental illnesses such as schizophrenia, bipolar 
disorder and autism disorders, often complicated by co-
morbidity. The prevalence rates of poor mental health for 
young people in prison are very high, including over half 
with conduct disorders (7) and around a third of young 
girls having a major depression. Studies in some countries 
have shown that the risk of suicide is much greater in a 
prison population, particularly in adolescent prisoners (8).
Where studies of mental illness have been conducted with 
prison populations, the prevalence has been consistently 
shown to be high. There is no reason to believe that 
countries which have not conducted such surveys will 
have significantly different prevalence rates.
Complexity and multiple needs
Prisoners seldom have just one problem, and those 
suffering from mental health disorders may find that their 
mental health problems are exacerbated by their other 
problems or even caused by them.
The likelihood is that many prisoners will have interwoven 
multiple and complex problems. In a prison, the severe 
major disorders can be treated with medicines and basic 
talking/counselling therapies, but other more social 
problems need to be addressed too.
Prisoners in the United Kingdom interviewed by Durcan (9), 
in addition to having mental health problems, commonly 
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experienced most if not all of the following problems 
concurrently:
•	 a	history	of	unemployment
•	 poor	education
•	 learning	difficulties
•	 addiction	or	problematic	substance	misuse
•	 poor	life	and	social	skills
•	 poor	access	to	stable	housing
•	 debts	both	inside	and	outside	prison	
•	 poor	general	health
•	 past	life	trauma.
Many, if not most, of the above are beyond the scope of 
health or mental health care services, and yet they are 
crucial to the health of prisoners and their recovery.
Illness and social focus
A focus needs to be adopted on both illness and wellness/
social health. The former characterizes much health care 
in many settings, certainly in many prison settings, but 
increasingly there is recognition of the importance of 
social interventions, although these are not standard 
in most services geared towards detecting and treating 
illness. Because resources are limited in prison systems, 
the risk of focusing on illness is that only those with the 
most severe problems are dealt with. High mental health 
service thresholds have to be set, leading inevitably to 
frustration for the many prisoners who fall below this 
threshold.
Given the large number of prisoners who suffer from 
poor mental health, it seems wise to encourage all the 
prison staff to recognize their responsibility in this area, 
rather than relying on a possibly small number of health 
professionals.
Attempting to have a whole-prison focus on promoting 
and improving mental well-being can mean that the 
limited resources dedicated to mental health care can 
be put to the most effective use. It is also likely to have 
a positive impact on the regime in terms of safety and 
security. Additionally, it may result in improved outcomes 
for prisoners on release from prison, both for the risk 
of exacerbation of illness and in the recidivism risk for 
criminal offences.
The impact of prison on mental health and 
well-being
The following are factors that WHO and the International 
Red Cross (10) identify as negatively impacting on prison 
mental health:
•	 overcrowding;
•	 various	forms	of	violence;
•	 enforced	solitude;
•	 lack	of	privacy;
•	 lack	of	meaningful	activity,
•	 isolation	from	social	networks;
•	 insecurity	about	future	prospects	(work,	relationships);
•	 inadequate	health	services,	especially	mental	health	
services, in prisons.
The English prisoners interviewed by Durcan (9) on the 
aspects of their lives in prison that challenged their 
mental well-being identified issues very similar to those 
listed above:
•	 bullying	by	other	inmates;
•	 concerns	 about	 family	 –	 difficulty	 in	 communicating	
with them;
•	 lack	of	a	person	they	could	trust	to	talk	to;
•	 little	 meaningful	 activity	 and	 the	 monotony	 of	 the	
regime;
•	 no	privacy;
•	 worries	and	concerns	over	release;
•	 substance	misuse;
•	 incompatibility	with	cell-mates;
•	 poor	diet;
•	 limited	access	to	physical	activity	such	as	the	gym;
•	 unresolved	past	life	traumas;
•	 difficulty	in	accessing	services,	particularly	health	care	
and counselling.
Once again, much of the above is beyond the scope of 
a health service and provides a further argument for 
making prisoners’ mental well-being a whole-prison 
responsibility.
On the other hand, in well-resourced prison systems the 
prison can also be a place to stabilize, to start treatment 
and to recover.
Prisoners’ views of their needs
The best source of information on prisoners’ mental health 
needs is prisoners themselves. Ideally, basic mental 
health needs assessments should be conducted on entry, 
including an element of direct consultation with prisoners.
In 2006, Durcan conducted just such a needs assessment in 
5 prisons in the United Kingdom that involved interviewing 
about 100 prisoners in depth (9). The prisoners included 
men, women and young males and juveniles, some 
sentenced and some awaiting trial or sentence. Some 
of the prisoners had severe and enduring mental health 
problems and some had mild to moderate mental health 
problems. Despite the heterogeneous nature of the 
sample of prisoners interviewed, the way in which they 
saw their mental health needs being best met were 
remarkably similar. The findings from this exercise are not 
unique to these prisons nor are they likely to be unique to 
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western Europe. A striking finding about prisoners’ views 
on the best way to improve their mental health, when 
compared to the findings from interviews conducted 
with staff (particularly health and mental health staff), 
was the emphasis on social recovery and the meeting of 
their most basic survival needs. The lists of needs that 
both staff and prisoners identified were similar, but the 
order of priority was markedly different. Professionals 
tended to give prominence to direct mental health 
interventions, such as medication and psychological 
therapy, but the prisoners (who often focused most on 
their release) prioritized access to housing, access to 
adequate funds (especially through a job), and often 
support for a substance misuse problem as their first 
health need. The following summarizes these prisoners’ 
views of their mental health needs.
Someone to talk to
A non-judgemental person for a prisoner to talk to could 
be a psychiatrist, therapist or counsellor, or even a peer 
mentor.
Preparation for release
Most prisoners will eventually leave prison. Many current 
prisoners may have left prison before, failed to reintegrate 
successfully into society and want help with getting a 
place to live and enough money (preferably through a job) 
and support with any substance misuse problems.
Something meaningful to do
Prisoners want to be active and preferably involved in an 
activity that might help them when they leave prison, such 
as work or training to get work on release. Prisoners with 
mental health problems are no different; indeed, there is 
strong evidence that work is effective in helping people 
with mental health problems to recover (11).
For young people and children, access to education should 
be an important part of their purposeful activity in prison.
Help in a crisis
Prisoners say they need someone to talk to and provide 
support when they most need it. If a prisoner receives bad 
news from home, being able to talk to someone can help 
reduce the likelihood of any deterioration.
Therapy and medication
Prisoners do recognize the importance of getting the right 
medication and support in using it if and when they need 
it, just as professionals do.
Advocacy
Prisons can be harsh environments where, by definition, a 
prisoner loses much control over his or her life. This can 
induce a sense of powerlessness, which is aggravated 
in the more vulnerable prisoners with mental health 
problems. Sometimes this means that even when the 
right help is available, prisoners may not feel able to 
seek it. The importance of having someone to talk to who 
can represent the prisoner’s needs becomes all the more 
urgent. As well as health professionals, the role of peer 
mentors is being recognized in this area.
Prisoners’ views on what constitutes a 
good mental health service
Prisoners in focus groups conducted by Rob Jayne in 2006 
(12) identified the following positive characteristics of a 
mental health service:
•	 an	 ability	 to	 form	 trusting	 relationships	 with	 health	
professionals;
•	 continuity	of	care;
•	 not	 being	 misinformed	 or	 deceived	 with	 false	
information;
•	 clear	and	detailed	 information	regarding	side-effects	
of medications;
•	 education	about	the	nature	of	their	illness;
•	 involvement	in	planning	their	own	care	and	pathways	
of care;
•	 rapid	 transfer	 to	 hospital	 if	 treatment	 cannot	 take	
place in the prison when acutely unwell;
•	 treatment	 or	 therapy	 appropriate	 to	 a	 prisoner’s	
condition.
Mental health awareness in the prison 
system
If improving mental well-being is going to be a whole-
prison responsibility, then awareness of what supports 
mental health and the ability to recognize mental health 
problems are crucial. There are many approaches to 
mental health awareness training. Some prison staff may 
require more extensive training than others, but all prison 
staff and managers require some training. Ideally the basic 
training for any prison officer should include a module on 
prison mental health well-being, with opportunities to 
refresh this knowledge. Some prisoners with experience 
of mental health problems can make an extremely useful 
contribution by providing insights that a professional 
trainer often does not have.
Prisoners and their families
Many prisoners will lose contact with their families, and 
this can have a negative impact on both parties. The 
focus of this chapter is on the prisoner, but it should be 
recognized that imprisonment of parents can lead to poor 
outcomes for their children. This is particularly critical 
when a mother or the more active carer is imprisoned. 
Maintaining contact for both male and female prisoners 
(where appropriate) is important.
91
Mental health in prison
From the perspective of prisoners with mental illness, their 
families are often the sole source of support. They may 
be critical for a prisoner to re-enter society successfully. 
Prisoners who are fortunate enough to get jobs on release 
often do so through personal contacts, primarily their 
families.
Maintaining healthy social networks is important for good 
mental health and, like many interventions that are likely to 
maintain and improve a prisoner’s mental health, keeping 
contact with his or her family is not the sole domain of the 
prison health/mental health service. The health services 
do, however, have a role in the recognition of a prisoner’s 
needs and advocacy on behalf of the prisoner in the local 
community.
It is important to foster the links between younger 
prisoners and their families, especially their carers or 
parents. This should include supporting positive parenting 
approaches.
Diagnosis and assessment
Many textbooks describe the signs and symptoms of 
mental illness and their assessment, as does WHO 
in Mental health primary care in prison (13). This text 
provides recommendations to diagnosis for a wide 
range of psychiatric disorders, symptom and assessment 
checklists and treatment responses.
Screening and assessment
Prisons have very little control over who arrives at their 
gates but they can control the detection of poor mental 
health in new prisoners. This is not just crucial in ensuring 
appropriate interventions and the best outcome for 
prisoners, but can also help in increasing the safety of 
both prisoners and staff and in the running of the regime.
In practice, screening immediately on arrival may not 
achieve all that could be desired because prison reception 
areas can be busy, with little space allowing for privacy 
and often time limitations. Often the most that can be 
achieved on arrival is a crude screening for the most 
obvious signs of poor mental health or the most obvious 
risks. It is, therefore, strongly recommended that either 
the health staff, or prison staff with some training, should 
conduct a more detailed screening in the first few days, to 
include the following:
•	 look	for	signs	of	poor	mental	health	in	the	past;
•	 check	the	prisoner’s	current	mental	health;
•	 look	for	signs	of	particular	symptoms	of	poor	mental	
health;
•	 check	for	addiction	problems;
•	 look	for	evidence	of	learning	disability	or	difficulty;
•	 gauge	possible	traits	suggesting	personality	disorder;
•	 look	for	evidence	of	autistic	spectrum	disorder;
•	 look	for	signs	of	possible	head	injury;
•	 try	 to	 learn	 something	 of	 the	 social	 and	 relational	
circumstances of the prisoner;
•	 ask	about	aspects	of	 the	offence	or	alleged	offence	–	
certain offences (such as where violence is used or those 
that carry greater legal sanctions) can add to the risk of 
poor mental health and even self-harm and suicide;
•	 check	any	aspect	which	may	make	the	prisoner	more	
vulnerable.
The sources of information that can be used for screening 
are numerous and include the prisoners themselves 
together with written reports and information arriving 
with them. For younger people, parents should be an 
important source of information.
Mechanisms for the continuing monitoring of prisoners 
with potential risks are important. These can include 
reviewing the use of health resources in the prison and 
regularly checking with the prison staff who have day-
to-day contact with the prisoners about any changes in 
their behaviour. In practice, such monitoring can prove 
difficult, as prison health and mental health services tend 
to be under pressure. Additional sources are the courts or 
police, health and other services in the prisoner’s home 
community, observations by prison staff working with the 
prisoner, other prisoners and the prisoner’s family.
Young people may manifest poor mental health in very 
different ways to adults. Difficulties in communication, 
challenging behaviour and behavioural difficulties could 
be signs of poor mental health.
Treatment in prison
The social structure in a prison is often relatively stable. 
Basic rules give safety and oversight, and basic needs 
(food, shelter) are met. For many inmates, this was not the 
case before they were imprisoned. This means that prison 
can be the place where disorders can be (re)detected, 
diagnosed and given basic treatment. It should be 
possible to give basic interventions, such as psychological 
support through counselling from a psychologist, nurse 
or stable peer, and psychotropic medications such as 
antipsychotics, as well as to motivate patients for 
treatment and medication during and after prison and to 
stabilize addiction problems.
For a limited number of severely psychiatric-disordered 
prisoners, it will also be necessary to have a crisis facility 
within or outside the national prison system, the latter 
depending on the relevant legislation. These facilities 
should be adequately staffed. They can also be used as a 
training facility for staff in other prisons.
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Personality disorders
It is probable that a high proportion of both male and 
female prisoners will suffer from at least some personality 
disorder traits, especially antisocial personality disorder 
and traits.
The Sainsbury Centre for Mental Health (12) describes 
personality disorders in the following way:
People with a personality disorder can have difficulty dealing 
with other people. They tend to be unable to respond to 
the changes and demands of life. Although they feel that 
their behaviour patterns are perfectly acceptable, people 
with personality disorders tend to have a narrow view of 
the world and find it difficult to participate in normal social 
activities. Consequently their behaviour deviates markedly 
from the expectations of their culture. It is persistent and 
inflexible, and can often lead to distress for themselves or 
others.
Some prisoners with personality disorders will pose the 
highest danger to others, but most will not. How they 
relate to others can prove challenging to prison staff. 
There is limited evidence about the treatability of these 
disorders, particularly in prisons, but an understanding 
of them applied to the management of these prisoners 
can lead to improved outcomes and can help staff who 
may otherwise find people with personality disorders 
challenging. Often, the basic rule is to offer structure and 
a form of support.
Training that includes awareness of personality disorders 
should be part of broader mental health awareness 
training. Since it is likely that a large number of prisoners 
will have personality disorders, prisons should aim to 
be much more psychologically informed environments. 
All staff should have a good grounding in the different 
forms of personality disorder and the way each can affect 
behaviour. Equally important, staff should be aware of the 
impact their behaviour and responses can have on such 
prisoners. Ideally, regular opportunities should be provided 
for all staff to meet a psychologist or similarly trained 
professional to reflect on their interactions with these 
prisoners, and even plan interactions and interventions.
Continuity of care
Prison is often a limited phase in a person’s life. Prison 
mental health care professionals should use information 
about a prisoner’s earlier treatments and try to ensure 
that treatment is continued after his or her release (if 
necessary), especially for the severely mentally ill. If 
help and support has been possible in prison, part of the 
answer to a successful re-entry into society is to ensure 
that similar help and support continues outside. It can be 
hugely difficult for prison health services to reconnect 
prisoners to external health services, sometimes due 
to unwillingness on the part of the external service, 
sometimes due to limited prison health resources or a 
prison being located a considerable distance away from 
the prisoner’s home. Once again, some prison systems have 
begun using peer mentors to support such reconnecting: 
a mentor meets the prisoner on release and comes with 
him or her to visit services that might help, thus providing 
active advocacy. Society has a broad interest both in the 
stability of ex-prisoners with psychiatric disorders and in 
a lower rate of recidivism.
Meeting the needs of different groups in 
the prison population
Prisons include many different groups. Three such groups 
are considered below, to show that one approach to 
mental health care will not suit all prisoners.
Women
Several surveys show that the prevalence of poor mental 
well-being among women is even higher than among the 
general prison population. It is also more common for 
women prisoners to have experienced traumatic events, 
such as sexual abuse. Additionally, women may well have 
been the main carer for their children and imprisonment 
often involves separation from them, which can add to the 
difficulties they experience with their mental health.
Young people
For incarcerated children and young people, special 
attention should be given to the United Nations 
Convention on the Rights of the Child (4), in particular to 
article 40 dealing with justice for juveniles, and article 25 
dealing with children held in care, including those held in 
custody. All the other articles also apply to children and 
young people in prison, however, and a prison system 
catering for children and young people must ensure that 
all of them are adequately addressed. The Convention 
is crucial to the maintenance of children’s and young 
people’s well-being. The United Nations Children’s Fund 
provides a useful summary fact sheet (14), while General 
Comment No. 10 on the Convention includes a discussion 
of Article 40 (15).
Children and adolescents will often manifest poor mental 
health differently from adults, and the treatments and 
interventions for them need to reflect this. This also 
applies to young adults who may legally be regarded as 
adults (at 18 or 21 years, for example) but who may have 
very specific needs. Young adults may well express their 
thoughts and emotions differently and often have a very 
different language to describe their feelings compared to 
older people. This can add to the difficulty in detecting 
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and recognizing mental health needs in young people. 
Additionally, their cognition is different to that of a mature 
adult.
Foreign prisoners and prisoners from different 
cultural communities
Foreign prisoners can experience greater isolation than 
other prisoners and can face greater uncertainty about 
life after release, which can add to any difficulties with 
their mental health. If possible, foreign prisoners should 
be transferred to prisons in their own countries.
Awareness of mental illness, and the language used to 
describe it, can differ between cultural communities. In 
some communities there is an even greater stigma around 
mental illness. Diverse cultural needs pose a major 
challenge, but direct consultation with different groups of 
prisoners can help to get an understanding of their needs 
and how these might be addressed. Language barriers 
often lead to difficulties in communication for both 
foreign prisoners and health care staff. In such situations, 
inmates and health professionals should benefit from the 
services of a qualified interpreter, as recommended by the 
Committee for the Prevention of Torture and Inhuman or 
Degrading Treatment or Punishment (16). The relevant 
authorities should try to ensure that an adequate number 
of suitably qualified interpreters are trained and available.
The recovery approach
The needs of a person with mental illness are not 
necessarily determined by their diagnosis. Prisoners with 
schizophrenia, depression or personality disorder, while 
suffering from very different disorders, may have similar 
needs. This is because mental health problems do not just 
manifest themselves as a set of clinical symptoms. Poor 
mental health has many social symptoms and can have 
an impact on people’s housing, employment, finances, 
ability to meaningfully occupy themselves, relationships 
and social networks.
The notion of mental health recovery is gaining greater 
credence in many countries as the ultimate goal. It 
provides a radically new way of thinking about mental 
services and care, moving away from professionalization. 
It is not one and the same as clinical recovery; indeed it 
is recognized that some people with mental illness will 
continue to experience the symptoms of their illness. 
Mental health recovery is much more about social 
recovery and supporting the sufferer in overcoming 
many social deficits, thereby improving their quality 
of life. Such recovery is self-defined. Professionals 
cannot “recover” their patients: recovery is something 
that can only be achieved by the person experiencing 
the mental health problem. The role of the professional 
is to facilitate this. Mental health services that give 
credence to this notion of mental health recovery are 
giving greater emphasis to a different type of expert, the 
“expert by experience”. People who have experienced 
recovery themselves can provide credible support to 
current sufferers. In some areas, such “experts” are 
being employed by mental health services to become 
peer mentors and advocates.
The roles of peers and mentors
In some prisons, prisoners already provide a peer mentor 
role, usually on a voluntary basis. Some ex-offenders also 
provide mentoring, some on a voluntary basis and some 
as employees. While peer mentoring is not totally cost-
neutral (training, support and coordination are crucial), it 
provides considerable value for the small investment it 
takes. Peer mentors are “experts by experience”: those 
that have experience of recovering from poor mental 
health can provide credible support for other prisoners. 
In some prison systems, ex-prisoners provide mentoring 
support on release and give crucial support to otherwise 
isolated people. This usually involves meeting prisoners 
at the prison gate and being available, especially during 
the first few weeks when a released prisoner can be at his 
or her most vulnerable.
Inside prisons, mentors can have very different roles. 
Some provide advice and guidance for new prisoners (a 
potentially vulnerable group), some provide crisis support 
and some provide health promotion advice.
Peers in a mentoring role are not unique to mental health, 
and in prison systems they can provide a critical role in 
supporting fellow prisoners in a process of change and 
rehabilitation. In some countries they already do so, and 
some ex-offenders can provide a mentoring support role to 
released prisoners who may not necessarily be suffering 
from mental health difficulties. This can also be a cheap 
and effective tool for low-income countries.
The following set of principles is quoted by the Sainsbury 
Centre for Mental Health in its paper Making recovery a 
reality (17) from Recovery – concepts and application by 
Laurie Davidson: 
•	 Recovery	 is	 about	 building	 a	meaningful	 and	 satisfying	
life, as defined by the person themselves, whether or not 
there are ongoing or recurring symptoms or problems.
•	 Recovery	represents	a	movement	away	from	pathology,	
illness and symptoms to health, strengths and wellness.
•	 Hope	is	central	to	recovery	and	can	be	enhanced	by	each	
person seeing how they can have more active control 
over their lives (‘agency’) and by seeing how others have 
found a way forward.
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•	 Self-management	 is	 encouraged	 and	 facilitated.	 The	
processes of self-management are similar, but what 
works may be very different for each individual. No ‘one 
size fits all’.
•	 The	helping	relationship	between	clinicians	and	patients	
moves away from being expert/patient to being ‘coaches’ 
or ‘partners’ on a journey of discovery. Clinicians are 
there to be “on tap, not on top”.
•	 People	 do	 not	 recover	 in	 isolation.	 Recovery	 is	 closely	
associated with social inclusion and being able to take 
on meaningful and satisfying social roles within local 
communities, rather than in segregated services.
•	 Recovery	 is	 about	 discovering	 –	 or	 re-discovering	 –	 a	
sense of personal identity, separate from illness or 
disability.
•	 The	language	used	and	the	stories	and	meanings	that	are	
constructed have great significance as mediators of the 
recovery process. These shared meanings either support 
a sense of hope and possibility, or invite pessimism and 
chronicity.
•	 The	development	of	recovery-based	services	emphasizes	
the personal qualities of staff as much as their formal 
qualifications. It seeks to cultivate their capacity for hope, 
creativity, care, compassion, realism and resilience.
•	 Family	and	other	supporters	are	often	crucial	to	recovery	
and they should be included as partners wherever 
possible. However, peer support is central for many 
people in their recovery.
Diversion and liaison
Some people with mental health problems come into 
prison for relatively minor offences that could be dealt 
with in the community with appropriate treatment and 
support. Others who commit more serious offences related 
to their mental illness may be better treated in a secure 
hospital rather than a prison, where one exists. In both 
cases, the mental health services need to work closely 
with the police and courts to identify people with mental 
health problems, make recommendations to the police 
and/or courts, and provide packages of care as soon as 
possible that address the needs of the people concerned.
Mental health services working with the police and courts 
attempt to divert people with mental health problems, 
where appropriate, either to community- or hospital-
based services. When a person is being sent to prison, 
the mental health service working with the police or court 
passes information to the prison health service to ensure 
continuity of care. Such services provide an important 
liaison role between the criminal justice system and 
community health and social care services.
These services obviously go beyond what prison mental 
health services can provide. A system of comprehensive 
community mental health care should see those who 
enter (and leave) the criminal justice system as part of 
their business.
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12. Dental health in prisons  
Ruth Gray, Sue Gregory
Key points 
•	 Good	dental	health	is	as	important	for	prisoners	as	it	is	
for everybody else.
•	 Many	prisoners	suffer	from	poor	oral	health	when	they	
enter prison.
•	 Many	prisoners	only	access	dental	services	when	they	
are imprisoned.
•	 Prisons	 should	 offer	 a	 comprehensive	 dental	 health	
care service and provide an appropriate range of 
treatments based on patients’ clinical needs.
•	 Oral	 health	 should	 be	 included	 in	 prisoner	 induction	
programmes and health triage systems.
•	 Oral	 health	 promotion	 should	 be	 an	 integral	 part	 of	
health service provision.
•	 Prison	dental	 teams	should	be	clinically	experienced	
and competent.
•	 Dental	teams	should	encompass	a	varied	mix	of	skills	
and include dental hygienists, therapists and oral 
health educators, where appropriate.
•	 Commissioners	 of	 dental	 services	 for	 prisons	 should	
have a good understanding of the complex needs of 
prisoners and the difficulties of providing a dental 
service in the prison structure.
•	 Remuneration	 systems	 for	 dental	 professionals	
should be appropriately weighted for patients’ special 
conditions and the special requirements of the prison 
environment.
Introduction
The oral health needs of prisoners are complex. Coupled 
with chronic diseases and high levels of co-morbidity, this 
creates a high demand for dental services. The prison 
dental team needs to have good clinical experience and 
competence and a good understanding of the prison 
structures and processes. Commissioners and managers 
of services should be aware of the special demands of 
providing prison dentistry and should plan, evaluate and 
remunerate these services accordingly.
Oral health
The oral health needs of the prison population are greater 
than those of the general population. Prisoners exhibit a 
higher prevalence of dental caries compared to the general 
population, with considerable unmet needs for treatment. 
Studies have revealed that prisoners had significantly 
more decayed and missing teeth and fewer restorations 
than the general population (1–3).
A high prevalence of periodontal disease has been 
recorded among prisoners (4), exacerbated by the large 
number of prisoners who smoke, misuse substances and 
exhibit stress-induced parafunctional habits.9
Current evidence supports the finding that these high 
levels of oral disease have an impact on prisoners’ quality 
of life (5).
General impact of general health on oral 
health
Prisoners have a disproportionately high prevalence of 
health problems. A high prevalence of infectious disease, 
chronic medical conditions and psychological disorders 
has been reported. Additionally, prisoners are likely to 
experience social exclusion (6).
Studies have shown that the prevalence of dental caries 
and periodontal disease is higher among substance 
misusers than in the general population (7). Mental health 
illness among prisoners is also associated with oral health 
issues such as xerostomia, smoking and poor oral hygiene. 
The behavioural management of people with mental 
health problems or those who have experienced sexual or 
physical abuse must be competent and appropriate, and 
the dental team should be given relevant training (8).
Utilization of the prison dental service 
The demand for dental services in prisons is high, resulting 
in long waiting-lists for dental care. Many prisoners only 
access dental services when they are incarcerated; outside 
prison they often only seek emergency dental care (9).
A study of young offenders in the United States found 
that the commonest reason for health care visits was 
for dental care (10), while the results of an Australian 
study revealed that prisoners used the prison dental 
service to a greater extent than they had used general 
dentists before being incarcerated (11). An Irish study 
examining and interviewing methadone and heroin 
users in Dublin revealed that their most likely access 
to dentistry was through the prison dental service (12). 
9 Parafunctional habits are the habitual use of the mouth in ways unrelated to  eating, drinking or speaking, such as teeth-grinding or nail-biting.
100
Prisons and health
Many prisoners only become aware of their poor oral 
health when they enter prison and start a detoxification 
regime. The analgesic properties of substances such as 
opiates or alcohol mask dental disease. Once these are 
removed, the patient may experience severe pain and 
seek immediate dental care.
In a prison survey, 76.8% of participants claimed to 
have difficulty accessing dental care. The barriers they 
cited included lack of information about dental services, 
anxiety, long waiting-lists, appointments clashing with 
legal and family visits, transfers between prisons and 
lack of an available escort to take prisoners to dental 
appointments (3).
Provision of prison dental services
Equity of access to health care is a key aim of prison dental 
services. The Strategy for modernising dental services 
for prisoners in England (13) calls for prisons to identify 
resources and operational issues specific to prisons to 
meet the dental needs of prisoners. The most significant 
challenges to prison health providers were summarized 
in the document Reforming prison dental services in 
England. A guide to good practice (14) (Fig. 3).
Accessibility of dental services
On committal, every prisoner undergoes a medical 
assessment, which should include an oral health 
screening assessment. A dental care professional or 
trained member of health care staff can conduct a dental 
triage at committal. This initial screening assessment can 
be used to prioritize dental treatment (3,15).
A prisoner should undergo an induction programme soon 
after committal. This should include information about 
the medical and dental services, which should be simple 
and accessible and outline the dental services available 
in the prison, details of how to make a referral, patients’ 
entitlements and the range of treatments available.
To ensure that services are efficient, the dental team must 
work in close cooperation with the prison officers and health 
care staff. Prisoners or health care staff can make referrals. 
Protocols are necessary for these referral processes.
Fig. 3. The challenges in providing effective dental care to prisoners
Source: Harvey et al. (16).
Needs
•	 High	levels	of	need
•	 Longstanding	neglect	in	oral	health
•	 Routine	checks	and	health	promotion	given	
less priority due to high needs
•	 Drug	misuse	and	smoking	increase	dental	
health needs
•	 NutritionDemand
•	 Demanding	consumers
•	 Tumover	of	prison	
population
•	 Difficulties	in	
providing continuity of 
care
•	 Interrupted	treatments	
and non-attendance Resources
•	 Availability	of	dental	care	products
•	 Outdated	facilities	and	equipment
•	 Lack	of	space
•	 Lack	of	funding	for	health	promotion	and	
additional sessions
•	 Insufficient	staff	for	treatment	and	for	security
•	 Staff	training	and	quality	assurance
Supply
•	 Shortages	in	dental	time
•	 Sessions	shortened	by	
security procedures
•	 Recruitment	and	retention
•	 Quality	of	dental	care
•	 Availability	of	routine	
treatment in some prisons
•	 Availability	of	oral	health	
promotion
Waiting times
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Many prison dental services do not work at full capacity 
due to delays and cancellations of appointments. It is 
essential that a coordinated approach is taken with 
the prison management to maximize sessions, with a 
high priority given to dental appointments in prisoner 
movement programmes. 
The frequent transfer of prisoners between prisons 
causes much difficulty in accessing services. Where 
possible, a record of ongoing dental treatment should be 
transferred with the prisoner. Continuity of care between 
prison and the community dental services is reliant upon 
clear communication and robust protocols on release of 
the prisoner.
Good clinical practice
The high quality of dental care in prisons should be based 
on the principles of clinical governance.
Prison dental teams have the responsibility of looking 
after patients in a high-risk environment. Good equipment, 
infection control and decontamination procedures are 
essential. Evidence-based practice should be the focus of 
each service (14).
Good record-keeping is essential, and training in the 
response to legal queries is recommended. The dental 
notes in every prison should be integrated into the 
prisoner’s clinical record.
Dental teams should incorporate the values of fairness, 
respect, equality, dignity and autonomy into high 
standards of clinical care and the provision of a service 
accessible to all.
Oral health promotion
The Strategy for modernising dental services for prisoners 
in England (13) stated that prisons should aim “to raise 
awareness of good oral health throughout the prison, 
among prisoners, prison staff and voluntary agencies 
working in prisons”.
Most prisons recognize the importance of oral health 
promotion although not all have the resources or 
capacity to do so (14). A tension exists between the 
high demand for treatment, long waiting-lists and 
time to conduct health promotion initiatives. It is 
suggested that dental teams include time dedicated 
to oral health promotion activities in their job plans, 
and work in collaboration with the prison governor and 
staff to aim for a holistic approach to oral health care 
(Fig. 4) (16).
Fig. 4. Good practices for prison dental health services
Source: Bose & Jenner (16).
Holistic approach  
and contributing to  
changes in diet and 
nutrition, as this can  
greatly improve  
prisoners’ dental  
health
Ensuring that the  
governor and prison  
officers understand the 
importance of good oral 
health and dental care 
satisfaction and  
security
Networking  
between prison dentists 
and the external dental 
community to avold 
professional isolation
Make effective use of 
existing resources to 
increase dental activity and 
reduce waiting times
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The availability of materials for dental care is limited. 
Toothbrushes and toothpaste are available, but a better 
range of toothbrushes, higher fluoride concentration in 
toothpaste, interdental aids and fluoride products are not 
available or are expensive to buy in prisons (14). A study 
concluded that improvements in the prison issue oral 
health kits led to better oral health and hygiene among 
the population (4).
Coordinated health promotion programmes, involving the 
common risk factor approach, should be interdisciplinary 
with the dental team also involved in their planning and 
administration.
A prison shop can be an important part of the prisoner’s 
week, enabling a small amount of autonomy. It is 
recommended that the dental team work with the 
administrators of the shop to highlight and promote 
healthy options for prisoners, and evaluate this regularly.
Good oral health enables individuals to communicate 
effectively and is important to the overall quality of life, 
self-esteem and social confidence.
The dental team
To provide an efficient and effective dental service, the 
dental team must have a good understanding of the prison 
structures and processes. They must be able to interact with 
the prison managers and health care and security staff.
All prisons should provide support for dentists working 
in a prison environment by ensuring that there is an 
effective induction programme. They should also ensure 
that dentists have the appropriate qualifications and work 
within a clinical quality assurance framework.
The dental team often works in isolation and should have 
good clinical experience and be competent in simple oral 
surgery techniques.
There should be a good skill mix of dental professionals 
in the team, including dental hygienists and therapists to 
plan and run oral care clinics and initiatives.
The dental team should collaborate with other prison 
health care staff and dental teams to produce relevant 
research evidence in this field.
All dental teams working in prisons have a duty to 
undertake continuing professional development and 
should be encouraged and supported to attend courses 
and conferences related to prison dentistry. They should 
demonstrate appropriate professional standards through 
peer review, appraisal and clinical audit.
Commissioning prison dental services
Commissioning is one of the means by which the best 
value service is secured. A good commissioning process 
includes five components (16).
1. An oral health needs assessment assesses the oral 
health needs of the population and reviews the 
resources and capacity of the existing service.
2. Following the needs assessment, priorities should be 
decided in terms of the range of dental treatments 
available, length of a prisoner’s stay, management of 
referrals, prevention, skill mix of the team, research 
priorities, risk management and the creation of a 
supportive prison environment. Strategic planning 
should be carried out and minimum standards assured.
3. A service-level agreement should be developed and 
the services reviewed against it. The agreement 
should be specific to the prison dental service and take 
into account the high prevalence of oral disease, the 
complex needs of prisoners and the difficulties in and 
barriers to providing a dental service in the prison.
4. Commissioners are encouraged to shape the supply 
and manage the market by using open tendering in 
their procurement strategy to ensure innovation, 
quality and value.
5. Arrangements should be made to manage performance 
and support quality improvement through frequent 
service reviews, using a robust and balanced set of 
measures for quality improvement (17).
Remuneration systems for service payment should be 
appropriately weighted for the special conditions and 
complex demands of the prison environment.
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13. Drug use and related consequences among prison  
populations in European countries  
Linda Montanari, Luis Royuela, Manuela Pasinetti, Isabelle Giraudon, Lucas Wiessing, Julian Vicente
Key points 
•	 A	 history	 of	 drug	 use	 is	 common	 among	 European	
prisoners, with levels disproportionately high 
compared to the general population.
•	 Health	 problems,	 especially	 communicable	 diseases	
and psychiatric co-morbidity, are especially prevalent 
among prisoners using drugs.
•	 The	mortality	risk	in	the	first	weeks	after	release	from	
prison is extremely high.
•	 Relevant	differences	are	reported	between	European	
countries in drug use and drug-related problems 
among prisoners.
•	 In	European	countries,	valid	and	comparable	data	on	
drug use and related consequences among prisoners 
are still scarce and harmonization work is needed
Introduction
Prisons are places with difficult living conditions, where 
populations from poor communities and marginal social 
groups are overrepresented (1).
According to data from the Council of Europe, about 635 000 
people were estimated to be in penal institutions in the 
28 EU member states and Norway on 1 September 2010, 
an average of 135 prisoners per 100 000 population in 
European countries (ranging from 60–70 per 100 000 
population in Denmark, the Netherlands, Norway, Slovenia 
and Sweden to over 200 in the Czech Republic, Estonia, 
Latvia, Lithuania and Poland). This figure is lower than 
in some large countries, for example 620 in the Russian 
Federation and 740 in the United States (2).
Drug users, including problematic drug users,10 often 
represent a large part of the prison population. Drug users 
may be reported among prisoners who are sentenced for a 
drug offence such as supply or use (although many of them 
are only drug traffickers), among prisoners sentenced for 
a crime committed to support their drug use and among 
people imprisoned for offences not related to drugs. The 
available data on drug use among prisoners usually reflect 
the whole prison population, without a breakdown by type 
of sentence.
Even though many drug users stop or reduce their use of 
drugs when they enter prison, some continue to use and 
some may even start to use drugs there (4–6).
At present, data on illicit drug use and its consequences 
among prisoners in Europe are limited, and there are 
significant national differences in data collection methods. 
This should be borne in mind when data are interpreted. 
Nevertheless, a general profile of drug users in European 
prisons can be drawn from the latest data reported in 
2011 (referring to 2010) by European countries to the 
European Monitoring Centre for Drug and Drug Addiction 
(EMCDDA) (5,6).
Drug use among the prison population
In Europe, data on past or current drug use among 
prisoners are scarce and mainly based on research 
studies and/or routine assessment at prison entry. 
The availability, methods of collection and quality of 
data vary greatly among countries. Data on drug use 
among prisoners are reported by the EU countries to 
the EMCDDA once a year. They refer to prisoners who 
have ever used illicit drugs in their lifetimes and to 
those who are currently using drugs while in prison, 
but not to the recent history of drug use (in the last 
year or last month). Furthermore, not all countries are 
able to provide these data, and the number of reporting 
countries varies according to the type of data and the 
year of reporting.
Drug use and drug use patterns before 
imprisonment
The most recent available data from EU countries (mainly 
from 2010) show that a high percentage of prisoners have 
used illicit drugs at some point in their lives (Fig. 5) (7). 
Variations between countries appear to be important, 
but they may also reflect differences in data collection 
methods. Among 17 EU countries reporting data on drugs 
and prison since 2000, the proportion of prisoners who 
have ever used any drug ranges from 16% in Romania 
to 79% in the United Kingdom (England and Wales) and 
the Netherlands, with 9 countries reporting percentages 
higher than 50%.11
10 The EMCDDA defines problem drug use as “injecting drug use or long-duration/regular use of opioids, cocaine and/or amphetamines” (3).
11 These percentages mainly correspond to the prevalence levels of people who have ever used cannabis (the illicit substance most frequently used).
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The most common drugs ever used by prisoners are, 
in descending order, cannabis, cocaine, heroin and 
amphetamines, the same as in the general population 
even if the latter present a substantially lower prevalence 
for all those substances.
Cannabis has the highest prevalence of lifetime use among 
prisoners who have ever used any illicit drug (ranging from 
12% to 70% of prisoners who have ever tried it). Cannabis 
is also the most ever-used substance in the general 
population, although the levels there are substantially 
lower (1.6% to 33% among the group aged 15–64 years). 
The prevalence of lifetime use of cocaine among prisoners 
who have ever used any illicit drug ranges from 6% in 
Romania to 53% in Spain (in the general population, the 
prevalence rates range from 0.3% in Malta to 10% in 
Spain); 7 out of 15 European countries where data were 
available report a lifetime prevalence of cocaine use of 
20–50% of prisoners. Amphetamine experience among 
prisoners ranges from 1% to 45%, whereas among the 
a Any of amphetamines, cannabis, crack, cocaine or heroin. 
b Includes crack cocaine. 
c Opioids. 
Data refer to lifetime prevalence of use prior to imprisonment, with the exception of data for Belgium and Bulgaria, which refer to lifetime prevalence inside and 
outside prison. The prisoner sample in Finland was made up of convicts presenting for voluntary HIV testing. In the United Kingdom, the sample consisted of adults 
receiving sentences of between one month and four years. The studies were carried out in 2000 (Greece), 2001 (Finland), 2003 (Italy, Lithuania, Netherlands), 2005/6 
(United Kingdom), 2006 (Romania, Spain), 2007 (Poland, Portugal), 2008 (Slovenia), 2009 (Hungary) and 2010 (Belgium, Bulgaria, Croatia, Czech Republic, Latvia).
 
Source: EMCDDA (7), based on data supplied by REITOX focal points.
general population the range is from almost 0% to 12%. 
Lifetime prevalence of heroin use among the prisoners 
who have ever used any illicit drugs ranges from 8 to 
39%, with 8 out of 13 countries that were able to provide 
information reporting levels in the range 15 to 39%. In 
the general population, lifetime prevalence of heroin use 
is below 1% in all countries. Equivalent data on lifetime 
use of other substances (such as volatile substances, 
hypnotics and sedatives) are hardly available in prison, or 
are only reported by a few countries. For many of those 
substances, prevalence rates among prisoners and among 
the general population are usually low.
Data on more problematic patterns of drug use among 
prisoners are limited. One international review of studies 
on prisoners found that 25–50% of people received 
into custody were clinically assessed as having serious 
drug problems (8), often including opioid dependence. 
Furthermore, a systematic review of 13 studies measuring 
the prevalence of drug and alcohol abuse and dependence 
Fig. 5. Lifetime prevalence of drug use among prisoners in European countries 
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in male and female prisoners on reception into prison 
(n=7563) noted that 10–48% of men and 30–60% of 
women were abusing or dependent on illicit drugs on entry 
to prison (9,10). Although these data are mainly based on 
American research, European prisoners also often have 
histories of harmful patterns of drug use, including heroin 
injection and polydrug use.
Drug injection (mainly of heroin) is a particularly harmful 
way to use drugs, being associated with the spread of 
communicable diseases, especially when drug injectors 
share needles and/or other paraphernalia. Injecting use 
is also associated with a higher risk of overdose, resulting 
in significant mortality. Rates of ever-injecting drugs are 
substantially higher among prisoners than among the 
general population (on average, current injectors among 
the general population are estimated to be 0.3% of all 
adults). Based on available data, countries report that 
between 5% and 38% of prisoners admit that they have 
ever injected drugs prior to imprisonment (7).
Drug use and patterns of drug use in prison
Even if most users reduce or stop consuming drugs when 
entering prison, it is recognized that illicit drugs find their 
way into prisons. Furthermore, prison may be a setting for 
initiation into drug use, initiation of the use of additional 
drugs or for switching from one substance to another, 
sometimes to more harmful patterns of drug use (11). The 
reasons for switching to a different drug may be related to 
a lack of the preferred substance inside prison, the choice 
of substances for which it is easier to avoid control, or 
other factors which are still unclear (9,12).
A Belgian study carried out in 2008 found that more than 
one third of drug-using prisoners had started to use a new 
additional drug during detention that they were not using 
before prison, with heroin most frequently mentioned (13).
Studies carried out in 15 EU countries since 2000 estimate 
that 2–56% of prisoners have ever used any type of drug 
while incarcerated, with 9 countries reporting levels in 
the range 20–40%. The drug most frequently used by 
prisoners is cannabis, followed by cocaine and heroin. 
The rates of prisoners who have ever used heroin while in 
prison vary between 1% and 21% of prisoners. The wide 
variation in prevalence rates between countries mainly 
reflects methodological limitations, which are particularly 
relevant when drug use prevalence is surveyed within 
prisons.
Some prisoners may have been drug injectors in the 
community and either continue to inject or start to 
inject drugs while in prison. In the EU  (according to 
data reported since 2000), between 2% and 31% of 
prisoners, depending on the country, are reported to have 
ever injected any drug while in prison, although data are 
limited to a few countries and methods for collecting data 
vary greatly between them (for example, through surveys 
or clinical assessments, self-reports or interviews). The 
findings of qualitative studies suggest that in prison 
settings the likelihood of injecting in order to maximize 
the effect of the substance could increase, owing to the 
scarcity of drugs. The scarcity of sterile equipment may 
lead to prisoners sharing syringes and other injecting 
paraphernalia (14).
The social characteristics of drug  
treatment clients in prison 
Information on the social characteristics of prisoners using 
drugs is scarce and come mainly from qualitative studies 
(15). In Europe, information on the characteristics of drug 
users in prison is reported through the national reports 
on the drug situation and the treatment demand indicator 
(16), which refers to people who enter drug treatment in 
specialized drug treatment centres, including treatment 
units in prison (4,5).
Eight European countries (France, Germany, Ireland, 
Luxembourg, Hungary, Romania, Slovakia, Sweden) 
reported data on people who entered drug treatment in 
prison in 2010 (n=5146 persons). In these countries, the 
social profile of drug clients entering treatment in prison, 
while generally similar to that of those entering treatment 
in the community, had some distinct characteristics.
In prison, about 90% were males compared to 80% in 
the community; they were slightly younger (29 years) 
than those in the community (30 years), and reported 
starting their drug use at an earlier age (18 years in prison 
compared to 21 years in the community).
The social conditions of drug clients before entering 
prison were generally poor. Many individuals had a low 
educational level, were unemployed before entering 
prison and/or were living in unstable accommodation. 
Despite differences in definitions of what constitutes an 
immigrant, the presence of immigrants among imprisoned 
drug users is high and seems to have increased in the last 
decade, although it is important to note that there is no 
scientific evidence to suggest that drug use is higher or 
lower among immigrants than in the general population. 
Finally, many prisoners who have used or are using drugs 
have a past history of violence, abuse and poverty (17–19). 
Health problems
Communicable diseases
Prisoners, including drug users, suffer from high levels 
of physical and psychiatric disorders, ranging from 
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communicable diseases (HIV, hepatitis B and C, TB) 
to psychiatric co-morbidity (antisocial and borderline 
personality disorder, depression, post-traumatic stress 
disorder, psychosis and alcohol dependence) (10,20,21).
European data on HIV infection among injecting drug 
users in prison are limited. The prevalence of infection 
does, however, vary and in some countries can be high 
among prisoners who have ever injected. In the eight 
countries providing communicable disease data to 
the EMCDDA (Bulgaria, Croatia, the Czech Republic, 
Finland, Hungary, Malta, Spain, Sweden), HIV prevalence 
among injecting drug users in prisons was mostly low 
to moderate (0–7.7%) in four countries, although Spain 
reported a prevalence of 39.7%. According to EMCDDA 
national reports, in countries with a high prevalence of 
HIV among injectors outside prison, HIV prevalence is also 
high among lifetime injectors in prison. Although no large 
differences can be observed in HIV prevalence between 
injecting drug users in prison and those in other settings, 
it should be noted that prisons may concentrate a high 
proportion of injectors and, therefore, the prevalence of 
HIV in the overall prison population can be much higher 
than in the general population (5,6,22).
Seven countries in Europe reported data on HCV antibody 
prevalence among injecting drug users in prison, with a 
range of 11.5% (Hungary) to 90.7% (Luxembourg). In the 
Czech Republic, Luxembourg and Malta, HCV appears to 
be somewhat more prevalent among injectors tested in 
prison compared to those tested in other settings.
Psychiatric co-morbidity
Prisoners with a history of drug use often have multiple 
and complex mental illnesses. Differences in psychiatric 
morbidity between the prison population and the general 
population are demonstrated by several studies, with 
prisoners more often presenting a problematic mental 
health profile. This involves both severe pathologies, 
such as psychosis and personality disorders (especially 
antisocial and borderline disorders), and other problems 
such as anxiety and depression. A systematic review 
of 62 surveys covering about 23 000 prisoners from 12 
countries worldwide showed that up to 65% of prisoners 
have a mental health disorder, ranging from personality 
disorder (42–65%, mostly antisocial disorder) to major 
depression (10–12%) to psychotic illnesses (4%, 
including schizophrenia, schizophreniform disorder, 
manic episodes and delusional disorder) (23). Those 
disorders represent a serious risk factor for suicide, 
which is the leading cause of death among prisoners 
(23). Studies from European countries, including France, 
Spain and the United Kingdom, support those results 
(24). Particular attention has been drawn to personality 
disorders, which are often associated with problem drug 
use (25). In a French study, the most common problems 
among prisoners with a diagnosis of psychiatric co-
morbidity were depressive syndromes (40%), generalized 
anxiety (33%), traumatic neuroses (20%), agoraphobia 
(17%), schizophrenia (7%), and paranoia or chronic 
hallucinatory psychoses (7%) (26).
Mortality among prisoners using drugs
Mortality among prisoners in general (both drug users and 
non-drug users) is high, with suicide accounting for about 
half of all prison deaths. Recent cohort studies in Europe 
report that suicide accounts for 10–20% of deaths among 
problem drug users in the community (10).
Increased mortality from all causes, and particularly 
from drug overdoses on release, has been documented 
in many countries (27). Prisoners should receive 
particular attention during the period following release 
because of their extreme vulnerability on return to the 
community. This is when there is a very high risk of 
overdose, frequently due to their relapse into heroin 
use and reduced tolerance to opioids (28). A review of 
drug-related deaths soon after release from prison in 
Australia, Europe and the United States showed that 6 
out 10 deaths in the first 12 weeks after release were 
drug-related. The authors concluded that there is an 
increased risk of drug-related death during the first 
two weeks after release from prison and that the risk 
remains elevated up to at least the fourth week (29). 
A study in the United Kingdom (England and Wales) 
also showed that 6 out of 10 deaths were drug-related 
and that the risk of death was strikingly acute in the 
first and second weeks following release from prison 
(30). Male prisoners were 29 times more likely to die 
and female prisoners were 69 times more likely to die 
compared to the general population during the week 
following their release (30). In Ireland, an investigation 
of deaths among drug users following release from 
prison between 1998 and 2005 showed a considerable 
risk of death at the time of release: of 105 deaths 
observed after release from prison, 28% occurred 
within the first week of release and a further 18% in 
the first month (31).
Methodological limitations
The data presented in this chapter have several 
methodological limitations, partly related to the subject 
(drug use) and the setting (prison) of the analysis, and 
partly to the lack of European harmonization. Clustering, 
self-selection and self-reporting biases particularly affect 
data collection and research in prison settings. Validity 
biases are particularly evident due to the sensitivity of the 
topic studied (drug use) (32).
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Methodological differences between European countries 
and between individual prisons are wide. Data may be 
collected through ad hoc studies or routine monitoring 
systems or both. Coverage and sampling may vary 
considerably between studies. Representativeness 
of the sample is an issue, since studies may refer to 
different types of prison population (for example, only 
convicted prisoners or also prisoners on remand) or to 
different types of prison (for example, prisons for young 
people, or for women or for all adults). Variables and 
time windows included in the studies (such as type of 
drug or reference time for using the drug) may also vary 
between countries. Finally, the routine reporting and 
the studies may be conducted between different time 
periods and dates.
This lack of common standards and of a consensus on data 
collection methods on drug use at European level limits 
the comparability and harmonization of data. If health 
consequences are to be monitored to provide support 
and evidence for policy, there is a need to develop a 
rationalized and more standardized approach at European 
level to the collection of data on drugs and prison (33).
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14. Drug treatment and harm reduction in prisons  
Heino Stöver, Andrej Kastelic
Key points 
•	 Estimates	 suggest	 that	 half	 the	 prisoners	 in	 the	 EU	
have a history of drug use, many with problematic 
injecting drug use.
•	 Drug	 use	 is	 one	 of	 the	main	 problems	 facing	 prison	
systems. It threatens security, dominates relationships 
between prisoners and staff and leads to violence, 
bullying and mobbing for both prisoners and often 
their spouses and friends in the community.
•	 The	prevalence	of	infectious	diseases	(particularly	HIV	
and AIDS, hepatitis B and C, and TB) is often much 
higher in prisons than outside and often related to 
injecting drug use.
•	 High	rates	of	injecting	drug	use,	if	coupled	with	lack	
of access to evidence-based prevention measures, 
can result in a frighteningly rapid spread of HIV and 
hepatitis B and C.
•	 Drug	 dependence	 services	 and	measures	 to	 address	
infectious diseases in prisons should be equivalent to 
the services provided outside prisons. Continuity of 
treatment for prisoners entering and leaving prison 
necessitates close cooperation between prisons and 
external agencies.
•	 Relapses	 into	 drug	 use	 and	 fatal	 overdoses	 after	
release are widespread. A wide range of drug services 
should be available to prisoners, based on local and 
individual needs. 
•	 Prison	 drug	 strategies	 require	 action	 for	 individual	
behavioural change as well as on the structural level. 
National and international networking and the exchange 
of good practice models seems to be a valuable method 
for all prison systems. Guidelines and detailed protocols 
are needed at national level in delivering adequate 
health care services (for example, for substitution 
treatment for opiate-dependent prisoners).
•	 Drug	 services	 in	 prisons	 should	 be	 subject	 to	
monitoring and evaluation.
Introduction
Drug use and the consequences for prisoners, 
prisons and prison health care
Drug use and bloodborne virus infections (including HIV/
AIDS and viral hepatitis) are serious health problems in 
prisons and wider criminal justice systems (1). This makes 
these places important settings for the provision of effective 
drug-related and bloodborne virus services to help reduce 
the damage that drug use does to health, prison safety 
and security as well as the broader community (through 
increased re-offending and infections on release).
Large proportions of the people who enter criminal 
justice systems and prison have a history of drug use and 
injecting. Many of these people continue to use drugs 
while they are in prison. The prison environment may 
have a positive impact on some drug users, helping them 
to stop or reduce their drug use or to use less frequently, 
but for others prison will be an environment where they 
switch to more harmful patterns of drug use.
Prisons are risky environments because they are often 
overcrowded, stressful, hostile and (sometimes) violent 
places in which individuals from poor communities and 
from ethnic and social minorities are overrepresented, 
including people who use drugs and migrants.
A European study of health problems arising in prison 
highlighted three main issues: substance abuse, mental 
health problems and communicable diseases (2). These 
three problem areas are closely interrelated. Some of the 
harms associated with drug users in the criminal justice 
system include:
•	 high	 rates	 of	 HIV	 and	 viral	 hepatitis	 infection	
(imprisonment is associated with higher rates of 
bloodborne virus infection among injecting drug users);
•	 high	rates	of	TB	in	some	countries;
•	 restricted	 access	 to	 harm	 reduction	 services	 and	
treatment for drug dependence and bloodborne viruses;
•	 increased	risk	of	death	by	overdose	after	release;
•	 increased	 risks	 of	 transmission	 of	 prison-acquired	
infections;
•	 increased	risk	of	reoffending	after	release.
Although alternatives to imprisonment have been 
introduced in many countries, more and more people who 
have used or still use drugs enter prisons. Only some are 
in prison as a result of conviction for a drug offence. Most 
are there for other drug-related offences.
Generally, in many countries the number of drug users with 
problematic consumption patterns in prison populations 
has dramatically increased over the last two decades.12 
12 Problematic drug use is defined as “injecting drug use or long duration/regular use of heroin/cocaine and/or amphetamines” (3). This definition can include other 
opioids such as methadone. Drug consumption is deemed to be problematic if it is combined with other risky behaviour, causes damage to other people or produces 
negative social consequences.
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Every sixth prisoner is thought to be a problem drug user (4). 
Thus, people who use drugs are overrepresented in prisons 
throughout Europe (see Chapter 13). Several factors have 
contributed to this, including poverty, migration, violence 
and the fact that increased incarceration is often politically 
expedient. Ultimately, however, repressive legislation 
against drugs in the context of growing drug consumption 
in the community has often played an important role.
This fact inevitably affects life in penal institutions. 
Drugs have become a central theme, a dominating factor 
in the relationships between prisoners and between 
prisoners and staff. Many security measures are aimed 
at controlling drug use and drug trafficking within the 
prison system. Daily prison routine in many respects is 
dictated by drug-dependent inmates and drug-related 
problems: drug-related deaths, drug-induced cases of 
emergency, increases in the number of people who use 
drugs, hierarchies of dealers, debts, mixed drugs, drugs 
of poor quality, incalculable purity of drugs and risks of 
infection (particularly with HIV and hepatitis) resulting 
from contaminated and shared syringes and drugs. 
Drugs become the central medium and currency in prison 
subcultures. Many routine activities for inmates focus 
on the acquisition, smuggling, consumption, sale and 
financing of drugs.
Prison managements are faced with increased public 
pressure to keep prisons drug-free. Few prison managers 
talk frankly and in public about drug use in prisons, 
establish adequate drug services or develop new drug 
strategies. People who confess that drug use is prevalent 
in prisons and that prison is a risk environment are 
frequently blamed for failing to maintain security in 
prisons, so a considerable number of prison managers 
continue to deny or ignore drug use in prison.
Furthermore, many prison physicians believe they can cure 
the inmates’ drug problems by temporarily forcing them to 
stop using drugs. Thus it becomes obvious why dealing 
with people who are dependent on drugs in detention is 
difficult. The goal of rehabilitating the convicts must be 
pursued, but prison managers in many countries face 
rising drug consumption among inmates and political 
and economic circumstances that make solving the drug 
problem even more difficult. The current judicial situation 
is paradoxical: a solution has to be found to a problem 
that is not supposed to exist – drugs in prisons.
Nature and prevalence of drug use and related 
risks in prisons and on release
Many drug users in prisons come from the more 
disadvantaged groups in society, with a high prevalence 
of low educational attainment, unemployment, a history 
of physical or sexual abuse, relationship breakdown or 
mental disorder. Many drug users lead chaotic lives and 
experience a range of issues with housing, employment, 
education and health that need to be addressed. Many 
of these prisoners have never had access to health care 
and health promotion services before imprisonment. The 
health care services, therefore, offer an opportunity to 
improve their health and personal well-being (5).
Drug use in prison takes place in extreme secrecy, and 
drug seizure statistics, based solely on the confiscation 
of needles/syringes and positive urine test rates, only 
indicate some of the story of drug use behind bars. The 
patterns of drug use vary considerably between different 
groups in the prison population. For instance, drug use 
among women differs significantly from that among men, 
with different levels and types of misuse and different 
motivations and behavioural consequences.
Many countries report changes in the patterns of drug 
use (volume and type of drug) when the preferred drugs 
are scarce (6). Studies and observations by prison officers 
indicate that, on the one hand, switching to alternative 
drugs (such as from opiates to cannabis) or to any 
substitute drugs with psychotropic effects, no matter how 
damaging this would be (illegal drugs and/or medicine) is 
widespread. On the other hand, due to a lack of access 
to the preferred drug or because of controls (such as 
mandatory drug testing), some prisoners seem to switch 
from cannabis to heroin, even if on an experimental basis, 
because cannabis is deposed within fatty tissue and may 
be detected in urine up to 30 days after consumption.
In many prisons, the most commonly used drug besides 
tobacco is cannabis, which is used for relaxation purposes. 
Some studies have shown that more than 50% of prisoners 
use cannabis while in prison: prevalence on entry varies 
between 38% in France (7) to 50–55% in the United 
Kingdom (England and Wales) (8,9), 65% in Switzerland 
(10), 74% in Greece (11) and 81% in the United Kingdom 
(Scotland) (12). Studies indicate that both prison staff and 
inmates consider that cannabis provides psychological 
relief and has a positive impact on the social ambiance in 
the particular setting of prisons.
Tackling cannabis use in prison needs to take these effects 
into account and to include harm reduction measures 
tailored to the individual users and their therapeutic 
needs (13).
A much smaller percentage of prisoners report that they 
inject drugs in prison (14). The extent and pattern of 
injecting and needle-sharing vary significantly from prison 
to prison. Prisoners who use drugs on the outside usually 
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reduce their use in prison, and only a minority of prisoners 
use drugs daily.
According to various studies undertaken in Europe, 
between 16% and 60% of people who injected on the 
outside continue to inject in prison (15). Although they 
inject less frequently than outside prison, prisoners 
are much more likely to share injecting equipment than 
are drug injectors in the community, and with a greater 
number of people (16). Many were accustomed to easy 
and anonymous access to sterile injecting equipment 
outside prison and start sharing injecting equipment in 
prison because they lack access to safe equipment there.
Although injecting drug use in prison seems to be less 
frequent than in the community, each episode of injection 
is far more dangerous than outside due to the lack of 
sterile injecting equipment, the high prevalence of sharing 
and already widespread infectious diseases.
Prisons are high-risk environments for the transmission of 
HIV and other bloodborne infections for several reasons:
•	 a	disproportionate	number	of	inmates	come	from	and	
return to backgrounds where the prevalence of HIV 
and bloodborne virus infection is high;
•	 the	 authorities	 fail	 to	 acknowledge	 officially	 the	
presence of HIV and bloodborne viruses, thus hindering 
education efforts;
•	 activities	such	as	injecting	drug	use	and	unsafe	sexual	
practices (consensual or otherwise) continue to occur 
in prison, with clean injecting equipment and condoms 
rarely provided to prisoners;
•	 tattooing	and	piercing	using	non-sterile	equipment	is	
prevalent in many prisons; and
•	 epidemics	of	other	STIs	such	as	syphilis,	coupled	with	
their inadequate treatment, lead to a higher risk of 
transmitting HIV through sexual activity.
There were early indications that HIV could be transmitted 
extensively in prisons. HIV outbreaks in prison have been 
documented in some countries, demonstrating how 
rapidly HIV can spread in prison unless effective action is 
taken to prevent transmission (17, p.11).
Although smoking heroin (“chasing the dragon”) instead of 
injecting plays an increasing and significant role all over 
Europe, this route of administration is not widespread 
in prison. Drugs are expensive in prison, and injecting 
maximizes the effect of a minimal amount of drugs and is 
not as easily detectable as smoking (both by prison staff 
and other prisoners).
A substantial number of drug users report having first 
started to inject while in prison. Studies of drug users in 
prison suggest that between 3% and 26% first used drugs 
while they were incarcerated, and up to 21% of injectors 
initiated injecting while in prison (18). 
In addition to illegal drugs, legal drugs such as tobacco 
(19), alcohol and prescribed pharmaceuticals (20) often 
contribute to substance dependence and related health 
problems among prisoners. Many prisoners have a long 
history of regular use of legal drugs. Polydrug use is 
common among offenders entering custody, codependent 
on any combination of alcohol, opiates, stimulants and 
benzodiazepines. Dual diagnosis, or the coexistence 
of mental health and substance use problems, has also 
increased in recent years.
Prevention, treatment, harm reduction and 
aftercare 
In general, drug services in prisons can be divided 
into assessment, prevention, counselling, abstinence-
oriented and medication-assisted treatment, self-help 
groups and peer-driven interventions, harm-reduction 
measures and pre-release and aftercare programmes. It 
is essential to recognize that drug dependence (whether 
on opiates, cocaine, tobacco, alcohol or other drugs) is not 
criminal or hedonistic behaviour but a chronic disease, 
characterized by a long process of relapses and attempts 
at stabilization, which consequently requires a continuing 
care and support approach. It should be treated in the 
same way as other chronic illnesses, including diagnosis 
and a treatment plan. It is vital that any drug treatment 
and intervention strategies are not developed in isolation 
but linked to other relevant initiatives and strategies. A 
prison drug strategy should be part of and in line with the 
national drug strategy (21):
All drug services available in the community should also 
be available in prisons, in the same quality, size and 
accessibility than outside. The World Health Organization 
(WHO) Health in Prisons Programme and the Pompidou 
Group of the Council of Europe principles for the provision 
of health care services in prisons (2001) state that: “… 
there should be health services in prisons which are broadly 
equivalent to health services in the wider community” (22) 
(the principle of equivalence).
The goals of drug treatment services in prisons must be, 
at the least, that prisoners leave in a healthier state than 
when they arrived and, as the best outcome, that they are 
psychosocially stabilized and their treatment is continued 
after release. Thus, the ultimate goal of all treatment for 
drug dependency, on an individual level, is to achieve 
abstinence from the drug (or drugs) on which prisoners 
are dependent with or without medication-assisted 
treatment. On a system or institutional level, reducing 
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re-offending and improving health and rehabilitation are 
the overarching twin aims.
Throughout the EU, the introduction of prevention, 
treatment and harm reduction measures in prisons is still 
inadequate compared to developments achieved in the 
last 30 years in the community. An EU report emphasizes 
this lack of equivalence, in that interventions in prisons 
within the EU are still not in accordance with the principle 
of equivalence adopted by the United Nations General 
Assembly (23), UNAIDS/WHO (24) and UNODC (25), 
which calls for equivalence between the health services 
and care (including harm reduction) available inside prison 
and those available to society outside prison.
What works?
It is well-established that good drug treatment for prisoners 
can reduce both drug use and rates of re-offending. The 
Lisbon agenda for prisons stated that “positive experience 
from in-prison treatment helps inmates to continue 
treatment after release, reduce relapse rates and related 
health risks, and also reduce delinquency recidivism” (26).
Opioid substitution therapy is the most effective treatment 
for preventing HIV and hepatitis C among opiate users 
(27–29).Intensive psychosocial support and/or supervision 
on release, therapeutic communities and the 12-step 
abstinence-based programme have evidential support. 
This means that pharmacological and psychosocial as 
well as other supportive “wraparound” interventions 
are promising strategies for stabilizing prisoners. The 
inclusion of integrated medical and psychosocial services 
in a comprehensive package, together with a range of 
offers meeting the needs of drug-dependent prisoners, is 
critical for effective drug services.
The Patel Report puts it this way (5, p.24):
One of the overall themes to emerge is that people need to 
feel they have choices. This is as important when deciding 
about treatment and interventions options and in choosing 
their own route to recovery i.e. working toward abstinence. 
The reality of supported self-change is vital in a recovery 
focused treatment system in order to raise aspirations and 
create opportunities for further self-change and personal 
development. 
Coping with drug use in prison is difficult for several 
reasons. Drug use is illegal. If discovered, it leads to 
harsh consequences for the time spent in prison including 
loss of privileges (such as home leave), segregation, more 
frequent controls (such as cell searches) and discrimination 
by non-drug-using prisoners (fear of transmitting infectious 
diseases). In the prison subculture, drug users are often 
perceived to be in the lower ranks: they are blamed for 
new supervisory and control procedures that aggravate 
the custodial conditions (30).
Prison health services face a dilemma regarding therapeutic 
resources. Staff in prison health care units and security 
staff have to deal with the consequences of drug use, but 
the causes of drug use usually remain beyond their reach. 
The prison staff and administration often do not have the 
capacity to respond adequately to the health problems 
of drug users, especially if they are in prison for short 
periods of time. Prisons are not therapeutic institutions. 
Time in prison should not, however, be considered lost. 
The opportunities prisons may provide in terms of health 
care, social support and the involvement of community 
health agencies should be used. Prisons can provide 
an opportunity to help drug users, many of whom have 
not had any previous contact with helping or treatment 
agencies. People often change the drug use patterns they 
had before imprisonment, voluntarily or not. Because of a 
lack of drugs, they might stop using altogether, reduce the 
quantity or change the route of administration because of 
a lack of sterile needles and syringes.
Measures designed to achieve abstention from drug use 
in prison, or at least a reduction in harmful drug-using 
patterns, include:
•	 counselling	on	drug-related	 issues	by	prison	staff	or	
specialized personnel, integrated with external drug 
services;
•	 housing	 for	 drug-using	 prisoners	 in	 specialized	 units	
with a treatment approach and multidisciplinary staff;
•	 provision	 of	 printed	 and	 audiovisual	 material	 in	
different languages, with the involvement of prisoners 
and external counselling agencies in its production.
Measures to prevent the transmission of infectious 
diseases among drug users include:
•	 availability	of	sterile	injecting	equipment;
•	 provision	 of	 opiate	 substitution	 treatment	 to	
opioid-dependent prisoners at any stage of their 
imprisonment;
•	 availability	of	condoms	and	lubricants;
•	 implementation	 of	 vaccination	 programmes	 against	
hepatitis A and B;
•	 face	 to	 face	 communication:	 counselling,	 personal	
assistance, assistance from and integration of outside 
agencies for AIDS help or bloodborne viruses, and 
safer use training for drug users;
•	 provision	of	leaflets;
•	 availability	of	bleach	or	other	decontaminants	(30). 
Strategies to reduce risk applied outside prison are often 
regarded as undermining the measures taken inside prison 
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to reduce the supply of drugs. Supporting the safer use 
of illegal drugs (such as by providing bleach and sterile 
injecting equipment) and at the same time confiscating 
the drugs is a fundamental dilemma. Studies show, 
however, that harm reduction measures can be provided 
safely and without compromising the measures aimed at 
reducing drug use in prisons (31).
Prison drug policies should allow for:
•	 assessment,	screening,	counselling	and	treatment	on	
a voluntary basis;
•	 the	 keeping	 of	 a	 distance	 from	 the	 drug-using	
subculture, since drug users who are motivated to 
undergo a treatment programme have to be able to 
do so in a protected environment, which is difficult for 
many prisons due to overcrowding;
•	 throughcare	 and	 aftercare,	 which	 are	 essential	
elements of efforts to reduce relapse and re-offence 
and build trust with caregivers;
•	 provision	of	the	diversity	of	measures	that	are	offered	
outside prisons: social services, drug-care units, drug 
counselling and treatment services (including harm 
reduction); and
•	 discouragement	of	 the	 import	and	 traffic	of	drugs	 in	
the prison system.
Psychosocial drug treatment and 
pharmacological approaches as 
complementary measures in a 
comprehensive package of drug services
An integrated drug  treatment system, such as that 
developed in the United Kingdom (England) (32), is 
needed for a comprehensive response to the complex 
phenomenon of drug dependence. Drug-free as well as 
pharmacological interventions, together with stimulation 
for self-help, are key to the success of drug services. 
Psychosocial drug treatment and clinical substance 
dependence management must be integrated and 
harmonized. Drug-free orientation and pharmacological 
treatment are not contradictory strategies; on the contrary, 
they can complement each other with psychosocial drug 
treatment and rehabilitation.
Inside prisons, the use of illegal drugs is a criminal offence 
and abstinence-based interventions are, therefore, 
generally viewed as compatible with the goal of prison 
systems to eradicate drug use. Abstinence is compatible 
with, and reinforces, the aims of custody in general and 
is envisaged as enabling prisoners to avoid committing 
criminal offences after release.
Prisons run a variety of rehabilitation programmes for 
drug users based on different therapeutic approaches and 
assumptions. These programmes are designed to reduce 
the risk of re-offending through alleviating prisoners’ 
problems with substance use. Three main approaches and 
types of programme can be distinguished.
The cognitive behavioural therapy approach has different 
levels of intensity (low/medium intensity programme, 
gender-specific and short duration). The aim is to gain 
social learning experience, and to understand and 
treat drug-related problem behaviour associated with 
substance-related offending.
The 12-step approach is based on social learning within a 
peer approach, with new group members given instruction 
in ways to lead a drug-free life by more established 
prisoners. It works on the assumption that addiction is a 
life-long illness that can be controlled but not necessarily 
completely cured. The programmes are high intensity for 
highly dependent prisoners, regardless of the specific 
drug (they may last for 15 to 18 weeks).
The structured therapeutic community approach is 
based on hierarchical treatment and aims to teach new 
behaviour, attitudes and values, reinforced through peer 
and therapeutic community support. It is available for 
adult prisoners with a medium or high risk of reconviction 
and level of dependence on drugs (5).
Referral to these programmes is based on individual risks 
and needs. The different approaches allow individual 
prisoners to be directed towards the treatment most 
suited to the severity of their problem and fitting their 
personal characteristics and circumstances. Some of the 
cognitive behavioural therapy programmes are suitable 
for people who are stabilized on opioid substitution 
programmes, either as part of the process of working 
towards abstinence or towards better stabilization, while 
the 12-step and therapeutic community models require 
participants to be entirely drug-free before starting the 
programme: “The factors which are rated as being good 
include the quality of relationships, ease of access and 
experiencing a transformation in which drug users 
describe their life as having being ‘turned around’.” (5, 
p.29).
These approaches can be matched with, on the one 
hand, voluntary drug testing that aims to provide an 
incentive for prisoners to stay drug-free because they 
are recovering from drug dependence or because they 
wish to continue receiving particular privileges (such as 
release on temporary licence or a better job in the prison) 
or, on the other hand, having something meaningful to 
do such as work, education and structured programmes, 
which seems to be a key determinant in remaining drug-
free.
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Abstinence-oriented treatment and therapeutic 
communities in prisons
Abstinence-oriented treatment for prisoners is generally 
provided in special facilities (therapeutic communities). 
Most of the member states of the Council of Europe have 
abstinence-based programmes. Therapeutic communities 
are intensive treatment programmes for prisoners 
with histories of severe drug dependence and related 
offending who have a minimum of 12–15 months of their 
sentence left to serve. They are drug-free environments 
implementing an intensive treatment approach that 
requires 24-hour residential care and comprehensive 
rehabilitation services. Residents are expected to take 
from 3 to 12 months to complete the programme. In general, 
therapeutic community treatment models are designed as 
total-milieu therapy, which promotes the development of 
social values, attitudes and behaviour through positive 
peer pressure. Although each therapeutic community 
differs in terms of the services provided, most programmes 
are based on a combination of behavioural models with 
traditional group-based, confrontational techniques. As 
high-intensity, often multistage programmes, therapeutic 
communities are provided in a separate unit of the prison. 
Many prison therapeutic communities ensure a continuum 
of care by providing community-based aftercare, which is 
closely connected to the specific therapeutic community 
and part of the correctional system.
Little research has been done on the effectiveness 
of therapeutic communities and the sustainability of 
abstinence. The unsolved problem is that therapeutic 
communities are often not linked with interventions 
for safer drug use and the prevention of death after 
relapse following release. It is suggested that prisoners’ 
experience in treatment should be followed up after 
release.
Contract treatment units and drug-free units
Drug-free units or wings or contract treatment units aim 
to allow prisoners to keep a distance from the prison drug 
scene and to provide a space to work on dependence-
related problems. The focus in these units is on drug-
free living. Prisoners stay in these units voluntarily. 
They commit themselves (sometimes with a contract) to 
abstinence from drugs and not to bring in any drugs and 
agree to regular medical check-ups often associated with 
drug testing. Prisoners staying in these units sometimes 
enjoy a regime with more favours and privileges, such as 
additional leave, education or work outside, excursions 
and more frequent contact with their families. Drug-free 
units (often called drug-free zones) do not necessarily 
include a treatment element. They aim to offer a drug-
free environment for everyone who wants to keep away 
from drug-using inmates.
The purpose of staying in a contract treatment unit is 
that the inmate will remain drug-free or at least become 
motivated to continue treatment after release. Attempts 
will be made to motivate the inmate to strengthen his or 
her health and personality, to participate in work routines 
and to maintain and strengthen his or her social network.
Counselling, peer support and peer-driven 
interventions
Peer education and peer support can be defined as the 
process by which trained people carry out informal and 
organized educational activities with individuals or small 
groups in their peer group, such as those of the same 
age or – in this context – other prisoners. Peer education 
targets individuals and groups that cannot effectively 
be reached by existing services, with the overall aim of 
facilitating improvements in health and reducing the risk 
of transmitting HIV or other bloodborne diseases. Peer-
driven interventions make systematic use of the authentic 
value of peers.
On the basis of the data available and extrapolating from 
the literature on community-based programmes, education 
programmes in prisons (as in community settings) are 
more likely to be effective if peers develop and deliver 
them. As Grinstead et al. (33) have stated:
When the target audience is culturally, geographically, or 
linguistically distinct, peer education may be an effective 
intervention approach. Inmate peer educators are more likely 
to have specific knowledge about risk behaviour occurring 
both inside and outside the prison. Peer educators who are 
living with HIV may also be ideal to increase the perception 
of personal risk and to reinforce community norms for 
safer sexual and injection practices. Peer education has 
the additional advantage of being cost-effective and, 
consequently, sustainable. Inmate peer educators are 
always available to provide services as they live alongside 
the other inmates who are their educational target.
Peer educators can play a vital role in educating other 
prisoners, since most of the behaviour that puts prisoners 
at risk of HIV, hepatitis and overdoses in prisons involves 
illegal (injecting drug use) or forbidden (same-sex activity 
and tattooing) and stigmatized (same-sex activity) 
practices. Peers may, therefore, be the only people who can 
speak candidly to other prisoners about ways to reduce the 
risk of contracting infection. In addition, peer educators’ 
input is not likely to be viewed with the same suspicion 
as the information provided by the prison hierarchy. Peer 
educators are more likely to be able to discuss realistically 
the alternatives to risky behaviour that are available to 
prisoners and are better able to judge which educational 
strategies will work within their prison and the informal 
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power structure among prisoners. Finally, peer-led education 
has been shown to be beneficial for the peer educators 
themselves: individuals who participate as peer educators 
report significant improvements in their self-esteem (34).
Opioid substitution treatment in custodial 
settings
Background
Prisons are not the right place for treating drug-dependent 
men and women, and countries should develop policies 
for alternatives to imprisonment. As long as these 
alternatives are not available, prison authorities are faced 
with this specific population in need of treatment, care 
and support. Research has shown that treatment for 
opioid dependence (opioid substitution therapy – OST) 
is the most effective way to treat opioid dependence, to 
reduce the risk of HIV and hepatitis C transmission, and to 
reduce the risk of overdose (35,36).
The need for access to treatment for opioid dependence in 
prison was internationally recognized more than 30 years 
ago. In 1993, WHO issued guidelines on HIV infection and 
AIDS in prisons (24) which stated the following: 
Drug-dependent prisoners should be encouraged to enrol in 
drug treatment programmes while in prison, with adequate 
protection of their confidentiality. Such programmes should 
include information on the treatment of drug dependency and 
on the risks associated with different methods of drug use. 
Prisoners on methadone maintenance prior to imprisonment 
should be able to continue this treatment while in prison. In 
countries in which opioid substitution treatment is available 
to opiate dependent individuals in the community, this 
treatment should also be available in prisons. 
In 2004, in a position paper on substitution maintenance 
treatment, UNAIDS, UNODC and WHO concluded that the 
provision of substitution maintenance treatment for opioid 
dependence is an effective strategy for preventing HIV/
AIDS, which should be considered for implementation as 
soon as possible in communities at risk of HIV infection (37). 
A failure to implement effective drug treatment and HIV 
and hepatitis C prevention measures could result in the 
further spread of HIV and hepatitis C infection among 
injecting drug-users and the wider prison population, and 
could potentially lead to generalized epidemics in the 
local non-injecting drug-user population.
Injecting drug-users who do not enter OST are up to six 
times more likely to become infected with HIV than those 
who enter and remain in treatment. The death rate of 
people with opioid dependence in OST is one third to one 
quarter the rate in those not in treatment.
The most common form of OST is methadone maintenance 
treatment. Methadone has been used to treat heroin and 
other opiate dependence for decades. The more recently 
developed buprenorphine is also quite common in many 
countries. Both have been proved to make a major 
reduction in the risk of HIV infection by reducing the use 
of opioids and the sharing of drug injection, needles and 
syringes, and improving the health and quality of life of 
opiate-dependent people.
OST is, therefore, an effective strategy for preventing 
the transmission of HIV and hepatitis C. It should be 
implemented as soon as possible in prisons at high risk of 
HIV infection (38).
Before starting treatment, drug users must be provided 
with relevant information, especially about the risk of 
overdose and the potential risks of multiple drug use and 
interactions with other medications. They should also be 
informed about the primary physician’s obligations to the 
state, to the prison and to the prisoner (39).
Medication-assisted treatment for opioid dependence 
(OST – substitution treatment, agonist pharmacotherapy, 
agonist replacement therapy or agonist-assisted therapy) 
is defined as the administration under medical supervision 
of a prescribed opioid substance, pharmaceutically related 
to that producing dependence, to people with substance 
dependence so as to achieve defined therapeutic aims.
OST is a form of health care for heroin- and other opioid-
dependent people. It uses prescribed opioid agonists or 
partial agonists which have some properties similar to or 
identical with heroin and morphine in their action on the 
nervous system, alleviate withdrawal symptoms and block 
the craving for illicit opioids. Examples of opioid agonists 
are methadone, sustained-release morphine, codeine, 
buprenorphine (a partial agonist-antagonist) and, in some 
countries, diamorphine. Most of these substances, except 
for diamorphine, are characterized by a long duration of 
action and the absence of “rush” (Table 6).
Antagonists, which reverse the effects of opioids, are also 
used in treating opioid dependence. They occupy the same 
receptor sites in the brain as opioids and, therefore, block 
the effects of opioids. However, they do not stop craving. 
If a person takes an antagonist followed by an opioid, the 
euphoric effects of the opioid are nullified as they cannot 
act on the brain. If the antagonist, which has a higher 
affinity for opioid receptors, is taken after the opioid, an 
opioid-dependent person will go into opioid withdrawal 
(so antagonists are contraindicated for people who have 
not been detoxified from opioids). Naltrexone is the 
opioid antagonist most commonly used in treating opioid 
120
Prisons and health
Ta
bl
e 
6.
 S
ub
st
itu
tio
n 
ag
en
ts
 
M
ed
ic
at
io
n 
Fr
eq
ue
nc
y 
O
pt
im
al
 
Ro
ut
e 
of
 
O
ve
rd
os
e 
W
ith
- 
N
ot
es
 
 
 
re
co
m
m
en
de
d 
 
ad
m
in
is
tr
at
io
n 
 
ri
sk
 
dr
aw
al
 
 
 
do
se
 
M
et
ha
do
ne
Bu
pr
en
or
-
ph
in
e
Bu
pr
en
or
-
ph
in
e 
na
lo
xo
ne
 
(4
:1
 ra
tio
)
Su
st
ai
ne
d 
re
le
as
e 
m
or
ph
in
e
Di
am
or
-
ph
in
e
Le
vo
-a
lp
ha
-
ac
et
yl
-
m
et
ha
do
l
Le
vo
-
m
et
ha
do
ne
Co
de
in
e
Ev
er
y 
24
 
ho
ur
s
Ev
er
y 
24
 
to
 4
8 
or
 7
2 
ho
ur
s
Ev
er
y 
24
 
ho
ur
s
2–
3 
tim
es
 
ev
er
y 
24
 h
ou
rs
Ev
er
y 
4–
72
 
ho
ur
s
Ev
er
y 
24
 h
ou
rs
60
–1
20
 
m
g/
da
y
8–
24
 
m
g/
da
y
30
0–
12
00
 m
g/
da
y
40
0–
70
0 
m
g/
da
y
70
–1
20
 
m
g 
3 
tim
es
pe
r w
ee
k
40
–6
0
m
g/
da
y
Or
al
 (s
yr
up
, 
ta
bl
et
s)
 
In
je
ct
ab
le
Su
bl
in
gu
al
Or
al
 
(c
ap
su
le
s)
In
je
ct
ab
le
,
sm
ok
ea
bl
e
Or
al
Or
al
 (s
yr
up
)
Or
al
 (s
yr
up
, 
ta
bl
et
s)
++
+
+ (w
ith
 
ad
di
tio
na
l 
dr
ug
s)
++
+
++
+
++
+
++
+
++
++
+
+ ++
(+
)
++
+
++
+
++
+
++
+
Op
tim
al
 d
os
e 
le
ve
l d
ep
en
de
nt
 o
n 
su
bj
ec
t c
an
 b
e 
<6
0m
g 
or
 >
12
0m
g 
 
ac
co
rd
in
g 
to
 in
di
vi
du
al
 v
ar
ia
bi
lit
y
St
ar
t 6
–8
 h
ou
rs
 a
fte
r t
he
 la
st
 h
er
oi
n 
in
ta
ke
 o
r o
n 
ap
pe
ar
an
ce
 o
f w
ith
dr
aw
al
 
sy
m
pt
om
s.
 If
 th
e 
pe
rs
on
 w
as
 p
re
vi
ou
sl
y 
us
in
g 
m
et
ha
do
ne
, m
et
ha
do
ne
 h
as
 
to
 b
e 
ta
pe
re
d 
un
til
 3
0 
m
g/
da
y 
an
d 
bu
pr
en
or
ph
in
e 
ca
n 
be
 a
dm
in
is
te
re
d 
at
 4
8 
ho
ur
s 
af
te
r l
as
t m
et
ha
do
ne
 d
os
e 
or
 o
n 
ap
pe
ar
an
ce
 o
f w
ith
dr
aw
al
 s
ym
pt
om
s.
 
Pr
ov
id
ed
 in
 s
om
e 
co
un
tri
es
 w
he
n 
pr
ov
is
io
n 
of
 m
et
ha
do
ne
 o
r b
up
re
no
rp
hi
ne
 
is
 c
on
tra
in
di
ca
te
d 
or
 w
he
n 
th
es
e 
su
bs
ta
nc
es
 a
re
 n
ot
 to
le
ra
te
d 
(A
us
tra
lia
, 
Au
st
ria
, B
ul
ga
ria
, S
lo
ve
ni
a,
 S
w
itz
er
la
nd
 a
nd
 th
e 
Un
ite
d 
Ki
ng
do
m
).
On
ly
 le
ga
lly
 a
va
ila
bl
e 
to
 lo
ng
-te
rm
, n
on
-s
ta
bi
liz
ed
 o
pi
oi
d 
us
er
s 
in
 D
en
m
ar
k,
 
Ge
rm
an
y, 
th
e 
N
et
he
rla
nd
s,
 S
w
itz
er
la
nd
 th
e 
Un
ite
d 
Ki
ng
do
m
 w
hi
le
 in
 C
an
ad
a 
an
d 
Sp
ai
n 
it 
is
 p
er
m
itt
ed
 in
 th
e 
co
nt
ex
t o
f r
es
ea
rc
h 
tri
al
s 
on
ly.
 
N
ot
 a
va
ila
bl
e 
in
 th
e 
EU
, a
nd
 th
er
e 
ar
e 
co
nc
er
ns
 re
ga
rd
in
g 
sa
fe
ty
 (Q
Tc
  
in
te
rv
al
 e
xt
en
si
on
 in
 e
le
ct
ro
ca
rd
io
gr
am
) 
On
ly
 a
va
ila
bl
e 
in
 G
er
m
an
y
Av
ai
la
bl
e 
fo
r m
ai
nt
en
an
ce
 tr
ea
tm
en
t i
n 
Ge
rm
an
y
So
ur
ce
: a
da
pt
ed
 fr
ao
m
 V
er
st
er
 &
 B
un
in
g 
(4
0)
.
121
Drug treatment and harm reduction in prisons
dependence. Naloxone is only used for the emergency 
reversal of opioid overdose situations. Buprenorphine is a 
partial agonist-antagonist and is being used increasingly 
to treat opioid dependence. There are combinations of 
naloxone with buprenorphine (1:4 ratio) to prevent the 
abuse of the medication via injection.
The differences between OST (agonists) and blocking or 
aversion treatment (antagonists) are shown in Table 7.
OST is valuable because it provides an opportunity for 
dependent drug users to reduce their exposure to high-
risk behaviour and to stabilize themselves in health and 
social terms before they address the physical adaptation 
dimension of dependence. OST is generally considered for 
people who have difficulty in stopping their drug use and 
completing withdrawal.
It is desirable that medications used in OST have a longer 
duration of action, or half-life, than the drug they are replacing 
so as to delay the emergence of withdrawal symptoms and 
reduce the frequency of administration. This allows the 
person to focus on normal activities without the need to 
obtain and administer drugs. Further, prescribed medication 
for an illicit drug helps to break the connections with criminal 
activity while supporting the change in lifestyle.
Good-quality treatment should be:
•	 ongoing,	in	keeping	with	treatments	for	other	chronic	
illness (for example, antiviral/antiretroviral treatment 
and psychiatric comorbidities);
•	 able	to	address	the	multiple	problems	posing	a	risk	of	
relapse (such as physical and mental health disorders 
and social instability);
•	 well-integrated	into	society	to	permit	ready	access	for	
monitoring purposes and to forestall relapse.
Other characteristics of good models include:
Table 7. Differences between OST (agonists)and blocking or aversion treatment (antagonists)
OST                                                                      Blocking or aversion treatment
Agonists (methadone, levo-alpha-acetylmethol,  Antagonists (naltrexone and naloxone): 
long-acting	morphine	and	heroin):	 •	 block	the	action	for	opioids
•	 in	some	ways,	act	similarly	to	opioids	 •	 block	opioid	receptors
•	 stimulate	opioid	receptors	 •	 do	not	alleviate	or	stop	the	craving	for	opioids
•	 alleviate	or	stop	the	craving	for	opioids	 •	 do	not	produce	a	rush
•	 do	not	produce	a	rush	(except	diamorphine)	 •	 do	not	produce	physical	dependence
 can produce or maintain physical dependence 
•	 adequacy	of	the	time	available	for	treatment;
•	 availability	 of	 close	 links	 to	 community	 health	 and	
drug services, together with training provided for 
health and other treatment professionals;
•	 the	 extent	 to	 which	 the	 views	 of	 the	 prisoners	
themselves have been considered.
The main goals of OST
Although the ultimate goal of treatment may be to get 
people to stop using drugs, the main aims of OST are based 
on the concepts of public health and harm reduction. They 
are:
•	 to	 assist	 people	 to	 remain	 healthy	 until	 (with	 the	
appropriate care and support) they can achieve a drug-
free life; when they are stabilized, if they cannot or do 
not want to quit OST, they can remain in treatment for 
years or even for their lifetime;
•	 to	 reduce	 the	use	of	 illicit	 drugs	and	non-prescribed	
medications;
•	 to	deal	with	problems	related	to	drug	use;
•	 to	 reduce	 the	 dangers	 associated	 with	 drug	 use,	
particularly the risk of transmitting HIV, hepatitis B and 
C virus and other bloodborne infections from injecting 
and sharing injecting paraphernalia;
•	 to	reduce	the	chances	of	future	relapse	into	drug	use;
•	 to	reduce	the	need	for	criminal	activity	to	finance	drug	
use;
•	 when	 appropriate,	 to	 stabilize	 the	 person	 on	 a	
medication to alleviate withdrawal symptoms and 
craving;
•	 to	 improve	 overall	 personal,	 social	 and	 family	
functioning; and
•	 to	reduce	the	risk	of	drug-related	death,	particularly	at	
the time of release from prison.
In their 2004 common position paper, UNAIDS, UNODC 
and WHO stated the following:
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Substitution maintenance therapy is one of the most 
effective treatment options for opioid dependence. It can 
decrease the high cost of opioid dependence to individuals, 
their families and society at large by reducing heroin use, 
associated deaths, HIV risk behaviours and criminal activity. 
Substitution maintenance therapy is a critical component of 
community-based approaches in the management of opioid 
dependence and the prevention of HIV infection among 
injecting drug users. (41) 
Ample data support the effectiveness of OST in reducing 
high-risk injecting behaviour and the risk of contracting 
HIV (27–29). OST is the most effective treatment available 
for heroin-dependent injecting drug users in terms of 
reducing mortality (the death rate of people with opioid 
dependence in methadone maintenance treatment is one 
third to one quarter the rate of those not in treatment), 
heroin consumption and crime. Drug users are often 
heavily involved in crime before entering treatment, but 
after one year of methadone maintenance treatment, 
these levels go down by about half. The benefits are 
greatest during and immediately after treatment, but 
a significant improvement continues for several years 
after treatment. The reductions are most marked in drug-
related criminal behaviour.
Many of the concerns raised about OST have been shown to 
be unfounded. In particular, OST maintenance has not been 
shown to be an obstacle to ceasing drug use and, in fact, it 
is more effective than detoxification programmes in stopping 
people from using drugs illegally and keeping them in drug 
treatment programmes. Injecting drug users who do not enter 
treatment are up to six times more likely to become infected 
with HIV than those who enter and remain in treatment (42).
OST is a cost-effective method of treatment, comparing 
favourably in terms of cost-effectiveness with other health 
care interventions, such as therapy for severe hypertension 
or for HIV/AIDS. According to several conservative 
estimates, every euro invested in OST programmes may 
yield a return of between four and seven euros in reduced 
drug-related crime, criminal justice costs and theft. When 
savings related to health care are included, total savings 
can exceed costs by a ratio of 12:1.
Finally, people treated with OST who are forced to withdraw 
from methadone when they are incarcerated often return 
to narcotic use, often within the prison system and often 
via injection. It has, therefore, been widely recommended 
that prisoners who were in OST outside prison should be 
allowed to continue this treatment in prison (43).
In many countries, however, OST is unavailable or not 
widely enough available in prisons. Initially, OST was often 
only made available in prisons to inmates living with HIV 
or with other infectious diseases or to pregnant women. 
Provision generally remains inadequate and below the 
standards of OST in the community. In many countries, 
OST is still likely to be discontinued when people on 
treatment enter prison. A treatment gap persists between 
those requiring OST and those receiving it.
Some prison systems are reluctant to make OST available 
or to extend its availability to prisoners who were 
not receiving it before incarceration. Methadone or 
buprenorphine are sometimes viewed as just more mood-
altering drugs, delaying the personal growth necessary to 
move beyond a drug-centred existence. Some people also 
object to OST on moral grounds, arguing that it merely 
replaces one drug of dependence with another. Other 
reasons for resistance to OST include:
•	 the	fact	that	prisons	are	supposed	to	be	drug-free;
•	 the	 fear	 that	 the	 opioid	 medications	 used	 may	 be	
diverted and sold;
•	 a	 lack	 of	 understanding	 of	 drug	 dependence	 as	 a	
chronic disease;
•	 limited	space	and	lack	of	resources	and	staff	in	many	
prisons;
•	 the	cost	of	and	additional	organizational	tasks	required	
to implement it;
•	 anxiety	that	it	will	destabilize	the	prison.
If other reliable and effective methods could achieve 
enduring abstinence, OST could indeed be seen as 
inadequate. However, there are no such alternatives (44).
In recent years, evaluations of prison OST have provided 
clear evidence of its benefits. Studies have shown that, 
if dosage is adequate (at least 60–80 mg methadone or 
12–16 mg buprenorphine) and treatment is provided for 
the duration of imprisonment, such programmes reduce 
drug-injecting and needle-sharing and the resulting 
spread of HIV and other bloodborne infections. In addition, 
they have other worthwhile benefits, both for the health of 
prisoners participating in the programmes and for prison 
systems and the community.
•	 OST	positively	affects	institutional	behaviour	by	reducing	
drug-seeking and thus improving prison safety. Prison 
systems where OST is provided benefit by, among other 
things, reduced withdrawal symptoms on admission (often 
accompanied by self-harm or even suicide attempts), 
alleviation of anxiety upon entry, reduced trade in drugs 
and increased productivity among prisoners on OST.
•	 Re-offending	 is	 significantly	 less	 likely	 among	
prisoners who receive OST.
•	 Prisoners	on	OST	in	prison	are	significantly	more	likely	
to enter and remain in post-release treatment than 
those enrolled in detoxification programmes.
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•	 Although	 prison	 administrations	 often	 initially	 raise	
concerns about security, violent behaviour and 
diversion of prescribed drugs, these problems are 
less frequent than when substitution treatment 
programmes are absent.
•	 Both	prisoners	and	correctional	staff	report	how	OST	
positively influences life in prison.
•	 OST	 offers	 daily	 contact	 between	 the	 health	 care	
services in prison and the prisoners, a relationship 
that can serve as baseline for raising further health 
issues and links with other strategies for preventing 
HIV transmission.
•	 There	 is	 evidence	 that	 abrupt	 cessation	 of	 OST	
increases the risk of self-harm and suicide.
In addition, OST can help to reduce the risk of overdose 
(45). Many prisoners resume injecting once they are 
released but are at increased risk of a fatal overdose as a 
result of reduced tolerance for opioids. Extensive research 
has noted a large number of deaths during the first weeks 
post-release attributed to drug overdose. Following a 
United Kingdom study of 51 590 releases from prison (46), 
it has been estimated that approximately 35% of all male 
drug-related deaths and 12% of all female drug-related 
deaths are among prisoners recently released from 
prison custody. This points to the utility and necessity 
of throughcare (in prison and post-release) via drug 
treatment and OST to counteract such risky situations, 
and highlights the importance of OST as a strategy not 
only for preventing the transmission of HIV and hepatitis C 
in prisons but also for reducing overdose deaths after 
release.
Effective treatment
In order to be effective, OST, as any other type of 
treatment, must be: (i) based on the needs of prisoners; 
(ii) provided for the right period of time and at the right dose 
required by the individual; and (iii) provided continuously 
throughout imprisonment and following release.
As mentioned above, effective treatment has many 
benefits for individuals by helping them to stay alive, 
reducing the risk of infection (particularly from HIV and 
hepatitis), achieving abstinence or a stabilized pattern 
of use, stabilizing their social life, improving physical 
and mental health and reducing criminal activity. It also 
benefits society by improving public health, reducing 
emergencies and hospitalization, reducing the spread of 
HIV and other infectious diseases, reducing social welfare 
costs and reducing costs to the criminal justice system.
OST programmes vary in duration, dosage and scheme. 
Although much evidence (47) indicates that OST is more 
effective when higher dosages are prescribed on a 
maintenance basis, many programmes focus on short-
term detoxification with decreasing dosages.
In addition, distinguishing between low- and high-
threshold programmes is important. The distinctions can 
be broadly summarized as follows.
Low-threshold programmes:
•	 are	easy	to	enter;
•	 are	oriented	towards	harm	reduction;
•	 aim	 principally	 to	 relieve	withdrawal	 symptoms	 and	
craving and improve quality of life;
•	 offer	a	range	of	treatment	options.
High-threshold programmes:
•	 are	 more	 difficult	 to	 enter	 and	 may	 have	 selective	
intake criteria;
•	 are	 abstinence-oriented	 (which	 could	 include	
subsequent abstinence from OST medications);
•	 do	not	have	flexible	treatment	options;
•	 adopt	regular	(urine)	control;
•	 have	 an	 inflexible	 discharge	 policy	 which	 may	 lead	
to patients that continue using illegal drugs at the 
same time as the substitutes being excluded from 
the programmes; this would be against both medical 
ethics (because OST has been proved to be good for 
their health) and the rationale of OST, since its aim is 
precisely to help people suffering from illegal opioid 
use;
•	 may	include	compulsory	counselling	and	psychotherapy.
Low-threshold should not be regarded as synonymous with 
low-quality. In general, low-threshold programmes are 
more successful in serving harm reduction purposes for 
both addicted individuals and society, by rapidly engaging 
and keeping people in treatment. For those with a chaotic 
lifestyle due to their drug habits, such programmes are 
associated with better treatment outcomes and thus 
meeting the aims of OST.
Treatment criteria and treatment plan
OST should be restricted to people who meet the clinical 
criteria for opioid dependence. Restrictive regulations 
regarding the admission and inclusion criteria of OST 
are, however, counterproductive with regard to access to 
treatment and prevention of HIV and hepatitis transmission. 
Issues such as the maximum dose or maximum length 
of treatment should be left to the practitioner’s clinical 
judgment, based on the assessment of the individual.
In principle, everyone who is opioid-dependent and 
in need of treatment and expresses a desire for OST 
can be stabilized after appropriate assessment and 
start of treatment. It is, however, recommended that 
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the availability of treatment sites is taken into account 
when adopting admission criteria. Age, length of opioid 
addiction, physical and mental health and personal 
motivation of the opioid-dependent person should all be 
considered. Some groups, such as pregnant women or 
people living with HIV or other illnesses, should be given 
priority, although this should not entail compulsory HIV-
antibody testing. Furthermore, since release from prison 
is associated with an increase in drug-related deaths 
due to restart of drug use after a period of abstinence 
or reduced use (during which opioid tolerance may have 
been reduced), where resources are limited those about 
to be released from prison should be given priority for 
treatment.
Risks and limitations
The most significant risk with methadone and other 
opioid agonists is an overdose, which can be fatal. 
Research evidence (40) indicates that the highest risk of 
overdose is when OST is begun. Low doses are, therefore, 
recommended at the beginning of treatment with 
methadone. However, once a stable dose of methadone 
is settled (after about two weeks), the risk of overdose 
death is substantially reduced compared with the risk 
before treatment.
Buprenorphine as a partial agonist has less intrinsic 
activity than full agonists, and there is a plateau (ceiling) 
to dose–effect with much less possibility of overdose, 
allowing for a much faster reduction rate (two to three 
days).
Methadone
Methadone (methadone hydrochloride) is the predominant 
medication used for OST inside and outside prison in a 
majority of countries. It is a synthetic opioid agonist with 
an effect similar to that of morphine. Methadone is well-
absorbed from the gastrointestinal tract, irrespective 
of formulation (syrup versus tablet). It has very good 
bioavailability of 80–95%. The half-life of methadone 
is 24–36 hours, with considerable variations between 
individuals (10 to 80 hours). This pharmaceutical profile 
makes methadone useful as an OST medication, because 
it allows oral administration, single daily dosage 
and achievement of steady-state plasma levels after 
repeated administration, with no opioid withdrawal. 
Some patients experience side-effects, the most 
common being increased perspiration, constipation and 
sleep disturbances, reduced libido, reduced power of 
concentration and potential weight gain. Such undesirable 
side-effects generally occur at the beginning of treatment 
and decrease over time, although in some patients they 
can persist generally without medical consequences. 
Fewer than 20% of patients taking methadone therapy 
experience side-effects. Methadone is a safe medication 
with no lasting deleterious physical or physiological 
effects. Contrary to popular assumption, it has no directly 
damaging effects on bones or teeth (opioids do restrict 
saliva production, which in turn can lead to dental caries). 
For some patients, however, detoxifying from methadone 
might be very difficult and protracted. Methadone is a 
cheap medication; it is easy to deliver to the prisoner and 
the intake can easily be supervised. In most cases, little 
information is given to patients about the medication 
prescribed, possibly because the providers assume that 
experienced patients already know everything about the 
medication. However, this is not always the case.
Dosage
The general rule with dosing of methadone is to start low 
and go slow, but aim high.
•	 First,	do	no	harm:	estimates	of	degrees	of	dependence	
and tolerance are unreliable and should never be the 
basis for starting with high doses of methadone that 
could, if the estimation is wrong, cause overdose.
•	 There	is	no	moral	value	associated	with	either	high	or	
low doses.
•	 Methadone	should	not	be	given	as	reward	or	withheld	
as punishment.
•	 Doses	should	be	 increased	and	decreased	gradually.	
Both for safety and comfort, smaller changes (such as 
5 mg at a time) at wider intervals (such as every five 
days) should be made for people on less than 60 mg a 
day, whereas larger and more frequent changes (such 
as 10 mg every three days) will generally be safe at 
higher levels.
•	 In	general,	higher	maintenance	doses	are	associated	
with better therapeutic outcomes than are lower 
doses. The optimal range for most people is 60–120 mg 
per day.
•	 When	 there	 are	 subjective	 complaints	 of	 the	
methadone “not holding”, the daily dose could be 
divided or increased. This may be particularly relevant 
for women who are pregnant and/or receiving ART.
Buprenorphine
Buprenorphine is a partial opioid agonist with weaker 
opioid agonist activity than methadone. Buprenorphine is 
not well-absorbed if taken orally, and the usual route of 
administration in treating opioid dependence is, therefore, 
sublingual. With increasing doses of buprenorphine, the 
opioid effect reaches a plateau, so it is less likely than 
either methadone or heroin to result in opioid overdose, 
even when taken with other opioids at the same time. 
The effectiveness of buprenorphine is similar to that 
of methadone at adequate doses in terms of reduction 
in illicit opioid use and improvements in psychosocial 
functioning. Buprenorphine may, however, be associated 
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with lower rates of staying in treatment. It is currently 
more expensive than methadone.
Buprenorphine is acceptable to heroin users, has few side-
effects and is associated with a relatively mild withdrawal 
syndrome. When used in OST for pregnant women with 
opioid dependence, it appears to be associated with a 
lower incidence of neonatal withdrawal syndrome.
A combination product of buprenorphine with a small 
amount of naloxone (4:1 ratio) has been developed to reduce 
potential diversion and misuse of the drug. Naloxone is poorly 
absorbed sublingually, which limits its pharmacological 
effect. If the tablet is crushed and used intravenously by 
an opioid-dependent person, the naloxone is bio-available 
and can precipitate severe opioid withdrawal, which can 
potentially deter further such abuse by this route.
Sustained-release morphine
Sustained-release morphine is seen as a valuable 
contribution to OST in some countries (Australia, Austria, 
Bulgaria, Slovenia, Switzerland and the United Kingdom). 
Some studies have reported that oral sustained-release 
morphine leads to improved well-being for its recipients 
compared to those receiving methadone maintenance 
due to a better side-effect profile. In particular, sustained-
release morphine is easy to use (once daily), and the users 
report better concentration, no major mood disturbances, 
no weight gain and a better sexual drive.
Dosing and supervision of intake
There is no such thing as an average dose. Dosage should 
be part of the doctor–patient relationship and adjusted 
according to individual needs. The dose needs to be at a 
level that can reduce craving and block the use of heroin 
to produce euphoria. Prisoners should be informed of their 
dose unless they specifically request not to know.
Either nurses or guards can supervise the ingestion of the 
(liquid or solid) methadone, depending on how and where 
the medication for OST is dispensed: either within the 
medical unit or on the cells/wards. This is to ensure that 
the substance is swallowed (methadone) or diluted under 
the tongue (buprenorphine) completely.
There is a consensus that the administration of OST 
(as well as other psychoactive substances) must be 
supervised to make sure that the medication has been 
used correctly, to avoid coercion to sell or divert it, and 
to avoid overdoses in prisoners with no opioid tolerance.
Antagonist treatment: naltrexone
If a prisoner abstains from opioid drugs, therapy with 
naltrexone can be started in prison or prior to release. 
Naltrexone is a pure opioid antagonist and, as such, is 
often not considered an OST medication. It has, however, 
received considerable attention when used for ultra-rapid 
detoxification under general anaesthesia, a practice that 
is not without risk to the patient. In addition to its use 
as a rapid detoxification agent, naltrexone has been used 
for decades as a longer-term blocking agent (full opiate 
antagonist) in maintenance treatment.
Naltrexone may be used as part of relapse prevention 
programmes. A single maintenance dose of naltrexone 
binds to opioid receptor sites in the brain and blocks the 
effects of any opioid taken for the next 24 hours, or it can 
be taken in a double/triple dose three times a week. It 
produces no euphoria, tolerance or dependence. Patients 
generally require 5–10 days of abstinence before starting 
naltrexone (the length of abstinence depends on the 
length of half-life of the opioid that was regularly taken 
prior to starting naltrexone).
A Cochrane review on the effectiveness of naltrexone 
maintenance treatment (48,49) did not find evidence for 
its effectiveness in maintenance therapy. A trend in favour 
of treatment with naltrexone was, however, observed for 
certain target groups (especially people who are highly 
motivated).
Medication-assisted treatment of opioid 
dependence in prisons
Initiation of OST in prisons
Historically there has only been limited availability of 
OST in prisons. The principle of equivalence with health 
care offered in community settings would, however, 
suggest that OST should be available and accessible to 
all prisoners according to their health needs. Since many 
prisoners experience immediate relapse after release they 
should have an informed choice of either detoxification or 
maintenance.
Given the often relapsing/remitting nature of opioid 
dependence, detoxification alone is only effective in 
producing a long-term change for a minority of users. The 
benefits of OST programmes can be maximized by:
•	 keeping	people	in	treatment;
•	 prescribing	 higher	 rather	 than	 lower	 doses	 of	
methadone;
•	 orienting	 programmes	 towards	 maintenance	 rather	
than abstinence;
•	 offering	 counselling,	 assessment	 and	 treatment	 of	
both psychiatric co-morbidity and social problems;
•	 using	 and	 strengthening	 the	 therapeutic	 alliance	
between clinician and patient to reduce the use of 
additional drugs.
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There are three scenarios where it may be appropriate to 
start users on opioid maintenance in prison as the first 
stage of OST. These are: immediately upon admission 
to prison, during incarceration and for a period before 
release.
As mentioned above, there is an extremely high risk for 
prisoners using drugs to relapse and take an overdose 
shortly after release. Overdoses on release and suicides 
in prisons were key elements in some countries for 
integrating OST into prison health care services. In order to 
avoid relapse and overdose on release, it is recommended 
that the prisoner be kept on a stable dose until he or she 
is released.
Overdoses on release and suicides in prisons were also 
key drivers in some countries to use OST in prisons (50).
Detoxification
Some drug-users manage to abstain permanently while in 
prison, although detoxification alone is seldom effective in 
producing a long-term change for the majority of drug-users.
Institution-related factors militating against continued 
abstinence are a lack of resources and/or personnel 
resulting in a limitation on the availability of treatment 
places, lack of knowledge, lack of supporting regulations 
and guidelines, dependence on the development of OST 
in the community, opposition to OST in prisons and a 
restrictive OST policy in the local community.
Relapses after detoxification are extremely common and 
detoxification on its own rarely constitutes adequate 
treatment for substance dependence. The options include 
managing withdrawal on admission in the form of gradual 
detoxification or moving to abstinence-oriented treatment 
or maintaining long-term substitution. Interventions that are 
client-centred and personalized have the best outcomes.
Urine controls
Urine analysis has been much debated in this field. 
Although urine controls are a vital part of the initial 
medical assessment of the patient (for confirmation that 
the patient is actually using opiates), they are often used 
as a form of control over patients to monitor for illicit drug 
use. Many professionals question the effectiveness of 
urine analysis as a positive factor in treatment.
It is also argued that a positive urine sample should never 
be the sole reason for discontinuing treatment, as this is 
part of the condition for which the patient is being treated.
OST should never be a reward for good behaviour or 
withheld as punishment, but rather administered as a 
normal part of a variety of medical and psychosocial 
treatments.
Psychosocial care
A combination of physical, psychological and social 
experiences contributes to the complexity of drug 
dependence. To treat the disease successfully and 
overcome drug dependence, it is necessary to address 
both the physical and psychosocial dimensions of the 
disease (27). For many dependent drug-users this may 
entail substantial physical, psychological and lifestyle 
adjustments – a process that typically requires a lot of 
time. OST must not only treat the opioid addiction but also 
deal with mental and physical health and social problems. 
Psychosocial care is, therefore, regarded as an additional 
and necessary part of treatment in support of the medical 
part of OST in prison.
Personalized patient care in prisons can be a significant 
challenge. A personalized treatment plan should be drawn 
up with the patient and regularly evaluated.
Polyvalent drug use
Clear and transparent protocols and guidelines should be 
in operation regarding the use of other drugs prisoners 
may have been using. In particular, benzodiazepines, 
barbiturates and alcohol may pose severe health risks for 
patients on OST. In these cases, the continuity of OST should 
be thoroughly discussed, case by case. The options should 
ideally be considered by a multidisciplinary team and (if one 
is available) with the prison drug counselling service. Future 
plans and goals should be decided and agreed, including 
increasing the dose of OST medication and psychosocial 
therapy and possibly even discontinuing OST.
Continuing OST between the community and prison 
The medication of patients who are on OST prior to 
imprisonment should be continued in prison, although 
there are many barriers to such continuity of care. The 
most significant barrier is that maintenance therapy is 
interrupted for many patients if they spend time in police 
custody prior to prison. This can result in significant loss 
of opioid tolerance. Wherever possible, users should 
continue their opioid maintenance therapy at their 
prescribed dose while in police custody.
The high numbers of users requiring treatment in prison, 
where the supply of illicit drugs is markedly reduced, can 
mean that the protocols and practices of OST are oriented 
more to the institution’s governance requirements than 
to each patient’s needs and wishes. For instance, it 
takes approximately five minutes for the supervised 
administration of buprenorphine (sublingual). This is both 
time-consuming and allows for the potential diversion 
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of the medication, so methadone is often prescribed 
as the first-line medication in prisons. Since some 
users could perceive this as not being equivalent to the 
treatment offered in the community, the replacement of 
one substitution drug with another for the newly arrived 
prisoner obviously needs to be clearly communicated to 
him/her and is not recommended.
OST in the criminal justice system
OST should be available at all stages of the criminal 
justice system if it is available at the community level and 
should be started and/or continued from arrest to release 
and afterwards.
It may also play an important role in police detention and 
pre-trial detention institutions. People addicted to heroin 
or other opioids who are arrested and taken into police 
detention can face severe withdrawal symptoms.
OST should be offered as a form of throughcare, providing 
stability in the physical and mental health of offenders 
as well as in terms of overdose prevention. The risk of 
overdose after a short period of detoxification rises, as 
opioid addicts lose their opioid tolerance within days. The 
effect of OST on reducing suicide risk has not been studied 
but a positive impact is thought to be likely whether in 
prisons, remand facilities or police detention. Moreover, 
the risk of relapse increases during home leave, holidays 
and so on.
Special considerations for women
Women tend to experience both drug dependence and 
treatment differently from men. Major issues are related 
to the high levels of both physical and mental co-morbidity 
of women with opioid dependence, which need to be 
taken into account in their treatment. Women with opioid 
dependence often face a variety of barriers to treatment, 
including a lack of financial resources, absence of services 
and referral networks oriented to women and conflicting 
child-care responsibilities.
Effective OST can substantially improve obstetric, prenatal 
and neonatal outcomes. OST also has an important role in 
attracting and keeping pregnant women in treatment and 
ensuring good contact with the obstetric and community-
based services, including primary care.
Harm reduction programmes
Definition of harm reduction
In their broadest sense, harm reduction policies, 
programmes, services and action work to reduce the 
health, social and economic harms to individuals, 
communities and society that are associated with the use 
of drugs (51). The Status paper on prisons, drugs and harm 
reduction (21) defined harm reduction measures in prisons 
as follows: 
In public health relating to prisons, harm reduction describes 
a concept aiming to prevent or reduce negative health 
effects associated with certain types of behaviour (such as 
drug injecting) and with imprisonment and overcrowding as 
well as adverse effects on mental health.
Harm reduction acknowledges that many drug users 
cannot totally abstain from using drugs in the short term 
and aims to help them reduce the potential harm from 
drug use, including through assistance to stop or reduce 
the sharing of injecting equipment so as to prevent the 
transmission of HIV or hepatitis which, in many ways, is 
an even greater harm than drug use. A harm reduction 
approach recognizes that a valid aim of drug interventions 
is to reduce the relative risks associated with drug misuse.
In addition, the definition adopted by WHO acknowledges 
the negative health effects of imprisonment (51). These 
include the impact on mental health, the risk of suicide 
and self-harm, the need to reduce the risk of drug overdose 
on release and the harm resulting from inappropriate 
imprisonment of people who in fact require facilities 
unavailable in prison, especially when overcrowded.
All drug treatment services, both residential and 
community-based, should incorporate a distinct harm 
reduction element to reduce the spread of bloodborne 
viruses and risk of drug-related deaths, notably deaths 
from overdose (15). Specific harm reduction interventions 
include:
•	 advice	 and	 information	 to	 prevent	 transmission	 of	
bloodborne viruses (particularly hepatitis A, B and C 
and HIV) and other infections related to drug use;
•	 vaccination	for	hepatitis	B;	
•	 access	to	testing	and	treatment	for	hepatitis	B	and	C	
and HIV/AIDS; 
•	 counselling	 related	 to	 HIV/hepatitis	 testing	 (pre-and	
post-test);
•	 advice	and	support	on	preventing	the	risk	of	overdose;
•	 risk	 assessment	 and	 referral	 to	 other	 treatment	
services;
•	 needle	 exchange	 services,	 that	 is,	 the	 provision	 and	
disposal of needles and syringes and other clean 
injecting equipment (such as spoons, filters and citric 
acid) in a variety of settings;
•	 advice	 and	 (peer)	 support	 on	 safer	 injection	 and	
reducing injecting, and reducing the initiation of 
others into injecting;
As shown above, many prisoners continue to use drugs in 
prison, and some people start using and injecting drugs 
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while in prison. Despite often massive efforts to reduce 
the supply of drugs, the reality is that there is a demand 
and drugs can and do enter prisons.
In prisons, as in the community, harm reduction measures 
have been successfully implemented during the past 20 
years throughout Europe as a supplementary strategy to 
existing programmes oriented to drug-free treatment. 
Harm reduction does not replace the need for other 
interventions but adds to them, and should be seen as 
a complementary component of wider health promotion 
strategies. The following hierarchy of goals should guide 
drug policy, in prisons as outside:
•	 securing	survival;
•	 securing	 survival	 without	 the	 person	 contracting	
irreversible damage;
•	 stabilizing	the	addict’s	physical	and	social	condition;	
•	 supporting	 people	 dependent	 on	 drugs	 in	 their	
attempts to lead drug-free lives.
Harm reduction has been addressed in Risk reduction for 
drug users in European prisons, which has been translated 
into and adapted to seven European languages (52). The 
major objectives of this book are:
•	 to	 raise	awareness	of	health	problems	connected	 to	
drug use and drug-related infectious diseases;
•	 to	initiate	and	support	a	discussion	about	risk	reduction	
in response to these health problems;
•	 to	contribute	to	knowledge,	skills	and	insight	into	the	
problems and encourage a positive attitude towards 
risk reduction activities by both inmates and personnel;
•	 to	 disseminate	 information	 relevant	 for	 health	
promotion by a range of means;
•	 to	 stimulate	 and	 support	 the	 carrying	 out	 of	 risk	
reduction activities for both inmates and staff.
The book also contains information for prison staff about 
health and workplace safety, drugs, addiction, infectious 
diseases and the services needed. Interactive material 
about risk situations and risky conditions in prisons has 
been included for inmates.
Provision of disinfectants
The provision of bleach or other disinfectants to 
prisoners is an option to reduce the risk of transmission 
of bloodborne viruses through the sharing of injection 
equipment, particularly when sterile injection equipment 
is not available. Many prison systems have adopted 
programmes that provide disinfectants to prisoners who 
inject drugs as well as instructions on how to disinfect 
injecting equipment before reusing it. Evaluations of such 
programmes have shown that it is feasible to distribute 
bleach in prisons and does not compromise security (53–
56). Studies in the community have, however, raised doubts 
about the effectiveness of bleach in decontaminating 
injecting equipment. Today, disinfection as a means of 
preventing HIV is regarded only as a second-line strategy 
to syringe exchange programmes. Cleaning guidelines 
recommend that injecting equipment should be soaked 
in fresh full-strength bleach (5% sodium hypochlorite) 
for a minimum of 30 seconds. More time is needed for 
decontamination if diluted concentrations of bleach are 
used. Further, a review of the effectiveness of bleach in 
the prevention of hepatitis C infection concluded that 
“although partial effectiveness cannot be excluded, the 
published data clearly indicates that bleach disinfection 
has limited benefit in preventing [hepatitis C virus] 
transmission among injection drug users” (57). In prisons, 
the effectiveness of bleach as a decontaminant may be 
even further reduced.
Needle and syringe exchange programmes
In the community, needle and syringe exchange 
programmes are widely available in many countries 
and have been proved to be the most effective measure 
available to reduce the spread of HIV and hepatitis through 
the sharing of contaminated injecting equipment. In 
prisons, however, needle and syringe programmes remain 
rare, although they have been successfully introduced 
in about 70 prisons in a growing number of countries 
including Germany, Kyrgyzstan, Luxembourg, the Republic 
of Moldova, Romania, Spain, Switzerland and Tajikistan. 
Evaluations of existing programmes (56,58,59) have 
shown that they:
•	 do	not	endanger	staff	or	prisoner	safety,	and	 in	 fact	
make prisons safer places to live and work;
•	 do	not	increase	drug	consumption	or	injecting;
•	 reduce	risk	behaviour	and	the	transmission	of	disease,	
including HIV and hepatitis C virus;
•	 have	 other	 positive	 outcomes	 for	 the	 health	 of	
prisoners, including a drastic reduction in overdoses 
(reported in some prisons) and increased referral to 
drug treatment programmes;
•	 have	been	effective	in	a	wide	range	of	prisons;
•	 have	 successfully	 employed	 different	 methods	 of	
needle distribution to meet the needs of staff and 
prisoners in a range of prisons; and
•	 have	 been	 successfully	 used	 in	 prisons	 alongside	
other programmes for preventing and treating drug 
dependence.
When prison authorities have any evidence that injecting 
is occurring, they should introduce needle and syringe 
programmes, regardless of the current prevalence of HIV 
and the hepatitis infection rate.
Despite the massive overrepresentation of injecting drug 
users in custodial settings worldwide, the availability 
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of harm reduction measures in prisons lags far behind 
the availability of these interventions in the general 
community. Illustrating this gap most vividly is the provision 
– or lack – of needle and syringe programmes. In 2007, for 
instance, the Commission of the European Communities 
found that although 24 of the EU member states had 
needle and syringe programmes in the community, only 3 
of those countries had introduced them into prisons. This 
disparity led the Commission to conclude the following: 
Harm reduction interventions in prisons within the European 
Union are still not in accordance with the principle of 
equivalence adopted by United Nations General Assembly, 
UNAIDS/ WHO and UNODC, which calls for equivalence 
between health services and care (including harm reduction) 
inside prison and those available to society outside prison. 
Therefore, it is important for the countries to adapt prison-
based harm reduction activities to meet the needs of drug 
users and staff in prisons and improve access to services. 
(60)
The Commission’s findings were recently confirmed, and 
expanded upon, in a 2008 report from the Regional Office 
which monitored Member States’ progress in achieving 
the goals of the Dublin Declaration (61). This report 
found that, of the 53 signatory countries, condoms were 
available in prisons in only 18, substitution treatment in 17 
and syringe exchange programmes in 6 (61,62). A review 
by the International Harm Reduction Association in 2009 
found the situation had only marginally improved, with 9 
countries in Europe and central Asia having introduced 
syringe exchange in prisons and 28 with substitution 
treatment (63).
Transferring harm reduction strategies into the 
prison setting
Despite the evidence that prisons can successfully 
introduce harm reduction measures, with positive results 
for prisoners, staff and ultimately for the community, many 
are still afraid that introducing such measures would send 
the wrong message and make illicit drugs more socially 
acceptable. Many prisoners are in prison because of drug 
offences or because of drug-related offences. Preventing 
their drug use is an important part of their rehabilitation. 
Some have said that acknowledging that drug use is a 
reality in prisons would be acknowledging that prison staff 
and prison authorities have failed. Others say that making 
needles and syringes available to prisoners would mean 
condoning behaviour that is illegal in prisons. However, 
since HIV and hepatitis B and C seriously threaten prisons 
and communities, harm reduction measures must be 
introduced to protect public health. Making available to 
prisoners the means necessary to protect them from the 
transmission of HIV and hepatitis C virus does not mean 
condoning drug use in prisons. Introducing needles and 
syringes is not incompatible with a goal of reducing drug 
use in prisons. Making needles and syringes available to 
drug users has not increased drug use but has reduced the 
number of injecting drug users contracting HIV and other 
infections.
Involvement of community services
In the past decade, there have been new approaches 
aiming to divert individuals away from prison and into 
treatment alternatives as well as (for prisoners) into 
a range of services in prisons. Specific legislation in 
several countries has been introduced with the purpose 
of enhancing links between the criminal justice system 
and health services to reduce the number of drug users 
entering prison. Despite these developments, the number 
of prisoners with drug dependence has continued to grow. 
As drug users often serve short sentences, they return 
to their communities and many return to their old drug-
using habits. Support services need to be continued in 
order to sustain successes achieved while in custody. This 
indicates that criminal justice agencies need to improve 
their links with drug services.
Pre-release units
Prisoners should begin to be prepared for release on the 
day the sentence starts, as part of the sentence planning 
process. All staff should be involved in preparing prisoners 
for release. Good release planning is particularly important 
for drug-using prisoners. The risks of relapse and overdose 
are extremely high. Measures taken in prison to prepare 
drug-using prisoners for release include:
•	 implementing	measures	to	get	prisoners	off	drugs	and	
keep them drug-free after release;
•	 granting	 home	 leave	 and	 conditional	 release,	
integrated into treatment processes;
•	 cooperating	with	external	drug	services	or	doctors	in	
planning a prisoner’s release;
•	 involving	self-help	groups	in	the	release	phase;	and
•	 taking	 effective	 measures	 (such	 as	 the	 provision	 of	
naloxone and training) in prison to prevent prisoners 
dying of a drug overdose shortly after release.
The challenge for prison services in facilitating a 
successful return to the community is not only to treat a 
drug problem, but also to address other issues including 
employability, educational deficits and the maintenance 
of family ties.
Many prisons undertake efforts to reduce relapse and 
to provide social reintegration. Protocols are sometimes 
set up with drug treatment centres from the national and 
community health networks. In Portugal, for instance, 
some projects focus on preparing for freedom and that 
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getting a life means getting a job. Peer groups have been 
developed to support treated drug addicts to prevent 
relapse.
Aftercare
Several studies show that effective aftercare for drug-
using prisoners is essential to maintain gains made in 
prison-based treatment (64, pp.223–231). Nevertheless, 
prisoners often have difficulty in accessing assessments 
and payment for treatment on release under community 
care arrangements. In view of the increased risk of 
overdose deaths, especially the first two weeks after 
release, it is important to prepare prisoners with drug 
problems about the risk of overdose and to ensure the 
close follow-up of released prisoners with any drug 
problems (65).
Therapy instead of punishment
Several countries have legal provisions for suspending 
the sentences of drug users. In Sweden, Section 34 of 
the Prison Treatment Act states that a prisoner may be 
permitted – while still serving the prison sentence – to 
be placed in a treatment facility outside prison. This is not 
by definition a suspended sentence: it is an alternative 
to staying in prison until release. Another possibility 
is that the court sentences a person to probation with 
contract treatment. This is possible when there is a clear 
connection between drug abuse and crime. The person 
has to accept and give consent to treatment instead of 
prison. If the person interrupts or neglects the treatment, 
the contract treatment will be interrupted and converted 
into a prison sentence.
In Germany, Section 35 of the Opium Law allows prisoners 
to undergo treatment instead of punishment when the 
sentence is no more than two years.
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15. Alcohol and prisons 
Lesley Graham
Key points 
•	 The	 harmful	 use	 of	 alcohol	 is	 a	major	 public	 health	
problem in Europe.
•	 The	 link	 between	 alcohol	 and	 crime,	 particularly	
violent crime, is strong.
•	 The	 prevalence	 of	 alcohol	 problems	 in	 prisoners	 is	
high.
•	 The	prison	setting	is	an	opportunity	to	detect	and	treat	
those who are hard to reach.
•	 Delivering	 interventions	 for	 alcohol	 problems	 in	
prisoners has the potential to reduce alcohol problems, 
reduce re-offending and tackle health inequalities.
Introduction
Health problems in prisoners mirror and often magnify 
those of the wider population. The same is true for alcohol 
problems.
Alcohol in Europe 
Alcohol is a psychoactive, toxic and potentially addictive 
substance (1). It is a causal factor in over 60 diseases and 
injuries and accounted for 6.4% of all deaths in the Region in 
2004 (2). Some consequences, such as intoxication or injury, 
are acute while others, such as liver disease and cancers, 
result from longer-term consumption. As well as the impact 
on individuals, the consequences of alcohol consumption 
may result in harm to others, such as drink–driving (3).
In most European countries, the drinking of alcohol is 
common in the adult population, with 80–95% drinking at 
least occasionally (4). Over the past two decades average 
population consumption has been stable, although in 
countries such as France and Italy there has been a 
decrease and in others (Estonia, Ireland and the United 
Kingdom) levels have been rising (5). Average population 
consumption is linked to the number of heavy drinkers and 
to the levels of alcohol-related harm (1). In 2004, the one-
year prevalence of alcohol use disorders (alcohol problems 
which can be defined as hazardous drinking, harmful use 
or dependency (6)) in the Region was 1 in 20 (5.5%), with 
a higher proportion in men (9.1%) (2).
Alcohol and crime
The link between alcohol and crime, particularly violent 
crime, is strong and evident in all European countries. 
Alcohol-related crime is both common and costly. In 2003, 
alcohol-related crime in Europe was estimated to cost 
€33 billion (7).
Table 8 shows the percentage of all crimes and violent 
crimes related to alcohol in selected European countries. 
As there is no standardized definition of alcohol-related 
crime, caution should be taken in drawing comparisons.
Alcohol-related crime can be described in three broad 
categories: (i) where there is a direct causal relationship 
(alcohol-specific offences such as drunk–driving and 
drunkenness); (ii) where alcohol is a contributory factor 
(with alcohol a trigger or facilitator to offending, for 
example, assault, antisocial behaviour); and (iii) where 
there is a co-existent relationship (the offender’s alcohol 
consumption has no relation to the crime) (8).
The relationship between alcohol and crime is not, 
therefore, a simple causal one. With regard to violence 
where alcohol is recognized as a contributory factor, 
theoretical models based on empirical evidence have 
grouped factors into the following four broad areas (9):
Source: Anderson & Baumberg (7).
Table 8. All alcohol-related crimes and violent crimes in selected European countries (%)
Country Alcohol-related crime (%) Alcohol-related violent crimes %)
Belgium 20 40
Finland 47 66
Germany 7 24
United Kingdom (England and Wales) 25 48
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•	 physical	 and	 psychological	 effects	 of	 alcohol	 on	 the	
individual:
 − reduced impulse control and impaired motor 
functioning;
 − impaired cognition, less self-reflection, impaired 
ability to process multiple cues and solve problems;
 − alcohol-induced myopia (short-sighted focus on 
the immediate situation);
 − greater willingness to take risks;
•	 personal	characteristics:
 − impulsiveness;
 − frustration;
 − anxiety;
 − drinking patterns;
•	 situational	context	within	which	alcohol	is	consumed:.
 − poor layout of bars with increased likelihood of 
crowding;
 − low staff-to-patron ratio;
 − encouragement to drink large quantities;
•	 cultural	context:
 − acceptance of public drunkenness;
 − acceptance of violence;
 − unstructured drinking; 
 − beliefs about personal responsibility when drunk.
Measures to tackle alcohol-related crime need to include 
interventions at the level of the individual as well as 
broader interventions aimed at the social, physical and 
cultural environments.
Alcohol problems in prisoners
The prevalence of alcohol problems in prisoners is 
high, although the evidence base to date is limited. An 
international systematic review found that 18–30% of men 
and 10–24% of women prisoners had alcohol problems, 
but the studies were noted to be heterogeneous (10). In 
the United Kingdom (Scotland) in 2011, 50% of prisoners 
reported that they were drunk at the time of their offences, 
an increase of 10% over the previous 5 years (11). Nearly 
half (48%) said they would accept help for their alcohol 
problems if it was offered in the prison. Further Scottish 
research found that 73% of prisoners had an alcohol-use 
disorder, with 36% possibly being alcohol-dependent (12). 
A further breakdown showed differences, with younger 
drinkers less likely to show habitual and addictive forms 
of behaviour, which is of importance for the delivery of 
appropriate interventions (13).
The prison setting is an opportunity to detect, intervene or 
direct into treatment prisoners who have alcohol problems 
which may or may not be directly linked to their offences 
but who are often hard to reach. Prisoners often come 
from disadvantaged areas where alcohol mortality can 
be disproportionately high. Tackling alcohol problems in 
prison has the potential not only to reduce such problems 
but also to reduce health inequalities and re-offending.
Effective detection
The first step in addressing an alcohol problem in a prisoner 
is to be able to identify it. The routine taking of a clinical 
history can be augmented through the use of a validated 
alcohol screening tool, although there is limited evidence 
of the testing of screening tools in the prisoner population. 
A rapid literature review identified three screening tools as 
having good validity and reliability in offending populations, 
although no single tool was identified as superior (12). The 
WHO Alcohol Use Disorders Identification Test (AUDIT) 
screening tool (14) (Table 9) was considered to be the most 
promising, although more than one screening tool may be 
required for this diverse population. One small-scale study 
has shown that the timing of the screening may be relevant: 
screening immediately on reception into prison, a time of 
competing demand and stress, is perhaps less effective 
(15). 
Effective interventions
Interventions for alcohol problems need to be effective for 
the type of alcohol problem identified. They can range from 
brief interventions for hazardous drinking, to cognitive-
behavioural approaches for more harmful and dependent 
drinkers, to pharmaceutical treatment for acute alcohol 
withdrawal or prevention of relapse. Current evidence about 
effective interventions in the prisoner population is limited 
as many studies conflate alcohol and drug problems, making 
it difficult to identify alcohol-specific outcomes. There is 
evidence of the effectiveness of therapeutic communities, 
but only for those with alcohol and drug problems, and they 
can be costly and time-intensive to provide. The highest 
quality evidence base is that for alcohol brief interventions. 
Some studies have been conducted in the wider offender 
population but the effectiveness of these interventions 
in prisons has yet to be established (12). There is some 
limited evidence that alcohol interventions can reduce re-
offending (16). Further details about interventions targeting 
prisoners with an alcohol problem can be found in the WHO 
publication Alcohol problems in the criminal justice system: 
an opportunity for intervention (17).
Integrated care
The detection and treatment of, and interventions for, 
alcohol problems in prisons are optimized when delivered 
with an integrated, person-centred approach. What care is 
delivered by whom, when and where can be mapped out 
in an alcohol care pathway. This enables care delivery to 
be seen as a whole system, promoting appropriate access 
and continuity of care. The key elements should include 
screening on arrival, detoxification for those in need, triage, 
a range of effective interventions and throughcare (12).
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Table 9. The WHO Alcohol Use Disorders Identification Test (AUDIT): interview version
1. How often do you have a drink containing alcohol?
(0) Never [Skip to questions 9–10]
(1) Monthly or less
(2) 2–4 times a month
(3) 2–3 times a week
(4) 4 or more times a week
2. How many drinks containing alcohol do you have on a 
    typical day when you are drinking?
(0) 1 or 2
(1) 3 or 4
(2) 5 or 6
(3) 7, 8 or 9
(4) 10 or more
3. How often do you have six or more drinks on one  
    occasion?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
     [Skip to questions 9 and 10 if total score for questions  
     2 and 3 = 0]
4. How often during the last year have you found that you  
    were not able to stop drinking once you had started?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
5. How often during the last year have you failed to do  
    what was normally expected from you because of  
    drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
6. How often during the last year have you needed a 
    first drink in the morning to get yourself going after 
    a heavy drinking session?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
7. How often during the last year have you had a  
    feeling of guilt or remorse after drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
8. How often during the last year have you been  
    unable to remember what happened the night  
    before because you had been drinking?
(0) Never
(1) Less than monthly
(2) Monthly
(3) Weekly
(4) Daily or almost daily
9. Have you or someone else been injured as a result  
    of your drinking?
(0) No
(2) Yes, but not in the last year
(4) Yes, during the last year
10. Has a relative or friend or a doctor or another  
      health worker been concerned about your drinking 
      or suggested you cut down?
(0) No
(2) Yes, but not in the last year
(4) Yes, during the last year
Issues and challenges with alcohol  
problems in prisons
Alcohol services in prisons, as with all prison health 
delivery, take place within the constraints of a custodial 
regime where security and order are necessary. Prisons 
can often be overcrowded and with a high turnover that 
can make access to treatment and continuity of care more 
difficult to achieve. Many prisoners have other complex 
needs, such as drug misuse and mental health problems, 
which can make treatment all the more challenging. 
Literacy problems can limit understanding of, for example, 
health education materials, or make self-referral to 
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services difficult if this has to be by written request. On first 
arrival, the absence of alcohol in the prison environment 
and other pressures can mask alcohol problems, except 
in the case of those who develop alcohol withdrawal 
symptoms. Prisoners can also be unwilling to admit to 
alcohol problems at any point in their incarceration. On 
release, there is the risk of relapse into previous drinking 
behaviour as prisoners return to their communities.
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16. Tobacco use in prison settings: a need for policy  
implementation 
Michelle Baybutt, Catherine Ritter, Heino Stöver
Key points 
•	 Tobacco	is	the	psychoactive	substance	most	widely	used	
by prisoners, with prevalence rates ranging from 64% to 
more than 90%, depending on the country and the setting.
•	 Tobacco	 use	 is	 completely	 entangled	 in	 prison	 life	
where it helps to cope with boredom, deprivation or 
stress, relieve anxiety and tension and function as a 
source of pleasure or monetary value in an environment 
without currency.
•	 Few	measures	other	than	the	implementation	of	bans	
have been taken so far to reduce exposure to second-
hand smoke (SHS), indicating the low priority attached 
to this factor in health promotion in prisons.
•	 There	 is	 limited	 available	 evidence	 for	 best	 practice	
regarding smoking cessation in prison populations. 
More cessation programmes need to be implemented. 
Smoking by staff should be addressed systematically 
in tobacco control policies in prisons. Since the broader 
public health system should systematically include 
incarcerated people, national and local tobacco 
strategies and plans should include prisons.
Introduction
Tobacco is the psychoactive substance most widely used 
by prisoners, with prevalence rates ranging from 64% 
to more than 90%, depending on the country and the 
setting. The rates regarding female prisoners are either 
comparable or higher (1). Whereas a remarkable decline 
in smoking prevalence rates has been observed in the 
general population where tobacco control policies are 
being implemented (2), no comparable changes have 
occurred in prisons over the last decades. Smoking 
prevalence rates in prison populations remain two to four 
times higher than in the general population.
Prisoners face an elevated probability of being exposed 
to SHS due to the high prevalence of smokers and the 
fact that they are often forced to spend most of their time 
indoors where ventilation is usually poor. This creates 
a need for effective interventions to reduce involuntary 
health risks to both detainees and staff.
Main issues: prevalence and exposure to 
SHS in prison settings
The reported prevalence rates of exposure to SHS in 
the literature vary according to the setting (prison, jail, 
remand custody), the country and the study population. 
One common trend, however, shows higher prevalence 
inside prisons (two to four times) or proportions that tally 
with the proportion of non-smokers outside prison (for 
example, 75% of smokers inside and 25% outside) (3).
In the United States, it has been reported that 82.5% of 
male prisoners smoke (4,5). In Australia, values reach 
90% or even 97% (6,7). In Europe, high prevalences are 
reported in: Greece 91.8% (8) or 80% (9), France 90% (10), 
Germany 88% (11), Lithuania 85.5% (12), Switzerland 83% 
(13), Poland 81% (14), United Kingdom 78% in London (15) 
or 89% (16) and  Italy 77% (17).
Fewer data are available for women. In the United States, 
prevalence varies from 42% to 91% (18,19). In Australia, 
88% has been reported (20). Values are similarly high 
in Europe, with 85.3% in Lithuania (21), and 85% in the 
United Kingdom (22). Smoking is also reported during 
pregnancy in 66% of women (23).
Almost no data are available for younger prisoners. In the 
United States, 46.6% smoke daily (24). In Australia, 58% 
smoke despite a total ban (25).
The situation among staff is also largely unexplored and 
few data are available. In some countries, the prevalence 
rates among staff in detention facilities are higher than or 
comparable to those of the general population. In Canada 
they are 2.5 times higher in prison (26). In Switzerland, 
prevalences of smoking among staff ranging from 26% to 
55% have been reported (17).
Related to the high prevalence of tobacco-smoking, 
exposure to SHS is frequent when prisoners spend a 
lot of their time indoors and in compounds with poor 
ventilation systems. SHS is known to have health-
damaging effects, including an increased risk of heart 
disease and lung cancer (by 25% to 30%) in non-smokers 
(27). There is no threshold below which exposure is risk-
free, and measures such as separating smokers from non-
smokers and improving ventilation are either inadequate 
or impracticable in most situations and do not provide full 
protection from SHS (2,28–31).
The introduction of total bans, where the entire compound 
should be completely smoke-free, and partial bans, where 
smoking is allowed in cells or designated places indoors or 
outdoors, have shown improvements in air quality. These 
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are still insufficient, however, as the detected thresholds 
of dust particles or nicotine concentrations remain above 
those detected outdoors or in completely smoke-free areas 
(28,32,33). Such isolated measures can bring an improvement 
that remains partial. A more comprehensive approach is 
needed to reduce SHS further, by helping tobacco-users to 
change their behaviour and not just regulating the places 
where they are allowed to smoke or not.
WHO Framework Convention on Tobacco 
Control (WHO FCTC)
In 2003, the Fifty-sixth World Health Assembly developed 
the WHO Framework Convention on Tobacco Control (WHO 
FCTC) (34). This declares that all persons need to be protected 
from exposure to environmental tobacco smoke (Articles 4 
and 8), which in practice includes prisoners and prison staff, 
as specified in the Guidelines regarding the implementation 
of Article 8: “Careful consideration should be given to 
workplaces that are also individuals’ homes or dwelling 
places, for example, prisons, mental health institutions or 
nursing homes. These places also constitute workplaces for 
others, who should be protected from exposure to tobacco 
smoke” (31). A further specific document considers the 
application of Article 8 in prisons (35).
Reasons for the high prevalence of tobacco 
use in prisons
Prisons concentrate people who frequently use tobacco 
and show an important degree of dependence. They 
often have a lower socioeconomic status, use multiple 
drugs (including alcohol) and suffer from mental health 
problems. They are also recognized as the groups resistant 
to smoking cessation strategies outside (7,9,15,25,36–38).
Another main reason for the high prevalence rates 
of smoking in prisons is the absence of interventions 
addressing this issue, specifically among prisoners. Prisons 
have rarely been included in national tobacco strategies 
(9,39) and there is still a lack of evidence for best practice 
regarding smoking cessation among inmates (7).
As with the great majority of all smokers, incarcerated 
men and women are interested in stopping their tobacco 
use (40,41). As spontaneous cessation is rare, however, 
there is a need for a policy to address the characteristics of 
closed settings and the complex needs of the individuals 
living and working there.
Even if prisons are considered as places where there are 
opportunities to equilibrate access to health care services 
(15,42), effective prevention messages and smoking 
cessation programmes have not maximized the potential 
reach to the incarcerated population (5). In most places, 
quitting remains a lone and environmentally unsupported 
decision and process.
Smoking cessation programmes are given a lower priority 
than other health care issues or other substance abuse 
programmes. It is not uncommon to find, along with highly 
developed access to health care, inclusive harm reduction 
and OST for intravenous drug users, an absence of concern 
or programme addressing tobacco use and a lack of health 
staff specifically trained to address tobacco cessation 
support. Tobacco-smoking seems to be the health risk 
addressed the least compared to abuse of other substances, 
which are massively overrepresented in prisons (43).
Furthermore, even when they are available, prisoners 
seem to make little use of treatment programmes for 
smoking cessation (40,44).
Significance of tobacco use in prison 
Smoking is an established and integral part of the culture 
and a social norm in prisons and other criminal justice 
settings (7,38,45). Prisons have entrenched cultures 
that shape the ways in which social relations between 
prisoners, and between prisoners and staff, are conducted 
(46,47). A male prisoner in a category C prison in England 
described the significance of tobacco as “everybody’s 
lifeline in here” (48).
Smoking habits can change in prison, either positively or 
negatively. For example, a lack of access to tobacco and 
other factors can be associated with a reduction in the 
amount of tobacco smoked and/or frequency of smoking 
(12,22). Conversely, being imprisoned can lead to an 
increase in smoking behaviour. Factors such as boredom 
and coping with stress are frequently given by prisoners 
to explain why they feel a stronger need to smoke while 
in prison – 40% of Polish prisoners in a survey said that 
the boredom associated with being in prison encouraged 
smoking (9,49). Smoking can be seen by prisoners as a 
way of helping to manage stressful situations such as 
prison transfers, court appearances and prison visits (49). 
Lack of family support and missing friends and family have 
been identified as further reasons why prisoners may feel 
a need to smoke while in prison (9).
Further, boredom, prolonged periods locked in cells, 
bullying and stress have also been given as reasons for 
relapse by prisoners who tried to stop while in prison 
(49). Cigarettes and tobacco are frequently used by 
prisoners as currency (38,50) and there are reports that 
this may apply to medicinal nicotine as well (15,50,51). In 
some instances, it has been reported that prisoners have 
gone on to stop smoking programmes in order to obtain 
nicotine replacement therapy to sell to other prisoners 
while they themselves continue to smoke (15). Nicotine 
patch exchange schemes have been introduced into some 
prisons in response to this problem (51). Some prisons 
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insist on the use of transparent patches to prevent the 
concealment of illicit substances.
Offenders often show other challenging issues in addition 
to smoking, including addiction to other substances. 
Social and interpersonal difficulties can also affect their 
motivation and ability to stop smoking (22,52,53).
Learning difficulties and high rates of low educational 
attainment among prisoners (54) can have an impact on 
their ability to access services through the application 
process, in addition to coping with complex health 
information materials (55) which frequently do not 
translate easily to the prison setting.
The transient lives of prisoners can provide additional 
challenges in terms of engaging them and keeping them 
in contact with smoking cessation services as well as the 
continuation of support and counselling (51,56). The post-
release period is particularly challenging and a stressful 
time of readjustment. Smoking cessation services 
should, therefore, plan for the likelihood of transfers (49) 
by ensuring that medical records are transferred with 
prisoners together with a short supply of pharmacotherapy 
to last until prescribing can be renewed at the new location 
(51). Linking community smoking cessation services with 
prison programmes could offer post-release support and 
thus reduce rates of relapse (44,52).
On the other hand, qualitative research conducted in United 
Kingdom prisons has revealed that many prisoners want 
to achieve something while in prison and view stopping 
smoking as a big achievement (51). Prisoners have described 
being in prison as an opportunity to access stop smoking 
services and nicotine replacement therapy (57).
Resistance and negative attitudes to smoking cessation in 
prisons can be based on the belief that stopping smoking, 
especially if this is enforced through smoking restrictions, 
would place an intolerable burden of stress on prisoners 
at an already stressful time (58). Mitigating stress and 
boredom among prisoners should be considered as part 
of stop smoking initiatives. Since physical exercise has 
been described by prisoners as a substitute for smoking, 
these could include improved access to gym facilities or 
sporting activities, for example, as part of a joint response 
across the prison setting (49).
While not primarily concerned with the health of the 
prison population, prisons have a duty of care for those 
they hold in detention. In relation to smoking, this should 
include the promotion and support of cessation for those 
smokers wishing to stop, protecting non-smokers from 
starting to smoke and protecting prisoners, staff and 
visitors from exposure to passive smoke. Tackling smoking 
is difficult in an environment where it is an established 
and integral part of the culture and social norms, widely 
used in social rituals to relieve boredom and stress, and in 
which tobacco is often used as currency (7,38,45).
Addressing smoking among the offender population 
should not be limited to prisons, as smokers awaiting 
trial or on probation after serving a sentence may 
also need help and support. It is well recognized that 
addressing inequality issues through an engagement 
with stop smoking initiatives with offenders will have 
improved health outcomes for their families and the wider 
communities in which they live. A current study in the 
north-west of England addresses these issues by looking 
at the organizational and systems perspectives across a 
series of criminal justice settings in relation to tobacco 
control and stop smoking support and treatment (Box 3).
Tobacco use by prison staff
Tobacco is particular in the sense that it is the only 
psychoactive substance visibly used by prison staff. 
The regulations regarding their use of tobacco while at 
work vary greatly between countries, ranging from total 
prohibition to smoking being allowed in designated areas, 
even indoors (Germany, for example) (37). The United 
Kingdom is an example of how support for smoking 
cessation is sometimes available and included as a health 
promotion target for staff (59). It is particularly important 
to gain a better acceptance of regulations. Staff have 
been shown to be resistant to changes in smoking policy 
(60), with non-smokers being more supportive of a ban 
(61). As part of a whole-prison approach, staff should 
systematically be included in tobacco control policies in 
prisons and supported in their attempts to stop (62).
Addressing the smoking issue in prisons
Prison administrators should address the tobacco issue 
in cooperation with prison health staff and tobacco 
cessation specialists from the regional network, to ensure 
the inclusion of the various components of an efficient 
policy and, in particular the regional regulations prevailing 
outside prison, cessation support, training of medical and 
prison staff, and education of prisoners about tobacco 
and the consequences of its use (63,64). Confusion over 
ownership of the smoking problem between the health 
department and custodial authorities has to be avoided. 
The importance of a whole-prison approach managed 
through a multidisciplinary team is also underlined (65).
A study completed in 2011 in prisons in Germany included 
the design of a tobacco control policy in prisons (66). 
It is intentionally addressed to prison administrators, to guide 
their reflections on and implementation of comprehensive 
tobacco control policies in their institutions. 
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Background
In England and Wales, over 80% of men and women in prison are smokers, compared to general population 
levels of around 21% (20,22,36,37). Similar levels are apparent in police custody and probation, although 
there is less information available. A strong case for addressing tobacco control issues in prisons and the 
wider criminal justice setting is increasingly being recognized (67,68), with positive effects on public health as 
individuals move in, through and out of criminal justice settings.
Prisoners’ health has been a responsibility of the National Health Service since 1995. The aim is to give 
prisoners access to the same range and quality of health care services as the public receives in the 
community (69,70). Support to stop smoking is commissioned by primary care trusts and provided in a 
variety of ways, typically by specialists going into prisons or by prison health care staff being trained and 
supported by community stop smoking services. Cessation work with other categories of offender, such as 
those in custody or on probation, is minimal. Common areas in prisons are smoke-free but prisoners may 
smoke in their cells in adult prisons, with issues recognized in relation to shared cells and staff exposure 
on entering cells.
Achievements
With the innovative appointment of a tobacco control coordinator for the North West Region, the project (2010–
2011) has focused on organizational systems in prisons, probation and police custody and the relevant health 
commissioners and providers in relation to tobacco control and stop smoking services and treatment. This project 
is part of the Health Inequalities Programme funded by the Department of Health and led by the United Kingdom 
Centre for Tobacco Control Studies (a United Kingdom public health research centre of excellence and a strategic 
partnership of nine universities involved in tobacco research in the United Kingdom) (71).
A wide range of activities have encompassed: (i) a rapid review of literature (72); (ii) initial mapping of cessation 
activity across 16 prisons in the north-west of England, which highlighted a wide variety of models for the 
provision of stop smoking services – all establishments have smoking policies in place as required in Prison 
Service Order 3200, Health Promotion (73); and (iii) five in-depth case studies, which provide a focus on the key 
issues of tobacco in varied criminal justice settings.
Key project outputs have included the development of a Stop Smoking Training Framework for Prisons, a 
service delivery framework for stop smoking services in prison, a nicotine replacement therapy protocol for 
prisons to provide consistency and a data collection reminder paper.
The tobacco control coordinator was an active participant in various regional meetings and tobacco control 
local alliances. This made it easier to raise awareness of tobacco control issues in criminal justice settings for 
health care commissioners and providers and to help establish tobacco control issues on the broader criminal 
justice agenda.
Conclusion 
This project is evidently unique and, with its emphasis on the role of a project coordinator, many strengths 
have been identified which are clarified in its evaluation, including acting as a conduit for information-
sharing and knowledge transfer, supporting the development of services and networking. The coordinator 
has provided a proactive and consistent voice in a range of health and criminal justice settings. It is vital 
that these strengths are disseminated directly to a variety of audiences including the criminal justice 
system, agencies providing smoking cessation support and relevant geographical alliances, whether or not 
additional funding for a separate role can be identified. More information on the project can be found on 
the web site (72).
Source: Baybutt M, MacAskill S, Woods S. Report of North West Case Studies of Best Practice and Innovation, 2011. Prepared as part of the Tobacco 
Control in Prisons and Criminal Justice Settings: Regional Coordination Pilot Project (unpublished document). 
Box 3. Case study: local action for tobacco control: criminal justice setting, United Kingdom 
(England and Wales) 
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Outline of a tobacco control policy in  
German prisons  
Introduction13
In 2011, a study was undertaken in German prisons, 
supported by the Federal Ministry of Health, with the 
aim of proposing a sustainable tobacco control policy in 
German prisons.
The objectives of the policy are to improve the living and 
working conditions of prisoners and staff by creating a 
better health-promoting environment, in particular to 
reduce their exposure to SHS, to support smoking reduction 
and cessation attempts, and to optimize cooperation 
between health services and prison administrators. 
Some of the elements presented here might not be 
adaptable to the exact situations prevailing in other 
countries, where different degrees of protection against 
exposure to SHS might already have been implemented.
The policy is aimed at prisoners and staff. It consists 
of six modules: (i) general principles of the policy; 
(ii) regulations; (iii) health education and training; 
(iv) individual support to reduce or stop smoking; 
(v) networking with tobacco prevention experts; and 
(vi) a checklist.
General principles of the policy
The concept is based on the following principles.
According to the regional laws protecting against SHS 
(Germany counts 16 regions and laws) smoking is only 
allowed in designated areas. The cell is considered a 
private area. Smoking is prohibited when numerous 
people, including non-smokers, are together in the same 
area (74).
Isolated measures are insufficient. Examples are: the 
availability of therapeutic services with no account taken 
of the environment; or the implementation of smoke-free 
regulations alone, when they should be supplemented by 
therapeutic and counselling services, efficient networking 
and staff training.
Regulations for protection against SHS or for smoke-free 
areas should be as comparable as possible with those 
prevailing outside prisons (in the corresponding area). 
This allows for greater acceptance by everyone involved 
and prepares prisoners for their return to life outside 
prison, since they are familiar with the same rules. In this 
respect, efforts to accept measures for protection against 
SHS are part of social reintegration.
13 This policy was prepared by Catherine Ritter and Heino Stöver in 2012 as part of a research project on tobacco prevention in prisons.
A health promotion officer should be designated in the 
prison and trained to implement the tobacco control policy 
and develop advice, reduction and cessation programmes 
for both prisoners and staff.
Tobacco use and protection against exposure to SHS should 
be tackled as part of health promotion in the workplace. 
It is a crossover issue and requires concerted work with 
clearly defined responsibilities for the health services, 
prison staff representatives, prison administration and 
representatives of prisoners.
Tobacco is often used together with other substances. 
Tobacco control should, therefore, be included in the 
implementation of comprehensive addiction strategies at 
institutional, regional and national levels.
Campaigns that are organized outside prison can also be 
implemented inside prison, in particular activities during 
the World No Tobacco Day on 31 May (75) or, for example, 
during a one-week campaign before or after that date, 
when prisons can focus on tobacco issues.
Smoke-free regulations
Prison regulations should be checked for their inclusion 
of rules governing exposure to SHS. Non-smokers should 
not share cells with smokers. Smoke-free floors should be 
established, with specific smoke-free cells available for 
prisoners on the first day of their arrival in the prison. The 
smoke-free regulations covering the working areas should 
be implemented and endorsed uniformly, especially 
regarding breaks. Working areas and toilets should be 
smoke-free, in line with the law prevailing outside prison.
Health education and training
Information should be available about the consequences of 
tobacco use and reducing or stopping it. Each region should 
provide education and training for staff. Unfortunately, the 
tobacco use issue is still rarely systematically included in 
training programmes, meaning that interested prison and 
health staff have to find out by themselves where such 
training is available.
Individual support to reduce or stop smoking
Support in reducing or stopping smoking should be 
available to individual prisoners and staff members, as 
follows.
Prisoners should actively and regularly (at all stages of 
detention) be approached about their smoking behaviour.
Support should be available for prisoners seeking to 
reduce or stop their use of tobacco. Such support should be 
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developed according to the uses and resources available 
in each setting (for example, access to medication either 
free of charge or with shared costs).
Staff should be told about the smoke-free regulations 
applying to them when they start work in the detention 
setting. These regulations should be one of the main 
principles in each setting.
As a general rule, staff should not smoke with prisoners, 
especially not in their cells. This is to avoid giving a false 
impression of solidarity, to respect prisoner’ private space 
and to avoid hiding when smoking has been banned indoors.
Conversations between prisoners and staff should take 
place in rooms other than cells occupied by smokers (74).
Cells should be intensively aired before they are searched 
and prisoners should be asked to refrain from smoking 
when staff are present.
The motivation for staff to reduce or stop using tobacco 
should be regularly tested. Smoke-free workplaces 
promote smoke-free homes, which further protect families 
and strengthen smoking cessation attempts in general.
To avoid the promotion of smoking while at work, there 
should be no indoor smoking areas and tobacco use should 
be limited to designated places outdoor and during breaks 
(even where it is legally permitted to smoke indoors, as in 
Germany (76,77)).
A qualified professional should be available to provide 
support for individuals trying to reduce or stop their 
smoking.
Rewards (or contingency management) could be 
introduced as part of the support for people trying to stop 
smoking, such as a half-day off for non-smokers.
Networking with tobacco prevention experts
Cooperation with competent and qualified experts in 
tobacco use, reduction and cessation should be sought 
and developed at local or national level. This is important 
and useful for the provision of training materials (in 
particular for vulnerable groups, such as young people) 
and in certain facilities such as prison hospitals.
Checklist
A checklist is useful in reviewing the situation regarding 
exposure to SHS and efforts to reduce it. It clarifies which 
points in this policy have been achieved and which need 
closer attention (Fig. 6). 
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If you answer one or more questions with “No”, you are recommended to look up those particular aspects with the 
help of specialized literature or local experts in tobacco-related issues. 
Prisoners
Smoke-free regulation
Is protection for prisoners against exposure to SHS discussed with the medical unit?  Yes   No
Is protection for prisoners against exposure to SHS discussed with their representatives?  Yes   No
Has a person been nominated to be in charge of protection against exposure to SHS or of 
  health promotion among the prisoners?  Yes   No
Are experts in protection against exposure to SHS involved, for example in a local network?  Yes   No
Are there smoke-free regulations?  Yes   No
Are the regulations endorsed?  Yes   No
Do non-smoking prisoners have systematic and straightforward access to smoke-free cells?   Yes   No
Are the work areas smoke-free?  Yes   No
Are the toilets smoke-free?  Yes   No
Are the indoor break rooms smoke-free?  Yes   No
Health education
Are the sources of information on tobacco use (consequences, cessation) known?  Yes   No 
Is information on tobacco use (consequences, cessation) regularly and proactively distributed?  Yes   No
Are prisoners involved in the transmission of information to other prisoners?  Yes   No
Training
Are the staff (health, social or prison) trained in health education regarding tobacco use?  Yes   No
Are the health staff trained to support prisoners trying to reduce or stop their tobacco use?  Yes   No
Is the nominated person in charge of prisoners’ protection against exposure to SHS
  trained in this issue?  Yes   No
Individual support to reduce or quit smoking
Is it easy for prisoners to get access to help in reducing or stopping tobacco smoking?  Yes   No
Are prisoners regularly approached to reduce or stop their tobacco smoking?  Yes   No
Staff
Smoke-free regulations
Is protection for staff against exposure to SHS discussed with the medical unit?  Yes   No
Is protection for staff against exposure to SHS discussed with their union or representatives?   Yes   No
Has a person been nominated to be in charge of protection against exposure to SHS or of 
  health promotion among the staff?  Yes   No
Are experts in protection against exposure to SHS involved, for example in a local network?  Yes   No
Are there smoke-free regulations?  Yes   No
Are the regulations endorsed?  Yes   No
Are staff protected against exposure to SHS outside the cells?  Yes   No
Is the purchase of tobacco impossible at work?  Yes   No
Are staff restricted to smoking in their breaks in designated areas outdoors?  Yes   No
Are staff restricted to smoking in their breaks?  Yes   No
Health education
Are the sources of information on tobacco use (consequences, cessation) known?  Yes   No 
Is information on tobacco use (consequences, cessation) regularly and proactively distributed?  Yes   No
Training
Is the tobacco issue addressed in staff training?  Yes   No
Is the nominated person in charge of staff protection against exposure to SHS
  trained in this issue?  Yes   No
Individual support to reduce or quit smoking
Is it easy for staff to get access to help in reducing or stopping tobacco smoking?  Yes   No
Are staff regularly approached to reduce or stop their tobacco smoking?  Yes   No
Fig. 6. Suggested checklist for reviewing exposure to SHS
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17. Prisoners with special needs 
Alex Gatherer, Tomris Atabay, Fabienne Hariga
Key points 
•	 All	 prisoners	 are	 potentially	 vulnerable	 people,	with	
individual health and care needs requiring proper 
assessment and management.
•	 Prison	 populations	 in	 many	 parts	 of	 Europe	 are	
becoming increasingly complex with regard to special 
needs.
•	 Overcrowding	has	a	negative	 impact	on	 the	physical	
and mental health of prisoners, and particularly on 
the health of prisoners with special needs, posing 
additional challenges to prison authorities.
•	 Two	 major	 requirements	 in	 dealing	 with	 prisoners	
with special needs are: (i) a skilled assessment as part 
of the admissions procedure; and (ii) a suitable staff 
recruitment and training policy so that the staff who 
work in prisons are enabled to respond appropriately 
and effectively to special needs.
•	 An	individualized	approach	is	essential.
•	 Needs	are	not	static,	so	re-assessments	are	necessary	
throughout the whole term of imprisonment. New 
needs emerge, such as those relating to the rising 
number of older prisoners in prison.
•	 It	 is	 not	 possible	 in	 prisons	 to	 deal	 satisfactorily	
with people with severe special needs that require 
facilities and skilled attention which are only available 
in specialist institutions.
•	 Admission	of	severely	ill	or	disabled	people	to	prison	
should be avoided and only used as a last resort.
•	 Diversion	 schemes	 and	 other	 alternatives	 to	
imprisonment should be used more widely and 
consistently than at present.
This chapter concerns prisoners with specific needs 
associated with their disability, minority status, nationality, 
sexual orientation and age. Prisoners with mental health 
care needs (another large group with special needs) are 
covered extensively in Chapter 11, and a more detailed 
discussion of the health care needs of older prisoners is 
included in Chapter 19.
The starting point in the discussion of prisoners with 
special needs today must be the recognition of the 
growing complexity of prison populations. Nearly all 
prisoners may have special needs, all are vulnerable to 
a greater or lesser extent and the vast majority come 
from difficult and deprived backgrounds, with personal 
histories which can considerably influence the care and 
treatment they require. Thus it is essential to give priority 
to the reception process, the early days in prison and the 
health and other relevant assessments.
Many prisoners have needs that require special 
consideration. Women, young people and prisoners with 
mental health care needs are important examples. This 
chapter looks at prisoners who have special needs due 
to their disability or age, or because of their ethnicity, 
indigenous or minority status, nationality or sexual 
orientation, which present diverse and challenging needs. 
For those whose health care requirements are most 
difficult to meet within a prison, the correct approach is 
early appreciation of their needs and a diversion scheme 
to admit them to places equipped to provide them with 
appropriate care. This has become increasingly well-
recognized for those with severe mental ill health or 
advanced illnesses where it is not possible to provide 
the level of expertise and care necessary within the 
restrictions of a prison service. However, diversion 
schemes remain underdeveloped in many parts of Europe, 
which increases the pressures on criminal justice systems 
to meet the requirements of those with considerable 
needs who have to remain in prison.
International standards 
This chapter is mainly based on the UNODC Handbook on 
prisoners with special needs (1), which goes into greater 
detail and includes important information about the 
definitions of the conditions and groups being considered, 
the background and size of the problem, the relevant 
international standards and examples of good practice. 
Some relevant provisions from two of the key international 
treaties which are relevant to all of the groups covered in 
this chapter, including their health and care requirements, 
are quoted below. These instruments, and other standards 
relevant to specific groups, prohibit any discrimination in 
ensuring that everyone, including prisoners with diverse 
backgrounds and needs, enjoys the right to the highest 
attainable standard of physical and mental health:
International Covenant on Civil and Political Rights
Article 26 
All persons are equal before the law and are entitled 
without any discrimination to the equal protection of the 
law. In this respect, the law shall prohibit any discrimination 
and guarantee to all persons equal and effective protection 
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against discrimination on any ground such as race, colour, 
sex, language, religion, political or other opinion, national or 
social origin, property, birth or other status. (2)
International Covenant on Economic, Social and Cultural 
Rights
Article 12 (1) 
The States Parties to the present Covenant recognize the 
right of everyone to the enjoyment of the highest attainable 
standard of physical and mental health. (3)
General principles of care 
Prison systems are required to protect the physical 
and mental health and well-being of prisoners. This 
challenging task, within often old and overcrowded 
institutions, can only be tackled in accordance with 
the general principles of care stressed throughout this 
guide. These include: respect for the individuality of 
each prisoner; the importance of a holistic approach; the 
essential need for basic care such as adequate nutrition, 
exercise and constructive use of time; maintenance of 
contacts with family and friends; and a basis of hope for 
the future.
Treatment in prisons 
The medical examination on entry into prison should 
reveal whether a prisoner has special needs. If this 
is the case, a fuller assessment is necessary so that a 
diagnosis and plan of treatment can be prepared. Even 
in countries with good resources and with an established 
national health service, it is unlikely that the prisoner will 
be carrying a health notice drawing attention to a health 
condition or allergy, but these should be investigated 
and their presence or absence noted. If the prisoner is 
a non-national, and has brought medicines from his or 
her country of origin, these should be discussed with 
the prison’s pharmacist or brought to the attention of a 
medical member of the prison health team so that local 
equivalents can be obtained in good time.
The treatment to be provided should be confirmed in 
writing by the health team and should clearly indicate 
the quantity and frequency of treatment. The quality of 
the treatment is generally measured as equivalent to 
that provided for citizens in the local community. It is not 
possible to meet every special demand as some may be 
unrealistic or unreasonable. All requests should, however, 
be carefully considered and where they are impossible to 
meet, a record should be made of what was asked for 
with an explanation as to why the request could not be 
met. The standard of treatment must be enough to meet 
the requirements of the illness and must comply with 
established medical opinion.
A suitable prison or place of detention 
Prison authorities are obliged to recognize that prisoners 
with special needs should be admitted to prisons capable 
of handling the needs and providing the necessary care. 
This can create problems for prison staff who have no say 
in who is sent to the prison and often have little warning 
as to the special needs involved. It is essential, therefore, 
that the whole criminal justice system should be alert 
to plans for dealing with prisoners with special needs. 
Where there is serious mental illness, there should be a 
possibility of diversion at an early stage of the criminal 
justice process to a place with the specialist psychiatric 
facilities necessary for the treatment of that prisoner. 
Responding to the needs of prisoners with severe physical 
disabilities or with more than one serious health or other 
problem can be very challenging. While it is not possible 
to plan for every rare condition, a whole criminal justice 
system plan for the more common conditions with advice 
on what to do in emergency situations is becoming an 
essential part of a well-managed prison health care 
system.
A proper manner of detention 
With reference to a proper manner of detention, the 
European Court of Human Rights issued a judgment in the 
case of Feher v. Hungary (2013) which is applicable to all 
prisoners, including those with special needs. The Court 
stressed that States must ensure that “the manner and 
method of the execution of the measure do not subject the 
individual to distress or hardship of an intensity exceeding 
the unavoidable level of suffering inherent in detention” 
(4). The proper manner of detention will depend on the 
training of all staff working in prisons and on the ethos 
of the prison as developed by the senior management 
team. It also requires the embedding of knowledge and 
attitudes which will be conducive to meeting the above 
requirements as regards all prisoners with special needs. 
The importance of staff training has led to the inclusion 
of a chapter on the subject in this guide. The additional 
requirement for meeting special needs is to conduct 
joint training and multidisciplinary training in the training 
programme, in order to improve the capacity of the staff 
to respond to the sometimes complex needs of individuals 
with special needs in the most holistic and effective way.
Some important messages 
The difficulties encountered by policy-makers, courts 
and prison authorities when trying to meet the needs 
of offenders with special needs encourage an approach 
which looks carefully at the following points. First, 
prisons must meet the needs of the clear majority of 
prisoners, who are relatively young and relatively lacking 
in handicapping conditions. Second, imprisonment 
should as a general principle be considered as a last 
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resort. This is particularly important in the case of older 
or severely handicapped people: alternatives to prisons 
and community sentences need serious consideration and 
are often the best way to ensure the most humane and 
acceptable way to carry out the decisions of the courts. 
Third, when assessing the suitability of the necessary 
treatment in a suitable place and in the desired manner, 
it should be remembered that prisons inevitably magnify 
the individual’s problems. Fourth, regular monitoring and 
reassessment is necessary as illnesses can become more 
serious and disabilities more complicated over time. Fifth, 
most prisoners with special needs have more than one 
serious condition and several challenging needs, which 
need to be assessed and treated in a holistic manner. 
Finally, while prison staff are becoming more professional 
and their training and continuing training will probably 
increase, many prison systems find it difficult to recruit 
suitable people willing to work in prisons, especially as 
their status and remuneration are limited. In providing 
quite complicated treatment regimes, and in the need 
to have knowledge and understanding of the wide range 
of problems involved, the quality of staff must be a key 
priority and they must receive considerable skilled support 
before prisoners with special needs can be satisfactorily 
catered for in most prison systems.
Prisoners with physical disabilities 
An increasing number of prisoners have physical 
disabilities, in part due to the ageing of prison populations. 
The adoption of the United Nations Convention on the 
Rights of Persons with Disabilities (5), which entered into 
force in May 2008, has introduced clear obligations to 
prison authorities and health care services in relation to 
the treatment and care of prisoners with disabilities. In 
particular, Article 25 of the Convention covers the health 
care rights of persons with disabilities, as follows:  
States Parties recognize that persons with disabilities 
have the right to the enjoyment of the highest attainable 
standard of health without discrimination on the basis of 
disability. States Parties shall take all appropriate measures 
to ensure access for persons with disabilities to health 
services that are gender sensitive, including health-related 
rehabilitation. In particular, States Parties shall: (a) Provide 
persons with disabilities with the same range, quality and 
standard of free or affordable health care and programmes 
as provided to other persons, including in the area of sexual 
and reproductive health and population-based public health 
programmes; … 
Recommendation No. R (98) 7 of the Council of Europe 
Committee of Ministers (Concerning the Ethical and 
Organizational Aspects of Health Care in Prisons), 
paragraph 50, provides important guidance on the 
accommodation of prisoners with disabilities and older 
prisoners (6):  
Prisoners with serious physical handicaps and those of 
advanced age should be accommodated in such a way as 
to allow as normal a life as possible and should not be 
segregated from the general prison population. Structural 
alterations should be effected to assist the wheelchair-
bound and handicapped on lines similar to those in the 
outside environment. 
See the Handbook on prisoners with special needs (1) 
for other relevant provisions and additional international 
standards of relevance.
Health issues
Prisoners with physical disabilities require access to some 
services which may not be available in every prison, such 
as physiotherapy, occupational therapy, and regular dental, 
sight and hearing tests and aids. Close cooperation with 
community health care services is essential to ensure that 
such services are offered to prisoners according to their 
needs. The particular health problems which can arise 
in the case of, for example, prisoners in wheelchairs or 
with limited mobility, include pressure sores which must 
be detected early, suitably treated and deterioration 
prevented.
Some prisoners with disabilities, especially those with 
sensory disabilities, are at risk of developing mental 
health care needs, as the isolation experienced by such 
individuals may be intensified in the prison environment. 
Taking into account the problems with communication 
faced by prisoners with sensory disabilities, assistance 
should be provided to ensure that they have equal access 
to counselling programmes.
A suitable prison 
Careful assessment will be necessary to check that people 
with physical disabilities can cope with the arrangements 
of the prison, such as stairways, beds, access to toilets and 
bathing facilities, and access to prison programmes and 
leisure rooms. As recommended by the Council of Europe 
(see above), structural adjustments may need to be made 
to accommodate the needs of prisoners with physical 
disabilities. For example, handrails can be provided in 
their cells, bright colours may be used for steps to make 
them visible for those with visual disabilities, and ramps 
can be introduced to facilitate the access of those using 
wheelchairs.
A proper manner of detention 
Those with disabilities are highly vulnerable to humiliation 
and violence. Plans to tackle such stigma, discrimination 
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and bullying must be part of the prison coping mechanism 
for such prisoners, reflected in prison staff training.
Ethnic minorities and indigenous peoples 
In many countries, ethnic minorities and indigenous 
peoples are overrepresented in prisons. This is important 
to remember in assessing the treatment and care plans 
for these groups in prison. Why this occurs could be a 
useful topic for discussion among staff as part of their 
continuing training. It is important that there should be 
no discrimination in the treatment of members of these 
groups, including in responding to their health care needs 
which, in practice, requires some additional considerations 
to be taken in to account.
The International Convention on the Elimination of All 
Forms of Racial Discrimination, General recommendation 
XXXI on the prevention of racial discrimination in the 
administration and functioning of the criminal justice 
system, Article 38, states the following (7):
38. When persons belonging to the groups referred to in the 
last paragraph of the preamble are serving prison terms, the 
States parties should:
(a) Guarantee such persons the enjoyment of all the rights to 
which prisoners are entitled under the relevant international 
norms, in particular rights specially adapted to their 
situation: the right to respect for their religious and cultural 
practices, the right to respect for their customs as regards 
food, the right to relations with their families, the right to 
the assistance of an interpreter, the right to basic welfare 
benefits and, where appropriate, the right to consular 
assistance. The medical, psychological or social services 
offered to prisoners should take their cultural background 
into account; …
A full outline of the definitions differentiating these 
groups can be found in the Handbook on prisoners with 
special needs (1).
Health issues
An understanding of the needs of ethnic minorities and 
indigenous peoples will involve some awareness of the 
differences in traditions, religion and language. Some 
members of these groups may not speak the language 
most commonly spoken in the prison. It is essential that 
interpretation services are provided during their medical 
examinations and consultations and that written and 
visual information on health care be available in the 
languages of minority groups most commonly represented 
in prisons. The relationships of these groups with health 
teams can be complicated by the discrimination they have 
experienced, or feel they have experienced, as well as the 
physical and verbal abuse they may have been subjected 
to. Voluntary agencies who work on issues related to the 
needs of these groups can be of assistance.
Members of these groups may have special health 
care needs as a result of their socioeconomic 
marginalization in many societies. They are generally 
likely to have received inadequate medical care prior to 
imprisonment, and they may be at a higher risk of some 
conditions, such as STIs and health problems relating 
to substance abuse. There should be no differences 
in medical or nursing care otherwise, but respect and 
trust between them and the health teams have to be 
deliberately strengthened.
A suitable prison
The location (distance from place of origin) of the prison 
may have an impact on the mental well-being of members 
of some indigenous groups, as the family is central in 
some indigenous societies and critical to the well-being of 
the individuals. The breaking of family and community ties 
can have a particularly harmful effect on the mental health 
of members of indigenous groups, especially women.
A proper manner of detention
The proper manner of detention is key in meeting the 
needs of ethnic minorities and indigenous peoples. The 
attitudes of the staff and their understanding of diversity 
must be part of their continuing training. In addition, the 
assessment and allocation of these prisoners should 
aim to ensure that they are not accommodated with 
any other prisoners who may pose a risk to their safety, 
such as prisoners who are known to have racial or ethnic 
prejudices or backgrounds involving violence against 
minority groups.
Foreign prisoners
In recent times, there has been a marked increase in 
the number of foreign nationals in prisons in western 
Europe. Prison services are, therefore, likely to have 
policies and plans in place to meet their general 
needs. In its Recommendation No. R (84) 12 concerning 
foreign prisoners of 1984, the Council of Europe made 
specific recommendations on the treatment of foreign 
prisoners, requiring (among other things) that, as far as 
possible, authorities take measures to counterbalance 
disadvantages faced by this group of prisoners (8). 
This requirement applies to health care needs, which 
may sometimes differ from those of the national prison 
population:
13. Foreign prisoners, who in practice do not enjoy all the 
facilities accorded to nationals and whose conditions of 
detention are generally more difficult, should be treated 
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in such a manner as to counterbalance, so far as may be 
possible, these disadvantages.
Health issues
The most serious challenge for foreign prisoners is 
communication. It is essential that prison services 
make every effort to provide interpretation during 
medical examinations (as necessary), to prevent 
misunderstandings and health complications. This is also 
important to reassure foreign nationals, who do not speak 
the language of the country in which they are imprisoned, 
that their needs are being taken seriously. Nevertheless, 
the possibility of misunderstanding has to be remembered 
and follow-up of discussions with the health team may 
be necessary. Assessments should take into account the 
possible presence of a tropical disease or one that is 
endemic in the country of origin but rare in the country 
of imprisonment. Specialist help in diagnosis and the 
drawing up of treatment plans may be necessary.
It is more important than ever that information, health 
information, health promotion and harm reduction 
materials (leaflets, audiovisual materials) should be made 
available in different languages and using vocabulary 
adapted to the level of education of the prison population.
A suitable prison
Being imprisoned in a foreign country can complicate the 
maintenance of family contacts or planning for discharge. 
While it is not easy to see a remedy, the prison authorities 
could try to compensate by allowing foreign prisoners to 
make more telephone calls home and at more flexible times, 
facilitating contact by technical aids such as skype where 
feasible, and allowing longer than usual visits for family 
members travelling from abroad. A transfer of the prisoner 
to his or her country, if not a resident in the country of 
imprisonment, should be discussed with the prisoner at an 
early stage and transfer procedures started if he or she wishes 
such a transfer. Countries may have bilateral agreements to 
exchange or repatriate detainees, and such arrangements 
should be fully deployed on health grounds when necessary.
A proper manner of detention
Most prison staff are likely to share their native country’s 
attitudes and prejudices, so it is a further challenge for 
them to understand and accept the diverse backgrounds 
of people in the prison. Yet all prisoners, without 
discrimination, must be treated in the same way by all 
those working in the prison. Prison policies which do 
not tolerate any kind of discrimination together with the 
training and continuing training of staff are crucial in this 
regard. Once again, the assessment and allocation of 
foreign prisoners should aim to ensure that they are not 
accommodated with prisoners who may represent a risk 
to their safety due, for example, to nationalistic views and 
violence based on such views.
Lesbian, gay, bisexual and transgender 
prisoners 
Lesbian, gay, bisexual and transgender (LGBT) prisoners 
comprise a particularly vulnerable group, due to the 
heightened risk of discrimination and abuse in the closed 
environment. In comparison to other groups covered in 
this chapter, this group has the further complication that 
in some countries, sex relationships between consenting 
same sex adults are criminalized under various morality or 
other laws. It is, therefore, of great importance that there 
are top-level policies on how to deal with this particularly 
vulnerable group in prisons.
The relevant international standards relating to the 
treatment of LGBT persons in prisons are summarized 
in the Yogyakarta Principles on the Application of 
International Human Rights Law in relation to Sexual 
Orientation and Gender Identity, principle 9: the right to 
treatment with humanity while in detention (9),14 extracts 
from which are provided below:
STATES SHALL:
A. Ensure that placement in detention avoids further 
marginalising persons on the basis of sexual orientation or 
gender identity or subjecting them to risk of violence, ill-
treatment or physical, mental or sexual abuse;
B. Provide adequate access to medical care and counselling 
appropriate to the needs of those in custody, recognising 
any particular needs of persons on the basis of their sexual 
orientation or gender identity, including with regard to 
reproductive health, access to HIV/AIDS information and 
therapy and access to hormonal or other therapy as well as 
to gender-reassignment treatments where desired; …
See the Handbook on prisoners with special needs (1) 
for the definitions of each group and other important 
information.
Health issues
The major difference in terms of health needs for this 
group concerns the possibility of STIs, since often they will 
14 In 2006, a set of international legal principles on the application of international law to human rights violations based on sexual orientation and gender identity was 
developed by the International Commission of Jurists and the International Service for Human Rights, on behalf of a coalition of human rights organizations, in order to bring 
greater clarity and coherence to states’ human rights obligations. Following an experts’ meeting held in Yogyakarta, Indonesia, from 6 to 9 November 2006, experts from 
25 countries unanimously adopted the Yogyakarta Principles on the Application of International Human Rights Law in relation to Sexual Orientation and Gender Identity 
(The Yogyakarta Principles).
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have engaged, or been forced to be engaged, in a lifestyle 
that includes risky behaviour. With LGBT prisoners being 
at high risk of rape, they are also at high risk of acquiring 
HIV/AIDS in prisons. The health team will advise on 
detection and assessment as well as on therapeutic 
regimes. Transgender prisoners having undergone surgery 
might need specific attention and specialized care.
Prisoners with gender dysphoria should be provided with 
treatment available in the community, such as hormone 
therapy, as well as psychological support if required.
LGBT prisoners may also be in need of counselling for 
mental health needs associated with victimization.
There should be close collaboration with community-based 
organizations working on LGBT issues and specialized 
health care services to ensure that additional specialist 
help from outside the prison, including professional staff 
with added experience and skills in this field, is available 
to assist with the health care of these prisoners so as 
to meet the possible requirements mentioned above 
effectively.
A suitable prison 
The vulnerability of these prisoners, especially to 
violence (including sexual violence), has to be carefully 
assessed in terms of allocation of prisoners within the 
prison. While this is essentially a matter for the prison 
management, the health team should make it clear that 
safety is essential to protect their mental health and 
physical integrity and that protection and support are 
important requirements, if treatment of any illness is to 
be effectively provided.
A proper manner of detention 
As indicated above, staff will need the guidance 
of national policies and the leadership of senior 
management in providing a proper manner of detention. 
The prisoners themselves will not usually report 
victimization, aggression and humiliation as they are 
too well aware of retaliation. An essential principle of 
classification and allocation should be to house LGBT 
prisoners in whichever environment will best ensure 
their safety, while endeavouring to avoid segregation 
or isolation to the maximum possible extent unless the 
prisoners themselves request it. In the allocation of such 
prisoners, their wishes and concerns should be taken 
into account as far as possible, especially in the cases 
of transgender prisoners. When transgender prisoners 
are accommodated according to their birth gender, 
especially when male-to-female transgender prisoners 
are placed with men, this can pave the way to sexual 
abuse and rape.
Older prisoners
In many countries, older prisoners form a growing 
proportion of the prison population. The dividing line is 
often taken to be 50, 55 or 60 years because of the belief 
that vulnerable populations tend to have accelerated 
ageing by about 10 years. While there are no specific 
standards which apply exclusively to older prisoners, 
Council of Europe Recommendation No. R (98) 7 (6) 
referred to above includes some provisions which apply to 
older prisoners. Articles 13 and 14 of the United Nations 
Principles for Older Persons cover the needs of all older 
individuals, including prisoners (10): 
13. Older persons should be able to utilize appropriate levels 
of institutional care providing protection, rehabilitation 
and social and mental stimulation in a humane and secure 
environment.
14. Older persons should be able to enjoy human rights and 
fundamental freedoms when residing in any shelter, care 
or treatment facility, including full respect for their dignity, 
beliefs, needs and privacy and for the right to make decisions 
about their care and the quality of their lives.
See also Chapter 19 of this guide.
Health issues
Prisoners sentenced when they are older may receive 
different treatment from that for prisoners who age 
in prison. In the former case, there may well be a 
considerable medical history to check on admission, and 
many may be on long-term preventive medication such 
as aspirin or cholesterol-reducing medicines. As prisons 
are obligated to protect the physical and mental health of 
the prisoners, the principle of continuum of care should 
be applied and the treatment provided outside prison 
continued, while also taking into account any findings 
of the health assessment carried out on admission. The 
impact of unhealthy life styles and inadequate medical 
attention in the years leading up to imprisonment should 
be borne in mind. Older prisoners may typically suffer 
from chronic and multiple health problems, including 
heart and lung problems, diabetes, hypertension, cancer, 
Alzheimer’s disease, Parkinson’s disease, ulcers, poor 
hearing and eyesight, memory loss and a range of physical 
disabilities including dental  problems and related 
mastication difficulties. Alcohol abuse has also been 
identified as a widespread problem among this group. In 
addition, depression and fear of dying, and particularly 
dying in prison, affect the mental well-being of older 
prisoners. As a result, older prisoners are likely to require 
a number of health care services, including medical, 
nutritional and psychological treatment. Thus, the health 
care of older prisoners necessitates the engagement of 
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a multidisciplinary team of specialist staff, including a 
medical specialist, nurse and psychologist as a minimum. 
Prison authorities need to establish close cooperation 
with community health services to ensure that specialist 
care is provided by outside medical services, as necessary.
It is advisable for the admissions procedure to include a 
screening tool to establish any physical difficulties (such 
as impaired hearing and vision and decreased mobility) 
experienced by the prisoner so that adequate medical 
care and assistance can be provided.
Prison authorities should ensure that special dietary needs 
are catered for to maintain the health of older prisoners 
and to prevent serious health complications.
A suitable prison 
In most countries there is as yet no upper age limit as 
regards imprisonment, but the physical demands need 
to be considered against the probable development 
of incapacity in older prisoners. As with a number 
of the groups covered in this chapter, alternatives to 
imprisonment should be considered wherever possible, 
taking into account the probable harmful impact of 
imprisonment on older prisoners and the costs associated 
with catering for their multiple health care needs.
As older prisoners are also likely to include a high 
proportion of prisoners with physical disabilities, structural 
alterations may need to be made to their accommodation 
to facilitate their mobility in the prison and protect them 
from accidents.
A proper manner of detention 
Council of Europe Recommendation No. R (98) 7 
recommends that prisoners “of advanced age should be 
accommodated in such a way as to allow as normal a life 
as possible and should not be segregated from the general 
prison population” (6). The determination of suitable 
accommodation should be based on a careful assessment 
of individual needs. In general, allowing older prisoners 
to live with the general prison population is important to 
protect them from isolation and to ensure their access to 
all the programmes and activities offered in the prison. At 
the same time, account needs to be taken of their special 
accommodation requirements referred to above.
The day-to-day difficulties which may be faced by older 
prisoners are likely to be readily understandable to staff as 
most societies now have a proportion of elderly people in 
their midst. Such prisoners could well also deteriorate more 
rapidly in prison, both physically and mentally, with loss of 
hearing or problems with memory or eyesight. Issues of this 
kind should be revealed through regular monitoring.
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Key points 
•	 Female	 prisoners	 are	 a	 minority	 within	 prison	
populations worldwide, usually accounting for between 
2% and 9% of the prison population in a country.
•	 The	 majority	 of	 offences	 for	 which	 women	 are	
imprisoned are non-violent and property- or drug-
related. Female prisoners mainly serve short 
sentences.
•	 Many	women	 in	 prison	 are	mothers	 and	usually	 the	
primary or sole caregivers for their children.
•	 Female	 prisoners	 have	 complex	 health	 needs,	
particularly with regard to their physical and mental 
health. High rates of post-traumatic stress disorders 
are reported.
•	 Women	 in	 prison	 have	 mental	 health	 problems	 to	
a higher degree than both the general population 
and male prisoners. There is a close link between 
a woman’s criminal pathway and her mental and 
physical illness.
•	 Drugs	often	hold	a	key	to	a	woman’s	offending.	A	high	
percentage of women in prison suffer from a drug 
problem and problematic drug use rates are often 
higher among female than among male prisoners. 
•	 Women	are	at	greater	risk	than	men	of	entering	prison	
with HIV, hepatitis C, reproductive health needs and 
STIs such as chlamydia infection, gonorrhoea and 
syphilis.
•	 Three	times	as	many	women	as	men	report	that	they	
have experienced violence, either physical or sexual, 
before their imprisonment.
•	 Health	service	provision	in	prisons	needs	to	recognize	
women’s sex and gender-specific health care needs, 
and should be personalized and delivered in a holistic 
and humane manner.
•	 Gender-sensitive	training	and	training	on	the	specific	
health needs of women in prison should be widely 
available in all prison systems.
Introduction
Women in prison constitute a special group within the 
prison population, first and foremost because of their 
sex and gender inequalities. They constitute a small 
proportion of prison populations worldwide, usually 
between 2% and 9% of the prison population. Only 12 
prison systems worldwide report a percentage higher 
than 9% (1). Although women are a minority group within 
total prison populations, the number of women in prison 
is nevertheless increasing and the rate of the increase is 
often greater than that for men. For instance, in the United 
Kingdom (England and Wales), the number of women in 
prison increased by more than 200% over the period 
1996–2006 versus a 50% increase in the number of men 
in prison during the same period (2). Some of the increase 
can be explained by the global displacement of women 
due to war, social unrest, economic crisis and gender-
insensitive criminal justice systems.
Women in prison often come from deprived backgrounds, 
and many of them have experienced physical or sexual 
abuse, alcohol or drug dependence and inadequate health 
care before imprisonment (3). Offences for which women 
are imprisoned are mainly non-violent and property- or 
drug-related. This means that imprisoned women often 
serve a short sentence, resulting in a high turnover rate in 
women’s prisons (4). Because in most countries there are 
only a few women’s prisons, women convicted of a wide 
range of offences are frequently housed together, which 
implies that the overall regime is determined by the high-
security requirements of a very few high-risk prisoners (5).
As a result of the lifestyles many women have had before 
entering the prison system, their time in prison might be the 
first time in their lives that they have had access to health 
care, social support and counselling. The prison service 
should pay careful attention to women’s special needs, 
including specific health care needs, and guarantee a gender-
sensitive system of care while recognizing the opportunity 
for empowerment and supporting healthy choices.
This chapter discusses the health issues facing women in 
prisons, specifically:
•	 violence	and	abuse
•	 substance	use
•	 mental	health	issues
•	 infectious	diseases
•	 reproductive	health
•	 dental	health.
Special attention is given to children of imprisoned women, 
and the end of the chapter focuses on the organization 
of health care for female prisoners and opportunities for 
health promotion.
Violence and abuse
Many prisoners have experienced violence in their time 
before or in prison, often gender-based violence from 
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their intimate partners. Three times as many women as 
men report that they have experienced violence, either 
physical or sexual, before their imprisonment (6). Women 
who have experienced violence and abuse before their 
imprisonment may have low self-esteem and poor skills 
and suffer from a lack of confidence. Violence and abuse 
are also associated with poor outcomes in terms of mental 
and physical health problems, including reproductive 
health problems.
It is important that prison systems identify women who 
have been victims of violence or abuse before their 
imprisonment and take into account the possible re-
traumatizing effect of some aspects of the prison regime, 
such as strip-searching. Counselling and support should 
be available, and should continue after release.
Substance use
Drugs often hold a key to a woman’s offending. A high 
percentage of women in prison suffer from a drug problem 
and problematic drug use rates are often higher among 
female than male prisoners. It is estimated that around 
75% of women arriving in prison have some sort of drug-
related problem at the time of arrest.
Generally, women with substance use problems have 
fewer resources (education, employment and income), are 
more likely to be living with a partner with substance use 
problems, to be taking care of dependent children, have 
severe problems at the beginning of treatment for their 
substance use and have higher rates of trauma related to 
physical and sexual abuse and mental disorders than men. 
Post-traumatic stress disorder and anxiety disorders are 
especially common (7).
Women with substance use problems need treatment. A 
major concern is that prison systems frequently do not 
guarantee access to this treatment. A gender-sensitive 
approach to women’s health care should always take 
into account the need to provide specialized addiction 
treatment programmes. Substitution treatment has 
been proved to be the most effective treatment option 
for persons with substance use problems, and attention 
should be paid to implementing substitution treatment 
more widely in prison settings. Support for staff should 
also be developed, including the production of clear 
guidelines (8).
Alcohol use
The prevalence of alcohol use and dependence in 
women entering prison ranges from 10% to 24% (9), 
although more recent studies have identified higher 
prevalence rates. For example, in Finland 51% of 
women prisoners are alcohol-dependent and there 
is evidence to suggest that alcohol use disorders are 
an increasing problem among women prisoners (10). 
Despite the wide variation in prevalence estimates, it 
is clear that alcohol use is a greater problem for women 
in prison than for those in the general community. 
Prevalence rates tend to be higher among women 
prisoners than male prisoners – a consistent finding 
in several countries. Alcohol use disorders in women 
are associated with a range of other health and social 
issues including poverty, mental illness, drug use and a 
history of abuse in childhood.
Mental health issues
Women in prison are more likely to have mental health 
problems than both the general population and male 
prisoners (11), including high rates of post-traumatic 
stress disorders. Trauma are indirectly and directly linked 
to criminal pathways and to both mental and physical 
illness (12).
In the United Kingdom (England and Wales), it was shown 
that 90% of women in prison have a diagnosable mental 
disorder, substance use problem or both, and 9 out of 
10 women in prison have at least one of the following: 
neurosis, psychosis, personality disorder, alcohol abuse or 
drug dependence (13). The prevalence of severe mental 
illness (psychosis and major depression) is higher in 
the prison population than in the general population. A 
systematic review in 2002 showed that the prevalence of 
psychotic illnesses in women prisoners worldwide was 
4% and of major depression 12%, indicating that women 
prisoners are two to four times as likely to have a psychotic 
illness or major depression as the general population, 
and that 42% of women prisoners worldwide have a 
personality disorder, about 10 times the prevalence in the 
general population (14). Not only are women prisoners 
more likely to suffer from severe mental illness than the 
general population but they are more likely to do so than 
male prisoners. A British survey reported annual incidence 
rates of psychosis in women prisoners to be more than 
double that in male prisoners: 110 per 1000 compared to 
52 per 1000 (15).
Women’s mental health is likely to deteriorate in prisons 
that are overcrowded, where prisoners are not properly 
differentiated and programmes are either non-existent 
or inadequate to address the specific needs of women. 
Promoting mental health and well-being should be central 
to a prison’s health care policy (16).
Self-harm and suicide
Suicide and self-harm are important issues for female 
prisoners and the early period in custody is recognized as 
being a time of particularly high risk. Studies worldwide 
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have shown that suicide rates in prisons are up to 10 
times higher than those in the general population (17,18), 
and suicide is a leading cause of death in custody. The 
rate of suicide is higher in women prisoners than in male 
prisoners, in stark contrast to suicide rates in the general 
population which tend to be higher in men. Features of 
the prison regime as well as traumatic experiences in 
childhood and adulthood, mental health problems and 
a lack of social support are associated with suicidal 
behaviour (19).
Many more women in prison self-harm than commit 
suicide. Women prisoners are more likely to self-harm 
than male prisoners and than women in the community. A 
study of women prisoners showed that 16% had harmed 
themselves in the month before imprisonment (20). Those 
who self-harm are more likely to have a psychiatric 
disorder, drink hazardous amounts of alcohol and to have 
been abused as a child or adult.
To address the risk of suicide and self-harm, prison 
systems need to ensure that their health services are 
effective and that all staff working with women prisoners 
are aware of the issue.
Infectious diseases
Women are at greater risk than men of entering prison 
with HIV, hepatitis B and/or hepatitis C (21). Women who 
engage in risky behaviour, such as sex work or injecting 
drug use, are at particularly high risk. Women prisoners 
also have higher rates of STIs than male prisoners and the 
general female population. This has been attributed to the 
fact that they are more likely to participate in risky sexual 
behaviour, including sex work and injecting drug use. 
Syphilis is a rare disease among the general population 
but in some countries not uncommon in imprisoned 
women. 
Many STIs stay undetected. Some infections are more 
likely to be asymptomatic in women but at the same time 
more likely to have serious long-term health consequences 
such as ectopic pregnancy, infertility and chronic pelvic 
pain. They are a major factor in the spread of HIV, as they 
enhance transmission and diminish the woman’s general 
resistance.
Prison services should ensure that women living with 
HIV receive prevention, treatment, care and support 
equivalent to that available to people living with HIV 
in the community, including ART. Clean needles and 
syringes should be available to prevent women from 
sharing them and thus prevent the spread of HIV and 
other infectious diseases. If needles and syringes are 
not allowed in prison, other harm reduction measures 
should be accessible. While imprisoned women who are 
HIV-positive, or are at risk of being infected, face similar 
challenges to men in terms of access to essential care 
such as ART and harm reduction measures, they also have 
additional needs. Gender-specific interventions have been 
shown to be more successful than interventions that are 
gender-neutral. In particular, women prisoners benefit 
from interventions that address HIV prevention in terms 
of interactions and relationships with other people and 
those that also address the cultural and socioeconomic 
conditions in which the women live. Many women will 
have suffered from sexual abuse and need psychological 
interventions that address this together with gender-
specific empowerment strategies to enable them to 
negotiate safer sex practices effectively (22).
Reproductive health
Women prisoners are a high-risk group for sexual and 
reproductive health diseases, including cancer and STIs, 
particularly due to the typical background of these women 
which often includes injecting drug use, sexual abuse and 
violence, sex work and unsafe sexual practices (23).
Screening programmes for diseases such as cervical 
cancers should be included in the standard procedure 
in women’s prisons. Imprisoned women are at high risk 
of cervical cancer yet they are less likely to have been 
screened for it and are unlikely to complete appropriate 
follow-up and management of abnormal smear results. 
They are more likely to have a sexually transmitted 
disease and, more specifically, to have evidence of 
human papilloma virus infection that is causally related to 
cervical cancer. Several studies have shown higher rates 
of abnormal smears in the prison population. Evidence 
from Canada suggested that women prisoners presented 
with more severe abnormalities at a younger age than the 
general population (24). Paradoxically, these imprisoned 
women who are at greatest risk of cervical cancer are least 
likely to have been screened for this disease. This may be 
because of limited access for women with low incomes (if 
payment is required), a low level of knowledge or fear of a 
gynaecological examination. Prison health care providers 
need to develop locally appropriate services that ensure 
that women in need of cervical screening are rapidly 
screened and treated, if necessary, with clear pathways 
to ensure throughcare.
Women’s normal human functions, such as menstruation, 
are too often medicalized by prison systems and many fail 
to cope with women’s menstruation. For instance, they 
fail to provide menstrual products such as sanitary towels 
or adequate bathing and washing facilities (3). Menstrual 
products and frequent access to showers need to be 
freely available.
162
Prisons and health
Pregnancy, postnatal care and breastfeeding
Imprisoned women who are pregnant constitute a high-
risk obstetric group, that is, both mother and foetus are 
more likely to have problems during pregnancy and, 
subsequently, to have poorer outcomes. Some factors are 
likely to contribute to this: imprisoned women are likely 
to come from socially deprived backgrounds and are more 
likely to smoke, drink alcohol to excess and use illegal 
drugs than the general population. Various studies have 
shown that smoking rates in pregnant women prisoners 
approach 70% (25). The majority of these pregnant women 
have a history of drug abuse, and estimates of actual drug 
abuse during pregnancy range from 27% (26) to 71% (25). 
In addition, they are more likely to have a medical problem 
which could affect the pregnancy outcome and yet less 
likely to receive adequate antenatal care (27).
Women in prison also tend to have poorer birth outcomes 
than the general population. They are more likely to have 
a low birthweight baby and perinatal mortality rates are 
higher in this population (28). When compared to pregnant 
women matched for age, race, parity and socioeconomic 
status, however, there are no significant differences 
between the groups with regard to outcomes such as 
birthweight and foetal death rate. Furthermore, it seems 
that imprisonment has a favourable effect on pregnancy 
outcomes. Several studies have shown that longer periods 
spent in prison improve outcomes such as increasing the 
birthweight of the baby, or decreasing the likelihood of 
premature or instrumental delivery. Martin and colleagues 
estimate that for every day the mother spent in prison, the 
baby gained an additional 1.49 g (29). Possible explanations 
for these improved outcomes might be that prison provides 
food and shelter, moderates the use of drugs and alcohol, 
prevents strenuous activity, protects women against abusive 
partners and ensures access to antenatal care. However, 
imprisoning pregnant women when the majority have not 
committed a violent crime and therefore pose little risk to 
the public is ethically questionable. While the evidence 
that indicates that imprisonment may have benefits for the 
physical health of the mother and baby, imprisonment also 
presents many challenges to pregnant women. Imprisoned 
mothers are more stressed, anxious and depressed than the 
general population (30,31).
Dental health
Prisoners have significantly greater oral health needs than the 
general population and have often had very limited contact 
with dental health care services in the community. Many 
prisoners enter prison with dental health problems requiring 
urgent treatment. High levels of alcohol consumption, 
smoking and substance use all contribute to poor oral health. 
A survey in 2002 in the United Kingdom (Scotland) concluded 
that the severity of tooth decay was considerably worse in 
the prison population than in the community, especially for 
female prisoners (32). Providing appropriate dental services 
is an essential part of prison health services and must be 
guaranteed for all women prisoners.
Children of women in prison
Many women in prison are mothers and usually the sole 
or primary carers for their children. This results in large 
numbers of children being institutionalized when women 
are imprisoned, since the fathers often fail to care for 
the child(ren). In Europe, it is estimated that about 
10 000 children under the age of two years are affected 
by their mothers’ imprisonment every day. For instance, 
in the United Kingdom, a national study showed that in 
85% of the cases the father does not look after the child 
when the mother is imprisoned (20). The imprisonment of 
a mother may have a traumatic and lasting effect on both 
mother and child, in part due to great distress because 
of the separation together with a range of emotional 
and psychosocial problems, and also because they are 
less likely than imprisoned men to have someone in 
the family looking after their child and are more likely 
to lose their housing and children as a result of their 
imprisonment.
In many countries, babies born to women in prison can 
stay with their mothers in prison. Very young children may 
often accompany their mothers into prison, up to the age 
of three years on average in Europe. This age limit varies 
considerably across countries in Europe, with a maximum 
of six years old. 
Most countries where children are allowed to stay with 
their mothers in prison have special mother-and-baby 
units, where mother and child can stay together.
Children of imprisoned women have not committed a 
crime and should not suffer as if they had done so. The 
lives of the children who live in prison should be as good 
as the lives they would have led outside in the community, 
including good nutrition and decent playing areas. It 
should be possible for these children to leave the prison at 
any time if this is considered to be in their best interests.
Difficult problems and dilemmas arise both from 
accommodating children in prisons and separating them 
from their mothers. It is vital that in all decisions made 
concerning a child of an imprisoned woman, the best 
interest of the child is the primary consideration.
Organization of health care for women in 
prison
The specific needs of women are often not met by prison 
systems, which have been largely designed by and for 
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men. Women in prison need free access to a full range of 
gender-specific health services. There should be explicit 
recognition that women and men are different and that 
equal treatment of men and women does not result in 
equal outcomes.
The principles which should define a health care system 
for women in prison are listed in the 2009 WHO/UNODC 
Declaration on Women’s Health in Prison (5). These 
principles can be summarized as follows.
1. Imprisonment of women should be considered 
only when all other alternatives are unavailable or 
unsuitable. This is even more important as regards 
pregnant women and women with young children. Its 
importance becomes very clear when the personal 
and social costs of imprisonment of women are 
considered, in the context of their pathways to crime 
and their roles in their social, family and community 
contexts.
2. Services for mental illness, substance use disorders 
and post-traumatic stress disorders should be 
specifically included in the health services.
3. When children are involved, the best interest of the 
child(ren) should be the main factor in decisions 
regarding a woman’s imprisonment.
4. The wide variability of needs in women prisoners 
should be considered, as they are so heavily influenced 
by factors such as responsibility for children, personal 
experience of abuse and dependence problems.
5. There is a need for careful, comprehensive and 
detailed screening services, to include socioeconomic 
and educational background, trauma histories, current 
health status and an assessment of personal skills.
6. The underlying importance of human rights should 
pervade all thinking and policy development for 
everyone in compulsory detention.
These principles should be considered in the light of 
broad national political and cultural beliefs and in the 
context of a country’s criminal justice system. Countries 
seem to be at different stages as regards gender equity 
in national policies. Without broad acceptance of gender 
equity, women will struggle to have their specific needs 
recognized and applied at every contact with the criminal 
justice system. Even in countries that have national 
policies supporting gender equity, further gender-
sensitivity training and gender-specific services should be 
widely available.
There are other needs as regards staff training. For 
instance, the determinants of criminal behaviour in 
women and the long-lasting effects of histories of 
violence and abuse should be known and understood 
by those providing supervision and care. It is important 
that all prison staff working with women in prison attend 
gender-sensitive training and that the specific health care 
needs of women in prison are taken into account.
Continuity of care after release is of the utmost importance. 
Post-release care is essential and prison authorities 
should devote particular attention to the availability of 
treatment and social support services for women after 
release, even more so when it comes to women with 
a drug dependency. This is particularly important for 
women, who are often on very short sentences but whose 
physical and mental health needs are long-term.
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19. The older prisoner and complex chronic medical care 
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Key points 
•	 Prisoners	are	often	considered	geriatric	at	the	age	of	
50 or 55 years.
•	 Plans	should	be	made	for	the	increasing	use	of	health	
care services and medical care costs in the light of the 
growing number of older prisoners.
•	 Consideration	 should	 be	 given	 to	 developing	 a	
geriatric, team-based model of care for older prisoners, 
particularly those with multimorbidity.
•	 The	medication	lists	of	older	adults	should	be	regularly	
reviewed to avoid specific medications and to limit 
polypharmacy.
•	 The	physical	and	mental	health	status	of	older	prisoners	
should be assessed by focusing on geriatric syndromes, 
such as sensory impairment, functional impairment, 
incontinence and cognitive impairment, which are 
common and may pose unique risks in prison.
•	 Specific	 housing	 and	 prison	 environments	 should	 be	
evaluated and adapted as needed to ensure that older 
prisoners with limited function or mobility are not at 
risk for falls or social isolation. 
•	 The	 risks	 and	benefits	 of	 screening	 tests	 or	medical	
treatment plans should be discussed with older 
prisoners, taking into account life expectancy and the 
individual’s goals for care.
•	 Approaches	 should	 be	 developed	 to	 address	
behavioural infractions among older prisoners with 
sensory, functional or cognitive impairment, and 
prison officers and staff educated as needed.
•	 People	who	are	independent	in	the	community	might	
be functionally impaired in prison. Older prisoners 
should be assessed for their ability to perform physical 
prison tasks such as standing to be counted, getting 
in and out of a top bunk or responding to alarms, and 
adaptations made as needed.
•	 Prior	to	release	from	prison,	an	inmate	should	receive	
personalized discharge planning, including a bridging 
supply of medications, post-discharge medical appoint-
ments, summarized health records, a social support 
plan and age-specific community agency referrals.
•	 Resources	 should	 be	 developed,	 either	 prison-based	
or community-based working in the prison, to provide 
seriously ill and dying prisoners with palliative and/or 
hospice care according to individual need.
Introduction
General population ageing is a worldwide trend in nearly 
all regions outside sub-Saharan Africa, with prisons no 
exception. The growing number of older prisoners with 
complex medical co-morbidity has become a global 
challenge. Over the past decade, while overall prison 
populations have grown in nations as varied as Turkey 
(90% increase), Argentina (55%), Kenya (40%), Spain 
(30%), the United Kingdom (15%), the United States 
(13%) and China (10%) (1), in many places there has 
been a concurrent disproportionate growth in the number 
of older prisoners. In the United States, where the total 
prison population grew 100% between 1990 and 2009, 
the number of prisoners aged 55 years or older increased 
by more than 300% in the same period (2). In Japan, 
the number of older adults in prison has doubled in the 
last decade despite just a 30% increase in the number 
of older Japanese overall. Many other nations are also 
experiencing an increasing number of older prisoners, 
reflecting trends in ageing and in criminal justice policy. 
As societies age, the arrest and sentencing of older adults 
are on the rise. At the same time, more and more adults 
are growing old in prisons as countries embrace tougher 
criminal justice policies, including the increased use of 
life sentences, stronger drug and immigration laws and 
mandatory minimum sentencing practices. Regardless of 
nation-specific criminal justice policies that contribute 
to these shifting demographics, the growing population 
of older prisoners is expected to increase as the world 
population ages, unless there are significant policy 
changes.
Many prisons now provide primary care to a growing 
number of medically vulnerable older prisoners. 
Accordingly, prison health care systems must evaluate and 
optimize their ability to deliver complex chronic medical 
and social care for older prisoners if prison administrations 
are to provide for the basic rights of all prisoners. This 
imperative is also critical from a fiscal perspective as the 
ageing population in detention is a principal driver of the 
rising cost of incarceration, primarily due to greater health 
care costs (3).
To provide cost-effective and adequate health care to the 
growing number of older prisoners, prison administrations 
must first acknowledge the unique challenges associated 
with the ageing prisoner population. Ageing in general 
brings with it new physical, psychological and social 
challenges. Prisons and jails are typically designed for 
younger prisoners. For older prisoners, this introduces 
additional challenges to safety, functional ability and 
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health (4). Additionally, for older adults the health risks 
following release from prison may be magnified by 
challenges such as receiving only limited social support, 
being frail in unsafe neighbourhoods and having complex 
medication needs (5). Thus, for a growing number of older 
adults in countries around the world, prisons occupy an 
important place on the health care continuum.
This chapter applies the fundamental tenets of geriatric 
medicine to correctional health care to illustrate how to 
optimize care for older prisoners.
Accelerated ageing: who is old in prison?
The goal of geriatric medicine (and gerontology, its 
counterpart in nursing and the social sciences) is to increase 
the health, independence and quality of life of older adults 
by providing high-quality, patient-centred, interdisciplinary 
care (6). In the prison setting, geriatric care models may 
often be appropriate for prisoners who are younger than 
the 65-year cut-off typically used to define the elderly in 
the non-incarcerated population. This is because many 
medically and socially vulnerable adults (such as homeless 
or impoverished people, refugees and prisoners) experience 
accelerated ageing, that is, they develop chronic illness and 
disability approximately 10–15 years earlier than the rest 
of the population (7). Older prisoners often fall into several 
categories of the medically vulnerable, owing to a history of 
poverty, poor access to health care, substance use or other 
factors. As a result, many criminal justice systems consider 
prisoners to be older, or geriatric, by the age of 50 or 55 
years (5,7,8). Prison health care administrations should 
take accelerated ageing into account when determining 
the eligibility criteria for age-related screening tools and 
medical care protocols.
Geriatric medicine and the multimorbidity 
model of care
The first step towards optimizing the care of older 
prisoners is to adapt care models already developed 
and tested in the fields of geriatrics and gerontology to 
older prisoner health care. Geriatric medicine uses the 
multimorbidity model of care. Rather than focus on a 
single disease, the multimorbidity care model prioritizes 
the chronic medical conditions that most affect health 
status and quality of life for each individual (9). As 
with all older adults, the prevalence of multiple chronic 
medical conditions in prisoners increases with age. One 
study from the United States found that 85% of prisoners 
aged 50 years or older in the Texas prison system (which 
holds more than 150 000 prisoners of all ages) have one 
or more chronic medical conditions and 61% have two 
or more conditions. In contrast, just 37% of prisoners in 
Texas aged 30–49 years and 16% of those aged under 
30 years reported two or more chronic medical conditions 
(10). Other studies similarly reveal higher rates of chronic 
illness in older versus younger prisoners for conditions 
including hypertension, arthritis, heart disease, chronic 
obstructive pulmonary disease and cancer (11). In Texas, 
older prisoners were also substantially more likely than 
other prisoners to have infectious diseases such as TB, 
hepatitis B and C, methicillin-resistant staphylococcus 
aureus, syphilis and pneumonia (8).
The multimorbidity care model uses care coordination, 
patient education and shared decision-making between 
the health care clinician and the patient to weigh the risks 
and benefits of each medical decision on the individual 
patient. In acknowledgement of the complex needs of older 
adults, geriatric medicine is often practised in teams that 
include, for example, physician and nurse clinicians, social 
workers and pharmacists. Many older adults entering 
prison will not have had extensive contact with the health 
care system prior to their incarceration, and a complete 
medical assessment on arrival is often an important first 
step in diagnosing chronic disease, cognitive impairment 
and disability. The results of a comprehensive assessment 
can also help with decisions related to housing, security 
risk and programming eligibility.
Polypharmacy
A key barrier to the optimal management of chronic 
disease for older patients is polypharmacy. Defined as the 
inappropriate use of multiple medications, polypharmacy 
is a particular risk for older adults because of age-related 
changes in the metabolism, clearance and delivery of 
many medications. This heightened risk is also increased 
when multiple medications are used at one time and with 
specific high-risk medications.
Several lists of inappropriate and potentially inappropriate 
medications in the elderly exist and should be made easily 
available to prison health care clinicians. Medications 
with anticholinergic properties, for example, should be 
avoided in older adults as these drugs can result in side-
effects that include falls, delirium (acute confusion) and 
urinary retention (12). Anticholinergic properties are found 
in many classes of medication including antihistamines, 
some benzodiazepines and some antibiotics (13). In 
addition to being aware of important medications to avoid 
in the elderly, it is also critical that prison health care 
clinicians use caution when adding new medications to 
the regimens of older adults. Older prisoners should have 
their entire medication list reviewed regularly to assess 
the need for continuation of each medication while 
considering the possibility of drug–drug interactions with 
other concurrent medications. In keeping with the geriatric 
care model, a team approach may help to ensure proper 
management of medications in older prisoners.
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Geriatric syndromes
Geriatric syndromes are conditions that have multifactoral 
etiologies, significant morbidity and adverse effects on 
quality of life and are more common in older adults (14). 
The common geriatric syndromes considered here include 
falls, dementia, incontinence, sensory impairment and 
symptom burden. Health care providers who specialize 
in older adults focus as much time on assessing and 
addressing geriatric syndromes as on the diagnosis and 
management of chronic medical illnesses. In prison, 
geriatric syndromes are similarly important, affecting 
many older prisoners and increasing their risk for adverse 
health events.
Falls
Studies have found that approximately 30% of people 
aged over 65 years fall each year, a rate that increases 
with advancing age (12). Of those who fall, approximately 
20–30% suffer injuries with significant consequences for 
their independence and functioning, and even their risk of 
death (15). Older prisoners are at heightened risk of falls if 
they are housed in institutions with poor lighting, uneven 
flooring or poorly marked stairs or if they are required to 
perform activities beyond their functional ability, such 
as standing for long periods or climbing onto a top bunk. 
Other factors contributing to the increased risk of falls in 
prison could include allocation to accommodation that 
necessitates the use of many stairs, crowded areas where 
others are moving quickly and may jostle the older prisoner, 
or the use of ankle and/or wrist shackles which can affect 
normal gait by decreasing arm swing and can restrict the 
ability to compensate for imbalance with a wide-spaced 
gait. In addition, vitamin D deficiency can lead to abnormal 
gait, muscle weakness and osteoporosis, increasing the 
risk of injury from falls. This can be a particular problem 
for prisoners with less outdoor access. One study of older 
women prisoners in the United States found that 51% 
experienced a fall over a one-year period in custody (16). 
Effective interventions to reduce falls in the community 
include exercise programmes to promote balance and 
muscle-strengthening, environmental modifications 
such as grab bars and reviews of medication to avoid 
polypharmacy.
Dementia
Dementia is defined as a decline in two or more areas of 
cognitive functioning severe enough to cause functional 
decline. The prevalence of dementia doubles every five 
years from the ages of 60 years to 80 years, when it 
affects one third to one half of the population (12). The 
dementia risk is worse for people that are also at risk 
of incarceration, including those with a history of post-
traumatic stress disorder, low educational attainment, 
traumatic brain injury or substance abuse. Some of 
these factors are also associated with the earlier onset 
of dementia, such that prisoners could be at risk for 
cognitive decline at young ages. Cognitive impairment 
can be harder to detect in prison, given that many of the 
daily tasks necessary for independence in the community 
are frequently not required of prisoners, such as doing 
their laundry, cooking and balancing their finances. If it 
goes undetected, however, cognitive impairment could 
have considerable consequences in prison, including 
victimization, unwarranted disciplinary measures or failure 
to meet complex release instructions. For these reasons, 
many recommend cognitive screening upon intake for all 
older prisoners, and annually for those ageing in prison 
(4).
Incontinence
The prevalence of incontinence increases with age and is 
often under-reported and under-diagnosed (12). One study 
of United States prisoners found that 40% of inmates aged 
60 years and older reported some incontinence (17). Many 
types of incontinence can improve with treatment, yet a 
study of Californian prisons found that incontinence was 
often not treated by medical staff. Incontinence supplies 
were also found to be lacking (18). For older prisoners, 
untreated incontinence could lead to social isolation, 
depression, decreased functional status, ridicule or 
physical victimization. Prison health care clinicians should 
be trained to diagnose incontinence, investigate its causes 
and provide treatment, including incontinence supplies.
Sensory impairment
Impairments to hearing and vision, both common with 
advancing age, are associated with problems with 
balance, social isolation and disability (12). In prisons, 
these risks may be magnified as older prisoners with visual 
impairment struggle to negotiate unseen obstacles, or 
those with hearing impairment are unable to hear orders 
or are misconstrued as disrespectful of fellow inmates 
whose comments they have not heard (16). For prisoners 
with active legal cases, unaddressed sensory impairment 
could reduce their capacity to participate effectively in 
their own defence. It is, therefore, critically important that 
sensory impairments are identified and that adaptations 
are made available. Lawyers, correctional and law 
enforcement officers and other front-line criminal justice 
professionals should also be trained to identify prisoners 
with potential impairments for referral to medical staff.
Symptom burden
A high prevalence of distressing symptoms in older 
prisoners can confound approaches to effective medical 
treatment. Among older prisoners, emotional symptoms 
related to social isolation and long-term incarceration 
(or institutionalization) are common and can lead to 
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adverse mental and physical health outcomes (7). Physical 
symptoms are also prevalent in ageing populations. 
Persistent pain, for example, is among the most common 
presenting complaints in older adults who visit hospital 
emergency departments. In prisons, pain treatment is often 
complicated by co-occurring substance use disorders, 
clinicians’ concerns about diversion of medicaments, 
prison policies limiting controlled substances and other 
factors (13). Yet without adequate treatment, distressing 
symptoms can lead to a lower quality of life, new or 
worsened functional impairment, increased use of the 
health care services and a rapid decline in health for 
older adults. Additional symptoms that are often under-
recognized and/or undertreated in older adults include 
shortness of breath, constipation and dizziness (12). Thus, 
a full assessment of symptoms and targeted planning of 
treatment should be considered critical components of all 
older prisoners’ medical care.
Functional status and environmental  
mismatch
Geriatric syndromes can greatly affect functional 
status, defined as a person’s degree of independence 
in the activities of daily living (ADL – bathing, dressing, 
eating, toileting and transferring between chair and bed 
or toilet). Dependence in these and instrumental ADL 
(IADL – typically including managing medications and 
finances, transportation or shopping) increases with 
age and is associated with more use of the health care 
services and higher health care costs, a further decline 
and greater morbidity (19). Although evidence describing 
the prevalence of functional impairment in prisons is 
limited, one study in a United States jail found that 20% 
of men aged over 50 years were dependent in some IADLs 
and 11% required assistance in some ADLs (17). Such 
studies may, however, significantly underestimate the 
prevalence of functional impairment in older prisoners 
because incarceration includes many unique physical 
activities not accounted for in traditional ADL and IADL 
assessments. Another study sought to identify the unique 
nature of functional ability in prison by identifying prison-
specific ADL. These included dropping to the floor for 
alarms, standing for head count, getting to the dining hall 
for meals, hearing orders from staff, and climbing on and 
off one’s bunk (16). The unique daily activities required for 
independence in prison differ by institution and housing 
unit. The study found that many older prisoners who 
would be independent in the community were functionally 
impaired in prison after accounting for the unique physical 
tasks required for independence in prison. As a result, 
experts recommend that a list should be drawn up of the 
physical activities necessary for independence in each 
housing unit or institution. These lists should be used 
to house and stratify for risk older prisoners in need of 
additional supervision and assistance, and an annual 
screening policy should be instituted to assess functional 
impairment in individuals growing old in prison (4).
Mental health issues 
Older prisoners are likely to suffer from mental illness at 
higher rates than their age-matched counterparts in the 
community (20–22). One study in the United Kingdom 
found that as many as one in three older prisoners 
suffered from depression. The same study also found 
that psychiatric conditions were among the most under-
detected and under-treated illnesses in older prisoners 
(22). Mental health issues in older prisoners may be 
particularly hard to detect or identify. As behavioural 
health risk factors associated with incarceration (such as 
traumatic brain injury and substance abuse) accumulate 
over time, challenges to effective diagnosis and the 
prescribing of medications are greater. Worsening 
physical health may also have an impact on mental 
health. Functional impairment, for example, can lead 
to decreased participation in social, vocational or work 
programmes which may, in turn, lead to social isolation, 
withdrawal and depression (23).
Older adults may also experience psychological trauma 
directly related to their incarceration. A sample of elderly 
first-timers in United Kingdom prisons were frequently 
anxious, depressed or psychologically traumatized by 
incarceration (24). After a long period of imprisonment, older 
prisoners may also have anxieties related to release (7). 
One study also showed that long-term prisoners experience 
a winnowing of their outside social support network, with 
fewer visits and less contact with outside family or friends 
over time (23). Other older prisoners may develop anxiety 
at the onset of new medical conditions or a fear of dying 
while in prison (7). Older prisoners should, therefore, be re-
evaluated by a mental health provider with knowledge of 
ageing-related mental health issues as factors related to 
their physical health, criminal justice disposition or changes 
in their outside social support structures.
End of life care and death 
Although many older prisoners will eventually be released, 
death in custody occurs in nearly any prison system. 
Some legal systems provide for the early (or medical 
or compassionate) release of terminally or seriously 
ill prisoners (25), although uniform standards for such 
programmes are not in place in every system. Where early 
release is provided for, prison health care professionals 
should be trained in the relevant legal and medical 
guidelines and, where appropriate, should be capable of 
assisting eligible prisoners to navigate the process. In the 
United States, in states with early release laws, the lack 
of a clearly defined prisoner advocate or role for the prison 
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health care provider has sometimes served as a barrier 
to the release of medically eligible prisoners (25). Prison 
administrations where early release laws exist should, 
therefore, consider implementing prisoner advocacy 
protocols that ensure prisoners have full access to the law 
regardless of their medical disposition.
In the many countries and cases where early release does 
not apply, hospice and/or palliative care may provide the 
best standard of care for seriously ill or dying prisoners. 
Hospice care is focused on people who are dying (usually 
in the last six months of life), while palliative care is 
focused on providing guidance and symptom control for 
all seriously ill individuals, regardless of prognosis. In 
the community, both care models have demonstrated 
improvements in the quality of patients’ remaining lives 
while reducing health care costs (26). At present, however, 
the most effective means of providing end-of-life medical 
care in prisons is not well understood. In the United States, 
approximately 70 prisons have hospice units modelled 
closely on community-based hospice programmes. These 
hospice units have been shown to produce cost-effective, 
high-quality end-of-life care. Issues remain, however. The 
appropriate use of volunteers in prison hospice units, 
patient-clinician trust, and the support mechanisms 
available to prisoners making decisions about life-
prolonging treatment, for example, have been identified 
as areas where more research is needed. In the United 
Kingdom, palliative care in prison provided by community 
providers is the commonly used care model for seriously 
ill prisoners (27). Yet, again, more research is needed to 
gain a better understanding of how prisoners experience 
these services and how they can be further optimized (2)
.
Ageing and re-entry into the community 
Studies have shown that advancing age is one of the 
few reliable predictors of decreasing recidivism (7). As a 
result, there have been many calls in the United States 
for the early release of nonviolent geriatric prisoners to 
alleviate overcrowded prisons and reduce correctional 
costs. Others have proposed wider use of alternatives 
to incarceration for nonviolent older prisoners, such as 
house arrest or electronic monitoring. If momentum builds 
behind such policies, and as ageing societies continue to 
process growing numbers of older adults through prison, 
effective preparation for the re-entry of older adults to the 
community will be increasingly important.
On release, geriatric ex-prisoners may face unique 
challenges, with potential consequences for community-
based health care and social services systems. Older 
adults are particularly vulnerable to difficulties in finding 
employment and suitable housing. After long periods of 
incarceration, many may also have difficulty navigating 
the bureaucratic processes required to re-enrol in social 
benefits programmes (5,28). Such social challenges both 
hinder successful reintegration and pose additional health 
risks. Inadequate planning for medical care and/or social 
support prior to release may also place older adults at risk 
of interruptions in treatment and failure to continue with 
needed medications (5,13). Such system-level deficiencies 
can result in avoidable use of the emergency services, 
hospitalization and even death. Steps can, however, 
be taken before release to smoothe the transition back 
into the community for older adults, such as training in 
independent living skills (cooking, shopping, banking), a 
health care transition plan that includes health care and 
access to medication, a summary of medical problems 
sent directly to the post-release physician, links to age-
specific community resources and social support, and 
education about self-care and disease management. 
Although the current evidence base is limited, intensive 
case management and peer mentoring programmes for 
older adults may also improve outcomes in the important 
period following release.
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20. Primary health care in prisons
Andrew Fraser
Key points 
•	 Prison	 is	 a	 special	 setting	 for	 primary	 health	 care.	
All prison health services should strive to provide 
prisoners with health care equivalent to that provided 
in the community.
•	 The	main	purpose	of	health	care	is	patient	care.	Prison	
health care is no different. Health professionals in prison 
also advise prison governors or directors and sometimes 
serve the courts. They should do so with the greatest 
possible involvement of their patients, balancing ethics 
and care within the controlled environment of prison.
•	 Prisoners	 and	 health	 professionals	 alike	 have	 rights	
and responsibilities. Professional groups should 
adhere to national standards of practice and to 
international rules and recommendations.
•	 Health	 professionals	 should	 understand	 and	 seek	 to	
minimize the negative effects of the experience of 
prison and use opportunities that prison can offer to 
benefit their patients.
•	 Prison	 health	 services	 should	 understand	 the	 health	
needs of their patients and seek to meet these needs 
to the greatest extent possible within the available 
resources and norms for the country.
•	 Mental	 health,	 addiction	 problems	 and	 infections	
dominate most health needs of prisoners. Other types 
of acute and chronic health condition are also common 
and deserve attention.
•	 The	 primary	 care	 service	 should	 get	 to	 know	 their	
patients on admission, care for them during their stay 
and help to prepare them for release.
•	 Prison	 health	 services	 should	 understand	 the	 justice	
and health policies and practices in their facilities 
and seek to link up with local services and resources, 
especially regarding the management of people with 
severe mental illness.
•	 Every	 prison	 should	 have	 medical,	 nursing,	 dental,	
psychological and pharmacy services, with 
administrative support.
•	 Every	 prison	 should	 have	 access	 to	 an	 appropriate	
level of health services at all hours.
•	 Every	prison	should	maintain	a	system	that	accounts	
for its work, including its assets, resources, processes, 
key clinical challenges and outcomes, including critical 
incidents.
•	 Primary	health	care	in	prison	is	important	for	the	well-
being of the patients, all prisoners and the community, 
for the effectiveness of prison services and the public 
health of the community.
Introduction
The health care of prisoners is an integral and essential 
part of every prison’s work.
Primary care is the foundation of prison health services. 
Primary care is the most effective and efficient element of 
health care in any public health system (1) and, as such, 
should be available to every prisoner. As described in 
more detail in Chapter 2, prisoners have the same right to 
health care as everyone else in society.
The purpose of health care
In most respects, the purpose of health care in prison is 
the same as outside prison. The care of patients is its core 
function and its main activities are clinical. A full primary 
care service, however, also includes elements of disease 
prevention and health promotion (2).
As with primary care in the community, there are secondary 
duties. Prison health professionals may occasionally carry 
out other duties and services. They may provide reports 
to the courts, and reports for when the early release of a 
prisoner is being considered on general or specific health 
grounds. In most countries, these processes occur under 
the protection of laws and regulations. Unless there are 
exceptional circumstances, such as the potential for 
damage to a patient or to the interests of someone else 
mentioned in the report (a third-party interest), patients 
should be involved in decisions about their health care and 
the use of personal health information, and be entitled to 
see and keep copies of reports and correspondence.
Despite the many similarities in health care between 
prison and the community, there are also differences. 
Prison brings a loss of freedom which has many 
consequences for health care.
•	 Prisoners	 automatically	 lose	 the	 social	 component	
of health, including the loss of control of their 
circumstances, the loss of family and familiar social 
support and a lack of information and familiarity with 
their surroundings.
•	 The	prison	environment	often	poses	a	threat	to	mental	
well-being, especially to the decision-making capacity, 
and to a sense of personal security.
•	 In	most	circumstances,	prisoners	are	unable	to	choose	
their professional health care team.
•	 Similarly,	primary	care	teams	in	prison	cannot	select	
their patients.
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•	 Neither	the	patient	nor	the	health	care	team	chooses	
the beginning and end of courses of treatment or of 
the clinician–patient relationship in general – this is 
largely decided by the courts.
•	 Generally,	 patients	 who	 are	 prisoners	 need	 a	 high	
level of health care.
The experience of prison
All aspects of prisoners’ lives in prison affect their health, 
not only the quality of the health services provided.
To create the best conditions for good health and effective 
health care, prisons should adopt a whole-prison approach 
(see Chapter 21) to the provision of:
•	 a	 healthy	 environment	 and	 a	 culture	 of	 care	 and	
rehabilitation;
•	 an	 atmosphere	 in	 which	 prisoners	 feel	 safe	 in	 the	
company of other prisoners and staff;
•	 opportunities	 for	prisoners	 to	 talk	 to	other	people	 in	
confidence;
•	 opportunities	 for	 properly	 supervised	 care,	 including	
basic social care for prisoners by other prisoners;
•	 opportunities,	through	visits,	to	maintain	family	links;
•	 information	about	the	prison	routine;
•	 ways	to	keep	loneliness	and	boredom	to	a	minimum;
•	 adequate	food,	opportunities	for	exercise	and	access	
to fresh air; and
•	 sufficient	privacy,	adequate	light,	ventilation,	heating	
(and sometimes cooling) and access to sanitation in 
the cell or barrack;
•	 basic	 training	 for	all	prison	staff	on	matters	of	health,	
health care and the  legal duties of care (Chapter 22).
Prison staff and management should be aware of, and 
educated in, basic health issues, particularly in factors 
that determine whether a prison environment promotes 
health. Staff should also be able to spot signs of serious 
illness and be expert in first aid and management of 
mental health crisis situations.
The components of primary care
The key components of a prison health service are 
contained in a section of the Standard minimum rules 
for the treatment of prisoners, produced by WHO and 
the Office of the United Nations High Commissioner for 
Human Rights (2). The remainder of this chapter is based 
on this authoritative source. Rules 22–26 cover the 
medical services that should be available in all prisons:
22. (1) At every institution, there shall be available the 
services of at least one qualified medical officer who should 
have some knowledge of psychiatry. The medical services 
should be organized in close relationship to the general 
health administration of the community or nation. They shall 
include a psychiatric service for the diagnosis and, in proper 
cases, the treatment of states of mental abnormality.
(2) Sick prisoners who require specialist treatment shall be 
transferred to specialized institutions or to civil hospitals. 
Where hospital facilities are provided in an institution, their 
equipment, furnishings and pharmaceutical supplies shall be 
proper for the medical care and treatment of sick prisoners, 
and there shall be a staff of suitable trained officers.
(3) The services of a qualified dental officer shall be available 
to every prisoner.
23. (1) In women’s institutions, there shall be special 
accommodation for all necessary prenatal and postnatal 
care and treatment. Arrangements shall be made wherever 
practicable for children to be born in a hospital outside the 
institution. If a child is born in prison, this fact shall not be 
mentioned in the birth certificate.
(2) Where nursing infants are allowed to remain in the 
institution with their mothers, provision shall be made for a 
nursery staffed by qualified persons, where the infants shall 
be placed when they are not in the care of their mothers.
24. The medical officer shall see and examine every prisoner 
as soon as possible after his admission and thereafter 
as necessary, with a view particularly to the discovery of 
physical or mental illness and the taking of all necessary 
measures; the segregation of prisoners suspected of 
infectious or contagious conditions; the noting of physical 
or mental defects which might hamper rehabilitation, and 
the determination of the physical capacity of every prisoner 
for work.
25. (1) The medical officer shall have the care of the physical 
and mental health of the prisoners and should daily see all 
sick prisoners, all who complain of illness, and any prisoner 
to whom his attention is specially directed.
(2) The medical officer shall report to the director whenever 
he considers that a prisoner’s physical or mental health 
has been or will be injuriously affected by continued 
imprisonment or by any condition of imprisonment.
The primary care journey
At the minimum, primary care interventions are required 
at the times of highest risk to the health of prisoners, 
namely on admission and before release. They are also 
needed to address health matters that arise during 
imprisonment.
Every prisoner should be seen by a health professional at 
the time of reception and by a doctor soon after reception. 
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On first assessment, the following questions should be 
examined.
1. What are the main health problems for the prisoner as 
a patient?
2. Is the patient a danger to him/herself?
 − Does he/she have a serious illness, or is he/she 
withdrawing from a substance misuse dependence 
or correct medication?
 − Is he/she at risk of self-harm or suicide?
3. Has the patient suffered injury or ill-treatment during 
arrest or detention?
4. Does the patient present a risk or a danger to others?
 − Does he/she have an easily transmitted disease 
that puts others at risk?
 − Is his/her mental state causing him/her to be a 
threat or likely to be violent? Note: prison health 
professionals should assess the patient’s risk to 
others on health grounds alone.
Every prisoner should be assessed, or his/her health care 
reviewed, after a suitable period of settling into prison, 
as follows.
1. Are any immediate health problems (questions 1 and 2 
above) under control?
2. Do the problems require more detailed assessment 
and a treatment plan?
3. What is the past record and wider assessment of this 
person’s health?
4. Does the person need specialist assessment, 
treatment plans or further reports?
5. Does the person need an integrated care plan for 
several problems, for instance, for mental health and 
dependence problems?
6. Who will take action on the care plans?
7. What can be done by:
 − the patient
 − the health care team
 − secondary or specialist care
 − the rehabilitation team
 − the prison generally?
8. Are there other key determinants that influence the 
patient’s health and well-being, such as housing, 
welfare or family matters?
Primary health care in prison should be accessible to 
all prisoners when they request it, according to their 
requirements. The needs of long-term prisoners should be 
reviewed regularly and care and treatment goals agreed 
with them.
Each patient should receive help in preparing for release 
and should be put into contact with primary care services 
in the community.
Prison health care resources
Prisons should recognize that most prisoners need a 
considerable amount of health care (3). Adequate resources 
should be channelled to prison health care services to 
provide prisoners with a standard of health care that is 
at least equivalent to that provided in the community. 
Further, it is important for prisoners to take advantage of 
the opportunity that imprisonment represents. Many come 
from marginalized and poor communities and are in poor 
health. Because prison health is integral to good public 
health, effective health care in prison ultimately reduces 
the health risks to people in the community.
All prison systems receive people who:
•	 are	marginalized,	poor,	homeless	or	out	of	work,	with	
mental health and dependence problems;
•	 have	led	a	chaotic	life,	without	access	to	proper	and	
regular health care, and have co-occurring health 
problems; and
•	 have	health	care	needs	requiring	specialists	from	some	
disciplines, including infectious diseases, dentistry, 
psychiatry and psychology, optometry and pharmacy.
The provision of adequate primary care in prisons ideally 
leads to a narrowing of the health gap and to promoting 
equity in health (4). Prisoners can gain access to care for 
known conditions that may not otherwise be available to 
them in the community such as mental health care, dental 
care and management of long-term conditions. Primary 
health services can offer an opportunity to assess, detect 
and treat serious illnesses, especially mental health, 
infections and dependence problems.
Common problems encountered in primary 
care practice in prisons
Primary care in prisons has to deal with a very wide 
range of common problems. Prisoners have a higher 
likelihood of almost any clinical problem compared with 
the general population, in line with their socioeconomic 
conditions and drug and alcohol use. No conditions are 
unique to prison, but many are more prevalent among 
prisoners, including suicide risk, addictive disorders, 
mental disorders and bloodborne communicable diseases 
(3). Some conditions can be promoted by prison conditions 
(often for the worse), such as airborne infection, shared 
injecting equipment, anxiety, depression and other mental 
health problems. Clinicians should always be vigilant for 
signs of recent injury and seek to establish the cause.
Common problems in prison health care practice include 
the following.
•	 Physical	problems	include:
 − dependence (drugs, alcohol, tobacco);
 − communicable diseases;
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 − oral diseases; 
 − chronic medical disorders (diabetes, epilepsy, 
diseases of the reproductive system, cancer, and 
heart, lung and liver disease).
•	 Mental	health	problems	include:
 − low mood or self-confidence (self-esteem and 
dependence on, for example, drugs or alcohol);
 − anxiety;
 − depression;
 − severe mental disorders;
 − post-traumatic stress disorder.
•	 Co-occurring	problems	include:
 − vulnerability (people with a learning disability, brain 
injury or learning difficulty resulting, for instance, 
from autistic spectrum disorder or dyslexia); 
 − the nature of the sentence (harm against women, 
offences against children, bullying or recollection 
of being a victim of abuse);
 − personality disorder;
 − physical and mental trauma and stress;
 − sensory, motor or cognitive disability;
 − social determinants of poor health.
Prison health care services must be able to address the 
following priority areas:
•	 access	as	necessary	to	an	appropriate	level	of	care;
•	 continuity	and	coordination	of	care;
•	 adequate	 recording	 and	 transfer	 of	 medical	
information;
•	 standardization	 of	 care	 for	 acute	 and	 chronic	
conditions, based on scientific evidence;
•	 attention	to	patient	safety	to	minimize	risk	of	harm;
•	 the	 health	 needs	 of	 special	 populations,	 including	
women and elderly and disabled people.
All health care services should be proficient in, or have 
ready access to, specialists in mental health care and 
drug dependence.
Mortality among the population involved with the criminal 
justice system is much higher than among their peers in 
the community, with the greatest risk to life immediately 
after release from violence, self-harm, or drug and alcohol 
intoxication (5,6). Primary and specialist services should 
work closely to prepare prisoners for release and find 
support thereafter.
Building blocks for primary care in prison
The quality of primary health care in prison depends on 
many factors:
•	 the	total	resources	available	to	the	prison	system;
•	 the	 state	 of	 development	 of	 primary	 health	 care	
in the community, including entitlement to dental, 
pharmacalogical and clinical investigations, and 
the fluidity with which prisoners can intersect with 
community health care resources (where medically 
appropriate);
•	 the	 development	 of	 mental	 health	 care	 in	 the	
community, specifically forensic psychiatry and 
addiction treatment; and
•	 the	 qualifications	 and	 experience	 of	 prison-based	
health professionals.
Within a prison, the factors that affect the quality of care 
include:
•	 the	size	of	the	prison	population;
•	 the	 commitment	 of	 the	 governor	 or	 director	 to	 the	
health care of prisoners;
•	 the	professional	independence	of	doctors	and	clinical	
managers from the prison management;
•	 the	 population	 dynamics	 of	 the	 institution,	 including	
length of stay;
•	 gender;	
•	 special	health	care	needs,	 including	 for	LGBT,	young	
and older people, people with a spectrum of disabilities 
and non-native speakers (7).
Women have specific needs for care and protection in 
prison (7,8 Rule 10). Their needs and rights have been 
highlighted in Chapter 18, with supporting documents 
ratified by United Nations agencies. Wherever possible, 
women should receive medical treatment from women 
nurses and doctors. A female prisoner is entitled to have 
her request met that she be examined or treated by a female 
physician or nurse. The prisoner’s preferences should also 
be taken into consideration in the medical establishment 
to which she is referred. If these arrangements are not 
possible, there must be a female supervisor during her 
examination in line with the prisoner’s request. The 
prisoner should not be obliged to explain the reasons for 
her preference.
Measuring performance in health care
Performance measurement is critical to the development 
and maintenance of high-quality health care services. 
The ability to measure performance depends on: (i) the 
resources allocated to prison health care; and (ii) the 
prison’s capacity for recording information and for having 
achievable and recognized standards for good practice 
that are aligned with the country’s public health system.
Key areas for measuring performance are:
•	 adequate	facilities	and	medical	equipment;
•	 equivalent	 standards	 and	 links	 with	 public	 health	
services for consultations and transitions;
•	 knowledge	of	the	population-based	distribution	of	risk	
and disease;
•	 a	supportive	prison	culture;
177
Primary health care in prisons
•	 adequate	staffing;
•	 compliance	 of	 clinical	 performance	 with	 evidence-
based guidelines;
•	 a	focus	on	public	health	and	health	protection;
•	 a	focus	on	health	promotion;
•	 functional	health	information	systems	and	transfer	of	
information.
Performance depends on adequate facilities and 
processes that allow prisoners to access health resources 
easily. This is an important matter, dependent on security 
staff being able to escort prisoners and to provide safety 
and assurance for health care staff. On balance, facilities 
should allow for protection of confidentiality and privacy, 
with assessment and diagnostic facilities that match 
the skill and capacity of the public health service. More 
complex primary care services can include day care and 
inpatient accommodation. Facilities should be adequate 
to deliver care, including of sufficient size and cleanliness, 
with equipment, natural light, good access for people with 
disabilities, and meeting, reference and administrative 
facilities.
Equivalence to public health services requires national 
prison health care services to adhere to national codes 
of professional practice, standards of quality of care and 
regulatory matters. A positive aspect of demonstrating 
such equivalence is to use the same measures of quality 
assessment for prison services as for:
•	 local	public	health	services;
•	 national	 medical	 and	 professional	 institutions,	
colleges, academies and independent prison 
inspection teams; 
•	 international	 organizations	 and	 comparable	 prison	
systems.
Prison health services require the capacity to record and 
understand the health needs of prisoners and to provide 
care with:
•	 resources	that	are	sufficient	to	meet	patient	needs;
•	 a	prison	culture	that	supports	the	health	service	and	
the access of prisoners to health care;
•	 links	to	other	rehabilitation	and	care	resources	in	the	
prison, between prisons and, following release, in the 
community.
The prison director’s leadership is vital in creating an 
environment in which prisoners and staff members value 
good health, feel safe and support each other. There 
should be a culture of respect and entitlement with:
•	 a	 humane	 health	 professional	 culture	 that	 respects	
patients’ confidentiality and privacy and their right to 
health care equivalent to that sought by the general 
public;
•	 links	to	other	functions	of	the	prison;
•	 an	effective	comments	and	complaints	system	when	
things go wrong; 
•	 a	sustained	commitment	to	limiting	the	illegal	supply	
of and trade in alcohol and illicit and prescription 
drugs.
Competencies of and support for prison 
clinical staff
Quality of care should be ensured through the following 
factors.
•	 Medical	practitioners	working	in	prison	should	strive	
to have expertise, at least in general medical practice, 
mental health, addictions and infection control. These 
skills should be reflected in health care staff from 
other disciplines.
•	 Dental	practitioners	should	be	well	trained	in	severe	
dental disease.
•	 Large	establishments	with	specialist	facilities	(such	
as hospitals and day care) should have adequate 
staffing levels and skills to deal with seriously ill 
patients.
•	 Prisons	 that	 contain	women	or	 young	people	 should	
employ practitioners with skills that are sensitive to 
the particular conditions of these groups, including the 
care of women and young children.
•	 All	 health	 care	 professionals	 should	 be	 properly	
trained in the constraints of clinical practice in a 
prison, including the need for high standards and 
consistent practice, teamwork skills, good judgement 
in prescribing potentially addictive or mood-altering 
drugs, and adherence to policies designed to uphold 
the confidence of vulnerable people who are patients 
in prisons.
There must be sufficient time:
•	 to	assess	and	treat	patients;
•	 to	meet	as	a	health	care	team;
•	 to	maintain	 professional	 development	 and	 networks	
of fellow professionals with common interests and to 
operate a method of appraisal that demonstrates that 
staff are learning in carrying out modern practice;
•	 to	support	active	 teaching	and	 training	programmes;	
and
•	 to	 have	 the	 capability	 to	 deliver	 care	 that	 meets	
modern standards.
The primary care service should have access to or skills 
or capacity in public health and health protection matters, 
including to the Standard minimum rules for the treatment 
of prisoners (2) as follows:
26. (1) The medical officer shall regularly inspect and advise 
the director upon:
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(a) the quantity, quality, preparation and service of food;
(b) the hygiene and cleanliness of the institution and the 
prisoners;
(c) the sanitation, heating, lighting and ventilation of the 
institution;
(d) the suitability and cleanliness of the prisoners’ clothing 
and bedding; and
(e) the observance of the rules concerning physical education 
and sports, in cases where there is no technical personnel in 
charge of these activities.
(2) The director shall take into consideration the reports and 
advice that the medical officer submits according to rules 
25(2) and 26 (see Box 4.1) and, in case he concurs with the 
recommendations made, shall take immediate steps to give 
effect to those recommendations; if they are not within his 
competence or if he does not concur with them, he shall 
immediately submit his own report and the advice of the 
medical officer to higher authority.
Methods of self-critical review of critical incidents should 
be in place for key events such as deaths in custody, 
deaths following custody, infectious disease outbreaks, 
suicide prevention programmes and people with serious 
mental illness.
Health protection and promotion as part of primary 
medical care in prison
Health promotion is an important part of the work of the 
prison health care service.
•	 Health	care	professionals	should	be:	educated,	aware	
and demonstrate high standards of hygienic practice; 
capable of assessing the cleanliness of patients and all 
prison facilities; and aware and capable of operating 
effective TB control, including auditing the results.
•	 Effective	 control	 procedures	 are	 needed	 to	 limit	 the	
transmission of bloodborne viruses and STIs.
•	 There	 should	 be	 a	 smoking	 control	 policy	 for	 health	
centres, prisoners and staff throughout the prison.
A service should be developed that incorporates health 
promotion into the wider work of the prison, such as:
•	 encouraging	people	to	acquire	basic	life	skills;
•	 encouraging	 training	 for	employment	and	purposeful	
activity;
•	 locating	suitable	accommodation	after	release;
•	 linking	 with	 welfare	 programmes	 and	 entitlements	
after release;
•	 encouraging	 participation	 in	 programmes	 to	 help	
people stop taking illegal and harmful drugs, smoking 
tobacco and drinking excessive alcohol; and 
•	 encouraging	people	to	exercise	regularly	and	to	learn	
to prepare and enjoy foods that provide a balanced 
and nutritious diet.
Key background factors that are important for health 
promotion for prisoners include:
•	 social,	 economic	 and	 life	 determinants	 of	 lifestyle	
health problems;
•	 overcrowding,	smoking,	drugs	and	dependence;
•	 ethnic	diversity,	 language	and	religion	 in	the	context	
of drugs and mental health;
•	 disability,	 especially	 intellectual	 or	 developmental	
disability or brain disease;
•	 alcohol	and	dental	health;
•	 nutrition	and	infections;
•	 poor	hygiene;
•	 sexual	health	and	chronic	conditions;
•	 chaotic,	unstructured	lifestyles;
•	 abusive	relationships;
•	 poor	educational	attainment;	
•	 personality	disorders;
•	 lack	of	assets	or	social	capital;
•	 history	of	past	abuse;
•	 poor	 family	 cohesion,	 parenting	 and	 supportive	
relationships.
Health services in prison should ensure that patients’ 
health records are kept at a high standard, equivalent to 
best practice in the national public health service, and 
including:
•	 practical	 processes	 for	 recording,	 recalling	 and	
sharing clinical information to support the care of the 
patient;
•	 standard	methods	for	reporting	to	the	prison	director,	
national prison services and outside organizations on 
the work of prison health centres and accounting for 
the delivery of health care, using anonymous data 
extracted from health care records;
•	 a	comments	and	complaints	system	for	patients	both	
to correct apparent faults and to learn from their 
experience.
Prison health care should have good links with public 
health services outside the prison, for many reasons, 
including:
•	 assuring	 the	 continuation	 of	 treatment	 for	 patients	
coming into prison;
•	 securing	 primary	 care	 services,	 mental	 health	 and	
addictions care and other continuing care following 
release from prison;
•	 ensuring	access	to	specialist	services,	including	secure	
forensic psychiatry facilities for those who require it;
•	 ensuring	access	to	specialist	public	health	help	in	the	
event of an incident or outbreak;
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•	 ensuring	that	prison	health	care	staff	can	access	and	
benefit from education and training opportunities; and
•	 allowing	for	the	sharing	of	clinical	information	between	
health professional staff for the purpose of direct 
patient care, in accordance with the patient’s wishes 
and with good practice in ensuring confidentiality.
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21. Promoting health in prisons: a settings approach
Michelle Baybutt, Enrique Acin, Paul Hayton, Mark Dooris
Key points 
•	 Prisoners	tend	to	have	much	poorer	physical,	mental	
and social health than the population at large.
•	 Health	 promotion	 and	 the	 prevention	 of	 disease	 for	
this group should be based on an assessment of health 
needs.
•	 The	 quantity	 and	 quality	 of	 service	 should	 be	 at	
least equivalent to services offered in the outside 
community.
•	 A	 whole-prison	 or	 settings	 approach	 to	 promoting	
health draws on three key elements: (i) prison policies 
that promote health (such as a smoking policy); (ii) an 
environment in a prison that is supportive of health; 
and (iii) disease prevention, health education and 
other health promotion initiatives that address the 
health needs assessed within each prison.
•	 A	policy	 framework	needs	 to	be	 in	place	at	national	
and local levels to support this type of work.
•	 Prison	 health	 services	 have	 the	 chance	 to	 engage	
those who are hard to reach. 
•	 The	needs	of	prisoners	should	be	considered	together	
with those of staff, where appropriate, especially 
in such areas as smoking restrictions and smoking 
cessation.
•	 All	 staff	 members	 need	 to	 be	 made	 aware	 of	 their	
potential roles in promoting prisoners’ health and 
should be trained and supported in these roles.
•	 The	 potential	 for	 using	 prisoners	 as	 effective	 peer	
educators has been demonstrated in many countries 
and can be of great value.
Introduction
In addition to providing health care, prisons should also 
provide synergistic health education, patient education, 
prevention and other health promotion interventions 
to meet the assessed needs of the prison population. 
Indeed, the whole prison regime and environment should 
demonstrate a commitment to health and well-being 
through supportive policies and practices. To underpin and 
support health promotion activities in prisons, there is a 
need for integrated and joined-up health services across 
the whole criminal justice system, including adequate 
throughcare and support with broad resettlement 
needs. Good health and well-being are key to successful 
rehabilitation and resettlement (1–3).
This chapter offers guidance to help those working with 
prisoners to:
•	 build	the	physical,	mental,	social	and	spiritual	health	
of prisoners (and, where appropriate, the staff) as part 
of a whole-prison approach;
•	 help	prevent	the	deterioration	of	their	health	during	or	
because of custody; and,
•	 help	 them	 to	 adopt	 healthy	 behaviour	 patterns	 that	
can be taken back into the community.
A whole-prison approach to health promotion is advocated, 
with extended use of evidence-informed health promotion 
initiatives.
Challenges and opportunities 
In general, the prison populations in Europe come from 
sections of society with high levels of poor health and 
social exclusion. Prisoners tend to have poorer physical, 
mental and social health than the general population 
(2–5). Their lifestyles are more likely to put them at risk 
of ill health. Many prisoners have had little or no regular 
contact with health services before entering prison. Mental 
illness, drug dependence and communicable diseases are 
the dominant health problems among prisoners (6).
Prison authorities should regularly assess the health needs 
of their populations, and ensure that health promotion and 
prevention programmes provided to prisoners meet their 
exact needs (7). The prison environment presents special 
challenges in the promotion of health.
The prison environment often undermines the values 
aligned to health promotion, such as empowerment (1). 
At the individual level, prison takes away autonomy and 
may inhibit or damage self-esteem. Common problems 
in prisons include bullying, boredom and overcrowding. 
Social exclusion on release from prison may be worsened 
as family ties are stressed by separation while in prison.
A health-promoting prison may, however, be instrumental 
in tackling health inequalities and reducing social exclusion 
(3), and present significant and useful opportunities for 
health promotion (8).
•	 Prison	can	offer	access	to	disadvantaged	groups	that	
would normally be considered hard to reach. This 
creates an opportunity to address inequality in health 
by means of specific health interventions, and to lessen 
the impact on prisoners’ health and self-reliance from 
years of disadvantage and personal neglect through, 
for example: 
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 − developing their capacity to improve personal 
skills, abilities and education;
 − improving the physical and social environments of 
the prison and their impact on mental well-being;
 − improving the management of the prison and daily 
prison regime;
 − establishing synergistic models of working with 
the external community.
•	 Prison	is	sometimes	the	only	opportunity	for	an	ordered	
approach to assessing and addressing the health needs 
of prisoners who have led chaotic lifestyles prior to 
imprisonment. It is, therefore, important to provide 
information, education and support in building the skills, 
confidence and self-esteem necessary for individuals to 
be empowered to make choices relating to health.
•	 Prison	 is	 a	 home	 to	 prisoners	 and	 a	 workplace	 to	
staff. Wherever possible, initiatives to promote the 
health of staff should be encouraged – both for their 
own well-being and in recognition that a healthy and 
motivated workforce is more able to promote the 
health of prisoners.
•	 Each	prison	has	the	potential	to	go	beyond	the	delivery	
of specific health promotion interventions and to work 
towards being a healthy setting, that is, adopting a 
whole-prison approach to addressing physical, mental, 
social and spiritual health (9).
•	 The	 development	 of	 an	 ethos	 and	 environment	
supportive to health is fundamental to the creation of a 
health-promoting prison, together with a participatory 
process that responds to assessed needs and 
harnesses assets across the whole prison community 
so as to promote well-being.
The health promotion needs of prisoners
An assessment of health needs lies at the heart of 
successful interventions and useful outcomes. This can 
be done by examining the epidemiological evidence and 
talking to the stakeholders (prisoners, doctors, health care 
staff, education and other prison staff).
The following lists provide a starting point for needs 
assessment in prisons (7). They focus both on defined 
health needs and on wider policy and practice (such as 
in the area of smoking policy) with the potential to have 
a more favourable impact on prisoners’ health and well-
being. This demonstrates the move from a biomedical 
perspective towards a more holistic and social model of 
health that is aligned to the whole-prison approach, with 
its more joined-up organizational response.
All prisoners are likely to need:
•	 appropriate	 screening	 for	 and	 advice	 on	 preventing	
communicable diseases (such as STIs, HIV and 
hepatitis);
•	 advice	and	education	on	high-risk	lifestyles	(relating,	
for example, to illegal drugs, alcohol, smoking and 
passive smoking);
•	 support	 in	 adopting	 healthy	 behaviour	 (for	 example,	
increased levels of physical activity and a balanced 
diet); 
•	 measures	to	promote	mental	health	(for	example,	for	
social interaction, meaningful occupation and building 
and maintaining strong family relationships).
Many prisoners are likely to need:
•	 training	 and	 support	 in	 psychological	 skills	 (such	
as cognitive behaviour, self-esteem and anger 
management);
•	 education	 in	 health	 and	 empowerment	 (including	
information about risk factors and behaviour, the 
development of decision-making skills and support in 
becoming more empowered); 
•	 development	of	life-skills	(for,	for	example,	looking	for	
work, employability and parenting);
•	 specific	health	promotion	interventions	(such	as	peer	
support, mentoring and smoking cessation).
Some prisoners are likely to need:
•	 education	related	to	specific	illnesses	(such	as	HIV	and	
TB), including the options for treatment and prevention 
of transmission;
•	 immunization	(TB,	pneumococcus,	hepatitis,	influenza);
•	 advice	 on	 specific	 conditions	 (diabetes,	 epilepsy,	
asthma, sickle-cell disease);
•	 access	to	cancer	prevention	and	advice	and	services	
for early detection;
•	 special	treatment	programmes	(for	example,	protection	
from gender-based violence);
•	 gender-specific	health	care	treatment	and	programmes.
A whole-prison approach: a vision for  
creating a health-promoting prison
Evidence from other healthy settings initiatives (such as 
Healthy Hospitals, Healthy Cities and Healthy Schools) 
has increasingly shown that effective programmes are 
likely to be complex and multifactoral and involve activity 
in more than one domain (10). Thus it is important to apply 
the healthy settings model to criminal justice and develop 
a whole-prison approach if health interventions are to 
have a chance of success (Boxes 4, 5).
The settings approach is rooted in core values and 
characterized by an ecological model of public health, 
a systems perspective and a whole-organization focus 
(11,12). When this framework is applied to the criminal 
justice system, it is clear that a health-promoting prison 
is one that is also safe, secure and reforming, and is 
underpinned by a commitment to participation, equity, 
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partnership, human rights, respect and decency. The 
concept of decency is a particularly important foundation 
for promoting health because it underpins all aspects of 
prison life. This means that:
•	 prisoners	 should	 be	 offered	 treatment	 that	 respects	
the law;
•	 promised	standards	should	be	delivered;	
•	 facilities	 should	 be	 maintained	 that	 are	 clean	 and	
properly equipped;
•	 prompt	attention	should	be	paid	 to	prisoners’	proper	
concerns;
•	 prisoners	should	be	protected	from	harm;
•	 prisoners	should	be	provided	with	a	regime	that	makes	
imprisonment bearable;
•	 staff	should	be	treated	fairly	and	consistently	(9).
An ecological model of public health means understanding 
health as a holistic concept determined by a complex 
interaction of environmental, organizational and 
personal factors, that requires prisons to be committed 
to supporting the health and well-being of prisoners and 
staff through their systems and structures.
At Risley prison (a medium security “training prison” for about 1000 men), a three-year health promotion strategy 
was developed, using a whole-systems approach to improving and promoting health. A multidisciplinary team 
of committed prison staff and external partners, together with prisoners, developed the Healthy Prisons health 
improvement plan to embed a whole-prison approach to health and well-being. This group also monitors the 
effectiveness of interventions and projects. In addition to a broad range of health services reflecting those 
available in the local community and mirroring the topics advocated in Prison Service Order 3200 – Health 
Promotion (13), the prison has focused attention on particular areas, such as prisoners as peer educators and 
interventions to help prisoners deal with being in prison.
Styal is a prison for female offenders, with an average daily population of up to 460 prisoners serving mainly 
short sentences or awaiting trial. It is one of the largest women’s prisons in the United Kingdom (England and 
Wales). Approximately 80% of the women originate from the north-west of England; 50% are primary carers 
or mothers (around 55% of women in prison have a child aged under 16 years, 33% have a child under 5 years 
and 20% are lone parents); 40% are in custody for the first time; 75% have significant literacy or numeracy 
problems; and 80% have serious drug and addiction problems.
The prison is running a horticultural project called Grow Your Way to Personal Success with a small number of 
adult and young offenders, funded as part of the Big Lottery Fund, Target: Well-being programme. It is a three-
stage project that focuses on growing produce, using it in the prison’s self-catering houses in educational 
cookery sessions and developing learning cards so that prisoners can pass on what they have learnt to other 
people in the prison and to families outside the prison. Bee-keeping and recycling are also key features of this 
project.
The project has prison-wide commitment as well as community-based partnerships that are enabling prisoners 
to develop life and social skills (such as those fundamental for employment and independent living), improve 
their literacy and numeracy and increase their qualifications. It has also had a positive impact on their health 
and well-being, particularly mental well-being, by encouraging resilience, confidence, self-esteem and 
reductions in self-injury.
In addition, the prison gardens have become a focal point for visitors to the prison, for staff to relax during 
breaks and for prisoners (both those who work there and those who visit), with a recognizably positive impact 
on prisoners’ mental well-being (they sleep better and are less anxious and more relaxed) and physical health 
(through exercise).
Box 4. Development of a whole-prison approach through a multidisciplinary team at a prison in 
the United Kingdom
Box 5. A holistic health project that develops self-esteem through horticulture and growing food
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A systems perspective means acknowledging that the 
various parts of the prison system (and not solely the 
health care service) work together over a wide range of 
health and social issues and across the wider offender 
pathway of the criminal justice system before, during and 
after prison.
A whole-system focus means using organizational 
development to introduce and manage change throughout 
the prison, with a concern to: 
•	 ensure	living	and	working	environments	that	promote	
health and effectively rehabilitate prisoners; 
•	 integrate	health	and	well-being	within	the	culture	and	
core business of the prison; and 
•	 forge	connections	to	the	wider	community.
In putting this healthy settings framework into operation, 
a strategic approach for health-promoting prisons could 
comprise three elements: 
•	 creation	 of	 an	 environment	 within	 each	 prison,	
through procedural and capacity-building measures, 
that is supportive of health and the concept of decency 
(that is, making sure that the prison regime in general 
supports prisoners’ well-being);
•	 implementation	of	policies	that	specifically	promote	
the health of staff and prisoners (in areas such as 
taking exercise or reducing or stopping smoking); 
and
•	 delivery	 of	 disease	 prevention,	 health	 education	
and other health promotion initiatives that address 
the health needs in each prison (for example, using 
motivational interviewing with individual prisoners to 
help them adopt healthy behaviour) (9).
A national approach: United Kingdom Prison 
Service Order 3200 
Prison Service Orders are mandatory for prison governors, 
who have to apply them in their own prisons. Prison 
Service Order 3200 – Health Promotion is a high-level 
policy instruction from the Prison Service for the United 
Kingdom (England and Wales) to encourage a whole-
prison approach to creating a health-promoting prison. It 
states the following (11):
Governors, working in partnership with the National Health 
Service, must ensure that ... they have included health 
promotion considerations adequately and explicitly within 
their local planning mechanisms … The Health Promotion 
Section in the local plan must specifically address, as a 
minimum, needs in the five major areas:
1. mental health promotion and well-being
2. smoking
3. healthy eating and nutrition
4. healthy lifestyles, including sex and relationships and 
     active living
5.  drugs and other substance misuse.
These areas of health and well-being should reflect a process 
of health needs assessment and not just health care needs 
assessment, and should involve a whole prison approach. 
Consultation should represent a wide variety of professional 
stakeholders, and prisoners must also be involved in this 
process.
Prison Service Order 3200 has helped to raise the profile 
of health promotion and the important contribution prisons 
can make to public health in the United Kingdom (England 
and Wales).
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22. Staff health and well-being in prisons: leadership and 
training  
Andrew Fraser
Key points 
•	 A	 successful	 prison	 ensures	 safe	 custody	 and	 good	
order within an environment of respect and decency.
•	 Prison	management	has	a	key	role	to	ensure	that	staff	
and prisoners alike feel safe and have opportunities to 
maintain and improve their health.
•	 Prisons	have	duties	to	care	for	both	staff	and	prisoners	
and offer an opportunity to maintain and improve 
public health, encourage good health for the individual 
and offer a rewarding and fulfilling career for staff.
•	 Prisons	 can,	 by	 reputation	 and	 experience,	 be	
hazardous and stressful places for staff. It need not be 
this way. Leadership and staff training are fundamental 
to ensure that employees can work productively, act as 
role models for prisoners, be healthy and be confident 
of support in the event of illness or injury.
•	 Prisons	 should	 aim	 to	 be	 healthy	 workplaces.	 They	
should apply the same safe systems of work, good 
health and safety practices and systems of employee 
support as other front-line public services.
•	 All	staff	in	prisons	should	recognize	the	importance	of	
balancing the need for safe custody and control on the 
one hand, and care and rehabilitation on the other. The 
needs for custody and order should not infringe human 
rights. 
•	 All	prison	staff	should	have	basic	training	in	the	laws	
and duties of care for prisoners, the right to health and 
access to health care in prison as in the community, 
the ethical duties of staff and health professionals 
working in prisons, and the ability to deal with health 
emergencies and administer first aid.
•	 To	 provide	 a	 consistent	 level	 of	 service	 and	
understanding, it is proposed that all prison systems 
have a core curriculum for health for all staff working 
in prisons, with added elements to support further 
development and updates for managers and leaders.
Introduction
Successful prison systems ensure safe custody and good 
order for detainees, but also opportunities for rehabilitation 
and reintegration on release back into the community. 
Effective prisons provide health care to a standard 
equivalent to that available in the community, which can 
only be achieved when  prison management and staff all 
understand and promote health and health care within 
a “healthy prisons” approach (1). Good health in prisons 
cannot flourish without an environment of safe custody and 
good order and without prisoners and staff feeling safe. 
Only then can all staff working together produce the kind of 
setting that protects and promotes health. In many countries, 
prison authorities have not appreciated their potential for 
benefit to the community, as leading employers of staff and 
rehabilitation settings for prisoners.
There is a significant opportunity for staff to create a 
healthy prison that benefits prisoners, staff and the wider 
community because “good prison health is essential 
to good public health” (2). Leadership is key to creating 
an ethos in prisons of upholding human rights and a 
full acceptance of the dignity, respect and self-efficacy 
of individuals. An effective, efficient and healthy prison 
requires adequate levels of staffing, with proper training, 
a mix of disciplines and specific expertise in key important 
areas. Policies and practices should be in place to prevent 
violence, threats and stress and to provide effective plans 
and interventions to cope when things go wrong.
This chapter describes the challenges for prisons as 
healthy settings for their staff, frameworks and examples 
for good practice, and the essential and core requirements 
for staff training and prison leadership in health.
Health and the prison
Prison is a place where detainees live and staff work. 
Often, each group perceives that they lead separate 
lives, but prisoners and staff have many aspects in 
common – often similar social backgrounds and, in 
small communities, possibly similar social networks. In 
prisons, staff and prisoners share the same space, air for 
breathing and water for washing or drinking, and face the 
same physical hazards of the prison environment. Above 
all, they have a common humanity.
The prison is a special setting – both an institution where 
people may live for long or short periods and a workplace. 
Prison staff have several roles, with a focus on control and 
security within a high-risk environment balanced with care 
for people with complex characteristics and problems.
The stressful workplace
Often, prison is a stressful and hazardous place to work, 
and the need for staff to be aware of and to maintain 
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their health is, therefore, strong. Prison systems can 
experience increasing absence rates due to stress, burn-
out and alcohol and drug use, often connected with 
the conditions of work. The combination of poor health 
and prolonged absence from work often leads to early 
retirement or to retirement with physical and mental 
problems, at significant costs to individuals, their families 
and the prison system.
The growing scale of penal institutions worldwide, and 
rising expectations from and duties imposed on them, 
means that urgent attention should be given to the 
pressure on staff. Current problems that affect staff 
and prisoners alike include overcrowding, intercultural 
conflicts, violence and gang crime, language problems, 
drug use, ageing buildings in poor repair and, frequently, 
insufficient staff levels with poor training to support them.
The experience of working in prisons has not been 
widely studied but it is clear that, while there is a need 
for safe systems in all workplaces, there is a particular 
requirement for these in prisons. Studies have drawn 
attention to the paradox of high levels of discontent not 
due primarily to stress from working with prisoners, but 
to organizational conditions and relationships between 
authorities and staff.
Risk factors and stress among prison  
employees
Studies of the health of prison staff have outlined 
problems arising from stress, particularly reflecting on 
the interaction between work and distinct factors in the 
prison setting. Goffman (3) recognized that prison staff 
work in a closed and “total” system, with a high degree 
of professional isolation. Strict routines and regimes, 
hierarchy, depersonalized relationships and bureaucracy 
serve to remove some amount of control for staff over 
their work circumstances. Communication between 
authorities and staff in prisons and old methods of 
personnel management compound these problems. 
Staff members need support to define their roles and 
identities with respect to the prisoners and to work 
through the divide between the necessary activities of 
security and basic services and growing expectations for 
their involvement in the care and rehabilitation process. 
Prison staff have to reconcile their roles between care 
and control, between being a guard and a helper. This 
challenge is greater in countries that lack respect and 
esteem for the contribution of prisons in society and 
where the media popularly focus on the withdrawal of 
liberty and punishment.
There should be wider moves to alter public attitudes 
towards prison. Management methods and structures 
in some prison systems need to be modernized to allow 
staff more control and influence over the circumstances of 
their work and to enable them to challenge and influence 
management. In turn, staff may respond better to the 
challenge of engaging with prisoners in moving towards 
rehabilitation, which should engender mutual respect 
and better relationships between prisoner and staff, and 
empower staff within the controlled environment. The net 
effect of these improvements would have a direct effect 
on staff health and well-being.
Health risk factors for prison staff 
Prisons can be hazardous locations. Large and sometimes 
old buildings, they are crowded and can be inadequately 
staffed while holding the most dangerous individuals in the 
community who are capable of harm to others, including 
other prisoners and members of staff. The net effect of 
prisons that do not address these realities shows in stress 
that affects people mentally, physically and cognitively. 
Adverse events and long-term poor working environments 
can result in post-traumatic stress disorder and similar 
conditions. While absence levels, vacancy rates and staff 
turnover may rise or remain high, other matters (such 
as misuse of coffee, cigarettes and alcohol, poor eating 
habits and use of medication) are also indicators of a 
poorly functioning workplace.
Successful prison systems rely on managing these factors 
through modern and enlightened employment practices. 
Reward and recognition schemes, opportunities for 
career progression and occupational health services are 
necessary components in strategies to address stress and 
poor working conditions. Good employers ensure that a 
good team spirit and productive work is encouraged and 
recognized, and that there is peer support. Mentoring 
schemes are modern and cost-effective developments. 
Prisons need to go to extra lengths to be seen as healthy 
workplaces and to attract and retain a healthy and 
committed workforce.
The healthy workplace should be a realistic goal for all 
employers, and most countries require prison systems 
to comply with health and safety laws, regulations and 
conventions. It is fundamental that prison systems have 
safe systems of work and that they recognize hazards and 
mitigate risks. If adverse and critical events occur, there 
should be contingency plans to manage them well and to 
support staff who are harmed or witness harm occurring. 
The wider environment of the good workplace is that 
the employer rewards the staff reliably, puts in place 
welfare schemes for necessary absences and following 
retirement, and ensures support in adversity, not only for 
sickness and injury at work but also for those who witness 
traumatic incidents.
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Good employers in the prison system plan for 
contingencies and train staff to cope. They will also offer 
a range of opportunities for assisting staff in the event 
of personal trouble, whether related to work or personal 
circumstances. This will ensure that the workforce remains 
committed to its task and less vulnerable to corruption 
or compromise with prisoners, and will underpin the 
performance of the workforce as a coherent team.
For prisons to be successful as institutions that employ 
staff and detain prisoners, they need:
•	 workforce	policies,	applied	consistently;
•	 capable	management	that	is	firm	and	fair	to	staff	and	
prisoners;
•	 enforcement	 and	 monitoring	 processes	 that	 are	
transparent and reasonable for staff who are unable 
to comply with the policies or who are found not to;
•	 an	 occupational	 health	 system	 that	 underpins	 these	
policies and practices.
A member of staff who sustains an injury as a result of 
his or her work should have access to prompt and expert 
treatment, suitable rehabilitation and a programme 
for return to work that suits his or her abilities or takes 
residual health problems into account.
Staff who have drug and alcohol problems or bloodborne 
virus infections resulting from risky lifestyles require 
approaches that support and motivate them to recover 
and contribute effectively to their work. For those whose 
work is persistently affected by problems of misuse, 
proper sanctions should be available.
Many prisons have smoking control policies for staff, not 
only in the interests of safety and security in the workplace 
but also for the general health of staff and prisoners 
alike. Smoking restrictions should be consistent and 
complementary with policies and entitlements for prisoners.
Staff have a very important part to play as role models 
in the rehabilitation of those in their care, engendering a 
culture of positive health that is an important contributor 
to a healthy workplace for everyone in the prison.
Health promotion programmes to support 
employees
Several countries operate programmes that promote good 
health in the workplace. WHO supports such programmes 
globally and regionally.
In the United Kingdom (Scotland), all prisons and the 
Prison Service headquarters subscribe to the Healthy 
Working Lives Award scheme that supports employers and 
employees in developing practical health promotion and 
safety themes in the workplace. The scheme encourages 
development of programmes, staff involvement and 
workplace engagement with the wider community. It is 
suitable for all settings, including prisons.
In Germany, a progressive scheme of prison-based health 
promotion began in 1997 in association with the WHO 
Health in Prisons project and has spread widely across 
the country. It has attracted support from politicians and 
ministries, who now realize the meaning and practical use 
of health promotion strategies and actively support their 
implementation.
The WHO publication Health in prisons (4) contains a 
checklist for action and initiatives for self-help in prisons, 
as follows: 
•	 set	up	a	health	promotion	group	(quality	circle);
•	 conduct	 internal	 public	 relations	 work	 in	 penal	
institutions;
•	 set	up	health	information	centres;
•	 provide	 assistance	 in	 health	 target	 and	 service	
agreements;
•	 initiate	service	agreements	concerning	drug	abuse;
•	 raise	money	for	work;
•	 prepare	 and	 carry	 out	 an	 interview	 survey	 for	 staff	
about their health status;
•	 prepare	and	carry	out	health	days;
•	 prepare	and	carry	out	information	days	on	such	topics	
as drugs, bullying and stress;
•	 prepare	stress	management	seminars;
•	 organize	consultations	on	nutrition;
•	 organize	fitness	and	sports;
•	 organize	fitness	offers;
•	 offer	supervision	for	team	consultations;
•	 promote	get-together	activities	(such	as	team	parties	
or hiking);
•	 improve	 nutrition	 during	 work,	 such	 as	 fruit	 in	 the	
canteen and a water cooler;
•	 encourage	 problem	 and	 crisis	 consultations	 with	
colleagues;
•	 mediate	drug,	crisis	or	debt	consultations;
•	 set	 up	 regional	 working	 groups	 for	 exchanging	
experience;
•	 offer	support	to	stop	smoking.
Health awareness
The positive features of health awareness among staff are 
that it will aid their own basic training, support their own 
well-being, support and influence those they supervise 
while acting as role models and develop a framework for 
staff training.
The foundation of health awareness is the culture in 
prisons. They should be safe, secure and those within 
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its walls should feel an individual benefit from health 
awareness measures. Safe custody and good order in 
prisons, as well as an atmosphere of respect and decency 
in adequate surroundings, are fundamental to good health.
Prison staff training in health
Prison staff require training in health matters if they are 
to achieve adequate levels of health, starting with basic 
measures to create a safe working and living environment. 
This chapter does not set out to prescribe the requirements 
for health professionals working in prison, but focuses on 
staff whose prime responsibilities lie elsewhere.
All staff working in prisons need a basic level of knowledge 
and understanding of health issues.
They need to be aware of the impact of the overall prison 
environment on health and of how their working methods 
and attitudes can enhance rather than hinder the well-
being of vulnerable people in their care (5). The public 
health importance of their work should be underlined 
(6). Such awareness and knowledge about health should 
be built into induction training programmes as well as 
into basic training, and there should be regular updates 
in specific subject areas. The relationship between the 
health of staff and of prisoners should be linked to matters 
such as standards of conduct, management of risks such 
as self-harm and suicide, and their role in detecting 
those who need further care, help in coping and in the 
prevention of serious harm such as suicide and injury to 
others. First aid training should be included, including 
recent developments in mental health first aid.
Managers, leaders and decision-making
The principles of health and disease and the organization 
and objectives of health care should be core subjects in 
induction programmes for senior and middle managers. 
Continuing professional education should include 
updates on more recent thinking on health protection, 
health promotion and quality and governance in health 
care. Simple facts regarding the health status of the 
offender population, such as about clinical diseases and 
an understanding of mental ill health, drug problems and 
other addictions, should be provided. Some reference 
material and special short courses would add value. 
Senior staff should understand their leadership role within 
prisons in protecting and promoting health and well-
being, including mental health. They need to know the 
purpose and objectives of the prison health services, both 
in support and independently of custody and operational 
matters, and the ways in which prison management 
can aid good prison health care. The difficult subject of 
dual loyalty of prison health staff should be included for 
discussion, including the reasons why health staff must 
obey professional good practice guidelines and rules of 
confidentiality so that good patient–doctor relationships 
can be the norm.
Health care professionals
The basic professional training of health staff should 
be the same as for doctors and nurses working in the 
community health services in the country. In post-
qualification terms, the first essential is that health staff 
must be aware of prison management techniques and 
approaches to working safely in a secure setting, and 
their application within that country and in that particular 
prison. This would include effective prison practice, any 
special circumstances affecting prison management, and 
the overall aims and objectives of prison management. In 
clinical subjects, they need further training in the main 
health problems facing prisoners, such as poor mental 
health, addictions and clinical disease including TB, 
HIV/AIDS and hepatitis. They also need further training, 
as appropriate, relating to the types of prisoner held in 
particular institutions, such as young people, women and 
foreign nationals.
Maintaining professional standards
Professional isolation in prison work is a risk as regards 
maintaining clinical standards. All health professionals 
working in prisons should have active and meaningful 
links to the health professional organizations within 
their countries. Such links may need to be especially 
strong in specific cases and sometimes in the setting of 
their work (addiction, mental health, women’s health and 
so on). Ideally, professionals should hold some clinical 
responsibilities outside prisons. Aside from maintaining 
the quality of clinical practice, this extra perspective can 
be important for the image of their work in the eyes of 
fellow professionals and may enhance respect between 
the prisoner as a patient and the doctor concerned.
Clinical governance and performance 
monitoring
Clear arrangements should be made for the management 
of prison staff and their employment, well-being and 
health. Training and learning should be shared with other 
staff who are in direct contact with prisoners with respect 
to the vital functions of prisons where responsibilities 
are shared, such as support for people with addictions, 
mental health crises and suicide attempts.
Facilities and arrangements should be available for staff 
training, associated with a public health system in the 
case of health care staff. Continuing training should be 
recognized and accepted as a priority for both staff and 
management. Part of the ethos of any training framework 
should include a discussion of simple ethical decision-
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making steps and opportunities for discussion of case 
studies and challenging or critical situations in operations 
and practice.
Health and equality is an important part of training. Some 
prison systems go further to meet their duties of care and 
compliance with the law regarding, for instance, equality 
in mental health matters or learning disabilities. Physical 
disability is an emerging issue as prison populations 
rise in number and groups with particular health needs 
(such as women and older people) grow more rapidly. 
Specific training should be available for staff who care for 
prisoners with particular needs and wider considerations.
Conclusion
Staff well-being, training and effectiveness, not only in 
ensuring secure custody but also in delivering care for 
prisoners, are interlinked and are important elements 
of a successful prison system. Staff have an interest in 
their own health as well as the health of those for whom 
they have responsibility. The workplace should ensure 
that health, safety and security for staff and ways of 
recognizing and dealing with stressful situations are 
well-founded through leadership and good training. 
Staff should understand their roles in the protection and 
creation of good health as well as facts relating to ill health 
and disease. A good employment environment as well as 
physical surroundings and cultural norms that promote 
health and positive role models are integral to successful 
prison work, rehabilitation for offenders and improving 
levels of public health which will all benefit prison staff, 
prisoners, their families and the wider community.
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